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General Introduction
“One of the principle qualities of pain is that it demands an explanation.” 
- Anne Carson
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The general introduction will first describe the study population included in this dissertation 
comprising patients with chronic idiopathic neck pain (INP), chronic whiplash associated 
disorders (WAD), and fibromyalgia (FM). Next, the neurophysiology of acute and chronic 
pain will be explained focusing on central sensitization (CS) and brain alterations in chronic 
musculoskeletal pain conditions. Also, the role of cognitive problems in patients with 
chronic musculoskeletal pain will be outlined. Finally, the last part of the introduction will 
describe the aims and outline of this dissertation.
1.  Study population
Chronic neck pain is one of the most prevalent musculoskeletal pain conditions worldwide 
(1, 2). In the general adult population, 30 to 50% will encounter an episode of neck pain in 
any given year (3), with a point prevalence of 10 to 20% (1). Furthermore, neck pain tends to 
be a recurrent and persistent disorder as the majority of individuals with neck pain will not 
experience a complete resolution of their pain but will suffer from some degree of 
ongoing pain after their first episode (4, 5). Unfortunately, the prevalence of chronic neck 
pain has been increasing, which results in growing socio-economic burden (6). Disabili-
ty-adjusted life-years due to neck pain increased globally from 23.9 million in 1990 to 33.6 
million in 2010 (7). Moreover, together with low back pain, neck pain is currently the leading 
global cause of disability (8). Chronic neck pain is associated with high personal health 
expenditures and health care costs, often unexplained symptoms, frequent medical and 
physiotherapy consultations, and poor conservative therapy outcome (9-12). It negatively 
affects activities of daily living, social participation, and work productivity, which results in 
burden among patients and their care providers (13). 
 Chronic neck pain can be subdivided, based on its etiology, into three categories i.e. 
1) specific neck pain, 2) trauma-induced or whiplash-induced neck pain, and 3) idiopathic 
non-traumatic neck pain. This dissertation focuses on chronic neck pain of idiopathic and 
traumatic nature, which will be described in detail in the following paragraphs. In recent 
years, the focus on determining a peripheral pathoanatomical diagnosis of chronic neck 
pain has shifted towards an approach which attempts to unravel the underlying mechanisms 
within a broader multifactorial pathophysiological perspective since it is recognized that 
in the majority of neck pain patients an apparent pathoanatomical cause may not be 
identified (14). As a consequence, there is much heterogeneity in clinical presentation and 
treatment response between and within the above mentioned two categories, thereby 
indicating differences in contributing mechanisms (15). 
1.1. Chronic idiopathic neck pain
Chronic INP is characterized by persistent neck pain lasting more than three months, 
without the presence of a specific cause such as trauma, cervical hernias with clinical 
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Lesions may occur to any cervical structure (e.g. intervertebral discs, ligaments, facet 
joints, muscles, nerve tissues) as a result of an acute whiplash injury (26). Due to the poor 
sensitivity of current radiological imaging techniques these proposed lesions remain 
poorly identified. Nevertheless, it is also possible that in some people no lesions occur in 
the cervical spine and the surrounding tissues.
 The trauma and the acceleration-deceleration mechanism of energy transfer to the 
neck and head may lead to the development of various clinical manifestations defined as 
WAD (27, 28), and defined as chronic WAD if the pain persists. Chronic WAD patients are 
characterized by trauma-induced chronic neck pain lasting more than three months (29). 
By three months after the traumatic event, approximately one-third of whiplash patients 
will have developed persistent low levels of pain and related disability, one-third will have 
developed persistent high levels of pain and related disability, and one-third will have 
recovered from their initial pain and disability (30-34). 
 The predominant symptom in individuals with chronic WAD is neck pain, which can 
radiate to the head, shoulder, arm, interscapular, thoracic and lumbar regions (28). Apart from 
persistent pain, a variety of other associated complaints are often reported by chronic 
WAD patients including numbness and tingling, concentration and memory problems, 
psychosocial deficits, post-traumatic stress, fatigue and sleep disturbances, headache, 
dizziness, and reduced quality of life (28, 35-41). The wide range of debilitating symptoms and 
only partially elucidated underlying mechanisms in chronic WAD contribute to the low 
treatment effects in this prevalent and complex condition (9, 29). 
The variable nature of symptoms encountered following a whiplash injury has led to a 
classification system in order to guide both research and treatment decision-making. 
In 1995, the Quebec Task Force (QTF) developed the QTF classification of WAD based on 
the type and severity of symptoms short after the traumatic event (39). The QTF classified 
WAD patients into four grades ranging from zero (no neck pain complaints or physical 
signs) to grade four (neck pain complaints and fracture or dislocation). Since WAD grade II is the 
most common subgroup of the QTF classifications and covers a very broad range of signs and 
symptoms, the WAD II patient group was further divided into different categories (28, 42), 
encompassing physical, psychological, and physiological mechanisms (28, 43-45). An improved 
classification system accounting for these prognostic factors was proposed by Sterling in 
2004 (28) (table 1). 
 The research quest to uncover the pathophysiological mechanisms contributing to 
the persistent complaints of chronic WAD has increased our knowledge substantially, and 
has revealed motor, sensorimotor, psychological-affective, cognitive, and central pain 
processing dysfunctions (25, 26). To date, a growing body of evidence supports the presence 
of CS as predominant pain mechanism contributing to the persistent symptoms in a large 
group of chronic WAD patients (35, 46-48). Yet, many questions remain unresolved. 
symptoms or radiculopathy. No clear anatomical pathology can be demonstrated and 
radiological imaging findings are poorly related to patient’s clinical symptoms (5). 
 In the absence of a specific pathoanatomical etiology, researchers have started to 
investigate possible underlying mechanisms of pain persistence in chronic INP. This multi-
dimensional research has focused on sensorimotor control as well as articular, myofascial, 
and psychosocial dysfunctions (16-23). To some extent, each of these dysfunctions could 
contribute to the persistent pain in chronic INP patients, yet it seems that subgroups are 
present within this heterogeneous condition (16-22). Consequently, a paucity of studies have 
examined the role of pain mechanisms including research with respect to the presence of 
sensory hypoesthesia (22) and disturbed central pain processing (24). Most studies could not 
reveal evidence for CS in the chronic INP population. However, few studies did find some 
evidence for distant hyperalgesia in chronic INP, resulting in an inconclusive message. 
1.2.  Chronic whiplash associated disorders
A whiplash injury usually originates from a rear-end motor vehicle crash and is caused by 
acceleration-deceleration forces acting on the neck, head, and torso (25, 26). To date, the 
mechanism of whiplash injury is advocated to result from the inertial response of the 
body, which causes displacement of the neck and head without being exposed to direct 
impact (26). Specifically, during a rear-end impact, the torso is rapidly carried forward 
resulting in thoracic and cervical spine straightening. This movement subsequently leads 
to a transitory ‘S-shaped’ cervical curvature, forcing the cervical spine into upper segmental 
flexion and lower segmental extension. As a result of this non-physiological motion it is 
proposed that energy is stored in the elastic cervical spine components. During the 
second phase of this motion, all cervical segmental levels are extended, followed by 
an abrupt energy release and subsequent forward thrust of the neck and the head. 
The described whiplash injury mechanism is illustrated in figure 1. 
Figure 1   Mechanism of whiplash injury during a rear-end motor vehicle collision. 
Adapted from (26).
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1.3.  Fibromyalgia
FM is a common chronic musculoskeletal pain condition that depending on the diagnostic 
criteria used, affects between 1.2 and 5.4% in the general population (49), and between 2.4 
and 6.8% in women (50). According to the 1990, 2010, and modified 2010 American College 
of Rheumatology (ACR) criteria the ratio of females to males was 14:1, 5:1, and 2:1, 
respectively (49).
 Chronic widespread musculoskeletal pain is the core feature of FM, however, most 
patients additionally report a wide range of co-occurring symptoms such as cognitive 
deficits including concentration and memory problems, headache, fatigue, and sleep 
disturbances (51-53). Furthermore, FM patients often report anxiety and depression and 
present diminished quality of life (54). Noteworthy, most of the neurotransmitters that 
affect pain transmission also affect mood, memory, sleep, and fatigue (55).
 FM is a heterogeneous condition and multiple potential etiologies have been 
reported such as the influence of chronic stress, altered immune function, psychological 
distress, and CS (56). Today, compelling evidence indicates that the pathophysiological 
hallmark of FM is a sensitized central nervous system (CNS) (55). FM often co-occurs with 
Table 1  Modified Quebec Task Force classification.
Proposed 
classification 
grade
Physical and psychological impairments present
WAD 0 No complaint about neck pain
No physical signs
WAD I Neck complaint of pain, stiffness, or tenderness only
No physical signs
WAD II A Neck pain
Motor impairment
- Decreased ROM
- Altered muscle recruitment patterns (CCFT)
Sensory impairment
- Local cervical mechanical hyperalgesia
WAD II B Neck pain
Motor impairment
- Decreased ROM
- Altered muscle recruitment patterns (CCFT)
Sensory impairment
- Local cervical mechanical hyperalgesia
 Psychological impairment
- Elevated psychological distress (GHQ-28, TSK)
WAD II C Neck pain
Motor impairment
- Decreased ROM 
- Altered muscle recruitment patterns (CCFT)
- Increased JPE
Sensory impairment
- Local cervical mechanical hyperalgesia
- Generalized sensory hypersensitivity (mechanical, thermal, BPPT)
- Some may show SNS disturbances
Psychological impairment
- Psychological distress (GHQ-28, TSK)
- Symptoms of acute posttraumatic stress (IES)
WAD III Neck pain
Motor impairment
- Decreased ROM
- Altered muscle recruitment patterns (CCFT)
- Increased JPE
Table 1  Modified Quebec Task Force classification.
Proposed 
classification 
grade
Physical and psychological impairments present
Sensory impairment
- Local cervical mechanical hyperalgesia
- Generalized sensory hypersensitivity (mechanical, thermal, BPPT)
- Some may show SNS disturbances
Psychological impairment
- Psychological distress (GHQ-28, TSK)
- Elevated levels of acute posttraumatic stress (IES)
Neurological signs of conduction loss including:
- Decreased or absent deep tendon reflexes
- Muscle weakness
- Sensory deficits
WAD IV Fracture or dislocation
Adapted from Sterling (28). Abbreviations: WAD= whiplash associated disorders, ROM= range of motion, CCFT= 
craniocervical flexion test, GHQ-28= General Health Questionnaire-28, TSK= tampa scale for kinesiophobia, 
JPE= joint position error, BPPT= brachial plexus provocation test, IES= impact of events scale, SNS= sympathetic 
nervous system.
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these pain mechanisms should be part of our clinical reasoning when assessing and 
treating individuals with chronic pain (60, 66, 67). 
 Extensive evidence supports the presence of CS as predominant pain mechanism 
contributing to pain persistence and associated symptoms in the majority of FM patients (56, 65, 
68, 69), and in a large group of chronic WAD patients (35, 46-48). On the contrary, based on a 
systematic review, CS is not a characteristic feature of chronic INP at group level, 
nevertheless CS can be present in some chronic INP patients, underpinning the possibility 
that subgroups exist within the chronic INP population (24).
It can be hypothesized that overlapping but also different underlying mechanisms exist 
between patients with chronic INP, patients with chronic WAD, and patients with FM. 
Furthermore, significant relationships between various symptoms and mechanisms are 
hypothesized (fig. 2). 
Chronic INP, chronic WAD and FM are heterogeneous conditions possibly with patients 
falling along a continuum with at one end a purely peripherally driven (e.g. nociceptive) 
painful condition and at the other end of the continuum a pain condition that is purely 
centrally driven (CS) (56) (fig. 3). Furthermore, as proposed by Nielsen and Henriksson, FM 
may be the far end of a continuum that starts with chronic localized musculoskeletal 
pain and ends with widespread chronic disabling pain (70). This way, the chronic INP group 
other conditions demonstrated to have a similar underlying pathophysiology such as 
tension-type headache, irritable bowel syndrome, temporomandibular disorders, chronic 
fatigue syndrome, and sometimes chronic WAD.  
In 1990, the ACR developed criteria for the classification of FM (57). These criteria required 
the presence of widespread pain for at least three months. In addition, tenderness on 
pressure, as determined by tender point examination, had to be present in at least 11 of 18 
specified sites. Because criticism developed to these 1990 criteria, the ACR published new 
criteria for clinical diagnosis of FM that are suitable for use in primary and specialty care, 
do not require tender point examination, and take into account key co-occurring symptoms 
in FM (58). To satisfy these diagnostic criteria for FM, the following three conditions have to 
be met: (1) a widespread pain index (WPI) score of ≥ 7 and symptom severity (SS) scale 
score of ≥ 5, or a WPI score between 3-6 and SS scale score of ≥ 9; (2) the symptoms have 
been present at a similar level for at least three months; and (3) the patient does not have a 
disorder that would otherwise explain the pain. The WPI is determined by noting the 
number of body regions in which the patient experienced pain over the last week. The 
score of the SS scale is the sum of the severity of three symptoms (i.e. fatigue, waking 
unrefreshed, and cognitive symptoms) plus the severity of somatic symptoms in general. 
In 2016, the ACR published an update of these 2010 criteria (59) and some modifications 
were made.
1.4.  The continuum of chronic musculoskeletal pain 
The three chronic pain conditions studied in the present thesis are all categorized as 
chronic musculoskeletal pain disorders. Based on the literature and clinical experience, we 
can infer that chronic INP, chronic WAD, and FM show overlapping symptoms and some 
similar mechanisms, however, they can also differ from each other in symptomatology, 
and hence in underlying pathophysiological mechanisms. 
One of the possible reasons for observed differences in clinical presentation in these 
chronic musculoskeletal pain patients may be the fact that different predominant pain 
mechanisms can be present, being nociceptive pain, neuropathic pain, or CS pain (60-63). 
Nociceptive pain is defined as pain arising from damage to non-neural tissue and is 
attributable to the activation of peripheral terminals of primary afferent neurons in 
response to noxious stimuli (63). Clinically, nociceptive pain is recognized as pain being 
proportional to peripheral nociceptive input (61). Neuropathic pain is defined as pain 
caused by a primary lesion or disease of the somatosensory nervous system (64). As last, CS 
is defined as “an amplification of neural signaling within the CNS that elicits pain hyper-
sensitivity” (65). The clinical picture of the patient can be dominated by one of these pain 
mechanisms, however the presence of for example predominant neuropathic pain does 
not exclude the co-existence of CS pain. The awareness is growing that recognition of 
Figure 2  Presentation of the study population included in this dissertation with an illustration 
of the hypothesized overlap and differences between the three conditions with respect 
to clinical symptoms, research findings, and underlying mechanisms. The lower circles 
present the hypothesized relationships between different symptoms, research findings, 
and underlying mechanisms within each study group.
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nociceptors that are connected to fast conducting Aδ myelinated axons, and high- 
threshold nociceptors that convey impulses in slow unmyelinated axons or C-fibers. Finally, 
the stimuli are conveyed to the thalamus from where they are send to the cortex. 
The thalamus, as relay station, receives information from multiple surrounding brain 
regions with respect to the presumed threat and context of the stimuli. The nociceptive 
stimuli are perceived as pain only when they arrive at the cortex. Many neurotransmitters 
(i.e. glutamate, substance P) are able to modulate the postsynaptic responses via 
transmission to and from supraspinal sites (e.g. anterior cingulate and insular cortex) via 
the ascending and descending pain pathways (68, 74, 75). 
2.2.  Peripheral sensitization
The nervous system is highly plastic, and even with acute pain it undergoes some changes. 
When tissues are damaged and pain persists for a few days, this is the result of adaptations 
of unimodal nociceptors and enhanced responsiveness of polymodal nociceptive 
endings. More specifically, the nociceptor peripheral terminals become ‘sensitized’ after 
injury, by reducing their threshold, only within the site of injury where the terminal was 
exposed to products of tissue damage and inflammation (73, 76), causing the zone of primary 
or local hyperalgesia (77, 78) (fig. 4). Local hyperalgesia involves increased sensitivity to 
noxious stimulation at the local site of injury. The underlying process is defined as 
peripheral sensitization of nociceptors, and represents a protective action by the human 
body in order to prevent further use of damaged structures and consequent further 
damage of surrounding tissues. 
 For example, during an acute whiplash injury, the facet joints, which are abundantly 
innervated with Aδ- and C-fibers may become peripherally sensitized by capsular 
stretching, local pressure changes, and release of pro-inflammatory agents (26). Furthermore, 
because of their anatomical location, the cervical dorsal root ganglia and nerve roots are 
vulnerable to injury during rapid acceleration-deceleration of the neck. In FM patients e.g., 
changes in intramuscular microcirculation could lead to ischemic muscle pain and 
peripheral sensitization (70) or in chronic INP patients active cervical myofascial trigger 
points could induce peripheral sensitization of nociceptors (79).
2.2.1.  Primary or local hyperalgesia
The IASP defines hyperalgesia as “increased pain from a stimulus that normally provokes 
pain” (80). Two types of hyperalgesia exist: primary or local hyperalgesia, and secondary or 
distant hyperalgesia which will be described later on. Local hyperalgesia can be assessed 
by measuring pain thresholds for mechanical, thermal, or electrical stimuli at the 
symptomatic regions. Accordingly, decreased pain thresholds at the primary painful 
region may represent local hyperalgesia and underlying peripheral sensitization, which 
has been demonstrated in the trapezius muscle and the neck in both chronic INP and 
chronic WAD patients compared to healthy controls (24, 46). 
may be situated somewhere at the beginning of the continuum, followed by the chronic 
WAD group, and the FM group may be the far end of the chronic musculoskeletal pain 
continuum. Various individuals with chronic musculoskeletal pain may be floating at 
various points in this continuum (56), and thus some may have stronger peripheral than 
central components, some may have mixed peripheral and central components, and 
others may have stronger central components, and increasing severity and complexity of 
associated symptoms and psychosocial problems. 
The following parts of the introduction will provide detailed information concerning the 
neurophysiology of acute and chronic pain, focusing on CS and reorganization of the 
brain in chronic musculoskeletal pain. 
2.  Neurophysiology of acute pain
In 1979, the International Association for the Study of Pain (IASP) defined pain as “an 
unpleasant sensory and emotional experience associated with actual or potential tissue 
damage or described in terms of such damage” (71). Since then, our understanding of pain 
has substantially increased, uncovering the biopsychosocial nature of pain. Accordingly, 
the following updated definition of pain was proposed in 2016 “pain is a distressing 
experience associated with actual or potential tissue damage with sensory, emotional, 
cognitive, and social components” (72). 
2.1.  Nociception
The nerve cell endings that initiate the sensation of pain are called nociceptors (noci is 
derived from the Latin nocere, “to hurt”) (73). Nociceptors arise from cell bodies in dorsal 
root ganglia that send one axon to the periphery (the primary afferent neuron) and one 
axon to the spinal cord and brainstem (the secondary afferent neuron). Mainly two types 
of pain receptors are activated by nociceptive input (73). These include low-threshold 
Figure 3  Continuum of chronic musculoskeletal pain.
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can be adaptive for example in the case of learning and memory, however, in the patho-
physiology of chronic pain including CS pain, neuroplasticity is maladaptive.
 In contrast to peripheral sensitization, which generally requires ongoing peripheral 
noxious stimulation for its maintenance, CS produces pain hypersensitivity in 
non-inflamated or non-damaged tissues (83). Spontaneous activity in dorsal horn neurons 
and enlargement of their receptive fields, reduction in the activation threshold by 
peripheral stimuli and increased response to suprathreshold stimuli, as well as increased 
synaptic strength in dorsal horn neurons, among others are present in CS (65, 83). Especially, 
the wide dynamic range neurons in the dorsal horn, change in structure, function, and 
biochemistry (70). Together, these changes in neuronal properties result in increased action 
potential output in response to previously subthreshold synaptic inputs. This way, CS 
represents an ‘uncoupling’ of the clear peripheral stimulus response relationship. 
 In addition, once CS is established, it remains highly plastic. Hence, any new peripheral 
injury may serve as a new source of afferent peripheral nociceptive input, which in turn 
sustains or aggravates CS (86). Nonetheless, without new peripheral input, CS will not 
resolve easily and is also able to sustain the chronic symptoms of the patient because of 
the described neuronal changes. In addition, alterations in microglia, astrocytes, and gene 
transcription all may contribute to the maintenance of CS (65, 87-89).
To date, considerable evidence shows that changes in neural processing in the CNS 
contribute to widespread pain hypersensitivity in various chronic musculoskeletal pain 
disorders, presenting overlapping symptoms (65). Accordingly, an important clinical 
implication is that the experience of pain, in for example patients with chronic WAD (35, 46-48) 
and FM (65, 68, 69) with CS, not necessarily reflects the presence of peripheral noxious 
stimulation but is rather the result of CNS alterations. Spinal cord hypersensitivity has for 
instance objectively been demonstrated by decreased nociceptive flexion reflex 
thresholds in chronic WAD and FM patients, which provides compelling evidence of neu-
rophysiological overlap between both conditions (90). Chronic pain is thus not a passive 
consequence of transmission of a defined peripheral input to a cortical pain region, but a 
reflection of dynamic central neuroplasticity (although maybe partially generated in the 
periphery) (84). 
3.1.1.  Secondary or distant hyperalgesia
Distant hyperalgesia involves increased sensitivity extending beyond the site of injury, 
and hence is believed to result from sensitization of central nociceptive signaling neurons 
(91). Quantitative Sensory Testing (QST) has been recommended to investigate signs of CS 
such as distant hyperalgesia for a variety of stimuli (mechanical, thermal, electrical) (92). 
Various QST tools have been developed to quantify different aspects of CS. Gold standards 
for examining CS are currently lacking and because numerous underlying mechanisms 
contribute to CS, it is advocated to assess a combination of QST measures (e.g. distant 
3.  Neurophysiology of chronic pain
Chronic pain is defined as prolonged and persistent pain of at least three months in 
duration (71, 81). The IASP defines chronic pain as “pain without apparent biological value 
that has persisted beyond the normal tissue healing time (usually taken to be three 
months)” (82). Prevalence estimates of chronic pain in the general adult population range 
from 10% to 55% with a higher prevalence among women (82). 
3.1.  Central sensitization
The pain mechanism that is crucially involved in the pathophysiology of numerous 
chronic pain states is CS (65). CS is defined as “an increased responsiveness of nociceptive 
neurons in the CNS to normal or subthreshold afferent input” (83) or as “an amplification of 
neural signaling within the CNS that elicits pain hypersensitivity” (65).
 The exact mechanisms by which the CNS becomes sensitized currently remain 
unknown, however some contributing factors have been proposed, which will be 
succinctly explained.  CS is an expression of structural, functional, and chemical changes 
in the properties of neurons in the somatosensory CNS, and reflects remarkable neuro-
plasticity occurring at different levels of the CNS (primary sensory and dorsal horn neurons, 
ascending and descending pain pathways, the brain) (65, 70, 83, 84). Neuronal plasticity, possible 
throughout life, refers to the ability of the CNS to reorganize itself in response to experience 
and thereby adapt, but also maladapt its structure and function (85). Hence, neuroplasticity 
Figure 4  Mechanism of peripheral sensitization and nociceptive transmission to the dorsal 
horn and subsequently the brain. Adapted from (76).
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3.1.3.  Endogenous pain modulation
In general, endogenous pain modulation delineates the actions that the CNS can use to 
modulate pain. There are two major pain modulatory mechanisms including pain facilitation 
and pain inhibition (96). In the following paragraphs, pain facilitation and pain inhibition will 
be described in detail.
3.1.4.  Changes in ascending pathways or overactivation of the bottom-up system
Overactivation of the bottom-up system is one possible contributing mechanism of CS (69). 
Wind-up and long-term potentiation (LTP) are two important mechanisms contributing to 
the increased efficiency of nociceptive signaling to the brain and will be explained in the 
following section. In particular, LTP is an important neurobiological source and contributor 
of CS.
3.1.4.1.  Wind-up and temporal summation (TS) of second pain
Wind-up occurs after repeated low-frequency (0.33 – 5 Hz) C-fiber stimulation at constant 
intensity and represents a progressive increase in action potential firing of the second-order 
neuron over the course of the stimulus. In particular, wind-up depends on activation of 
nociceptor-specific neurons and wide dynamic range neurons in the dorsal horn of the 
spinal cord (75, 97).  TS of second pain is the perceptual correlate in humans of wind-up in the 
hyperalgesia, endogenous pain inhibition, temporal summation (TS) as explained further 
on) in order to reveal the presence of CS. 
 Evidence is present to support distant hyperalgesia (i.e. decreased pain thresholds 
at non-injured distant regions compared to healthy persons) for mechanical, thermal 
(cold and heat) and electrical stimuli in patients with chronic WAD and FM (46, 48, 68). 
Results of the scarce studies available investigating distant hyperalgesia in chronic INP 
are variable and inconclusive (24). 
3.1.2.  Allodynia
Another clinical and experimental sign of CS is distant allodynia, which is defined as pain 
to a stimulus that does normally not provoke pain, such as light pressure, touch, or 
brushing (80, 93) (fig. 5 and 6). Allodynia results from phenotypic changes in Ab-fibers with 
low-threshold mechanoreceptors. It is demonstrated that Ab-fibers obtain qualities that 
are similar to those of C-fibers. As a consequence, these fibers will also convey pain (94). 
In case of CS, allodynia is the consequence of hyperexcitability of wide dynamic range 
neurons to input from cutaneous C-fiber stimuli (95). Allodynia can be present at the local 
injured symptomatic area in case of peripheral sensitization, but when allodynia arises at 
distant non-injured regions this is an indirect sign of CS (70).
Figure 5  Illustration of normal sensation (left) and presentation of CS mechanisms 
manifesting as hyperalgesia and allodynia (right).
(Left) The somatosensory system is organized such that the highly specialized primary 
sensory neurons that encode stimuli with low intensity only activate the central pathways 
that lead to innocuous sensations, while high intensity stimuli that activate nociceptors 
only activate the central pathways that lead to pain and the two parallel pathways do not 
functionally cross. (Right) With the installation of CS in somatosensory pathways with 
increased synaptic efficacy and reduced inhibition, a central amplification occurs 
enhancing the pain response to noxious stimuli in amplitude, duration and spatial extent, 
while the strengthening of normally ineffective synapses recruits subliminal inputs such 
that inputs in low threshold sensory inputs can now also activate the pain circuit. The two 
parallel sensory pathways converge. Reprinted from Woolf (65).
Figure 6  Hyperalgesia and allodynia.
The normal pain response as a function of stimulus intensity is depicted by the curve at 
the right, where even strong stimuli are not experienced as pain. However, an injury can 
shift the curve to the left. Then, noxious stimuli become more painful (hyperalgesia) and 
typically painless stimuli are experienced as pain (allodynia).
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3.1.4.2.  Long-term potentiation (LTP) in the dorsal horn and the brain
In case of excessive accumulation of glutamate in the synaptic cleft between C-fibers and 
second-order neurons, due to persistent strong stimulation, more long-term changes 
may occur. Long-term synaptic plasticity has been identified in the spinal dorsal horn, in 
particular at C-fiber synapses, and in the brain (83, 104, 105). After repetitive (0.5 – 5 Hz) synaptic 
stimulation, long-lasting increase in synaptic strengthening can be installed, known as LTP. 
LTP can manifest after repetitive stimulation in a short-time frame (e.g. seven successive 
days), defined as early LTP (83, 106) (fig. 8) encompassing a phosphorylation-dependent and 
transcription-independent phase resulting mainly from rapid changes in glutamate 
receptors and ion channel properties (84).
 The later, longer-lasting LTP, which manifests after repetitive stimulation in a longer 
time frame (e.g. months) is transcription-dependent and drives synthesis of new proteins 
responsible for the longer-lasting form of CS observed in chronic pain conditions (83). The 
synaptic strength can increase after repetitive stimulation because synapses in the CNS 
are plastic and can adapt through modifications in the presynaptic terminal (increases its 
capacity to produce and release neurotransmitters) and adaptations in the postsynaptic 
neuron (increases its capacity to bind neurotransmitters due to increased numbers of 
receptors at the postsynaptic cell membrane) (83, 104). As a consequence, CNS neurons 
become more efficient in nociceptive transmission.  Once LTP has been installed, identical 
presynaptic stimuli will now lead to a much powerful and longer-lasting response of the 
post-synaptic neuron. During the C-fibers transmitted stimuli, N-methyl-D-aspartate 
(NMDA) receptors of second-order neurons become activated. NMDA activation induces 
calcium entry into the dorsal horn neurons (107), which leads to nitric oxide (NO) synthesis 
(108). NO can subsequently affect the nociceptor terminals and enhance the release of 
neuropeptides (substance P), therefore contributing to the maintenance of CS (109). 
Substance P lowers the threshold of synaptic excitability, resulting in the unmasking of 
normally silent interspinal synapses and the sensitization of second-order neurons (110). 
Furthermore, substance P can expand for long distances in the spinal cord and thereby 
sensitize dorsal horn neurons at a distance from the nociceptive input location. This results 
in an expansion of receptive fields and the activation of wide dynamic range neurons by 
non-nociceptive afferent impulses (75).
 Moreover, in contrast to wind-up, persistent LTP does not require continuous neuronal 
activity from the periphery, and can have a duration of up to months or even longer (106). 
LTP is a crucial mechanism contributing to CS (106), and is one of the mechanisms 
underpinning brain alterations associated with chronic pain (111). This mechanism has been 
most thoroughly studied in the hippocampus and the amygdala, and is reported to be a 
neurobiological substrate for learning and memory, through synaptic strengthening and 
remodeling of neural networks (105, 111, 112). A role in fear and pain-related cognitive emotional 
factors of LTP in the brain has also been established (106). Research has furthermore put 
forward that LTP could induce the formation of the so-called ‘pain memory’ both in the 
dorsal horn and entails increasing pain perception or pain ratings in response to repeated 
noxious stimuli of equal intensity and duration delivered at low frequencies (98, 99) (fig. 7). 
Second pain, which is more dull and strongly related to chronic pain states, is transmitted 
through unmyelinated C-fibers to dorsal horn nociceptive neurons. TS of second pain is 
caused by the repeated stimulation of these C-fibers at frequencies between 0.33 – 5 Hz, 
leading to progressively increasing electrical responses in the corresponding spinal cord 
(posterior horn) neurons (95, 100).
 Noteworthy, wind-up only takes place in the dorsal horn of the spinal cord. It is a 
short-lasting phenomenon that enhances action potential firing of dorsal horn neurons to 
the first 10–30 stimuli i.e. during the first few seconds of an ongoing noxious stimulus (95). 
Thereafter, the response reaches a plateau or may decline as the membrane potential 
returns to its normal resting level (83). This electrophysiological phenomenon is also present 
in healthy pain-free persons, and thus constitutes a normal coding property of nociceptive 
spinal dorsal horn neurons, being not per se a sign of CS (95). 
 But in patients characterized by CS, wind-up is strengthened, which means stronger 
wind-up and lowering of the wind-up threshold frequency of a given neuron (83), indicating 
the presence of facilitation existing in spinal nociceptive pathways. Therefore, TS of second 
pain is widely used in pain research as an experimental paradigm to assess the latter CNS 
hyperexcitability (46, 101-103). This research has demonstrated increased TS of second pain in 
patients with chronic WAD and FM (46, 69), but no clear evidence for increased TS is available 
in chronic INP patients (24). 
Figure 7  Illustration of temporal summation of second pain demonstrated by increasing 
pain sensitivity in response to repeated noxious stimuli of equal intensity and duration 
delivered at a frequency of 0.33 Hz or more.
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In healthy pain-free persons, a balance exists between activity in descending inhibitory 
and facilitatory pathways. In case of CS in chronic pain states, it seems that an imbalance 
of these pain modulatory mechanisms emerges, turning the balance in favor of facilitation 
and leading to sensitization of second-order neurons, hence increasing the gain of 
nociceptive processing (112, 116). 
3.1.5.1  Increased activation of descending facilitatory pathways
Cognitive emotional sensitization refers to the capacity of a number of regions located in 
the forebrain to exert powerful influences on various brainstem nuclei, including the nuclei 
identified as the origin of descending facilitatory pathways (112, 119). Specifically, anatomical 
connections have been demonstrated between forebrain regions and the RVM, both 
directly as well as via the PAG (112). These regions include for example the anterior cingulate 
and insular cortices and subcortical hypothalamic and amygdalae nuclei. Connections 
between these limbic brain regions and descending facilitatory pathways thus play a neuro-
physiological role in cognitive emotional sensitization (120). This yields the clinical important 
knowledge that the activity in descending pathways is not constant but can be modulated by 
the level of attention, motivation, stress, anxiety, maladaptive pain cognitions or psychological 
correlates such as pain hypervigilance, catastrophizing, pain-related fear and kinesiophobia, 
avoidance behaviors, among others (112, 119, 121). Accordingly, a person’s pain experience can be 
influenced by the interplay of these cognitive- emotional and psychosocial factors. 
3.1.5.2  Dysfunctional activation of descending inhibitory pathways
The descending pain inhibitory system exerts its analgesic influence on the CNS through 
actions at the ‘off-cells’ in the RVM, and the release of neurotransmitters such as serotonin 
and noradrenaline (118). Research suggests that disruption of one or more of the elements 
of the inhibitory system can result in the equivalent of CS (112). A crucial function of 
the descending inhibitory pathway is to ‘focus’ the excitation of the dorsal horn neurons. 
The aim is to generate a more urgent, rapid, and localized pain signal by suppressing 
surrounding neuronal activity (84). This role is attributed to the ‘diffuse noxious inhibitory 
controls’ phenomenon (122) which is now called ‘conditioned pain modulation (CPM)’ 
based on expert recommendations (123). The term CPM was introduced in 2010 to describe 
the psychophysical paradigm to test diffuse noxious inhibitory controls (123, 124). According 
to this mechanism, descending pathways effectively enhance the biologically valuable 
pain signal by reducing the level of irrelevant ‘noise’ in the system. Research has reported 
that adequate activation of pain inhibition by the CPM response also seems to be under 
control of brain regions such as the orbitofrontal cortex and the amygdala (125).
 Inefficient endogenous pain inhibition and dysfunctional CPM activation have been 
demonstrated in patients with chronic WAD and FM (126-130). Only one previous study has 
investigated CPM in patients with chronic INP, and found no evidence for dysfunctional 
CPM efficacy (131).
spinal cord and the brain in various chronic pain states, including those with CS (113, 114). 
Hence, in the light of LTP, chronic CS pain can partially be understood as a learned 
mechanism that is now “marked” in the spinal cord and the brain, the so-called “neural 
pain signature” (115). Research towards the molecular mechanisms of CS and LTP indicates 
that, although there are differences between the synaptic plasticity contributing to 
memory and pain, there are also striking similarities (105). Preventing or ‘erasing’ LTP may 
serve as an important target to inhibit chronic pain in patients in the future (104).
3.1.5.  Changes in descending pathways or alterations in the top-down system
The dorsal horn of the spinal cord is the location of the first synapse in pain pathways, and 
as such, offers a powerful target for the regulation of nociceptive transmission not only by 
local dorsal horn mechanisms (as described above) but also by supraspinal modulation 
(116). Descending facilitatory and inhibitory neuronal pathways can influence the excitability 
of the spinal cord through this supraspinal modulation (117). This descending control on 
spinal nociceptive processes arises from a number of supraspinal sites, for example the 
periaqueductal grey (PAG)-rostral ventromedial medulla (RVM) system (116), as well as the 
subnucleus reticularis dorsalis (118). The PAG is interconnected with the hypothalamus and 
limbic forebrain regions including the amygdala, and projects to the RVM, which in turn 
sends its output to dorsal horn laminae involved in nociception. The subnucleus reticularis 
dorsalis communicates with the PAG and RVM, and projects directly to laminae of the 
dorsal horn including projection neurons which themselves project to the subnucleus 
reticularis dorsalis, thereby closing a reverberating loop. Mechanisms originating in the 
subnucleus reticularis dorsalis and in other supraspinal sites can mediate either descending 
facilitation or inhibition. 
Figure 8  Mechanism of long-term potentiation in the dorsal horn of the spinal cord 
and the brain. 
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A dysfunctional stress response system has been demonstrated in patients with chronic 
WAD (139) and FM (140, 141, 145). For example, dysfunctions of the HPA-axis have been found in 
both chronic pain conditions (139, 146, 147). In whiplash patients, stress response systems seem 
to influence the development of chronic pain after a motor vehicle crash. Due to the 
traumatic event, post-traumatic stress can develop in patients with WAD, and it is indeed 
demonstrated that post-traumatic stress is present in a subgroup of chronic WAD patients 
(148). Moreover, symptoms of post-traumatic stress in acute/subacute WAD patients is 
prognostic of poor recovery (149).
 To conclude, the experience of chronic stress which results in dysfunctional stress 
response systems is another overlapping clinical feature within patients with chronic WAD 
and FM.  In contrast, to the best of our knowledge no research or evidence exists 
supporting the presence of alterations in the stress response systems in patients with 
chronic INP. Moreover, the hypothesized relationship between stress and disturbed central 
pain modulation in chronic WAD and FM has not been clearly investigated. 
3.2.   Structural and functional reorganization of the brain in  
chronic musculoskeletal pain
“ The brain is a world consisting of a number of unexplored continents and great stretches of 
unknown territory.” - Santiago Ramon y Cajal
Understanding the human brain is one of the most difficult challenges that scientists have 
faced in the past and it will probably remain one of the most complex challenges in the 
future. Nonetheless, what we know about the brain is increasing and changing at a 
breathtaking pace. Scientists long viewed the adult brain as a relatively static organ, but 
now it is clear that the brain is constantly changing its structural and functional 
organization as a function of experience, and hence is highly plastic (150).
 Before we will elaborate on the role of brain plasticity and brain alterations in chronic 
musculoskeletal pain and associated symptoms, the following section will concisely 
describe the constitution of the human brain. Subsequently, we will succinctly run 
through the basic principles of MRI, T1-weighted structural MRI and Diffusion-Weighted 
Imaging (DWI) in order to provide the reader with sufficient theoretical background 
information on the different brain MRI techniques applied within this dissertation. 
3.2.1.  Human brain anatomy 
The brain is parcellated into three main components namely the cerebrum, the cerebellum 
and the brainstem (151). The cerebrum comprises the left and right cerebral hemispheres, 
the interbrain between the cerebrum and the brainstem termed the diencephalon, and 
the deep grey nuclei. The cerebral hemispheres are the largest compartments of the brain 
In addition to the ‘pain inhibits pain CPM paradigm’ it is recognized that also stress is an 
important factor that can exert complex modulatory influences on pain, and on 
descending pain inhibition and facilitation (132, 133). In particular, stress can have a major 
impact on pain perception by either suppressing pain (stress-induced analgesia) (132) or 
exacerbating it (stress-induced hyperalgesia) (133). 
 The autonomic nervous system and the hypothalamus-pituitary-adrenal (HPA) axis 
are primary responsible to respond adequately to stress (134) in life threatening situations 
but also in response to daily stressors. The acute short-term stress response is predominantly 
regulated by the sympathetic subdivision of the autonomic nervous system, whereas the 
later evoked and longer lasting stress response is mainly induced by the HPA-axis with 
releasing cortisol as most important stress hormone. 
 Many chronic pain patients display however a dysfunctional stress response (135). 
Clinically, this dysfunctional stress response becomes clear when chronic pain patients 
report that they are no longer able to deal with daily physical and psychological stressors, 
which were no problem to handle before their chronic pain problem. Furthermore, 
patients report that a mild stressor can already worsen their pain complaints. The latter is 
remarkable because one of the main functions of the stress response systems is activation 
of endogenous top-down pain inhibition in a stressful situation (118). As such, the stress 
hormones cortisol and noradrenaline are both pain inhibiting, and noradrenaline is an 
important neurotransmitter that contributes to pain inhibition exerted via the descending 
pain pathways (118). At the level of the spinal cord, cortisol binds at the glucocorticoid 
receptors of the dorsal horn, where cortisol performs its pain dampening actions (136). 
Noteworthy, the pain inhibiting functions of the stress systems are logical from an 
evolutionary survival based theory, however, when in chronic pain patients, daily stressors 
only worsen their pain severity and associated symptoms, this is clearly an indication that 
the stress response system in these patients has become dysfunctional (135). 
Research has proposed four important mechanisms underlying the dysfunctional stress 
response in chronic pain patients such as patients with chronic WAD and FM. 
- Decreased availability of inhibitory neurotransmitters such as Gamma-Aminobutyric 
acid and serotonin in the CNS including the brain (137, 138).
- Exhausted HPA-axis which results in decreased production of the stress hormone 
cortisol in response to a stressor (139-141).
- Stress activates in chronic pain patients the ‘on-cells’ and suppresses the ‘off-cells’ 
activity in the hypothalamus, which turns the balance in favor of pain facilitation instead 
of pain inhibition (142, 143). 
- Decreased ability of the parasympathetic part of the autonomic nervous system to 
recover the body of chronic pain patients from a stressful situation (144, 145).
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agitation and the Brownian motion, which results in no net magnetization vector for the 
protons in the brain. 
 When protons are placed in an extern magnetic field B
0
, e.g. when a person is placed 
in the MRI scanner (or the earth magnetic field in case of the compass-needle) they will 
align in the direction of this field. When a RF-pulse is applied to excite the protons (or tap 
the compass-needle), they will start oscillating with a constant frequency. This excitation 
is necessary to measure the signal, if you do not tap the compass-needle, the oscilla-
tion-frequency cannot be determined. In other words, when the body is placed in a 
strong magnetic field, such as an MRI scanner, the protons’ axes all line up. This uniform 
alignment creates a magnetic vector oriented along the axis of the MRI scanner. When 
additional energy in the form of a radio wave is added to the magnetic field, the magnetic 
vector is deflected. The RF-pulse gives a transverse component to the magnetization of 
the vector of all protons. This is called resonance. When the RF source is switched off, the 
magnetic vector returns to its resting state, and this causes a radio wave to be emitted. 
The time needed to realign is the relaxation time. 
 The strength of the magnetic field can be altered electronically using a series of 
gradient electric coils, and by altering the local magnetic field by these small increments, 
different slices of the body will resonate as different frequencies are applied. Receiver coils 
are used around the body part in question for example the brain to act as aerials to 
improve the detection of the emitted signal. 
and are interconnected by white matter (WM) fibers. The hemispheres are composed of 
outer grey matter (GM) termed the cerebral cortex and inner WM encompassing the deep 
grey nuclei (e.g. thalamus, amygdala, hippocampus) (fig. 9). The GM contains mainly nerve 
cell bodies, while the WM is made up predominantly of nerve fibers (axons). Cerebrospinal 
fluid surrounds the brain and acts as a cushion for absorbing the impact from light trauma, 
and maintains CNS homeostasis. In addition, within the brain there is a ventricular system, 
which contains four interconnected cerebral ventricles filled with cerebrospinal fluid. 
Furthermore, brain protection is provided by meninges surrounding the brain.
3.2.2.  Magnetic Resonance Imaging
“ In physics, you don’t have to go around making trouble for yourself, nature does it for you.” 
– Frank Wilczek
MRI is based on noninvasive radio frequency (RF) excitation of biological molecules with 
magnetic properties (152). To generate MR images, the hydrogen nucleus (a single proton) 
of water (H
2
O) is used. The hydrogen proton can be likened to the planet earth, spinning 
on its axis which creates an intrinsic angular momentum, with a north-south pole. In this 
respect the hydrogen atom 1H can be represented as a magnetic moment vector that 
causes the nucleus to behave like a small bar magnet, similar to a compass-needle. Under 
normal circumstances, these hydrogen proton “bar magnets” spin in the body with their 
axes randomly aligned (fig. 10). The proton spins are randomly distributed due to thermal 
Figure 9  A T1-weighted Magnetic Resonance Image illustrating cortical grey matter, 
white matter and ventricles filled with cerebrospinal fluid.
Figure 10  The hydrogen proton can be likened to the planet earth, spinning on its axis, 
with a north-south pole. In this respect it behaves like a small bar magnet. Under normal 
circumstances, these hydrogen proton “bar magnets” spin in the body with their axes 
randomly aligned. When the body is placed in a strong magnetic field, such as an MRI 
scanner, the protons’ axes all line up. This uniform alignment creates a magnetic vector 
oriented along the axis of the MRI scanner.
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Therefore, it is valuable to combine GM volume and cortical thickness analyses together 
for a comprehensive evaluation of GM morphology. Voxel-based morphometry is 
frequently used to examine GM volume (156). A voxel, is a volume element or a three- 
dimensional cube defined in a three-dimensional space such as the brain (three-dimensional 
equivalent of a pixel). Each voxel, depending on its size and location in the brain, contains 
thousands of neurons.  In the present dissertation, all T1-weighted MR images were 
processed using FreeSurfer, a surface-based analysis method (157), which is based on 
vertices instead of voxels. A vertex is a point or intersection of six triangles, whereas a voxel 
is an intersection of grid lines. Surface models respect anatomical boundaries to a greater 
extent than voxelwise measures (158). Noteworthy, various underlying molecular and 
cellular mechanisms may influence T1-weighted MRI signals (e.g. cell size, cell density, 
changes in dendritic spine structure, gliogenesis, synaptogenesis) (158). 
3.2.4.  Principles of Diffusion-Weighted MRI 
DWI examines the diffusion of water molecules in the brain (159). As a result of thermal 
energy, water molecules in the brain are in constant motion, which is called Brownian 
motion. DWI acquisition techniques make use of this Brownian motion to detect diffusion 
of water within and between individual cells. Diffusion can be appreciated when inserting 
a drop of ink in a glass of water; after some time, the ink molecules will gradually spread 
out. In an environment in which there are no obstacles in their path, such as in a glass of 
water, molecules jostling around due to thermal motion will disperse in a uniform manner, 
traveling an equal distance in all directions (160). This is defined as isotropic diffusion. 
However, if the molecules encounter obstructions that are coherently oriented, they will 
no longer disperse equally in all directions, and diffusion will be anisotropic.
 DW images can be analyzed using diffusion tensor analyzing techniques which 
model diffusion as a mathematical tensor (161). The diffusion tensor can be represented as 
an ellipsoid whose main axis represents the principal direction of diffusion (162). More 
specifically, the tensor is described by three orthogonal eigenvectors and their associated 
eigenvalues ([lambda]
1
, [lambda]
2
, [lambda]
3
), and can be applied to each brain voxel (163), 
thereby characterizing the magnitude of water diffusion (mean diffusivity (MD)), its 
directional nonuniformity (fractional anisotropy (FA), axial diffusivity (AD), radial diffusivity 
(RD)), and its orientation (the tensor eigenvectors) (164). In healthy WM, diffusion is more 
restricted perpendicular to an axon than parallel to it due to structural barriers (165). 
 The most commonly used DWI derived metric is FA (159), which ranges from 0 (maximal 
isotropic diffusion), meaning water molecules can diffuse equally in all directions (e.g. in 
cerebrospinal fluid), to 1 (maximal anisotropic diffusion), meaning the diffusion of water 
is hindered (e.g. movement is hindered perpendicular to the major axis of a WM tract) 
(fig. 12 and 13). FA is highly sensitive to microstructural WM changes, but not very specific 
to the type of changes (166). 
Multiple transmitted RF-pulses can be used in sequence to emphasize particular tissues. 
A different emphasis occurs because different tissues (such as fat and water) have different 
relaxation times when the transmitted RF-pulse is switched off and can therefore be 
identified separately. The time taken for the protons to fully relax is measured in two ways. 
The first is the time taken for the magnetic vector to return to its resting state, called T1 
relaxation, and the second is the time needed for the axial spin to return to its resting 
state, called T2 relaxation. 
 To produce a MR image, we also need to know what signal originates in which 
location. To this end, known variations are applied to the external magnetic field, in three 
orthogonal directions, making the signal place-dependent. This is achieved by the 
magnetic field gradients. The combination of spatial information from the gradient field 
and the signal intensity received after a series of RF-pulses allows a three-dimensional 
image to be reconstructed.
3.2.3.  T1-weighted structural brain MRI
High-resolution three-dimensional T1-weighted MR images of the brain can be acquired to 
examine structural brain characteristics including GM volume, surface area, and cortical 
thickness (fig. 11). GM volume is the product of surface area and cortical thickness (153). 
Cortical thickness and cortical surface area have a distinct genetic origin (153), and reflect 
different aspects of the underlying neural architecture (154). Specifically, cortical thickness is 
believed to reflect the number of cells within the cortical columns, whereas cortical 
surface area is primarily determined by the number of columns within a cortical region (155). 
GM volume reflects a combination of information obtained from several measures, as GM 
volume can reflect brain morphometric changes in both cortical and subcortical regions. 
Figure 11  An example of high-resolution T1-weighted anatomical axial, sagittal, and 
coronal brain MR images acquired using a three-dimensional magnetization prepared 
rapid acquisition gradient echo (MP-RAGE), as acquired in this dissertation. Permission is 
obtained from the subject for presenting these images. 
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alterations in chronic musculoskeletal pain patients including FM, and the relationship 
with clinical pain measures is systematically reviewed in part I of this thesis. Therefore, only 
a brief overview on this topic will be outlined in the following paragraph mainly focusing 
on the structural brain changes and providing a general overview of the somatosenso-
ry-discriminative, motivational-affective and cognitive aspects of pain.
 
During the past decades, a wide range of brain imaging techniques with a major role of 
MRI provided the opportunity to explore structural and functional alterations of the brain 
in-vivo in patients with chronic pain (167-169). Subsequently, the role of maladaptive brain 
alterations, including GM volume alterations (85, 168, 169), changes in cortical thickness, and 
alterations in WM properties, have been gradually elucidated in the persistent pain and 
associated complaints of various chronic musculoskeletal pain conditions (e.g. FM (170-173), 
chronic low back pain (174-176), temporomandibular disorders (177, 178), chronic pelvic pain 
syndrome (179, 180)), and in mild traumatic brain injury (TBI) patients (181-183).  Especially, GM 
morphology and WM alterations in regions/tracts involved in cognitive processing and 
sensory-discriminative, affective and cognitive processing of pain have been shown in 
various chronic musculoskeletal pain syndromes, such as FM and chronic low back pain, 
characterized by the common pathophysiology of CS (170, 174). 
 Somatosensory-discriminative processing of pain refers to the possibility to discriminate 
different stimulus modalities such as pain quality, location, intensity, and duration. Brain 
regions such as the thalamus, the primary and secondary somatosensory cortex, the 
posterior insula, the posterior parietal cortex, and the mid-cingulate cortex are involved in 
this type of sensory-discriminative/ nociceptive pain processing (120, 184). 
 The motivational-affective (e.g. ‘I am afraid that I will experience pain when I perform that 
cervical movement or activity’) and cognitive dimensions (e.g. ‘When I experience pain this 
means that my neck is damaged’) of pain processing reflect the emotional experiences or 
value related to pain, as well as attention, cognitive appraisal of the meaning of the 
sensory signals, anticipation, and distraction influences of pain (185-187). The anterior insula 
and the (dorsolateral, ventromedial) prefrontal cortex are for example associated with 
affective and cognitive processing of pain (188). Pain often results in feelings of sadness, 
fear, and anger depending on how the pain is cognitively appraised (187). Limbic brain 
regions are involved in various motivational-affective and cognitive components of pain 
processing such as the nucleus accumbens, amygdala, hippocampus, parahippocampal 
cortex, the (rostral) anterior and posterior cingulate cortex, and the orbitofrontal 
cortex (120, 169, 189). 
 The results of functional and structural brain MRI studies suggest that various chronic 
 musculoskeletal pain conditions show a shift away from pain processing in somatosensory- 
discriminative/nociceptive brain regions towards crucial involvement of cognitive and 
motivational-affective processing of pain in regions often part of the limbic system and 
several regions involved in descending endogenous pain modulation (169, 188). In addition, 
3.2.5.  Brain alterations in patients with chronic musculoskeletal pain
“ Neuroplasticity contributes to both the constrained and unconstrained aspects of our nature. 
It renders our brains not only more resourceful, but also more vulnerable to outside influences.” 
- Norman Doidge
Research regarding brain alterations in patients with chronic INP and chronic WAD is 
essentially lacking, which is a prominent gap in current literature. To this end, a core aim of 
this dissertation was to investigate structural brain alterations in patients with chronic INP 
and chronic WAD. The current evidence with respect to structural and functional brain 
Figure 12  Axial fractional anisotropy map acquired with diffusion-weighted MRI, presenting 
anisotropic cylindrical diffusion (due to the underlying fiber architecture) in WM and 
isotropic spherical diffusion in GM.
Figure 13  Representation of the directionality of water diffusion with cigar-shaped 
ellipsoids at the location of the WM pathway reflecting more diffusion parallel to the 
pathway and ball-shaped figures in GM to reflect multidirectional (isotropic) water 
diffusion. Figure from Alexander Leemans (http://www.exploredti.com). 
36 37
General Introduction General Introduction
function and pain processing (e.g. amygdala, prefrontal cortex, hippocampus, anterior 
cingulate cortex) (204). Pain-induced synaptic plasticity has also been shown to occur in 
brain regions with known roles in cognitive function such as the amygdala, anterior 
cingulate cortex, and hippocampus (106, 204). Furthermore, several neurotransmitters are 
commonly involved in both pain processing and cognition (204). For example, glutamate 
transmission through the NMDA receptor is essential for learning and memory through 
LTP (205). Additionally, NMDA receptors are implicated in strengthened wind-up and CS (83).
 Research has provided evidence for pain-related cognitive deficits in various chronic 
musculoskeletal pain conditions, including chronic WAD and FM (201). Decreased cognitive 
function seems to be related to pain severity in patients with chronic WAD (199) and FM (206), 
and is presumed to be a feature of CS (60). Although, there is increasing knowledge for the 
neurobiological overlap and relationship between cognitive function and CS, research 
exploring this relationship in patients with chronic musculoskeletal pain is essentially 
lacking. 
chronic pain has a widespread impact on overall brain function, and disruptions in the 
activity of resting-state functional brain networks such as the default mode network may 
underlie the cognitive, affective-motivational and behavioral dysfunctions accompanying 
chronic musculoskeletal pain (190, 191). 
 Interestingly, previous brain imaging studies revealed associations between GM 
morphology (e.g. GM volume, cortical thickness) and WM microstructural changes, and 
measures of cognition and pain in various chronic pain conditions (170, 174, 177, 179, 192-194), and in 
mild TBI patients (183, 195). Also, relationships between structural and functional brain 
alterations and features of cognitive emotional sensitization such as pain catastrophizing, 
and affective factors have been demonstrated in patients with chronic pain (196). 
4.  Cognition and chronic pain
Apart from persistent pain, chronic WAD and FM patients frequently complain of cognitive 
disturbances such as concentration and memory deficits (197-200). Moreover, clinical 
experience emphasizes the possibility that chronic INP patients may also have some 
cognitive manifestations based on reporting of cognitive problems experienced during 
daily life. Nevertheless, in previous research, the nature and severity of self-perceived 
cognitive deficits and objective cognitive impairment has received less attention 
compared to pain mechanisms in chronic WAD, FM, and in particular in chronic INP. 
Cognitive function covers a broad range of mental processes performed by the brain, 
including attention, information processing, memory, learning, planning, organization, 
visuomotor tracking, decision making, cognitive flexibility, task-switching, cognitive 
inhibition, and executive functioning. Adequate cognitive performance is required to 
perform activities of daily living and more complex tasks such as during occupational 
activities. Accordingly, cognitive deficits can strongly interfere with daily life, social 
activities, and occupational performance (201).  FM patients rank cognitive dysfunction 
highly in terms of disease impact (202), and sometimes even report their forgetfulness, 
declines in memory and mental alertness, as more disturbing than persistent pain (203).
It has been reported that neural substrates of cognition and pain processing are linked, 
and that pain and cognition modulate one another reciprocally (201, 204). Pain can negatively 
affect cognitive performance, and cognitively demanding tasks may reduce pain 
perception but possibly also may increase pain. The disruption of cognitive function by 
pain refers to the ability of pain to interfere and interrupt with one or more cognitive 
processes (201, 204). 
 Evidence exists for pain-related alterations in cognition, whereby anatomical, molecular 
and neurochemical features are common to both cognitive processing and supraspinal 
pain processing. Intriguingly, an overlap exists in brain regions involved in cognitive 
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The core aim of this dissertation was to improve our knowledge of the mechanisms 
that underlie the persistent, complex and often unexplained symptoms in patients with 
chronic INP, chronic WAD and FM. The core aim was furthermore to unravel differences 
in the nature and severity of underpinning mechanisms between these three chronic 
musculoskeletal pain conditions, displaying overlapping but also strikingly different 
features and clinical symptoms. 
More specifically, the above outlined core aim is threefold:
- Overall objective I: to investigate the current evidence regarding associations between 
structural and functional brain alterations and clinical pain measures in chronic musculo-
skeletal pain patients, and regarding structural and functional brain alterations specifically 
in INP and WAD. 
- Overall objective II: to examine differences between patients with idiopathic and 
traumatic chronic neck pain regarding disability, cognitive deficits, indices of CS, and 
structural brain alterations, and their interrelationships. 
- Overall objective III: to explore the interaction between cognitive performance, 
cognitive stress, and CS in patients with chronic WAD and FM, thereby studying differences 
between these chronic pain disorders.
Part I focuses on the first overall objective and comprises two chapters including two 
systematic reviews. No clear overview was present on how brain alterations are related to 
clinical correlates of pain in various chronic musculoskeletal pain conditions. However, 
knowledge on this relationship is important to further disentangle the underpinning 
mechanisms of persistent pain.
 Therefore, the aim of chapter 1 was to perform a systematic review analyzing relationships 
between structural and functional brain alterations, and clinical pain measures in patients 
with chronic musculoskeletal pain, examined with structural and functional brain MRI 
techniques. 
 In addition, no review has summarized the evidence regarding brain alterations 
specifically in INP and WAD. Yet, a systematic review on this topic seemed warranted to 
identify the present state of the art and steer further research.
 Accordingly, the aim of chapter 2 was to systematically review the current evidence 
regarding structural and functional brain alterations in patients with acute, subacute, or 
chronic INP, and acute, subacute, or chronic WAD, examined with MRI techniques, Positron 
Emission Tomography, and Single-Photon Emission Computed Tomography. In addition, 
this study explored associations between brain alterations and clinical symptoms in these 
patients. 
Part II includes three original research studies described in three chapters approaching 
the second overall objective of this dissertation. In particular, part II focuses on the 
examination of differences between patients with chronic INP and chronic WAD regarding 
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associated with cognitive performance and CS, encompassing distant hyperalgesia and 
CPM efficacy. 
The third and last overall objective of this thesis is addressed in part III, which consists 
of two chapters enclosing a randomized crossover study exploring the interaction 
between cognitive performance, cognitive stress, and CS in patients with chronic WAD 
and FM. Besides the growing evidence for cognitive deficits, CS, and reduced quality of life 
in patients with chronic WAD and FM, studies examining the relationship between these 
features in both disorders are limited. 
 The first aim of chapter 6 was to examine the presence of objective cognitive 
impairment using performance-based cognitive computer tests, signs of CS by 
experimentally assessing CPM and TS of second pain, and limitations on health-related 
quality of life in patients with chronic WAD and FM compared to controls. The second aim 
was to compare objective cognitive performance, signs of CS, and health-related quality 
of life between these two chronic pain conditions. The final aim was to investigate 
relationships between objective cognitive performance, and health-related quality of life 
and CS in patients with chronic WAD and FM, and controls. These objectives were tackled 
by performing the baseline case-control comparisons in the larger crossover study. 
 Furthermore, there is limited research concerning the influence of cognitive stress 
and relaxation on central pain modulation in patients with chronic WAD and FM. As such, 
it introduces the final manuscript of this thesis which is included in chapter 7 and reports 
the results of the intervention part of the randomized crossover study. 
 The aim of chapter 7 was to investigate the effect of performance-based cognitive 
tasks to induce cognitive stress, and a single progressive muscle relaxation session on 
central pain modulation encompassing TS of second pain and efficacy of CPM in patients 
with chronic WAD and FM compared to healthy individuals. Thereby, exploring interactions 
between cognitive stress and central pain modulation in both conditions characterized 
by CS. 
In the general discussion, the most important findings are summarized and discussed. On 
the basis of these findings, clinical implications are formulated. Limitations and strengths 
of this dissertation are addressed and suggestions for further research are provided. The 
general discussion is ended with a general conclusion. Finally, a summary of the doctoral 
thesis both in English and Dutch is provided. 
disability, cognitive deficits, CS, and structural brain alterations, and their interrelationships. 
In order to address this second overall objective, one large case-control study was 
performed, which only included adult women diagnosed as chronic INP or chronic WAD 
(WAD II A, B, or C according to the modified QTF scale) (28), and healthy pain-free women. 
In order to exclude the confounding factor of sex, only women were included, as research 
has demonstrated differences between men and women regarding brain structure, pain 
sensitivity and processing in healthy persons and pain patients. It can be hypothesized 
that the traumatic origin of neck pain in chronic WAD gives rise to more severe deficits 
compared to chronic INP. Nevertheless, studies exploring differences between both 
conditions remain scarce.
 The first aim of chapter 3 was to examine differences between patients with chronic 
INP and chronic WAD regarding disability, cognitive deficits, and CS encompassing 
hyperalgesia and CPM efficacy, compared to healthy controls. The second aim was to 
investigate relationships between measures of disability, cognitive deficits, and CS in both 
chronic neck pain conditions. The findings reported in chapter 3 yield insight in one piece 
of the puzzle for understanding chronic INP and chronic WAD. However, another part of 
the puzzle for disentangling the underlying mechanisms could possibly be uncovered by 
performing brain MRI research in chronic INP and chronic WAD patients. Although it can 
be hypothesized that GM volume alterations are present in chronic WAD due to the 
traumatic event, because of cognitive deficits (198) and CS (46), but significantly less in chronic 
INP, this research is lacking. 
 To address the current research gap, the first aim of chapter 4 was to examine GM 
volume alterations in brain regions involved in processing of cognition and pain in patients 
with chronic INP and chronic WAD compared to healthy controls. The second aim was to 
investigate associations between regional GM volume, and cognitive deficits, clinical pain 
measures, and indices of CS in both chronic neck pain conditions. 
Furthermore, it could be hypothesized that alterations in cortical thickness and WM 
microstructure are associated with more severe cognitive deficits and CS in patients with 
chronic WAD compared to chronic INP. Nonetheless, these structural brain alterations, and 
the relationship with cognitive performance and CS, have never been investigated in 
these patients. 
 This brings us to chapter 5 which aimed to investigate alterations in cortical thickness 
in regions involved in cognition or pain in patients with chronic WAD compared to chronic 
INP and controls. Secondly, this chapter aimed to examine abnormalities in WM micro-
structure, including alterations in FA, MD, AD, and RD in WM tracts carrying information 
between regions involved in cognition or pain in patients with chronic WAD compared to 
chronic INP and controls. In addition, the presence of brain microhemorrhages related to 
trauma was evaluated. Finally, the purpose of this chapter was to explore in each group 
separately whether alterations in regional cortical thickness and WM microstructure were 
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Chapter 1 Relations between brain alterations and clinical pain measures
Introduction
Chronic musculoskeletal pain (MSKP) is defined as pain in muscles, tendons, joints, and 
ligaments for >3 months.24 Additionally, this condition is frequently characterized by dis-
proportional pain, meaning that pain severity and dysfunction are disproportionate to the 
nature and extent of the musculoskeletal damage/deficit.77 Accordingly, increasing 
evidence suggests that most of these chronic MSKP syndromes are related to disturbed 
central pain processes and not strict to peripheral structures.75 Chronic MSKP conditions 
include temporomandibular disorders, idiopathic chronic low back pain, fibromyalgia, 
chronic pelvic pain, and chronic whiplash-associated disorders, among others.14,17 
 Chronic MSKP affects hundreds of millions of people worldwide and is one of the 
most common forms of chronic pain.95 This chronic pain condition can cause a profound 
negative effect on an individual’s physical, emotional, and social well-being and thus on 
quality of life.90,95 Additionally, MSKP syndromes result in a major burden on health systems, 
and social care systems, resulting in substantial financial costs.95 
 Accumulating research has shown that features of central sensitization are often 
present in these chronic MSKP conditions.20,25,29,81,92 Central sensitization can be defined as 
an augmented responsiveness of the central nervous system to nociceptive as well as 
nonnociceptive stimuli (eg, pain, electrical stimuli, pressure, and temperature).76,80 This 
exaggerated responsiveness can cause allodynia, hyperalgesia, hypersensitivity of senses 
unrelated to the musculoskeletal system, and referred pain across multiple spinal 
segments, leading to chronic widespread pain.66 Clinical measures/symptoms of central 
sensitization are for example widespread pain, heightened pain intensity, generalized 
hyperalgesia, and allodynia.77 
 Approximately 30 years ago noninvasive human brain imaging techniques emerged.2 
This advent provided the opportunity to examine brain structure and function in clinical 
chronic pain states. During the past decade, the role of the brain in chronic pain conditions 
has been gradually elucidated.82 This neuroimaging research has shown neuronal plasticity 
in the brain, which can lead to maladaptive changes due to sustained abnormal 
nociceptive input.3,26 Specifically, the brain of patients suffering from chronic pain displays 
alterations with respect to brain structure,5,56 function,44 and chemistry.33 In addition, 
neuroplastic brain remodeling can lead to persistence of pain, even in the absence of 
(further) nociceptive input.3,11 Emerging evidence suggests that chronic pain is associated 
with a distinct representation in the brain, which is often referred to as the neural pain 
signature.54 
 Magnetic resonance imaging (MRI) has been one of the most influential techniques 
that has led to an improved understanding of pain perception, modulation, and 
chronification.26,82 Brain MRI techniques can be roughly divided into structural and 
functional MRI (fMRI). 
Abstract
Background and aims: Compelling evidence has shown chronic widespread and 
exaggerated pain experience in chronic musculoskeletal pain (MSKP) conditions. In 
addition, neuroimaging research has revealed morphological and functional brain 
alterations in these patients. It is hypothesized that brain alterations play a role in the 
persistent pain complaints of patients with chronic MSKP. Nevertheless, lack of overview 
exists regarding the relations between brain alterations and clinical measures of pain. The 
present systematic review was performed according to the Preferred Reporting Items for 
Systematic reviews and Meta-Analyses guidelines, to investigate the relations between 
structural or functional brain alterations, using magnetic resonance imaging scans, and 
clinical pain measures in patients with chronic MSKP. 
Methods: PubMed, Web of Science, Cinahl, and Cochrane databases were searched. First, 
the obtained articles were screened according to title and abstract. Second, the screening 
was on the basis of full-text. Risk of bias in included studies was investigated according to 
the modified Newcastle-Ottawa Scale. 
Results: Twenty studies met the inclusion criteria. Moderate evidence shows that higher 
pain intensity and pressure pain sensitivity are related to decreased regional gray matter 
(GM) volume in brain regions encompassing the cingulate cortex, the insula, and the 
superior frontal and temporal gyrus. Further, some evidence exists that longer disease 
duration in fibromyalgia is correlated with decreased total GM volume. Yet, inconclusive 
evidence exists regarding the association of longer disease duration with decreased or 
increased regional GM volume in other chronic MSKP conditions. Inconclusive evidence 
was found regarding the direction of the relation of pain intensity and pressure pain 
sensitivity with microstructural white matter and functional connectivity alterations. 
Conclusion: In conclusion, preliminary to moderate evidence demonstrates relations 
between clinical pain measures, and structural and functional connectivity alterations 
within brain regions involved in somatosensory, affective, and cognitive processing of 
pain in chronic MSKP. Nevertheless, inconclusive results exist regarding the direction of 
these relations. Further research is warranted to unravel whether these brain alterations 
are positively or negatively correlated to clinical pain measures.
Perspective: Structural and functional brain alterations within regions involved in 
somatosensory, affective, and cognitive pain processing play a crucial role in the persistent pain 
of chronic MSKP patients. Accordingly, these brain alterations have to be taken into account 
when assessing and treating patients with chronic MSKP.
Key words: Chronic musculoskeletal pain, magnetic resonance imaging, brain alterations, 
pain intensity, pain duration.
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as the DMN and salience network in chronic pain patients.9,40,55,64 Resting-state fMRI and FC 
analyses have improved our knowledge on how brain regions work together as networks 
to modulate pain and how these networks may be modified in the presence of persistent 
pain.18,82 
 fMRI research has shown alterations in (resting-state) functional activity and 
connectivity within various brain regions involved in somatosensory, affective, and 
cognitive modulation of pain in patients with various chronic MSKP conditions.9,10,20,52
 During the past years, the relationship between brain alterations and clinical features 
of pain has been frequently hypothesized and studied.26 Scientific evidence for underlying 
central mechanisms of pain processing has become increasingly necessary. Imaging 
studies investigating the relation between brain alterations and clinical behavioral 
measures in chronic MSKP patients have been published during the past years.82 
In particular, accumulating research investigating the relationship between clinical measures 
of pain such as pain duration, pain intensity, pressure pain sensitivity, and brain alterations 
has been published.37,48,60 Evaluation of clinical pain measures is highly important and 
is often used in clinical assessment, therapy, and research in patients with chronic MSKP 
to evaluate the nature and extent of symptoms as well as the evolution of pain.36,57 
A systematic review has shown that clinical pain outcome measures, used in research to 
assess chronic MSKP, are very heterogeneous.57 In particular, various dimensions of pain, 
different types of scales/questionnaires and descriptors, and varying reporting periods 
of pain (eg, current pain intensity, mean pain intensity during past week or past month) 
are examined in chronic MSKP research. Overall, clinical pain measures can be subdivided 
into self-reported pain measures such as pain intensity and pain duration, and more 
objective experimental pain measures such as pressure pain sensitivity and hypersensitivity 
for various stimuli.57
 Unfortunately, currently no clear overview exists on how brain alterations are related 
to clinical correlates of pain in various chronic MSKP conditions. However, knowledge on 
this relationship is important to integrate neuroimaging findings into clinical practice and 
to further unravel the underlying mechanisms of persistent pain. Therefore, the aim of the 
present systematic review was to investigate the relations between structural and 
functional brain alterations and clinical pain measures in chronic MSKP patients, examined 
with structural and functional brain MRI techniques.
Methods 
Research Questions 
This systematic review was conducted following the Preferred Reporting Items for 
Systematic reviews and Meta-Analyses guidelines.70 The Patient, measurement Instrument, 
Comparison, Outcome (PICO) approach was applied to formulate the following research 
Structural MRI has the ability to measure gray matter (GM) and white matter (WM) 
morphology in vivo. High-resolution T1-weighted images can be used to assess global 
measures, such as whole brain volume, GM volume,30 as well as regional features, including 
surface area,31 cortical thickness,30 and regional GM volume.6 Voxel-based morphometry is 
frequently used to examine GM volume and is a voxel-wise comparison of the local 
concentration of GM between different groups.6 FreeSurfer is used to render construction 
of cortical surface models, volumetric segmentation of brain structures, and mapping of 
cortical GM thickness (http://freesurfer.net, v5.3.0).30 Three-dimensional mapping of 
cortical thickness is also possible using the Laplace equation method.47 
 Diffusion MRI is an innovative technique to investigate WM properties and micro-
structural WM changes.7 Diffusion imaging data are used to map the 3-dimensional 
diffusion of water molecules in the brain. Currently, diffusion tensor imaging (DTI) is the 
most widely used method for assessing WM orientation and integrity. The diffusion tensor 
characterizes the degree, the magnitude of anisotropy, and the orientation of directional 
diffusion.1 This technique provides measures such as fractional anisotropy (FA) and mean-, 
radial-, and axial diffusivity (AD).87 Nevertheless, it recently became clear that this tensor 
model is invalid in voxels containing crossing fibers.89 Therefore, various methods have 
been developed that are capable to extract multiple fiber orientations from the diffusion- 
weighted imaging signal, thereby overcoming the limitation of DTI.45 Compelling structural 
MRI research has shown alterations in GM morphology and WM properties in various 
chronic MSKP conditions, including patients with fibromyalgia, chronic low back pain, 
and chronic temporomandibular disorders,20,52,61,68 within brain regions involved in 
somatosensory, affective, and cognitive modulation of pain, such as the somatosensory 
cortex (S1, S2), medial and dorsolateral prefrontal cortex, anterior (ACC) and posterior 
cingulate cortex (PCC), insula, amygdala, hippocampus, and periaqueductal gray.8,19-
21,27,37,52,82,83 
 Functional MRI (fMRI) is used to evaluate human brain function in vivo and is on the 
basis of measuring the blood oxygen-level dependent (BOLD) contrast.15 fMRI is able to 
analyze changes in BOLD contrast during a task or during rest.13 During task-based fMRI, 
the BOLD contrast shows the hemodynamic brain changes after enhanced neural brain 
activity while performing a specific task.59,78 When a person is at rest (no task), spontaneous 
low-frequency (< .1 Hz) fluctuations of the BOLD signal occur throughout the brain.38 This 
signal exposes temporal correlations in spatially distinct brain regions. Certain patterns 
appear consistently and are referred to as resting-state functional networks.
 Resting-state fMRI research aims to generate statistical maps of these significant 
temporal BOLD correlations between brain areas.13 These correlations of signal fluctuations 
between distinct brain regions are calculated as an index of functional connectivity (FC).34 
The default mode network (DMN) and the salience network are examples of resting-state 
(no task) functional networks in the brain.54 Recently, various research groups have shown 
reorganized connectivity patterns within various resting-state functional networks such 
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Eligibility assessment of the obtained articles was performed by 2 independent researchers 
(I.C. and B.C.), who have published systematic reviews and were trained in conducting 
a systematic review by the second author (M.M.). After deduplication, a first screening 
was performed on the basis of the title and abstract of the remaining articles. 
If any of the inclusion criteria were not met, the article was excluded. In the second phase, 
publications were screened on the basis of the full-text and fulfilment of the inclusion 
criteria was ensured. 
Literature Search Strategy 
A systematic search of relevant literature was conducted by the authors. The electronic 
databases PubMed (http://www.ncbi.nlm.nih.gov/pubmed), Web of Science (http://isiwe-
bofknowledge.com), Cinahl (https://health.ebsco.com/products/cinahl-complete), and 
Cochrane (http://onlinelibrary.wiley.com/cochranelibrary/search) were searched through 
on September 7, 2015 to identify relevant articles. To make the search as complete as 
possible, reference lists of the included articles were screened. The search strategy consisted 
of a combination of free text words on the basis of the eligibility criteria. The complete 
search strategy is shown in Table 2. 
Risk of Bias in Individual Studies 
Methodological quality of all included studies was assessed by 2 independent reviewers 
(I.C. and J.K.), both PhD candidates working with chronic MSKP patients in the research 
field of brain MRI. Both reviewers were trained by M.M., a PhD experienced in conducting 
systematic reviews. Risk of bias was evaluated using the Newcastle-Ottawa Scale (NOS) for 
case-control studies (http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp).93 
The NOS applies a star rating system to judge methodological quality on the basis of 3 
subcategories: selection of groups, comparability, and ascertainment of exposure. This 
checklist is recommended for case-control studies99 and has frequently been used by the 
Cochrane Collaboration (www.cochrane.org). The criterion on response rate could not be 
scored because this item was not applicable for the articles on the current research topic. 
Therefore, item 9 was replaced by a self-constructed additional subcategory, ‘MRI data 
quality and preprocessing’ that includes 2 items, which was chosen specifically for the 
current systematic review. Item 9 scores whether the researchers performed visual 
inspection of the MRI data quality (eg, head motion). Item 10 scores whether manual 
exclusion in case of low data quality and/or data adjustment was included in the 
preprocessing pipeline. Subsequently, each study could reach a maximum score of 10 on 
the modified NOS, representing the highest methodological quality. A study earned 1 
point when controlling for sex or age in the ‘comparability’ section and an additional 
point when controlling for another factor (eg, medication use, collecting cardiorespiratory 
data). 
questions: 1) ‘What are the relations between structural brain alterations (O = outcome) 
and clinical pain measures (O) in chronic MSKP patients (P = patient), examined with 
structural brain MRI techniques (I = measurement instrument)? 2) ‘What are the relations 
between functional brain alterations (O) and clinical pain measures (O) in chronic MSKP 
patients (P), examined with functional brain MRI techniques (I)? 
Eligibility Criteria 
Eligibility assessment was performed by screening the obtained articles on the basis of 
the inclusion and exclusion criteria (Table 1). To be included, articles had to investigate a 
relation or association between structural or functional brain alterations and clinical 
measures/correlates of pain (ie, pain duration, pain intensity, pain perception, pressure 
sensitivity, hyperalgesia, hypersensitivity, allodynia, referred pain) (O) by using brain MRI 
techniques (I) in patients with chronic MSKP (P).
Table 1 Inclusion and Exclusion criteria
Inclusion Exclusion
Population · Human study
· Patients with chronic MSKP
· Adults (≥ 18 y of age)
· Animal study
· Children and adolescents  
(<18 y of age)
Instrument ·  At least 1 brain MRI technique  
is applied: T1 MRI, DTI, DWI, fMRI, 
rs-fMRI
· SPECT, PET, EEG, MEG, MR spectroscopy
Outcome 1 · At least 1 clinical pain measure 
was examined: pain intensity, pain 
perception, pain duration, allodynia, 
hyperalgesia, referred pain, pressure 
sensitivity
· Not examining the relation, association, 
or correlation between a clinical pain 
measure and structural or functional 
brain alterations
Outcome 2 · At least 1 type of brain change was 
examined: structural or functional 
alterations
· Not examining the relation, association, 
correlation between a clinical pain 
measure and brain alterations
Type of report · Clinical
· Full-text 
· Nonclinical: review, systematic review, 
meta-analysis, letters to the editor
· Full-text not available, abstracts, posters
Language · English, German, Dutch, French · All other languages
Abbreviations: T1 MRI, T1-weighted MRI; DWI, diffusion weighted imaging; rs-fMRI, resting-state fMRI; SPECT, 
single photon emission computed tomography; PET, photon emission tomography; EEG, electro-
encephalography; MEG, magnetoencephalography; MR, magnetic resonance.
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On the basis of study design and methodological quality, each individual study received 
a level of evidence, according to the 2005 classification system of the Dutch Institute for 
Healthcare Improvement (CBO) (Supplementary Table 1). Subsequently, strength of 
conclusion was determined after clustering studies with comparable experimental 
methods and research aims, accounting for the study design and the risk of bias 
(Supplementary Table 2). Strength of conclusion 2 was assigned when there were at least 
2 independently conducted studies of evidence level B. Strength of conclusion 3 was 
assigned when there was at least 1 study of evidence level B. Strength of conclusion 4 was 
given in case of inconclusive or inconsistent results between various studies.
Data Extraction Process 
The following information was extracted from each included study and is shown in the 
evidence table (Supplementary Table 3): 1) patients, 2) control group, 3) brain MRI 
technique, 4) clinical pain measures, 5) correlations, relations, associations, 6) main results, 
and 7) correlation coefficients, t-scores, Z-scores. The data were obtained by the first 
author (I.C.) and a second reviewer (R.D.P.) checked the extracted data. Noteworthy, the 
evidence table only includes the MRI techniques and clinical pain measures, which were 
used to evaluate possible relations. In addition, the main results regarding relations 
between clinical pain measures and brain alterations in chronic MSKP patients are 
summarized whereas the results among the healthy control group are not shown. 
Results 
Study Selection 
The selection process of relevant articles is presented in Figure 1. The initial search resulted 
in 137 articles. After removing the duplicates, 91 articles remained. Two articles32,37 were 
found by manual search: these articles were found in the reference list of included studies. 
The entire selection process resulted in 20 eligible articles.
Study Characteristics 
All included studies (n = 20) applied a case-control design, comparing chronic MSKP 
patients with healthy pain-free individuals. The characteristics of each study were 
extracted and presented in the evidence table (Supplementary Table 3). Articles were 
divided on the basis of the applied MRI technique. Six articles compared clinical pain 
measures with GM alterations,22,37,53,67,71,97 4 articles with WM alterations,48,56,61,68 and 11 
articles observed relations with functional brain alterations.9,22,28,32,43,44,49,51,60,74,98 
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Syntheses of Results 
Structural Brain MRI 
Overall, 10 studies investigated the relationship between structural brain alterations and 
clinical pain measures in chronic MSKP patients.22,37,48,53,56,61,67,68,71,97 Six of 10 articles used 
voxel-based morphometry,22,37,53,67,71,97 1 article performed cortical thickness analysis,67 and 
4 articles applied DTI.48,56,61,68 
Risk of Bias Within Studies and Level of Evidence 
The risk of bias and level of evidence is shown in Table 3. All studies scored a level of 
evidence B. Methodological quality was moderate to good, varying between 5 of 10 (50%) 
and 9 of 10 (90%). Most studies lost points on ‘representativeness of the cases’ (80%), 
‘selection of controls’ (85%), and ‘definition of controls’ (60%), either because authors did 
not mention the required information or the information was not adequate. Nevertheless, 
most studies were awarded for taking into account confounding factors (eg, matching for 
age and sex), ascertainment of exposure, and for using the same method of ascertainment 
for cases and controls. All studies were awarded for manual exclusion in case of low data 
quality and/or inclusion of automated data adjustment in the preprocessing pipeline. 
 In most cases (90.5% or 181 of the 200 items), the 2 reviewers (I.C. and J.K.) agreed. 
After a second review and a comparison of the 19 differences, the reviewers reached a 
consensus for 197 items. For the 3 remaining items, a third investigator was consulted 
(R.D.P.). The final score of each study is presented in Table 3.
Figure 1  Preferred Reporting Items for Systematic reviews and Meta-Analyses flow diagram 
of the conducted search.
Records identified through database searching
Pubmed (n=63); Web of Science (n=66); 
Cinahl (n=5); Cochrane (n=3)  
Additional records identified through
other sources
(n=2) 
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Records after duplicates removed
(n=91) 
Records screened on titles  and abstracts
(n=91)
Records excluded
(n=62)
Full-text articles
excluded (n=9)
Reasons:
•  Population (n=1)
•  Outcome 
 – no correlation (n=7)
•  Outcome
 – other (n=1)
Full-text articles assessed for eligibility
(n=29)
Studies included in qualitative synthesis
(n=20)
Table 3  Methodological Quality for Case-Control Studies
Study
Selection Com- 
parability
Exposure MRI data 
quality 
and pre-
processing
Total 
score 
(%)
LOE
1 2 3 4 5 6 7 8 9 10
Kim et al48 - + + + + + + + + + 9/10 (90) B
Moayedi et al68 + / - + + + + + + + 8/10 (80) B
Ichesco et al44 + - - + + + + + + + 8/10 (80) B
Ichesco et al43 + - - + + + + + + + 8/10 (80) B
Gerstner et al37 + - - + + + + + - + 8/10 (80) B
Lutz et al61 + / - + + + + + + + 8/10 (80) B
Moayedi et al67 + - - + + + + + - + 7/10 (70) B
Kim et al49 + - - + + + + + - + 7/10 (70) B
López-Solà et al60 + / - - + + + + + + 7/10 (70) B
Baliki et al10 + + - - + + + + - + 7/10 (70) B
Mordasini et al71 + - - - + + + + + + 7/10 (70) B
Yu et al98 + - + - + + + - - + 7/10 (60) B
Ceko et al22 + - - - + + + + - + 7/10 (70) B
Kong et al51 + - + - + + + - + + 7/10 (70) B
Flodin et al32 - - - - + + + + + + 6/10 (60) B
Farmer et al28 + + - - + + + + - + 6/10 (60) B
Lieberman et al56 + - - - + - + + + + 6/10 (60) B
Younger et al96 + + - - + - / + - + 5/10 (50) B
Napadow et al74 - - - - + + + + - + 5/10 (50) B
Kuchinad et al53 - - - - + + + + - + 5/10 (50) B
Abbreviations: LOE, level of evidence; +, score fulfilled; -, score not fulfilled; /, answer is unclear. 
NOTE. Newcastle-Ottawa Quality Assessment Scale: case-control studies: 1=Is the case definition adequate?; 
2=Representativeness of the cases; 3=Selection of controls; 4=Definition of controls; 5=Study controls for age 
or sex; 6=study controls for any additional factor; 7=Ascertainment of exposure; 8=Same method of 
ascertainment for cases and controls; 9= visual inspection of the MRI data quality; 10= manual exclusion in 
case of low data quality and/or automated data adjustment included in pre-processing pipeline.
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middle temporal gyrus. Kuchinad et al53 reported that longer disease duration in 
fibromyalgia patients was correlated with decreased total GM volume. In contrast, Younger 
et al96 and Moayedi et al67 described a positive relation between duration of temporo-
mandibular disorders and regional GM volume. Increased GM volume was found in the 
PCC and midbrain bilaterally, in the right hippocampus and in the right middle cerebellar 
peduncle.97 Further, longer temporomandibular disorders disease duration was correlated 
with increased GM volume in the sensory thalamus.67 
 In conclusion, there is moderate evidence that regional GM volume alterations are 
correlated with chronic MSKP duration (strength of conclusion 2). However, inconclusive 
evidence exists regarding the relation between longer disease duration and decreased or 
increased regional GM volume (strength of conclusion 4). Additionally, there is some 
evidence that longer disease duration in fibromyalgia patients is correlated with decreased 
total GM volume (strength of conclusion 3). 
WM Alterations Related to Clinical Pain Measures 
Pain Intensity. Four studies48,56,61,68 investigated the relationship between clinical pain 
correlates and structural alterations in WM using DTI as an MRI technique. Kim and 
colleagues48 and Moayedi and colleagues68 reported a correlation between higher pain 
intensity and lower FA in the corpus callosum,48 internal, external and extreme capsules,68 
and the thalamus.68 Moayedi et al68 also detected a negative correlation between pain 
unpleasantness and FA in the right internal capsule. In contrast, Lutz et al61 and Lieberman 
et al56 have reported positive correlations between higher pain intensity and increased 
FA values in the WM of the right superior frontal gyrus61 and between higher total pain 
experience score and increased FA in the left uncinate fasciculus.56 
 In conclusion, there is moderate evidence that higher pain intensity is correlated 
with FA alterations in regional WM tracts involved in transmission of somatosensory, pain, 
and affective and cognitive information (strength of conclusion 2). However, there is 
inconclusive evidence as to whether greater pain intensity is related to decreased or 
increased FA values in these WM tracts (strength of conclusion 4). 
Subjective Pain Scores 
Lieberman et al56 reported positive correlations in chronic MSKP patients between higher 
total pain experience scores and increased AD in the left anterior and posterior limb of the 
internal capsule. Additionally, increased typical pain scores on the McGill pain questionnaire 
were positively correlated with increased AD in the left anterior limb. 
 In conclusion, there is some evidence that increased subjective pain scores in chronic 
MSKP patients are correlated with increased AD in WM tracts involved in transmission of 
information through the anterior and posterior limb of the internal capsule (strength of 
conclusion 3). 
GM Alterations Related to Clinical Pain Measures 
Pain Intensity. Three studies examined the relation between clinical pain intensity and 
alterations in regional GM volume.67,71,97 
 Mordasini et al71 and Younger et al96 reported a significant relation between pain 
intensity and regional GM volume. Increased pain intensity in patients with chronic 
 temporomandibular disorders was associated with decreased GM volume in the right 
rostral ACC, right PCC, precuneus, and superior frontal and superior temporal gyrus.97 
Mordasini et al71 reported correlations between higher chronic pelvic pain intensity and 
decreased GM volume in the left ACC. 
 In conclusion, there is moderate evidence that higher clinical pain intensity in chronic 
MSKP patients is related to decreased GM volume in pain processing regions such as the 
ACC71,97 (strength of conclusion 2). 
 Moayedi et al67 reported a negative correlation between pain intensity in temporo-
mandibular disorders patients and GM thickness in the anterior midcingulate cortex and 
the ventrolateral aspect of the primary motor cortex. Furthermore, they reported that 
increased pain unpleasantness was associated with decreased GM thickness in the lateral 
orbitofrontal cortex. 
 In conclusion, there is some evidence that increased pain intensity and pain 
unpleasantness in chronic temporomandibular disorders patients is correlated with 
decreased GM thickness in pain, motor, and cognitive processing regions of the brain 
(strength of conclusion 3).
Pressure Pain Sensitivity 
Two studies reported an association between pressure pain sensitivity and regional GM 
volume alterations.22,97 
 Younger et al96 reported a negative association between pressure pain sensitivity and 
GM volume in the trigeminal nuclei in chronic temporomandibular disorders patients. 
Furthermore, Ceko and colleagues22 observed significant relations between increased 
pressure pain sensitivity and decreased GM volume in the left anterior insula and PCC in 
fibromyalgia patients.
 In conclusion, there is moderate evidence that increased pressure pain sensitivity in 
chronic MSKP patients is associated with decreased GM volume in somatosensory, pain, 
and affect-cognitive processing brain regions (strength of conclusion 2). 
Pain Duration
Four articles37,53,67,97 reported an association between the duration of chronic MSKP and GM 
volume alterations. Three articles described a relation with regional GM volume37,67,97 and 
1 article showed a relation with total GM volume.53 A negative correlation was reported by 
Gerstner et al,37 who observed that longer pain duration in chronic temporomandibular 
disorders patients was correlated with decreased GM volume in the right superior and 
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pain ratings and FC between periaqueductal gray and left ventromedial prefrontal cortex/
rostral ACC after a pain-inducing maneuver. 
 In conclusion, there is moderate evidence that greater clinical pain intensity is related 
to alterations in FC in chronic MSKP patients (strength of conclusion 2). However, 
inconclusive evidence exists regarding the direction of the relation within somatosensory, 
pain, and affect-cognitive processing regions/networks in chronic MSKP patients. 
Positive9,22,32,44,51,73,74 and negative32,43,49,73,74,98 relations between pain intensity and FC 
alterations were found (strength of conclusion 4). 
Pressure Pain Sensitivity 
Three studies investigated the relation between pressure pain sensitivity and FC 
alterations.32,43,44 Flodin et al32 reported that increased pressure pain sensitivity in 
fibromyalgia was correlated with decreased FC between the right inferior orbitofrontal 
regions and right associative visual cortex. In contrast, they also reported a relation 
between increased pressure pain sensitivity and increased FC between pain-related 
regions (ie, the left insula and dorsal PCC, the left Rolandic operculum, left parahippo-
campal gyrus, and thalamus and prefrontal cortex). 
 Ichesco et al44 investigated correlations between FC and pressure pain thresholds at 
different intensities. In fibromyalgia patients, a negative correlation was detected between 
lower pressure pain thresholds, hence increased pressure pain sensitivity and higher FC. 
Higher FC was reported between the right posterior insula and PCC during a faint, mild, and 
slightly intense stimulus. A slightly intense stimulus correlated with FC between the left 
middle insula and left middle cingulate cortex. When a faint stimulus was given, higher FC 
was reported between the left middle insula and right middle cingulate cortex and between 
the right posterior insula and left middle ACC. Ichesco et al43 reported that increased pressure 
pain sensitivity was related to decreased FC between the left anterior insula and the right 
ACC and medial frontal gyrus in chronic temporomandibular disorders patients. 
 In conclusion, there is moderate evidence that pressure pain sensitivity is related to 
alterations in FC within somatosensory, pain, and affect-cognitive processing brain 
regions/networks in chronic MSKP patients (strength of conclusion 2). However, 
inconclusive evidence exists regarding the direction of the relation between increased 
pressure pain sensitivity and FC alterations in chronic MSKP patients. Positive32,43 and 
negative32,44 relations between pressure pain sensitivity and FC alterations were found 
(strength of conclusion 4). 
Functional Activity Alterations Related to Clinical Pain Measures 
Pain Intensity. Farmer et al28 reported a positive correlation between pain intensity and 
activity in the anterior insula in men with chronic pelvic pain. Lopez-Sola et al60 observed 
negative correlations between pain intensity in fibromyalgia patients and activation in 
primary and secondary visual cortical areas. Furthermore, hypersensitivity to tactile 
Functional Brain MRI 
Overall, 11 articles described interrelations between clinical pain correlates and functional 
brain alterations using fMRI and/or resting-state fMRI in chronic MSKP patients.9,22,28,32,4 
3,44,49,51,60,74,98 Six studies examined fibromyalgia patients, 1 article included chronic pelvic 
pain patients, 3 articles assessed chronic low back pain patients, 1 article investigated 
osteoarthritis patients, and 1 article included patients with temporomandibular 
disorders. 
FC Alterations Related to Clinical Pain Measures 
Pain Intensity. Most studies investigated relations between clinical pain measures and FC 
alterations.9,22,32,43,44,49,51,73,74,98 Napadow et al74 reported in fibromyalgia patients a positive 
association between higher current pain intensity and increased FC between the DMN 
and right middle and anterior insula, cerebellum, dorsolateral prefrontal cortex, and 
subgenual ACC. Further, a positive covariation was reported between higher current pain 
intensity and increased FC between the right executive attention network and right 
anterior, left middle, and posterior insula and putamen. 
 In contrast, Napadow et al74 reported higher current pain intensity to be related to 
decreased FC between the right executive attention network and the hippocampus, 
periaqueductal gray, nucleus cuneiformis, and the pontine raphe. A negative relation was 
shown in temporomandibular disorders patients between pain intensity and FC between 
the left anterior insula and rostral ACC during resting-state fMRI by Ichesco et al.43 Ichesco 
et al,44 reported in fibromyalgia patients higher pain intensity to be related to increased FC 
between the right anterior insula and superior temporal gyrus. Kong et al51 reported 
positive relations between pain intensity changes after exercises and FC at the left insula, 
precuneus, amygdala, and fusiform in chronic low back pain patients. 
 Baliki et al10 reported in chronic low back pain and osteoarthritis patients positive 
correlations between current pain intensity and medial prefrontal cortex/insula FC. 
Further, Ceko et al22 reported in fibromyalgia patients positive relations between current 
pain intensity and FC of the left anterior insula to the primary somatosensory cortex (S1) 
and primary motor cortex. In addition, Kim et al49 reported a correlation between higher 
pain intensity and increased changes (from the pain phase through the rest phase) in S1 
leg connectivity to the anterior insula in fibromyalgia patients. Additionally, increased 
temporal summation of pain was correlated with increased changes in S1 leg connectivity 
to the right anterior/middle insula in fibromyalgia patients. In contrast, higher clinical pain 
intensity was related to decreased resting-state FC within S1. 
 Ichesco et al44 examined associations between pain rating index scores and FC in 
fibromyalgia patients. Higher FC, between insula and superior temporal gyrus, was 
associated with higher affective scores. Higher sensory scores were correlated with greater 
FC between the right middle insula and bilateral precuneus. In contrast, Yu et al98 observed 
in chronic low back pain patients a negative relationship between increased low back 
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It can be summarized that different chronic MSKP syndromes, which seem to be a 
heterogeneous group, expose unique (specific for each chronic MSKP condition) 
anatomical ‘brain signatures’ and functional reorganization. However, among all included 
chronic MSKP conditions it seems that brain regions involved in the limbic-affective and 
cognitive component of pain processing are involved in the observed neuroplastic brain 
remodeling. On the basis of this compelling evidence it can be stated that chronic MSKP 
is not only involved with somatosensory processing but also critically involves cognitive 
and affective-limbic processing in regions such as the ACC, insula, prefrontal cortex, and 
amygdala.
 Important to discuss is that the observed relations (eg, extent and direction) between 
clinical pain characteristics and brain alterations can be influenced by multiple factors. 
Research has shown in chronic MSKP and non-MSKP patients the influence on pain and 
neuroplasticity of sex, age, genetics, environment, preexisting vulnerabilities, previous 
experiences, medication, culture, and psychosocial factors.8,16,22,35,41,58,63,65,69,88,96 Accordingly, 
all of these variables could interfere with the observed relations between brain alterations 
and clinical pain measures and therefore may explain the incongruence found in this 
systematic review. 
 Various hypotheses can be made to explain the relation between clinical pain 
measures and GM decreases. It has been suggested that GM decrease is associated with 
long-term nociceptive input and neuroplastic changes.5,50,84 Furthermore, increased 
cortical thickness for example in frontal brain regions could be the consequence of 
increased cognitive load in chronic pain conditions.67 The frontal pole may process the 
cognitive dimension of pain, which suggests that pain has a cognitive load and this may 
require continuous engagement of regions in the frontal cortex and subsequently may 
lead to cortical thickening. The same theories could be hypothesized for alterations in 
limbic-affective brain regions. 
 To put the results of the current systematic review into a broader perspective, 
scientific studies regarding the relations between brain alterations and clinical pain 
measures in chronic non-MSKP patients should be reported. Research in other chronic 
pain syndromes such as irritable bowel syndrome and complex regional pain syndrome 
has also investigated the relationship between structural and functional brain alterations, 
and clinical pain measures such as pain intensity, pain inhibition, and pain duration.12,79,91,94 
Positive and negative correlations between clinical pain measures and GM morphology 
alterations have been reported in chronic non-MSKP patients in similar regions involved in 
somatosensory, affective, and cognitive components of pain processing, as reported in 
chronic MSKP patients.12,79,91 The observed relations between brain alterations and clinical 
pain measures in chronic non-MSKP patients are in accordance with the results of our 
systematic review, but the direction of the relation was often conflicting. 
stimulation (ie, allodynia) was related to decreased activation in the superior middle 
temporal gyri. 
 In conclusion, there is some evidence that higher pain intensity and allodynia are 
associated with decreased functional brain activation in fibromyalgia patients (strength of 
conclusion 3). Further, there is some evidence that greater pain intensity is related to 
increased functional activity in the anterior insula in men with chronic pelvic pain (strength 
of conclusion 3). 
Discussion 
The purpose of this systematic review was to summarize the evidence regarding relations 
between structural and functional brain alterations and clinical pain measures in chronic 
MSKP patients, examined with brain MRI techniques. Most studies reported significant 
relations between structural and functional alterations in the brain and various clinical 
pain correlates such as pain intensity, pain duration, and pressure pain sensitivity. Overall, 
the included studies examined a wide range of brain regions involved in somatosensory, 
cognitive, and affective processing of pain. Remarkably, the direction of the relations (eg, 
increased or decreased GM volume related to higher pain measures) often differed 
between and within various studies. This might be due to a variety of conditions that are 
classified as chronic MSKP, together with the multiple MRI acquisition and analytical 
techniques that have been applied to measure alterations in the brain. Furthermore, the 
different standardized scales and questionnaires that have been used to measure clinical 
features of pain could have influenced the direction and nature of the observed relations 
as well as the specific brain regions that were investigated. Nevertheless, several 
conclusions can be made and are summarized in Table 4. In addition, a glossary of 
important terms regarding MRI analysis of brain alterations is presented in Table 5. 
 Twenty case-control studies met the inclusion criteria. All studies scored a level of 
evidence B. Methodological quality was moderate to good, varying between 5 of 10 (50%) 
and 9 of 10 (90%). Moderate evidence shows that higher pain intensity and pressure pain 
sensitivity are related to decreased regional GM volume in brain regions encompassing 
the cingulate cortex, the insula, and the superior frontal and temporal gyrus.22,71,97 Further, 
some evidence exists that longer disease duration in fibromyalgia patients is correlated 
with decreased total GM volume. Yet, inconclusive evidence exists regarding the 
association of longer disease duration with decreased or increased regional GM volume in 
other chronic MSKP conditions.37,67,97 Moreover, moderate evidence is present for a 
correlation between higher pain intensity and FA alterations in regional WM tracts48,56,61,68 
and FC alterations.9,22,32,43,44,49,51,73,74,98 However, inconclusive evidence was found regarding 
the direction of the relation of pain intensity and pressure pain sensitivity with micro-
structural WM48,56,61,68 and FC9,22,32,43,44,49,51,73,74,98 alterations in chronic MSKP. 
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Clinical Relevance and Implications 
To our knowledge, this is the first systematic review summarizing the current evidence 
regarding relations between brain alterations explored with MRI, and clinical pain correlates 
(ie, pain duration, pain intensity, pain perception, pressure sensitivity, hyperalgesia, hyper-
sensitivity, allodynia, and referred pain) in patients with chronic MSKP. Regarding the 
results, it can be stated that structural and functional brain alterations are closely related 
to clinical aspects of pain perception, modulation, and duration. Increased pain intensity 
and pressure pain sensitivity seem to be related to decreased GM volume in regions 
involved in somatosensory, affective, and cognitive processing of pain. In contrast, 
inconclusive evidence was found regarding the direction of the relation between WM and 
FC alterations, and increased pain intensity or pressure pain sensitivity. 
 On the basis of the summarized evidence, we can presume that central pain 
processing mechanisms of the brain play a crucial role in the persistent pain complaints of T
ab
le
 4
  S
um
m
ar
y 
of
 e
vi
de
nc
e 
re
ga
rd
in
g 
in
te
rr
el
at
io
ns
 b
et
w
ee
n 
br
ai
n 
al
te
ra
tio
ns
 a
nd
 c
lin
ic
al
 p
ai
n 
m
ea
su
re
s
Br
ai
n 
st
ru
ct
ur
al
 &
 fu
nc
tio
na
l a
lte
ra
tio
ns
 ~
 C
lin
ic
al
 p
ai
n 
m
ea
su
re
s
St
re
ng
th
 o
f C
on
cl
us
io
n
Re
fe
re
nc
e
In
te
rr
el
at
io
ns
 b
et
w
ee
n 
G
M
 a
lte
ra
tio
ns
 a
nd
 c
lin
ic
al
 p
ai
n 
m
ea
su
re
s 
in
 c
hr
on
ic
 M
SK
P
 G
M
 v
ol
um
e 
(A
CC
) ~
 
 c
lin
ic
al
 p
ai
n 
in
te
ns
ity
M
od
er
at
e 
ev
id
en
ce
 (2
)
71
, 9
6
 G
M
 v
ol
um
e 
(p
ai
n 
pr
oc
es
si
ng
 re
gi
on
s)
 ~
 
 p
re
ss
ur
e 
pa
in
 s
en
si
tiv
ity
M
od
er
at
e 
ev
id
en
ce
 (2
)
22
, 9
6
Δ
 in
 re
gi
on
al
 G
M
 v
ol
um
e 
(p
ai
n 
pr
oc
es
si
ng
 re
gi
on
s)
 ~
 
 p
ai
n 
du
ra
tio
n
M
od
er
at
e 
ev
id
en
ce
 (2
)
37
, 6
7,
 9
6
 to
ta
l G
M
 v
ol
um
e 
~
 
 p
ai
n 
du
ra
tio
n 
in
 F
M
Pr
el
im
in
ar
y 
ev
id
en
ce
 (3
)
53
 G
M
 th
ic
kn
es
s 
(p
ai
n 
pr
oc
es
si
ng
 re
gi
on
s)
 ~
 
 p
ai
n 
in
te
ns
ity
 a
nd
 u
np
le
as
an
tn
es
s
Pr
el
im
in
ar
y 
ev
id
en
ce
 (3
)
67
In
te
rr
el
at
io
ns
 b
et
w
ee
n 
W
M
 a
lte
ra
tio
ns
 a
nd
 c
lin
ic
al
 p
ai
n 
m
ea
su
re
s 
in
 c
hr
on
ic
 M
SK
P
Δ
 in
 F
A
 (W
M
 tr
ac
ts
 in
vo
lv
ed
 in
 tr
an
sm
is
si
on
 o
f s
om
at
os
en
so
ry
, p
ai
n,
 a
ffe
ct
iv
e,
 a
nd
 c
og
ni
tiv
e 
in
fo
rm
at
io
n)
 ~
 
 c
lin
ic
al
 p
ai
n 
in
te
ns
ity
M
od
er
at
e 
ev
id
en
ce
 (2
)
56
, 4
8,
 6
1,
 6
8
 A
D
 (W
M
 tr
ac
ts
 in
vo
lv
ed
 in
 tr
an
sm
is
si
on
 o
f i
nf
or
m
at
io
n 
th
ro
ug
h 
th
e 
ba
sa
l g
an
gl
ia
) ~
 
 s
ub
je
ct
iv
e 
pa
in
 s
co
re
s
Pr
el
im
in
ar
y 
ev
id
en
ce
 (3
)
56
In
te
rr
el
at
io
ns
 b
et
w
ee
n 
FC
 a
lte
ra
tio
ns
 a
nd
 c
lin
ic
al
 p
ai
n 
m
ea
su
re
s 
in
 c
hr
on
ic
 M
SK
P
Δ
 in
 F
C
 (b
ra
in
 re
gi
on
s/
ne
tw
or
ks
 in
vo
lv
ed
 in
 s
om
at
os
en
so
ry
, p
ai
n,
 a
nd
 a
ffe
ct
-c
og
ni
tiv
e 
pr
oc
es
si
ng
  
of
 p
ai
n)
 ~
 
 c
lin
ic
al
 p
ai
n 
in
te
ns
ity
M
od
er
at
e 
ev
id
en
ce
 (2
)
10
, 2
2,
 3
2,
 4
4,
 7
4,
 4
3,
 4
9,
 5
1,
 7
3,
 9
8
Δ
 in
 F
C
 (b
ra
in
 re
gi
on
s/
ne
tw
or
ks
 in
vo
lv
ed
 in
 s
om
at
os
en
so
ry
, p
ai
n,
 a
nd
 a
ffe
ct
-c
og
ni
tiv
e 
pr
oc
es
si
ng
  
of
 p
ai
n)
 ~
 
 p
re
ss
ur
e 
pa
in
 s
en
si
tiv
ity
M
od
er
at
e 
ev
id
en
ce
 (2
)
32
, 4
3,
 4
4
In
te
rr
el
at
io
ns
 b
et
w
ee
n 
fu
nc
tio
na
l a
ct
iv
it
y 
al
te
ra
tio
ns
 a
nd
 c
lin
ic
al
 p
ai
n 
m
ea
su
re
s 
in
 c
hr
on
ic
 M
SK
P
 fu
nc
tio
na
l a
ct
iv
ity
 (t
em
po
ra
l, 
oc
ci
pi
ta
l r
eg
io
ns
) ~
 
 c
lin
ic
al
 p
ai
n 
in
te
ns
ity
 a
nd
 a
llo
dy
ni
a 
Pr
el
im
in
ar
y 
ev
id
en
ce
 (3
)
60
 fu
nc
tio
na
l a
ct
iv
ity
 in
 a
nt
er
io
r i
ns
ul
a 
~
 
 c
lin
ic
al
 p
ai
n 
in
te
ns
ity
 
Pr
el
im
in
ar
y 
ev
id
en
ce
 (3
)
28
A
bb
re
vi
at
io
ns
: 
, d
ec
re
as
ed
; 
, i
nc
re
as
ed
; F
M
, fi
br
om
ya
lg
ia
.
Table 5  Glossary of important terms regarding MRI analysis of brain alterations
DMN A constellation of brain regions thought to be involved in self-referential thinking.18, 32 
The DMN is deactivated during various externally focused task conditions.
ICA Technique to analyse resting-state fMRI data, which allows for the estimation of 
resting- state or functional connectivity networks. 
EAN The frontoparietal executive attention network is a brain network involved in cognitive 
processing of working memory and attention.23, 70
FA Fractional anisotropy is a measure of the degree of diffusion anisotropy. The FA is 
normalized so that it ranges from zero (diffusion is isotropic) to one (diffusion is 
constrained along one axis only). FA is typically much higher in WM structures than 
in CSF and GM, due to the highly organized and tightly packed myelinated axons in 
WM. Because of this, FA is often used as a surrogate marker for WM ‘integrity’.14
AD Axial diffusivity is a measure of diffusion along the first eigenvector. Decreased AD 
but unchanged radial diffusivity is typically assumed to indicate axonal damage or 
a lower axonal density.14 As such, AD leads to a more specific interpretation of the 
concept of WM ‘integrity’ associated with FA.
Z-score A Z-score is a way of standardizing the scale of two distributions. When the scales 
have been standardized, it is easier to compare scores on one distribution to scores 
on the other distribution. The mean of a distribution of Z-scores is always 0. The 
standard deviation of a distribution of Z-scores is always 1.
T-score The T-score is a measure not of the strength of the association but the confidence 
with which we can assert that there is an association.
A T-score is a standard score Z shifted and scaled to have a mean of 50 and a 
standard deviation of 10.
Abbreviations: DMN, default mode network; ICA, independent components analysis; EAN, executive attention 
network; fMRI, functional MRI; FA, fractional anisotropy; AD, axial diffusivity; GM, grey matter; WM, white matter; 
CSF, cerebrospinal fluid
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could have been evaluated more thoroughly giving a more accurate view on the 
preprocessing of the MRI analyses. 
Recommendations for Further Research 
In most included studies, the investigation of interrelations between brain alterations and 
clinical pain measures was a secondary aspect. Researchers are mostly primarily interested 
in the differences in brain structure and function between patients with pain and healthy 
individuals. In future research, it is important to include correlation analyses between 
clinical pain measures and brain alterations as a primary focus of interest. The current 
systematic review has not included studies that investigated the relation between brain 
alterations and pain measures associated with maladaptive pain cognitions such as pain 
catastrophizing and hypervigilance. Maladaptive pain cognitions could be interesting to 
include in a future systematic review on this topic. 
 Many chronic MSKP conditions remain largely unexplored regarding this research 
topic. It would be valuable in future research to investigate also patients with chronic 
whiplash and chronic idiopathic neck pain regarding brain alterations and the relation 
with clinical correlates of pain. 
 Furthermore, it could be interesting to explore the relation between brain alterations 
and experimental measures of central pain modulation, such as temporal summation or 
the efficacy of conditioned pain modulation. Efficacy of pain inhibition and the degree of 
bottom-up sensitization could then be related to potential brain alterations. The 
interaction between structural and functional brain alterations would also be a valuable 
research topic. In addition, it could be interesting to further examine the relationship 
between structural and functional brain connectivity in chronic MSKP patients. Innovative 
analytical techniques such as graph theoretical analyses of structural and functional brain 
networks (ie, connectomics) could be applied in pain research and can contribute to an 
increased insight in chronic pain. Also, new and more advanced data acquisition and 
analytic techniques such as multishell diffusion MRI and multitissue constrained spherical 
deconvolution should be used in future pain research.45 Further, it will be a challenge for 
researchers and physicians to integrate brain neuroimaging including structural and fMRI 
into clinical/radiological practice at the individual level. 
 Finally, despite existing longitudinal brain research in patients with chronic 
MSKP10,23,39,62,72,85 the causality of the relations between brain alterations and chronic pain is 
not yet elucidated. Further research is warranted to clarify the direction of the relations of 
structural and functional brain alterations with clinical pain measures. It remains a crucial 
issue to further explore the underlying mechanisms of pain chronification and the role of 
brain alterations in this transition. Last, it will be a challenge for researchers to explore the 
effectiveness of different therapy strategies for chronic MSKP patients by analyzing the 
effects of specific interventions on brain morphological and functional alterations as well 
as on clinical measures of pain using a longitudinal design. 
patients with chronic MSKP. It is clear that pain is associated with a complex interplay 
among various brain regions and networks. Therefore, it can be recommended that the 
rehabilitation of patients with chronic MSKP has to be biopsychosocially-driven and that 
the central nervous system, including the brain has to be addressed. Recently, Baliki and 
Apkarian and colleagues concluded in 2 reviews that the activity and neuroplasticity of 
the limbic system plays a crucial role in the chronification of pain.4,8 This statement is in 
accordance with our observations of alterations in brain regions that are often engaged in 
emotional, motivational, and cognitive processing of pain. However, on the basis of the 
current systematic review and on the available literature the causality of the relations 
between brain alterations and chronic pain is not yet clear. 
Limitations and Strengths 
When interpreting the results, the following study limitations have to be taken into 
account. First, 50% of included studies did not report visual inspection of the raw MRI data 
quality. Visual inspection of data quality is, however, extremely important in MRI research.42 
Nevertheless, all included studies adequately reported the application of manual exclusion 
in case of low data quality and/or included automated data adjustment in the pre -
processing pipeline. The latter is equally important to obtain valid and reliable structural 
and fMRI data results.46,86 Second, despite the fact that neuroimaging research in chronic 
pain conditions has not only shown alterations in brain structure5 and function44 but also 
alterations in brain chemistry,33 we did not include articles on brain chemistry. In addition, 
studies using other functional neuroimaging techniques such as positron emission 
tomography, magnetoencephalography, and electroencephalography were not included. 
However, this was beyond the scope of this systematic review. Further, it is crucial to 
mention the fact that different MRI analytical techniques were used in the included 
studies, because the specific MRI acquisition and analytical technique can very much 
affect the outcome of a study. Next, it should be noted that the included studies used 
different standardized scales or questionnaires to measure clinical features of pain. This 
might result in difficulties comparing results of different studies. Last, when interpreting 
results of correlation analyses it is important to realize that a correlation between 2 
variables does not imply a causal relationship. Therefore, no conclusions can be drawn on 
the causality of the observed relations. Longitudinal studies are required to unravel the 
direction of the relations and to answer the question of causality: Are brain alterations the 
result or the origin of chronic pain or a combination?
 Several strengths of this systematic review can be outlined. First, the present study is 
innovative and has important clinical relevance. Second, the methodological quality of 
the included studies was moderate to good. Furthermore, the methods used for screening 
and scoring were completed by 2 independent blinded researchers. Last, the NOS was 
modified by adding 2 items specifically developed for the topic of the current systematic 
review. Consequently, the methodological quality and risk of bias of the brain MRI articles 
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Supplementary dataConclusion 
Moderate evidence was found for relations between clinical pain measures and structural, 
regional GM and WM morphology, and FC brain alterations within regions involved in 
somatosensory, affective-motivational, and cognitive processing of pain in chronic MSKP 
patients. Nevertheless, inconclusive results were found regarding the direction of these 
relations. Further research is warranted to unravel whether these brain alterations occur as 
a result of chronic pain or vice versa and whether these alterations are positively or 
negatively related to clinical measures of pain.
Supplementary Table 1  Level of evidence, according to the 2005 classification 
system of the Dutch Institute for Healthcare Improvement CBO
Intervention
A1 Systematic review of at least 2 independent from each other conducted studies  
of evidence level A2
A2 Randomized double-blinded comparative clinical research of good quality  
and efficient size
B Comparative research, but not with al characteristics as mentioned for A2.  
This includes also patient-control research and cohort research.
C Not comparative research
D Opinion of experts
www.cbo.nl
Supplementary Table 2  Strength of Conclusion (modified table)
Conclusion based on 
1 Research of evidence level A1 or at least 2 independent conducted studies of  
evidence level A2
2 1 research of evidence level A2 or at least 2 independent conducted studies of  
evidence level B 
3 1 research of evidence level B or C
4 Opinion of experts or Inconclusive or inconsistent results between various studies
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Supplementary Table 3
Studies Chronic MSK pain 
patients (n)
Healthy controls 
(n)
Measurement techniques Correlations, relations, 
associations
Main results in 
chronic MSK pain patients
Correlation coefficient (r), 
T-score, Z-score, p-value Brain MRI Clinical pain measures
Structural MRI techniques
Gray matter morphology
Kuchinad et al. 
(2007)(53)
FM (10) HC (10)
Age-matched
MRI (T1)
VBM
Disease duration Disease duration 
~ Total GMV
- Correlation:
1.  disease duration ~  total GMV
r= - 0.79
p= 0.007
Younger et al. 
(2010)(96)
M-TMD (14)
♀
Bilateral pain
HC (15)
Age-matched
MRI (T1)
VBM
Disease duration,
NRS (current pain),
Algometry (pressure pain 
sensitivity)
Disease duration,
Pain intensity, Pressure 
pain sensitivity,
~ regional GMV
+ Correlation:
1.  Disease duration ~  GMV R&L PCC, 
R hippocampus, R&L midbrain & R mid 
cerebellar peduncle
- Correlation: 
2.  pain intensity ~  GMV in R rostral ACC, 
R PCC with precuneus, SFG & STG
3.  pressure pain sensitivity ~
 GMV R&L trigeminal nuclei 
T-scores:
1. 4.78-5.63 
2. 5.58-5.93 
3. 5.02-8.00 
Gerstner et al. 
(2011)(5)
M-TMD (9)
R-handed
HC (9):
Age-matched
R-handed 
MRI (T1)
VBM
Pain duration Pain duration 
~ regional GMV
- Correlation:
1.  pain duration ~  GMV R STG/MTG
r= - 0.78
p<0.05
Moayedi et al. 
(2011)(67)
M-TMD (17)
Idiopathic
R-handed
HC (17)
R-handed
MRI (T1)
VBM
Cortical thickness 
analysis
NRS (current pain),
NRS (pain unpleasantness),
NRS (average pain & 
unpleasantness last month),
Disease duration
Pain intensity,
Pain unpleasantness 
~ GM thickness
Disease duration 
~ regional GMV
- Correlation:
1.  pain intensity ~  GM thickness in ant 
MCC & ventro-lateral M1
2.  pain unpleasantness ~  GM thickness 
in L OFC + Correlation:
3.  disease duration ~  GMV in the 
sensory thalamus
1.  r= - 0.83 
p<0.05
2.  r= - 0.74 
p<0.05
3.  r= 0.91 
p<0.05
Mordasini et al. 
(2012)(68)
CPPS (20)
Refractory
Idiopathic
R-handed
HC (20) 
Age-matched
R-handed 
MRI (T1)
VBM
NIH-CPSI (pain subscale) Pain intensity ~ regional 
GMV
- Correlation:
1.  pain intensity ~  GMV L ACC
1.  r= - 0.51 
p= 0.02
White matter properties
Lutz et al. (2008)(61) FM (30)
R-handed
HC (30)
Age-matched
R-handed
MRI (T1, T2)
DTI 
Pain intensity 
(FIQ subscore for pain)
Pain intensity 
~ FA of regional WM 
+ Correlation:
1.  pain intensity ~  FA in the WM of the R 
superior frontal gyrus 
1.  r= 0.43 
p= 0.03
Kim et al. 
(2014)(48)
FM (19)
R-handed
HC (18)
Age-matched
R-handed
MRI (T1, T2)
DTI
VAS
SF-MPQ (sensory pain 
subscore)
Pain intensity 
~ FA of regional WM
- Correlation:
1.  sensory pain score ~  FA in corpus 
callosum body
1. r= - 0.47 
p= 0.04
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Supplementary Table 3  Continued
Studies Chronic MSK pain 
patients (n)
Healthy controls 
(n)
Measurement techniques Correlations, relations, 
associations
Main results in 
chronic MSK pain patients
Correlation coefficient (r), 
T-score, Z-score, p-value Brain MRI Clinical pain measures
Structural MRI techniques
White matter properties
Moayedi et al. 
(2012)(68)
M-TMD (17)
Idiopathic
R-handed
HC (17) 
R-handed
DTI NRS (current pain), 
NRS (pain unpleasantness)
Pain intensity, 
Pain unpleasantness  
~ FA of regional WM
- Correlation:
1. ↗ Pain intensity ~ ↘ FA in internal & ext/
extreme capsules 
2.  ↗ Pain intensity ~ ↘ FA in thalamic 
cluster
3. ↗ Pain intensity ~ ↘ FA in R internal 
capsule
4. ↗ pain unpleasantness ~ ↘ FA in R 
internal capsule
1. r= - 0.49 
p= 0.046
2. r= - 0.59 
p= 0.013
3. r= - 0.72 
p= 0.001
4. r= - 0.63 
p= 0.007
Lieberman et al. 
(2014)(56)
Chronic MSK (46)
 (12)
 (34)
HC (33)
 (14)
 (19)
Age-matched
DTI Pain severity,
SF-MPQ,
Pain subscale of the TOPS
Pain intensity 
~ FA & AD in regional WM
+ Correlation:
1. ↗ Total pain experience score ~ ↗ FA in 
the L uncinate fasciculus 
2. ↗ Total pain experience score ~ ↗ AD in 
the L ant limb of the internal capsule
3. ↗ Total pain experience score ~ ↗ AD 
in the L posterior limb of the internal 
capsule
4. ↗ MPQ typical pain ~ ↗ FA in the L 
uncinate
5. ↗ MPQ typical pain ~ ↗ AD in the L 
anterior limb
1. r= 0.393 
p= 0.007
2. r= 0.398 
p= 0.006
3. r= 0.373 
p= 0.011
4. r= 0.480 
p= 0.001
5. r= 0.451 
p= 0.002
Functional MRI techniques
Napadow et al. 
(2010)(74)
FM (18)
 
R-handed
HC (18)
 
Age-matched
R-handed
rs-fMRI 
dual-regression 
probalistic ICA
VAS (pain intensity 
immediately prior to rs-fMRI 
scan)
Pain intensity 
~ FC
+ Covariation: 
1. ↗ pain intensity ~ ↗ FC:
 a.   DMN to (R mid & ant IC, cerebellum, 
dlPFC & sgACC)
 b.   R EAN to (R ant & L mid & post IC & 
putamen)
- Covariation: 
2. ↗ pain intensity ~ ↘ FC:
1. R EAN to (Hippocampus, PAG, nucleus 
cuneiformis & pontine raphe)
Z-scores
1. DMN – ant IC: 
Low pain: 
-1.72(+/- 0.81) 
High pain: 0.55(+/- 1.32)
R EAN: 
Low pain: 0.57(+/- 0.48)
High pain: 2.72(+/- 0.95)
2. R EAN – PAG 
Low pain: 1.45(+/-0.91) 
High Pain: -0.52(+/-1.68)
Flodin et al.  
(2014)(32)
FM (16) HC (22)
Age-matched
MRI (T1)
rs-fMRI 
fMRI 
(pain exposure) 
VAS,
Computer-controlled 
pressure stimulator
Pressure pain sensitivity
~ FC
+ Correlation: 
1.  pressure pain sensitivity ~  FC
 -  L IC & dorsal PCC
 -  L rolandic operculum &      
L parahippocampus 
 -  Thalamus & PFC
+ correlation
p<0.00031
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Supplementary Table 3  Continued
Studies Chronic MSK pain 
patients (n)
Healthy controls 
(n)
Measurement techniques Correlations, relations, 
associations
Main results in 
chronic MSK pain patients
Correlation coefficient (r), 
T-score, Z-score, p-value Brain MRI Clinical pain measures
Functional MRI techniques
Ichesco et al.  
(2014)(44)
FM (18)
R-handed
HC (18)
Age-matched
R-handed
MRI (T1)
rs-fMRI: fMRI:
(experimental pain)
PRI,
GBS,
Pressure stimulator
PPT ~ IC-CC connectivity
Clinical pain ~ IC 
connectivity
+ Correlation:
1.  Clinical pain ~  FC:
 -  R ant IC & STG
2.  Affective scores PRI ~  FC:
 -  IC & STG
3.  Sensory scores PRI ~  FC 
 -  R mid IC & L&R precuneus
1. r= 0.51 
p=0.03
2. Z= 3.79 
p<0.001
3. Z= 4.48 
p<0.001
López-Solà et al. 
(2014)(60)
FM (35) HC (25)
Age-matched 
handedness 
-matched
fMRI NRS,
Non-nociceptive sensory 
stimulation (auditory, visual, 
tactile stimulation): allodynia,
Sensory hypersensitivity
Pain intensity,
Sensory hypersensitivity ~ 
Brain activity
- Correlation:
1.  pain intensity ~  activation in visual 
brain areas
2.  hypersensitivity to tactile stimulation 
(allodynia) ~  activation in superior/
middle temporal gyri
T-scores:
1. lat occ cortex: -3.92 
Med occ cortex: - 3.69
2. Sup temporal gyri:  
- 3.79; 3.00      
Kim et al. 
(2015)(49)
FM (35)
 (32)
 (3)
HC (14)
 (10)
 (4)
Age-matched
rs-fMRI
fMRI (6-minute 
continuous pain-
state run)
NRS,
BPI,
Pressure-pain stimuli (cuff 
algometry)
Pain intensity, 
TS of pain ~
FC
+ Correlation:
1.  clinical pain intensity at time of rs-
fMRI scan ~  changes (from the pain 
phase through the rest phase) in S1leg 
connectivity to the Ant INS 
2.  TS of pain ~  changes in S1leg 
connectivity to R Ant/Mid INS  
- Correlation:
3.  clinical pain intensity at time of rs-fMRI 
scan ~  resting connectivity within S1
1. r= 0.51
2. r= 0.37
3. T= - 12.30 
p<0.001
Kong et al.  
(2013)(51)
CLBP (18)
 (6)
 (12)
HC (18)
 (6)
 (12)
Age-, sex- & race-
matched
MRI (T1)
rs-fMRI
VAS,
Pain-inducing exercises
VAS changes 
~ FC
+ Correlation
1.  pain intensity change after exercises ~ 
 FC at the L insula, precuneus, amygdala 
& fusiform 
Z-scores:
Insula: 3.8
Precuneus: 3.93
Amygdala: 2.86
Fusiform: 3.23
Yu et al. 
(2014)(98)
CLBP (18)
 (6)
 (12)
HC (18)
 (6)
 (12)
Age-, sex- & race-
matched
MRI (T1)
rs-fMRI
VAS ,
BPI,
Pain-inducing exercises
Pain intensity,
Pain duration 
~ FC
- Correlation 
1. High pain:  LBP ratings ~  FC between 
PAG & L vmPFC (after exc)
- Correlation
2.  disease duration ~  FC between PAG 
& R posterior insula & PAG-L amygdala 
(before exc)
Z-scores:
1. PAG-L vmPFC: 2.96
2. R posterior inula-L 
amygdala: 3.04
Baliki et al. (2014)(10) CLBP (18)
 (13)
 (5)
OA (14):
 (8)
 (6)
HC (36)
 (12)
 (24)
Right-handed
MRI (T1)
VBM
rs-fMRI
Pain intensity,
Pain duration
Pain intensity
~ FC
Pain duration
~ HF power within the 
DMN, phase differences
CLBP, OA:
+ Correlation 
1.  pain intensity at the time of the scan ~ 
 MPFC-INS connectivity
2.  High frequency power within  
the DMN ~  pain duration.
CLBP:
3.  phase differences between  
the DMN and frontoparietal network ~  
 pain duration.
CLBP:
1. r= 0.75 
p<0.01
2. r= 0.65 
p<0.01
3. r= 0.68 
p<0.01
OA:
1. r= 0.61 
p<0.05
2. r= 0.77 
p<0.01
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Supplementary Table 3  Continued
Studies Chronic MSK pain 
patients (n)
Healthy controls 
(n)
Measurement techniques Correlations, relations, 
associations
Main results in 
chronic MSK pain patients
Correlation coefficient (r), 
T-score, Z-score, p-value Brain MRI Clinical pain measures
Functional MRI techniques
Ichesco et al.  
(2012)(43)
M-TMD (8) HC (8)
Age-matched
MRI (T1)
rs-fMRI
fMRI (pressure  
pain stimuli)
VAS,
PRI (SF-MPQ),
BPI
Pain intensity,
Experimental pressure 
pain
~ FC
- Correlation:
1. ↗ pain intensity ~ ↘ L anterior IC-  
rostral ACC connectivity
2. ↗ MPQ total scores ~ ↘ L anterior IC- 
rostral ACC connectivity
3. ↗ pressure sensitivity ~ ↘ FC between L 
ant IC & rostral ACC/the medial  
frontal gyrus
1. r= - 0.952 
p<0.001
2. r= - 0.830 
p<0.011
3. r= - 0.838 
p<0.009
Structural & Functional MRI techniques
Ceko et al.  
(2013)(22)
Younger FM (14)
Older FM (14)
Younger HC (15)
Older HC (13)
Age-matched 
handedness –
matched
MRI (T1)
VBM
rs-fMRI
NRS (Pain intensity)
Pain duration
Experimental pressure pain 
sensitivity
Pressure pain sensitivity ~ 
regional GMV
Pain intensity, 
Pain duration ~ 
FC
Younger FM patients:
- Correlation:
1. ↗ unpleasantness ratings of the pressure 
stimuli ~ ↘ GMV in LaINS
2. ↗ pressure pain sensitivity ~ ↘ GMV in 
NAc
+ Correlation:
3. ↗ pain intensity during rs-fMRI ~ ↗ 
connectivity of LaINS to S1 & M1
4. ↗ pain duration ~ ↗ connectivity of 
LaINS to S1 & M1Older FM patients:
-  Correlation:
5. ↗ pressure pain sensitivity ~ ↘ GMV in 
PCC
1. T= 12.14 
p<0.001
2. T= 6.06 
p= 0.001
3. T= 6.06 
p= 0.001
4. r=0.54 
p= 0.047
5. T= 5.32 
p= 0.014
Farmer et al.  
(2011)(28)
CPPS (19)
Right-handed
HC (16)
Age-  
& sex-matched
MRI (T1)
fMRI (pain task  
& visual task)
DTI
VAS,
MPQ,
Pain duration
Pain intensity ~ 
brain activity & regional  
GM density
Pain duration ~ regional 
GM density
+ Correlation:
1. ↗ pain intensity ~ ↗ Ant INS activity
2. ↗ MPQ score ~ ↗ Ant INS activity 
3. ↗ pain intensity ~ ↗ Ant INS GM density 
4. ↗ pain duration ~ ↗ ACC GM density 
1. r= 0.57 
p<0.05
2. Z=0.78 
p<0.01
3. r= 0.69 
p<0.01
4. r= 0.69 
p<0.01
R = Right; L = Left; OA = Osteoarthritis; HC = Healthy Controls; MRI = Magnetic Resonance Imaging; VBM = 
Voxel-based Morphometry; VAS = Visual Analog Scale; GMV= Grey Matter Volume; CPPS = Chronic Pelvic Pain 
Syndrome; NIH-CPSI = National Institutes of Health Chronic Prostatitis Symptom Index; ACC = Anterior 
Cingulate Cortex; M-TMD = Myofascial Temporomandibular disorder; STG = Superior Temporal Gyrus; MTG = 
Middle Temporal Gyrus; NRS = Numerical Rating Scale; PCC = Posterior Cingulate Cortex; SFG= Superior Frontal 
Gyrus; Mid = Middle; FM = Fibromyalgia; DTI = Diffusion Tensor Imaging; SF-MPQ = Short Form of the McGill 
Pain Questionnaire; FA = Fractional Anisotropy; TMD = Temporomandibular Disorder; EC/ExC= External/
Extreme Capsules; fMRI = Functional Magnetic Resonance Imaging; FC = Functional Connectivity; DMN = 
Default Mode Network; Ant = Anterior; IC = Insular Cortex; EAN = Executive Attention Network; Post = Posterior; 
dlPFC = Dorsolateral Prefrontal Cortex; sgACC = Subgenual Anterior Cingulate Cortices; PAG = Periaqueductal 
Grey; PRI = Pain rating Index; BPI = Brief Pain Inventory; GBS = Gracely Box Scale; NAc= nucleus accumbens; 
CC = Cingulate Cortex; MFG = Medial Frontal Gyrus; PFC = Prefrontal Cortex; Inf = Inferior; PPT = Pressure-pain 
Thresholds; CLBP = Chronic Low Back Pain;   S1 = Primary Somatosensory Cortex; S2 = Secondary Somatosensory 
Cortex; IPL = Inferior Parietal Lobule; MSK = musculoskeletal; vmPFC = ventral medial prefrontal cortex ; CPPS= 
Chronic pelvic pain syndrome; FM= Fibromyalgia; MSK= musculoskeletal pain; MPQ= McGill Pain Questionnaire; 
BPI= Brief Pain Inventory; TS= Temporal Summation; aINS= anterior Insula; TOPS= Treatment Outcomes in Pain 
Survey; IC= insular cortex; PRI= pain rating index; MCC= mid-cingulate cortex; OFC= orbitofrontal cortex; 
M-TMD= myofascial pain of the masticatory region; M1=primary motor cortex; FIQ= Fibromyalgia Impact 
Questionnaire; exc=excercises; ICA= independent components analysis
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Introduction
Chronic neck pain affects many people who have encountered an episode of neck pain 
throughout their lifetime with 50-85% of people who experienced neck pain reporting 
neck pain 1 – 5 years later (1, 2).
Two groups of non-specific neck pain patients have been identified in the literature, i.e. 
patients who have developed neck pain after a traumatic event, which are referred to as 
patients with whiplash associated disorders (WAD) (3), and patients with non-traumatic 
idiopathic neck pain (INP). Whiplash injuries usually result from rear-end motor vehicle 
collisions resulting in acceleration-deceleration mechanisms of forces acting on the neck 
and the head (4). The traumatic neck pain group is frequently seen as a special case as these 
patients develop more often chronic complaints (5, 6), which do not only consist of neck pain 
and/or headaches, but also include other symptoms such as dizziness (7), motor dysfunction 
(8-13), disturbed central pain processing or central sensitization (14, 15), and cognitive impairment 
(5, 16-19), hence the term “associated disorders”. In addition, patients with INP have developed 
neck pain without any clear underlying cause (20). These patients are mostly not characterized 
by central sensitization (21), cognitive impairment and dizziness, however they also display 
motor dysfunctions (22, 23), and chronic or recurrent pain.
The cause of this diversity in symptoms observed in patients suffering from acute and 
chronic pain is still not entirely clear. Some have suggested that alteration of the central 
nervous system could explain this diversity (24-28), and a theoretical framework for central 
nervous system alterations, such as brain alterations, has already been constructed for 
acute and chronic pain (29, 30). Surprisingly, only few have tried to analyze and publish results 
that might support these theories. In addition, it is known that a trauma can result in mild 
traumatic brain injury (MTBI) (31), which is associated with clinical symptoms similar to these 
observed in patients with WAD. However, information on the impact of a whiplash trauma 
on the brain remains scarce in patient with neck pain. To answer the question if brain 
alterations play a role in patients suffering from chronic pain, the application of new brain 
analysis tools is rising (32-37). However, only limited research is available on alterations in 
brain morphology and function in patients with WAD and INP.
Brain alterations are often categorized into functional alterations, and morphological 
or structural alterations. Brain function, which reflects the amount of “activity” that the 
brain generates at a certain location, is often measured via its blood perfusion and/or 
metabolism. Single Photon Emission Computed Tomography (SPECT) and Photon 
Emission Tomography (PET) are both applied for this purpose (37). Both methods use radio-
pharmaceutical tracers to assess the brain’s perfusion and/or metabolism. Active brain 
regions have a higher need of oxygen and glucose, which is reflected in a higher perfusion 
Abstract
Background: Chronic neck pain affects 50-85% of people who have experienced an acute 
episode. This transition and the persistence of chronic complaints is believed to be 
mediated by brain alterations among different central mechanisms. 
Objectives: This study aimed to systematically review and critically appraise the current 
existing evidence regarding structural and functional brain alterations in patients with 
whiplash associated disorders (WAD) and idiopathic neck pain (INP). Additionally, associations 
between brain alterations and clinical symptoms reported in neck pain patients were 
evaluated.
Setting: This systematic review examined brain imaging studies available on PubMed 
and/or Web of Science that analyzed structural and functional brain alterations in patients 
with WAD and INP.
Methods: The present systematic review was performed according to the PRISMA 
guidelines. PubMed, Web of Science, and Cochrane databases were searched. First, the 
obtained articles were screened based on title and abstract. Secondly, the screening was 
based on full-text. Risk of bias in included studies was investigated. 
Results: Twelve studies met the inclusion criteria. Alterations in brain morphology and 
function, including perfusion, neurotransmission and blood oxygenation level dependent- 
signal, were demonstrated in chronic neck pain patients. There is some to moderate 
evidence for both structural and functional brain alterations in patients with chronic neck 
pain. In contrast, no evidence for structural brain alterations in acute neck pain patients 
was found.
Limitations: Only 12 articles were included, which imposes the possibility to draw only 
cautious conclusions.
Conclusion: Brain alterations were observed in both patients with chronic WAD and 
chronic INP. Furthermore, more evidence exists for brain alterations in chronic WAD, and 
different underlying mechanisms might be present in both pathologies. Furthermore, 
pain and disability were correlated with the observed brain alterations. Accordingly, 
morphological and functional brain alterations should be further investigated in patients 
with chronic WAD and chronic INP with newer and more sensitive techniques, and 
associative clinical measurements seem indispensable in future research.
Key words: traumatic neck pain, idiopathic non-traumatic neck pain, brain alterations, 
Magnetic Resonance Imaging, Single Photon Emission Computed Tomography, Photon 
Emission Tomography, chronic neck pain.
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to suffer from acute, subacute or chronic INP, neck injuries or WAD; the measurement 
instrument (I) had to include medical brain imaging techniques such as MRI, PET, and 
SPECT; and the outcome (O) had to refer to brain alterations including brain function, and 
brain morphology. The complete entered search strategy in PubMed was (“neck pain” OR 
“Neck Pain”[Mesh] OR “whiplash” OR “Whiplash Injuries”[Mesh] OR “neck injury” OR “Neck 
Injuries”[Mesh]) AND (“brain imaging” OR “Neuroimaging”[Mesh] OR “fMRI” OR “rs-fMRI” OR 
“MRI” OR “Magnetic Resonance Imaging”[Mesh] OR “Magnetic Resonance Imaging” OR 
“Positron Emission Topography” OR “PET” OR “Positron-Emission Tomography”[Mesh] OR 
“CT” OR “Computed Tomography” OR “SPECT” OR “Tomography, X-Ray Computed”[Mesh]) 
AND (“brain morphology” OR “Brain”[Mesh] OR “brain” OR “white matter” OR “grey matter” 
OR “gray matter” OR “White Matter”[Mesh] OR “Gray Matter”[Mesh] OR “brain function” OR 
“resting state” OR “BOLD” OR “ brain volume”).
Eligibility criteria
Only patient-control, cross-sectional and cohort studies reporting on brain alterations in 
non-specific non-traumatic and traumatic acute, subacute or chronic neck pain patients 
were eligible for inclusion in this systematic review. No restrictions on publication date or 
status were imposed. Studies had to be written in English, Dutch or French to be included 
in this systematic review. Adult participants of age older than 18 suffering from INP or a 
whiplash injury were considered eligible. Assessment of brain alterations should focus on 
brain structure/morphology and/or brain function, and only imaging techniques, such as 
SPECT, PET, and MRI were considered to be included in this systematic literature review.
Study selection
Two reviewers, BC and RDP, independently screened all articles on eligibility in a standardized 
manner. Disagreement between the reviewers was resolved by consensus.
Data collection process and items
Data were extracted from eligible papers in a standardized manner by RDP, and the 
extracted data were checked afterwards by a second reviewer, IC, who made changes 
where necessary. Disagreements were resolved by consensus or the opinion of a third 
reviewer, MM. Extracted data consisted of: author and year of publication, description of 
the included population and if available the controls (sample size, neck pain type, mean 
age, sex, duration of complaints before scanning), the imaging protocol (SPECT, PET or 
MRI) with technical information on the scanning sequence or radiopharmaceutical tracers 
used in the scanning procedure, the brain tissue class and areas that were investigated 
during the scanning sequence, and the main findings and associations with clinical 
measures (Spearman correlations (r
s
), Pearson correlations (r
p
)). 
and/or metabolism (38, 39). These changes in metabolite concentration are captured and 
reflected in the image signal intensity. Another method to analyze brain function is by 
applying functional Magnetic Resonance Imaging (MRI). The MRI method most often 
used to provide information related to brain function is called blood oxygenation level 
dependent (BOLD) contrast imaging (40). This method is based on MR-images made 
sensitive to changes in oxygen consumption with an increase in consumption reflecting 
higher signal intensities in these BOLD-images. 
Besides brain function, brain morphology is also believed to be altered in certain pain 
conditions (41, 42). MRI has achieved the level of golden standard for measuring brain 
morphology, typically through voxel- or surface-based methods (43). Both methods are 
able to provide information on white and grey matter volume.
According to our knowledge, no systematic review has critically summarized the current 
evidence regarding brain alterations in patients with WAD, and patients with INP. This 
systematic review is able to determine the present state of the art and steer further 
research in patients with WAD and INP. The aim of this systematic review is to review and 
critically appraise the current existing evidence related to structural and functional brain 
alterations in patients with WAD and INP. In addition, this review evaluates the association 
between these brain alterations and the different clinical symptoms reported in patients 
with neck pain.
Methods
Protocol
This systematic review applies the guidelines issued in the PRISMA statement, an 
adaptation of the QUORUM statement for reporting systematic reviews (44, 45).
Information sources
The electronic databases PubMed (http://www.ncbi.nlm.nih.gov/pubmed), Cochrane 
Library (http://www.cochranelibrary.com), and Web of Science (http://www.webofscience.
com) were searched to identify relevant articles. Additionally, to make the search as 
complete as possible, reference lists of the eligible papers were screened. Databases were 
searched on the 4th of December 2015, and all articles were screened afterwards on 
eligibility criteria.
Literature search strategy
The search strategy was based on a combination of Mesh-terms (only for searching 
PubMed) and free text words derived from the following PICO format: participants (P) had 
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Results
Study selection
In total, 477 studies were retrieved from the different databases. After the first screening, 
26 studies were identified as potential eligible studies for inclusion. After the second 
screening, only 12 studies were retrieved that fulfilled all inclusion-criteria. The selection 
process of relevant articles is presented in figure 1. 
Study characteristics
The characteristics of each study were extracted and presented in the evidence table 
(Table 1). Four studies reported on structural brain alterations in neck pain patients (48-51), 
using a different MRI protocol. One study reported on changes in BOLD-signal through 
task-related fMRI-imaging (52), another one reported on alterations in neurotransmission 
through PET imaging (53), and six studies analyzed perfusion and/or metabolism via PET or 
SPECT-imaging using radiopharmaceutical tracers (54-59). The average age (+/- SD) of the 
total patient and control sample, when available, was 36.41 (+/-11.52) years and 33.0 
(+/-12.21) years respectively. In total, 75% (n=179) of the study participants were female. 
Eleven studies reported on patients after a whiplash injury or patients with WAD. Both 
longitudinal (49, 50) and cross-sectional studies (48, 51, 52, 54-59) have been included, using time 
periods ranging from 14 days to more than 1 year after the whiplash trauma before 
performing the scanning protocol. The key-findings of this systematic review are also 
depicted in figures 2 and 3.
Risk of bias in individual studies
Cross-sectional studies obtained a score ranging from 2/9 (22%) to 8/9 (89%) for risk of bias 
with a median score of 4.5/9 (50%). The risk of bias in studies was mostly high due to a lack 
of representativeness of cases in 6 out of 10 studies (60%) (55-59), indicating the lack of a 
random sample. In six cases (60%), the researchers were not blinded for the patient’s 
condition (53-57, 59), and six authors (60%) did not clearly describe how the quality of the 
images was assessed (48, 51, 54, 56, 57, 59). However, only one study (10%) did not provide a 
qualitative description of the cases included in their studies (57), and one study (10%) did 
not provide a detailed brain imaging protocol (48). Cohort-studies, of which only two were 
eligible for this systematic review (49, 50), obtained a score of 3/11 (27%) and 6/11 (54%). Both 
studies lost points on the representativeness of cases, selection of controls, new cases, 
quality control of images and blinding the researchers for the patient’s condition. In most 
cases (96%), the 2 reviewers (RDP & IC) agreed. After a second review and a comparison of 
the differences, the reviewers reached a consensus for all items. The risk of bias in the 
individual studies is presented in Table 2.
Risk of bias in individual studies
To assess the methodological quality of all eligible papers, two independent reviewers, 
RDP and IC, both PhD candidates experienced in conducting systematic reviews, screened 
all articles on risk of bias using a modified version of “The Newcastle-Ottawa Scale (NOS) 
for assessing the quality of non-randomized studies in meta-analyses” (http://www.ohri.
ca/programs/clinical_epidemiology/oxford.asp) (46). This checklist is recommended for 
case-control and cohort studies (47) and has been proposed by the Cochrane Collaboration 
(www.cochrane.org). Two different checklists were used to assess the quality of cross- 
sectional case-control and cohort studies. The case-control checklist evaluates selection 
of the population (case definition, representativeness of cases and selection of controls) 
and comparability (controlled for the most important confounders such as age, sex, 
education level, and BMI). The cohort checklist evaluates selection (representativeness of 
the cohort, selection controls, case definition, new cases), comparability (controlled for 
the most important confounders (age, sex, education level, BMI)), and exposure (follow-up). 
In addition, for both checklists, four scoring items, specifically developed for the content 
of this systematic review, were added (description of MRI protocol, quality control of 
images, blindness of researcher, same method used for cases and controls). Further details 
on the different criteria are displayed in table 2. Each cross-sectional study could reach a 
maximum score of 9 and each cohort study could reach a maximum score of 11 on the 
modified NOS, representing the highest methodological quality.
Based on the study design and risk of bias, a level of evidence was given to every study, 
according to the 2005 classification system of the Dutch Institute for Healthcare 
Improvement CBO (supplementary table 1). Prospective cohort trials of sufficient size 
and follow-up that have adequately controlled for confounding, and selective follow-up is 
sufficiently excluded, obtained a level of evidence A2, while cohort studies not meeting 
these criteria or case-control studies obtained a level of evidence B. Non-controlled trials 
and expert opinions obtained a level of evidence C and D, respectively. 
Strength of conclusion
Subsequently, the strength of conclusion (ranging from 1 to 4) was calculated for each 
cluster of studies reflecting one outcome parameter (supplementary table 2), and was 
placed between brackets in the results section. Strength of conclusion 1 was assigned for 
a study of level A1 or at least two independently conducted studies of level A2. Strength 
of conclusion 2 was given when at least two independently conducted studies of evidence 
level B or one trial of evidence level A2 was included in the cluster, and strength of 
conclusion 3 was assigned if one study of evidence level B or C was present. Strength of 
conclusion 4 was given in case of inconclusive or inconsistent results between various 
studies.
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Table 1  Evidence table
Author (year) Patient population Controls Imaging protocol Brain measure Main Findings Level of 
Evidence
Alterations in morphology
Borchgrevinck 
et al. (1997)(48)
n = 46; whiplash-injury within  
2 days (acute); no WAD* IV; 26  and 
20 ; age 35,7y +/- 11,5
n=20; healthy controls; 
employees hospital; 
34,5y +/- 10,2
Sagittal T1-spin echo; 
Transversal and Coronal 
T2-turbo spin echo
structural data: Lesions, 
CSF, cerebral sulci
NS B
Karlsborg et al. 
(1997)(49)
Whiplash-injury within 14 days 
(acute) and after 7 months 
(chronic): n = 39; 23 ; 33y  
(WAD*-II, III and IV)
NA T2-spin echo sequence structural: edema NS C
Obermann  
et al. (2009)(50)
Post-traumatic headache within 
14 days: (acute) n = 32; 35,2y  
+/- 12,1; 20 
n = 30; students or 
members hospital; 17 ; 
35y +/- 13,7
T1-weighted image structural data: VBM 
(grey matter volume 
changes)
NS A2
after 3 months and 1 year 
(chronic): n = 12; 39,6y +/- 15,1; 7 
non-chronic 
posttraumatic 
headaches (n = 20)
3 months: significant decrease in ACC and DLPFC; 1 year: resolved; 
increase: brainstem (PAG), thalamus and cerebellum.
Sturzenegger  
et al. (2008)(51)
WAD*-I or WAD*-II: n = 21;  
> 5 months (chronic); 71% 
n = 18; 72% T1-MPRAGE VBR: Ventricle-Brain 
Ratio’s (Diffuse Axonal 
Injury)
VBR: WAD = CON B
Alterations in function
Alterations in BOLD-signal
Freitag et al. 
(2001)(52)
WAD* II: n = 5; 43,2y; WAD* 0:  
n = 5; 33,2y; between 14 and  
34 months (chronic)
n = 7; 35,0y T2*-fMRI (1,5T Siemens) BOLD-response: middle 
temporal and middle 
superior temporal
BOLD: WADII < WAD0; WADII < CON (middle temporal and middle 
superior temporal)
B
Alterations in neurotransmission
Linmann et al. 
(2010)
WAD*-II: > 6 months (chronic);  
n = 18; 14 ; 38y +/- 11
n = 18; 9 ; 35y +/- 9 11C (NK1 specific 
radioligand)
15O-PET
Neurotransmission: 
NK1-receptor availability 
(pain processing) 
NK1-receptor availability: WAD < Controls: R. Ventromedial 
Prefrontal Cortex, Insula, R. Middle cingulate cortex, L. Hippocampus, 
L. Amygdala, PAG 
NK1-receptor availability correlates negatively with TSK, however not 
with pain duration or disability (NDI)
WAD: vmPFC NK1-receptor availability correlates negatively with 
rCBF in R. subgenual ACC
NK1-receptor availability alterations: independent of between group 
rCBF differences
B
Alterations in perfusion/metabolism
Bakhtadze et al. 
(2012)(54)
Chronic neck pain (> 3 months)  
n = 45; 40y +/- 10,9; 16  and 29 
NA SPECT (HMPAO) Perfusion: frontal, 
temporal, parietal, 
occipital (both 
hemispheres)
Perfusion: moderate and severe neck pain < mild (parietal and 
frontal); NDI and VAS scores correlates with SPECT-score.
C
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post-traumatic headache and neck pain, found no structural brain alterations in the acute 
phase (50). However, decreased grey matter volume in the Anterior Cingulate Cortex (ACC) 
and Dorsolateral Prefrontal Cortex (DLPFC) was observed after 3 months. These grey matter 
changes did, however, resolve after one year coinciding with the cessation of the 
post-traumatic headache. In comparison, an increase in grey matter volume was observed 
in the periaqueductal grey matter (PAG), the thalamus and cerebellum (50). 
 To conclude, moderate evidence exists for a lack of structural pathological brain abnormalities, 
such as edema or lesions in acute traumatic neck pain patients who have suffered from a 
whiplash injury (Strength of conclusion 2). Moderate evidence exists for grey matter volume 
alterations after a certain period in time in patients with post-traumatic headache (Strength of 
conclusion 2).  
Synthesis of results
Alterations in morphology
Two studies have examined structural abnormalities shortly after the occurrence of a 
whiplash injury (within 2 to 14 days), but found no signs of edema in the acute whiplash 
group (48) nor signs of lesions when they compared patients after a whiplash injury with 
healthy controls (49). Another study analyzed the ventricle-brain ratio (VBR) - calculated as the 
ratio of the total ventricle volume divided by the brain volume and normalized afterwards 
by accounting for the average distance between the frontal and occipital poles of the entire 
study group (51). The authors found no difference in VBR between patients with chronic WAD 
and healthy controls (51). A study that performed voxel-based morphometry in patients with 
Table 1  Continued
Author (year) Patient population Controls Imaging protocol Brain measure Main Findings Level of 
Evidence
Alterations in perfusion/metabolism
Linnman et al. 
(2009)(55)
WAD*-II patients: n = 21; 17 ;  
37y +/- 11; pain between 6 and  
24 months (chronic)
n = 18; 9 ; 35y +/- 9 15O-PET rCBF: different brain 
regions
rCBF: WAD < CON: Middle temporal gyrus, Middle occipital gyrus; 
WAD > CON: Left posterior corpus calossum; Left parahippocampal 
gyrus; posterior cingulate gyrus; lingual gyrus; Right posterior corpus 
calossum; Right parahippocampal gyrus, posterior cingulate gyrus, 
caudate nucleus; Right inferior temporal gyrus; Right Thalamus; Right 
Cerebellum, anterior lobe, dentae; Right middle frontal gyrus, Left 
precentral gyrus, right postcentral gyrus.
rCBF right middle frontal gyrus ~ NDI (r
p
 = 0.52, NS)
rCBF right temporo-occipital zone ~ NDI (r
p
 = -0.53, NS)
rCBF right precentral gyrus ~ Pain rating (r
p
 = 0.52, NS)
B
Sundström et al. 
(2006)(56)
Whiplash: n = 27; 41y; > 3 years 
(chronic); 18 
INP: n = 18; 44y;  
> 3 years; 13 
SPECT (HMPAO) rCBF rCBF: INP < CON: Right Temporal Lobe, Right temporal gyrus, Left 
cerebellum culmen, parahippocampal regions; WAD < CON: NS; INP 
< WAD: Right temporal lobe; WAD < INP: NS
B
Otte et al.  
(1997)(57)
Whiplash-syndrome: n = 6; 41 
+/- 17y; between 3 and 63 months 
(chronic)
n = 12; 44 +/- 19y FDG(18F)-PET;  
ECD-SPECT
Perfusion and 
metabolism  pariëto-
occipital
Perfusion & metabolism: whiplash < control (parieto-occipital) B
Lorberboym  
et al. (2002)(58)
Post-whiplash: n = 20; > 6 months 
(chronic)
NA SPECT (HMPAO) Perfusion 13 patients: perfusion abnormalities; 8 in temporal lobes; 3 in 
occipital lobes; 2 in frontal lobes; 2 in basal ganglia
C
Radanov et al. 
(1999)(59)
Whiplash-injury patients: n = 21; 
11 ; 42y +/- 8,6; between 6 and  
48 months (chronic)
NA SPECT (HMPAO);  
15O-PET; 18F-PET
Perfusion NS C
Abbreviations: n, amount of participants; y, age in years; , women; , men; CON, controls; WAD, whiplash 
associated disorders; INP, idiopathic neck pain; NS, not significant; <, smaller then; > larger then; NK1, 
Neurokinin 1; TSK, Tampa Scale for Kinesiophobia; NDI, Neck Disability Index; L., Left; R., Right; r
p
, Pearson 
correlation coefficient; NS, Not Significant; NA, not applicable; rCBF, regional cerebral blood flow; CSF, 
cerebrospinal fluid; SPECT, Single Photon Emission Computed Tomography; PET, Photon Emission Tomography; 
PAG, periaqueductal grey; ACC, anterior cingulate cortex; HMPAO, hexamethylpropyleneamine oxime; vmPFC, 
ventromedial prefrontal cortex; *WAD-classification according to Spitzer et al. (1995)(3).
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Alterations in function (BOLD-signal)
One study examined the BOLD-signal at visual areas (middle temporal and superior 
temporal) in patients with chronic WAD (52). Therefore, patients were exposed to a visual 
task in the scanner. Two fields of dots were presented to the patient by projection. 
One field was positioned in the left visual field, whereas the other field was presented in 
the right visual field. On both screens dots moved in random directions, and the subjects 
had to fixate their eyes on a central spot. At random coherent movement of dots was 
added to one of both screened resulting in a mixture of random and coherent motion, 
and the screen with this mixture had to be reported by the patients to the researchers. 
The authors demonstrated a lower BOLD-response during coherent motion perception in 
the symptomatic chronic WAD group compared to asymptomatic persons after a whiplash 
trauma and healthy controls. 
 In conclusion, some evidence exists for functional brain alterations in temporal regions in 
patients with chronic whiplash (Strength of conclusion 3).
Figure 1  Study selection process.
Figure 2  Lateral view of the brain with key-findings regarding brain alterations.
Figure from “An automated labeling system for subdividing the human cerebral cortex 
on MRI scans into gyral based regions of interest, Desikan et al., (2006). NeuroImage, 
31(3):968-80.”
Figure 3  Medial view of the brain with key-findings regarding brain alterations.
Figure from “An automated labeling system for subdividing the human cerebral cortex 
on MRI scans into gyral based regions of interest, Desikan et al., (2006). NeuroImage, 
31(3):968-80.”
DLPFC:
• Acute volume decrease
 in WAD
Middle frontal:
• Increased perfusion
 in WAD     
Parietal and frontal:
• Reduced perfusion
 in neck pain
Precentral and postcentral:
• Increased perfusion
 in WAD     
Middle temporal:
• Decreased BOLD-signal 
 in WAD
Inferior temporal:
• Increased perfusion
 in WAD     
Middle temporal
and middle occipital:
• Reduced perfusion
 in WAD
Insula:
• Decreased NK1-receptor
 availability in WAD  
MCC:
• Decreased NK1-receptor
 availability in WAD
vmPrefrontal:
• Decreased NK1-receptor
 availability in WAD
ACC:
• Volume decrease
 in WAD
Parahippocampal,
posterior cingulate, 
lingual:
• increased perfusion
 in WAD
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Table 2  Methodological quality of included studies
Cross-sectional study design
Case definition1 Representativeness2 Selection Controls3 Comparability4 MRI5a Quality control5b Blindness5c Same method6 Total /9 (%)
Borchgrevink et al. (1997) + + + + - - + + 6 (67)
Sundström et al. (2006) + - ++ + + - - - 5 (55)
Linnman et al. (2009) + - - + + + - + 5 (55)
Sturzenegger et al. (2008) + + ++ + + - + + 8 (89)
Radanov et al. (1999) + - - - + - - + 3 (25)
Otte et al. (1997) - - - - + - - + 2 (22)
Lorberboym et al. (2002) + - - - + + + - 4 (44)
Linnman et al. (2010) + + ++ + + + - + 8 (89)
Freitag et al. (2001) + - + - + + + + 6 (67)
Bakhtadze et al. (2012) + + - - + - - - 3 (25)
Cohort study design
Representativeness1 Selection Controls2 Ascertainment  
of exposure3
New cases4 Comparability5 MRI6a Quality  
control6b
Blindness6c Same  
method7
Follow-up8 Total /11 (%)
Karlsborg et al. (1997) - - + - - - - - - ++ 3 (27)
Obermann et al. (2009) - - + - + + - - + ++ 6 (54)
+ = score fulfilled; - = score not fulfilled
Modified Newcastle-Ottawa Quality Assessment Scale: cross-sectional studies: 1=Is the case definition 
adequate? (Independent validation or self-reported); 2=Representativeness of cases (Random sample: 
description of area, hospital and clinic); 3=Selection of controls (Community controls with no history of disease 
+ = score fulfilled; - = score not fulfilled
1=Representativeness of exposed cohort (truly representative average in the community); 2=Selection 
controls (Drawn from the same community); 3=Ascertainment of exposure (Independent validation or self-
reported); 4=New cases (Yes); 5=Comparability (Controlled for the most important confounders (age, sex, 
(++), Hospital controls with no history of disease (+)); 4=Comparability (Controlled for the most important 
confounders (age, sex, cognition, BMI); 5a=Description of MRI protocol (full description and optimal sequencing 
protocol); 5b=Quality control of images (fully descripted); 5c=Blindness (researchers was blinded for patient’s 
status); 5d=Same method used for controls/cases (yes).
cognition, BMI)); 6a=Description of MRI protocol (Full description and optimal sequencing protocol); 
6b=Quality control of images (fully descripted); 6c=Blindness (researcher was blinded for patient’s status); 
7=Same method used for controls/cases (yes); 8=Follow-up (Long enough (>3months) and > 80% (++), 
>80% (+)).
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not equal for all patients. In 8 patients, perfusion abnormalities were observed in the 
temporal lobes, in 3 patients in the occipital lobes, in 2 patients in the frontal lobes, and 
another 2 patients showed perfusion abnormalities in the basal ganglia (58). 
 To conclude, moderate evidence exists for alterations in brain perfusion and metabolism in 
chronic neck pain patients (Strength of conclusion 2), however the nature and location of these 
alterations is not entirely obvious. In addition, two studies found contradictory results for the 
association between clinical parameters and brain perfusion/metabolism in patients with 
chronic neck pain, resulting in strength of conclusion 4.
Discussion
This systematic review aimed to summarize and critically appraise the current state of the 
literature concerning brain alterations in patients with WAD and INP. Researchers have 
attempted to construct a solid hypothesis regarding the appearance of brain alterations 
in chronic pain and its associated symptoms (62, 63). However, only some to moderate 
evidence exists for empirical findings of structural and functional brain alterations in 
patients with chronic neck pain. 
Some of the included studies scored poorly on the modified NOS, signifying the potential 
risk of bias included in the sample of studies discussed in this review. It is important that in 
future research a random sample of the study population, and the healthy controls is 
included. New neuroimaging research indicates an important role of confounders in brain 
research, such as sex (64), age (65-69), BMI (70, 71), medication use (72, 73) and cognitive function (74). 
These confounders should be included by future neuroimaging studies into their statistical 
analysis to avoid biased estimates. About 75% of the included population were females, 
which is similar with current epidemiological data of (chronic) neck pain patients (1). In 
addition, most studies reported no statistical significant difference in age between the 
patient population and the included controls.
Morphological brain alterations
Although evidence for structural brain alterations in patients with chronic neck pain 
remains scarce, we can conclude that no structural brain abnormalities seem to be present 
in the acute phase after a whiplash trauma. Different authors observed nor signs of edema 
or lesions (48, 49), nor underlying structural differences between patients with chronic 
posttraumatic headache, acute posttraumatic headache and healthy controls within 14 
days after the accident, which makes morphometric predisposition in the affected patient 
group less likely (50). However, more longitudinal studies with a sufficiently large follow-up 
period are necessary to confirm these results and to determine a time frame for possible 
changes. After a three-month period, decreased grey matter volume in the ACC and 
Alterations in function (neurotransmission)
Only one study investigated functional brain alterations related to neurotransmission (53). 
Linnman et al. (2010) analyzed the Neurokinin 1 (NK1)-receptors, a receptor mostly 
mediated by the neuropeptide Substance P (SP), which allows the regulation of affective 
behavior and nociception (60). In their study a decrease of NK1-receptor availability was 
found in chronic WAD patients (53), which was observed in the insula, right middle cingulate 
cortex, left hippocampus, left amygdala, and the PAG, but most distinct in the right 
ventromedial prefrontal cortex (vmPFC). Furthermore, these changes were negatively 
correlated with the scores on the self-reported Tampa Scale for Kinesiophobia (TSK) 
Questionnaire. Also, vmPFC NK1-receptor availability was negatively correlated with 
regional cerebral blood flow (rCBF) in the right subgenual ACC in chronic WAD patients. 
 In conclusion, some evidence exists for a decrease in NK1-receptor availability in pain 
processing brain regions in patients with chronic WAD (Strength of conclusion 3). Furthermore, 
there is some evidence that decreased vmPFC NK1-receptor availability is negatively correlated 
with rCBF in the ACC in chronic WAD patients (Strength of conclusion 3).
Alterations in perfusion/metabolism
In total, six studies examined alterations in perfusion/metabolism of the brain through 
SPECT or PET-imaging (54-59). Only one study found no indication for changes of brain 
perfusion (59). Sundström et al (2006) demonstrated that patients with chronic INP showed 
a decreased rCBF pattern compared to healthy controls, which was most obvious in the 
parahippocampal and temporal regions, and the cerebellum. In contrast, no such 
alterations could be observed in patients suffering from chronic WAD compared with 
healthy controls (61). Linnman et al (2009) analyzed the rCBF in patients with chronic WAD 
and found alterations in the left parahippocampal gyrus, lingual gyrus, and posterior 
cingulate gyrus (55). In addition, alterations were also evident in the right parrahippocampal 
gyrus, caudate nucleus, pulvinar nucleus of the thalamus, and posterior cingulate gyrus. 
Perfusion appeared higher in these regions in patients with chronic WAD, whereas in 
regions around the temporo-occipital transition zone, a decreased perfusion was found in 
these patients (55). In a more recent study of Bakhtadze et al. (2012), a decreased perfusion 
of the parietal and frontal region was found in patients who suffered from moderate to 
severe chronic INP symptoms when compared to patients with only mild symptoms. 
Moreover, perfusion (SPECT-score) correlated with the amount of pain-related disability 
(utilizing the Neck Disability Index) (54). Two studies analyzed the perfusion in chronic WAD 
after a period of 6 months, and both found abnormalities in the patient group (56, 58). One 
study found predominantly decreased perfusion rates in patients with chronic INP 
compared to healthy controls in the right temporal gyrus, and left cerebellum culmen (56). 
However, no changes were found in the observation of perfusion in chronic WAD (56). This 
is in contrast with the study of Lorberboym et al. (2002), who found perfusion abnormalities 
in 13 of the 20 included patients with chronic WAD. However, these abnormalities were 
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modulation of pain via the neuropeptide SP, known to be elevated in patients with chronic 
WAD (86). Both, SP and NK1, have been implicated in locomotive activity (87) and in pain 
processing (88). Therefore, it is not surprising that the forebrain not only acts as a “top-down” 
pain inhibitor, but also modulates voluntary movement by altering the inhibition exerted 
by the basal ganglia on motor output, resulting in pain induced immobilization (53). 
A decrease in NK1-receptor availability, which was most pronounced in the vmPFC of 
patients with chronic WAD (53) may provide forebrain modulation through its dense 
projections to the striatum - globus pallidus complex (89), which is supported by the 
observed negative correlation between kinesiophobia and NK1-receptor availability (55). 
Consequently, high endogenous levels of SP could result in attenuation of NK1 function in 
the vmPFC, starting a negative vicious circle of increased avoidance (55). Furthermore, 
decreased grey matter volume in the forebrain (vmPFC) in pain processing regions was 
already observed in patients with chronic complex regional pain syndrome together with 
reduced white matter integrity (90).
Alterations in the brain perfusion of patients with chronic INP and chronic WAD have been 
observed by different studies (54-59). The diversity of results in brain perfusion and 
metabolism might be attributed to both methodological differences and technical issues. 
The use of different tracers results in different observations. Oxygen-15 (15-O) is for 
example often applied to determine blood flow, while fluorine-18 (18-F), which is injected 
as glucose, provides information on the brain’s metabolism. Some authors state that 
blood flow provides more accurate information on brain function compared to glucose 
consumption, as it is more sensitive to neural activation (91). These differences make 
comparison between both methods rather difficult. The comparison between SPECT and 
PET imaging remains challenging due to differences in technical features, such as the use 
of different tracers and sensitivity, with PET being more sensitive to neural events (37). Thus, 
only cautious interpretations can be drawn from the comparison between studies that 
applied different imaging methods. The diversity in brain perfusion alterations within one 
technique could again support the hypothesis of individual adaptations to restore the 
equilibrium between nociceptive and antinociceptive modulation (58). Surprisingly, many 
brain areas were found to exhibit a higher amount of rCBF, which may reflect a 
compensation mechanism for regional brain atrophy (92). In addition, one study found 
differences between patients with chronic INP and patients with WAD (56). These results 
might suggest that different mechanisms underlie the transition to a chronic or recurrent 
pain state in both patients group, which is in accordance with other study areas (28).
 Although the direction of brain perfusion alterations is still unclear, most authors do 
agree on the presence of perfusion alterations in patients with chronic neck pain. 
Furthermore, research suggests the presence of an association between the patient’s 
self-reported disability (NDI and pain ratings) and cerebral perfusion (54, 55). Therefore, future 
research should rather focus on the association between brain alterations and the severity 
DLPFC was observed in whiplash patients who have developed chronic headache. Yet, 
these changes were observed to resolve after one year in concurrence with the cessation 
of the headache. In contrast, an increased grey matter volume was observed in the PAG, 
thalamus and cerebellum after one year in these patients with chronic headache (50). These 
regions are known to be involved in pain sensation. The ACC and DLPFC are involved in 
the salience and affective-cognitive dimension of pain, and may play an important role in 
pain modulation, exerting top down inhibition (75-77). A disruption of the grey matter 
integrity of these regions might alter pain sensation. One study did identify the DLPFC as 
a site of major neurodegeneration in chronic pain patients (78), potentially leading to an 
increased pain sensation (79). In addition, increased grey matter volume of the PAG was 
demonstrated in patients with chronic WAD (50). The PAG is a brainstem structure that is 
part of the descending pain modulatory network and is crucially involved in pain inhibition 
or antinociception. These changes are furthermore in accordance with the current 
literature, where authors found primarily an increase of grey matter morphology in the 
brain stem (75). It has been suggested that the observed neuroplasticity (increase and 
decrease of grey matter morphology) might result from an aim to restore the balance 
between nociceptive and antinociceptive modulation (50). These changes in morphology 
seem to be very different across different pathologies and depend on timing (41). This 
diversity might correspond with the diversity of perfusion abnormalities in patients with 
chronic WAD found by Lorberboym et al. (2002), which are discussed in the section on 
functional brain alterations (58). 
 Sturzenegger et al. (2008) found no difference in VBR in patients suffering from 
chronic WAD, indicating their sample did not show any signs of diffuse axonal injury (DAI). 
They neither observed a correlation between VBR and any neuropsychological test (51). 
These results are somewhat surprising as diffuse axonal injuries have already been 
observed in patients with MTBI (80), who suffer from similar symptoms as patients with 
WAD. Also, Caeyenberghs et al. (2010) have reported the presence of an association 
between postural control and visuomotor tracking, and a measure of DAI in patients with 
TBI (81, 82). The use of Pearson correlations could contribute to the reason for not finding any 
associations between DAI and the patient’s symptoms, as this measure only analyzes a 
linear relationship between two variables. Furthermore, the authors stated that the 
method they used to evaluate brain tissue loss could not be sensitive enough to detect 
very mild diffuse focal atrophy (51). A newer and potentially more sensitive technique for 
assessing white matter tracts is diffusion weighted imaging (DWI), a technique that 
indirectly analyses the coherence of motion of protons (83, 84).
Functional brain alterations
One study examined alterations in neurotransmission by looking at the density of NK1–
receptors in the brain (53), which are widely distributed throughout the brain with high 
density in the striatum, the amygdala and the DLPFC (85). This receptor allows the 
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cortical surface area. Alterations in thickness and area cause different clinical effects, and 
non-uniformity of these changes has been shown in the brain in aging (95). DWI has also 
yielded better results in terms of analyzing the microstructural organization of white 
matter bundles (83). Besides improvement in morphological imaging, functional brain 
imaging has also evolved. One new popular method, defined as “resting state fMRI” could 
give more insight into the functional organization of the brain during rest (96). Recently, 
a new theoretical framework has risen which addresses the influence of alterations in the 
aggregation of different functional components of the brain and its influence on pain (4). 
Lastly, alterations in the network of the brain have been given attention in different 
conditions, including chronic pain conditions (97). Assessing the morphological and 
functional brain network could allow to assess the macroscopic organization of this 
complex organ (98).
Conclusion
Some to moderate evidence exists for both structural and/or functional brain alterations 
in patients with chronic INP or WAD. In the acute phase, no structural alterations were 
found, but if symptoms persisted, changes in different brain areas were demonstrated. 
Although, most authors agree that brain alterations are present in both patients with 
chronic WAD and patients with chronic INP, there is currently more evidence for brain 
alterations in chronic whiplash patients, and different underlying mechanisms might be 
present in both pathologies. Moreover, brain alterations observed in chronic neck pain 
patients are very diverse, indicating multiple mechanisms are responsible for the brain’s 
neuroplasticity associated with the presence of pain.  Pain and disability seems to be 
furthermore correlated with the observed brain alterations.  Based on our results, 
morphological and functional brain alterations should be further investigated in patients 
with chronic WAD and chronic INP via more sophisticated and sensitive techniques.
of self-reported disability (54), although differences in brain activation between patients 
with chronic WAD and chronic idiopathic neck pain were already observed (61). Only one 
study did not find any associations between brain activation and neuropsychological 
tests of divided attention and working memory (59).
Limitations and strengths 
When interpreting the results, the following study limitations have to be taken into 
consideration. Firstly, only 12 articles were included in this review, which imposes the 
possibility to draw only cautious conclusions. Secondly, the diversity in brain imaging 
techniques hampers the possibility of comparison, as we are aware of the different 
technical features in every technique, which potentially affect the observed outcome. 
Thirdly, authors tend to use different “brain atlases” for analyzing and describing their 
results. Some analyzed a global region, such as the temporal lobe, while others investigated 
specific parts of a certain lobe, such as the vmPFC. Many researchers have tried to address 
a certain function to the brain’s anatomy and have attributed a specific function to certain 
brain areas (93, 94). Lastly, many studies did suffer from certain risks of bias, which could affect 
their results, and this implies the impossibility to draw firm conclusions from the current 
literature.
 However, also several strengths of this systematic review can be outlined. Firstly, 
the present systematic review is innovative and is valuable to steer future brain research. 
Secondly, the methods used for screening and scoring were completed by two 
independent blinded researchers. At last, the NOS checklist was modified by adding 2 
MRI-related scoring items specifically developed for the topic of the current systematic 
review. Consequently, the methodological quality of the MRI articles could be evaluated 
more thoroughly giving a more accurate view on the MRI data acquisition, processing and 
quality control.
Recommendations for further research
Future studies should certainly try to avoid bias, and should consider the mentioned 
considerations regarding the inclusion of confounding factors. Furthermore, more 
longitudinal research could allow exploring the causal relationship between brain imaging 
results and the development and maintenance of persistent neck pain. In addition, 
research on disease-specific neck pain could reveal different neuroplastic brain changes 
when compared to non-specific neck pain. 
 To date, the imaging techniques used in studies that have assessed the brain in a 
population of neck pain patients are outdated. Recently, new morphological brain analysis 
tools were developed with new features allowing a more detailed assessment of the 
human brain. Surface-based morphometry (SBM) has yielded better results in terms of 
specificity compared to voxel-based morphometry (32, 43). One reason is the ability of SBM 
to assess not only volumetric measurements, but also measures of cortical thickness and 
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Supplementary Table 1  Level of evidence, according to the 2005 classification 
system of the Dutch Institute for Healthcare Improvement CBO
Intervention
A1 Systematic review of at least 2 independent from each other conducted studies  
of evidence level A2
A2 Randomized double-blinded comparative clinical research of good quality  
and efficient size
B Comparative research, but not with al characteristics as mentioned for A2.  
This includes also patient-control research and cohort research.
C Not comparative research
D Opinion of experts
www.cbo.nl
Supplementary Table 2  Strength of Conclusion (modified table)
Conclusion based on 
1 Research of evidence level A1 or at least 2 independent conducted studies  
of evidence level A2
2 1 research of evidence level A2 or at least 2 independent conducted studies  
of evidence level B 
3 1 research of evidence level B or C
4 Inconclusive or inconsistent results between various studies
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Introduction
Chronic neck pain is one of the most prevalent musculoskeletal pain disorders worldwide (1) 
and is associated with high socioeconomic and personal health costs, and extensive 
psychosocial burden, and frequent medical physician and physical therapist consultations (2-4). 
Moreover, the prevalence is still increasing; therefore, the socioeconomic burden is 
growing (5). 
Chronic neck pain can be subdivided, on the basis of its etiology, into 3 main categories: 
specific neck pain, trauma-induced neck pain, and idiopathic (nontraumatic) neck 
pain. This article focuses on chronic neck pain of a traumatic or an idiopathic nature. 
Chronic idiopathic neck pain (CINP) is defined as neck pain lasting more than 3 months, 
without the presence of specific causes, such as trauma, cervical hernias with clinical 
symptoms, or radiculopathy. Often no underlying structural pathology can be 
demonstrated (6, 7) and radiological imaging findings are poorly related to a patient’s 
clinical symptoms (6, 8). Scientific research concerning the factors contributing to pain 
persistence in CINP is limited. 
Chronic traumatic neck pain is characterized by persistent neck pain lasting more than 3 
months and resulting predominantly from a whiplash injury (9). Whiplash injuries usually 
originate from rear-end motor vehicle collisions and are caused by acceleration-deceleration 
forces acting on the neck (10). The trauma and indirect impact at the cervical spine may 
lead to the development of various clinical manifestations defined as chronic whiplash- 
associated disorders (CWAD) (11, 12). Apart from persistent pain, the main other complaints 
reported by patients with CWAD are concentration difficulties, psychosocial problems, 
fatigue, headache, and reduced quality of life (12-15). 
Research regarding the underlying pathophysiology of CWAD is extensive. There is 
compelling evidence for the presence of various cervical dysfunctions, such as impaired 
cervical movement control (16-18) and increased cervical muscle tone (19), and there is some 
evidence for alterations in neck muscle morphology (20). However, the contributions of 
these dysfunctions to the complex clinical scenario for patients with CWAD seem rather 
limited (21). 
Besides local neck problems, there is compelling evidence for the presence of central 
sensitization in patients with CWAD (13, 22-24). Central sensitization is defined as “an increased 
responsiveness of central nociceptive-signaling neurons to normal or subthreshold 
afferent input” (25). Distant hyperalgesia, enhanced bottom-up nociceptive transmission (13), 
and inefficient activation of endogenous pain inhibition (26) have been demonstrated in 
Abstract
Background: To date, a clear differentiation of disability, cognitive deficits, and central 
sensitization between chronic neck pain of traumatic nature and that of a nontraumatic 
nature is lacking. 
Objective: This study aimed to examine differences in disability, cognitive deficits, and 
central sensitization between women with traumatic and idiopathic (nontraumatic) 
chronic neck pain and women who were healthy. In addition, interrelationships among 
these variables were investigated.
Design: This was a case-control study.
Methods: Ninety-five women (28 women who were healthy (controls), 35 women with 
chronic idiopathic neck pain (CINP), and 32 women with chronic whiplash-associated 
disorders (CWAD) (traumatic) were enrolled in the study. First, all participants completed 
standardized questionnaires to investigate pain-related disability and health-related 
quality of life. Next, cognitive performance was assessed. Finally, pressure pain thresholds 
and conditioned pain modulation were examined to investigate central sensitization. 
Results: Pain-related disability, reduced health-related quality of life, and cognitive deficits 
were present in participants with CWAD and, to a significant lesser extent, in participants 
with CINP (p<.017). Local hyperalgesia was demonstrated in participants with CWAD 
(p<.001) and CINP (p<.017) but not in women who were healthy. However, distant 
hyperalgesia and decreased conditioned pain modulation efficacy were shown only in 
participants with CWAD (p<.017); this result is indicative of the presence of central 
sensitization. Moderate to strong Spearman correlations (ρ= .456 – .701) among disability, 
cognitive deficits, and hyperalgesia (local and distant) were observed in participants with 
CWAD (p<.01). In participants with CINP, only local hyperalgesia and subjective cognitive 
deficits were moderately (ρ= .463) correlated (p<.01). 
Limitations: No conclusions about the causality of the observed correlations can be 
drawn.
Conclusions: This innovative research revealed important differences between women 
with CWAD and women with CINP and thus provided evidence of the clinical importance 
of distinguishing the assessment and rehabilitation approaches for both pain conditions. 
Key words: chronic whiplash associated disorders, chronic idiopathic neck pain, central 
sensitization, disability, quality of life, cognitive performance
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chronic neck pain (CWAD) and CINP and people who were healthy. More deficits in these 
variables were presumed to be present in people with CWAD than in those with CINP. The 
second aim was to investigate significant relationships among measures of disability, 
cognitive deficits, and central sensitization in both chronic neck pain conditions. 
Methods
Study design and setting
This cross-sectional case-control study took place in the research laboratories of the 
Department of Rehabilitation Sciences and Physiotherapy, Ghent University, Ghent, 
Belgium. The study was performed from February 2014 to September 2015. The research 
protocol was approved by the local Ethics Committee of the Ghent University Hospital 
(EC/2013/1053) and was in compliance with the Declaration of Helsinki. 
Participants 
Ninety-five women (35 women with CINP, 32 women with CWAD, and 28 women who 
were healthy and pain-free (controls)) were enrolled in the study. Only women were 
included because research has demonstrated significant differences in pain sensitivity, 
pressure pain thresholds (PPTs), and efficacy of endogenous pain inhibition between men 
and women (38-40). All participants were Dutch native speakers and 18 to 65 years old. 
Participants were recruited by calls on social media and through advertisements placed in 
health magazines and an information brochure of an association for patients with 
whiplash, on the Ghent University website, and via local radio. Furthermore, informative 
flyers and posters were distributed in different medical institutes and associations in 
Flanders, Belgium (various hospitals, physical therapist practices, and medical physician 
practices). 
Inclusion criteria for people with traumatic chronic neck pain and CINP were persistent 
neck pain lasting more than 3 months, with a mean pain intensity of more than 3 of 10 on 
a numeric pain rating scale during the preceding month, which is the cut-off for clinically 
relevant pain (41). All participants with chronic neck pain had to report mild/moderate to 
severe pain-related disability, established by a score of 10 or more of a maximum of 50 on 
the Neck Disability Index (NDI) (42). Furthermore, participants with chronic neck pain had to 
report stability of pain medication intake for at least 4 weeks before study participation. 
People with CWAD were included only if they had neck pain resulting from a motor 
vehicle crash or traumatic event and classifiable as WAD II A, B, or C on the modified (12) 
Quebec Task Force Scale (43). 
patients with CWAD (27, 28). However, the underlying mechanisms of central sensitization 
are still largely unclear, and the relationship between central sensitization, and other 
clinical symptoms in patients with CWAD compared to patients with CINP has been 
poorly investigated. 
Besides persisting pain, patients with CWAD commonly have pain-related disability and 
reduced quality of life (13, 29-31). Depression and disability, which have a negative impact on 
quality of life, are associated with poor recovery in patients with CWAD (29). 
 Other important complaints in these patients are decreased cognitive capabilities, 
which have been demonstrated with cognitive tests (13, 32). Soon after the initial injury, 
patients with whiplash report difficulties with concentration and memory, and these 
complaints continue into the chronic phase (33). However, the association between 
cognitive deficits and the development and maintenance of chronic pain is unclear. 
Most research has focused solely on CWAD and has not addressed CINP. Scientific research 
into differences between the underlying mechanisms of chronic neck pain of traumatic 
origin (CWAD) and those of chronic neck pain of nontraumatic origin (CINP) is highly 
limited. On the basis of the scarce literature comparing CWAD and CINP, indications for 
different underlying mechanisms can be found (34). First, one study of central sensitization 
indicated that sensory hypoesthesia, altough present in CWAD, is not a feature of CINP (35). 
Second, a recent systematic review concluded that central sensitization and sensory 
abnormalities outside the cervical spine are rare in patients with CINP (36). However, the 
results of these few studies were inconclusive. Finally, biomedical studies focusing on 
dysfunctions in cervical muscle morphology and performance comparing CWAD and 
CINP also revealed differences (16, 17, 37). 
Accordingly, these findings indicate that CWAD and CINP are separate clinical conditions 
(34), and it can be hypothesized that the traumatic origin of chronic neck pain in patients 
with CWAD gives rise to deficits more severe than those seen in patients with CINP. 
Nevertheless, experimental studies exploring differences in disability and cognitive 
performance between both chronic neck pain conditions are essentially lacking. Moreover, 
associations among disability, cognitive deficits, and central sensitization have been 
hypothesized but remain largely unexplored. Gaining more insight into possible 
differences between and interrelationships among these variables could contribute to 
more effective assessment and therapy approaches for both pain conditions. Differentia-
tion in management between CINP and CWAD may be necessary to improve clinical 
outcomes.
For the reasons outlined above, the first aim of this study was to examine differences in 
disability, cognitive deficits, and central sensitization between people with traumatic 
130 131
3
Chapter 3 Disability, cognitive deficits, and central sensitization in chronic neck pain
Health-related quality of life
For the evaluation of health-related quality of life, the Medical Outcomes Study 36-Item 
Short-Form Health Survey Questionnaire (SF-36) was used (47). This self-report questionnaire 
can be divided into 2 main domains of health: the physical and mental health components. 
The SF-36 total score (0-800) is the summation of the physical health (0-500) and mental 
health (0-300) component scores. Higher scores represent better health for that particular 
health component. The Dutch language version of the SF-36 has been shown to have 
good reliability and validity in adults who are healthy and patients with chronic pain (48).
Cognitive performance
Self-perceived cognitive performance
For the evaluation of self-reported cognitive deficits, participants completed the Dutch 
modified Perceived Deficits Questionnaire (mPDQ) (0-72). This questionnaire investigates 
self-perceived cognitive symptoms in 4 different cognitive subdomains (prospective 
memory, retrospective memory, attention and concentration, and organization and 
planning) during the preceding 4 weeks; symptoms are rated on a 5-point Likert scale 
anchored from never (0) to almost always (4). Higher scores represent more self-perceived 
cognitive symptoms. The mPDQ is the modified version of the Perceived Deficits 
Questionnaire, which was adapted for patients with CWAD (49). The validity and reliability 
of the English language version of the mPDQ have been demonstrated in patients with 
CWAD and people who are healthy (49). 
Objective cognitive performance
The Trail Making Test (TMT) was administered to objectively obtain an instrumented 
measure of cognitive performance (50). First, in part A, the participants were asked to 
connect 25 numbers in ascending order as fast as possible. Second, in part B, the 
participants had to alternate between numbers and letters.  The goal of the TMT was to 
finish part A and part B as quickly as possible while still maintaining accuracy. The time 
taken to complete each part of the test was used as an outcome measure. Higher scores 
represent more deficits. 
 In addition, the ratio of scores on TMT part B to scores on TMT part A and the 
difference between scores on TMT part B and scores on TMT part A were calculated. These 
scores can elucidate the added task requirements of TMT part B and are purer indexes of 
the complex cognitive processes involved in part B. The difference between TMT part B 
and TMT part A removes the speed component from the TMT assessment and minimizes 
visuoperceptual and working memory requirements, thus providing an indication of 
executive function (50). Furthermore, the ratio of TMT part B to TMT part A diminishes the 
influence of psychomotor demands and controls on intrasubject variability factors, thus 
focusing on the measurement of cognitive flexibility (51). 
The inclusion criterion for people with CINP was persistent idiopathic (nontraumatic) neck 
pain. People with CINP were excluded if they ever experienced a whiplash trauma. 
In addition, people with specific causes of neck pain, such as cervical hernias with clinical 
symptoms, were excluded. 
Women who were healthy and pain-free could participate only if they were pain-free on 
the test day (numeric pain rating scale score of <2/10), had no history of neck-shoulder-
arm pain for more than 8 consecutive days during the preceding year, with a pain intensity 
of 2 or more on the numeric pain rating scale; no medical consultation for neck-shoulder-
arm pain during the preceding year; and no history of whiplash trauma. Additionally, 
women who were healthy and pain-free were included only if they had a score of less 
than 8 on the NDI.
General exclusion criteria for all study groups were the presence of major depression or 
psychiatric illness; neurologic, metabolic, cardiovascular disorders; inflammatory 
conditions; fibromyalgia; chronic fatigue syndrome; and a history of neck or shoulder 
girdle surgery. Furthermore, women who were pregnant and women who were 1 year 
postnatal were excluded to preclude confounding factors. All participants were asked to 
discontinue intake of nonopioid analgesics 48 hours before study participation. In 
addition, participants were asked to avoid heavy physical exertion and to refrain from 
consuming alcohol, caffeine, and nicotine on the day of testing. All participants were 
thoroughly informed about the study procedures and signed an informed consent 
statement before study enrolment.  
Procedure 
First, all participants completed a general survey to acquire information on demographics 
and education level. Subsequently, disability measures were obtained with 2 validated 
Dutch questionnaires. All participants completed these questionnaires online and in a 
fixed order. On the test day, participants reported neck pain duration and scored current 
neck pain intensity on a numeric pain rating scale (0-10). Afterward, assessments to 
investigate cognitive performance and central sensitization were performed. All tests 
were carried out by the same experienced researcher. 
Outcome measures
Disability
Neck pain-related disability
The NDI was used to investigate neck pain-related disability levels (0-50) (42, 44). Higher 
scores on the NDI indicate higher levels of pain-related disability. The Dutch language 
version of the NDI has been proven to be reliable and valid for patients with chronic neck 
pain (45, 46). 
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Conditioned Pain Modulation
The presence of dysfunctional endogenous pain inhibition was investigated by evaluating 
the efficacy of CPM by applying a CPM paradigm. This paradigm relies on the “pain-inhib-
its-pain” mechanism, in which a noxious stimulus is used as a conditioning stimulus to 
induce a reduction in the perception of pain from another test stimulus (61, 62). The 
conditioning stimulus for eliciting CPM was the cold pressor test. The assessment of PPTs 
was used as the test stimulus. 
 First, participants were given clear instructions about the test procedure. Next, one 
hand was immersed in water maintained at room temperature (22°C) for 1 minute to 
standardize the hand temperature, as previously described by other researchers (63). 
Subsequently, participants were asked to immerse the same hand (up to the wrist) in a 
bath (VersaCool, Thermo Fisher Scientific, Waltham, Massachusetts) with circulating cold 
water maintained at 12°C (SD=1°C) (64). The contralateral hand to the test stimulus (PPT 
measurement) was used to maximize the CPM effect, which is dependent on the distance 
between the stimuli (65). Participants were asked to keep their hand in the water bath for 
2 minutes (63). During the conditioning stimulus, after 25, 60, and 114 seconds, participants 
rated the perceived pain intensity of the cold water on an 11-point verbal numeric rating 
scale with responses ranging from 0 (“no pain”) to 10 (“worst imaginable pain”). 
 Pressure pain thresholds were re-evaluated at 2 of the predefined locations (trapezius 
muscle and quadriceps muscle) in the same randomized order as before. The PPT 
re-evaluation started at 30 seconds after immersion of the hand (Fig. 1). If participants 
removed the hand from the water before the end of the 2 minutes, the measurement was 
registered as missing. For analyses of CPM efficacy, the mean PPT measured before the 
cold pressor test was subtracted from the mean PPT measured during the cold pressor 
test. Hence, a lower CPM value reflected less efficient endogenous pain inhibition. 
Intrasession and intraclass correlation coefficients for the cold pressor test have been 
shown to be excellent (.85) (66). 
Data analysis
All statistical analyses were performed with IBM SPSS Statistics 22.0 (IBM SPSS, Armonk, 
New York). First, the normality of variables was checked with the Shapiro-Wilk test and by 
visual evaluation of quantile-quantile plots and histograms. Additionally, the equality of 
variance was examined with the Levene’s test. Only normally distributed data with an 
equality of variance were analysed with parametric tests. Otherwise, non-parametric tests 
were applied. 
 The comparability of study groups for age, current neck pain intensity, neck pain 
duration, and other demographics was explored with a 1-way analysis of variance (post 
hoc Bonferroni), the Kruskal-Wallis test (post-hoc Mann-Whitney U test), or Fisher exact 
test. Subsequently, differences in disability, cognitive deficits, and central sensitization 
between participants with CWAD and CINP and women who were healthy were explored 
Central sensitization
Self-perceived symptoms of central sensitization
All participants completed the Dutch language version of the Central Sensitization 
Inventory (CSI). The CSI is a self-report screening instrument for the measurement of 
clinical symptoms of central sensitization (0-100) in people with chronic pain (52, 53). 
The Dutch CSI has been shown to have good internal consistency, good discriminative 
power, and excellent test-retest reliability (52). Neblett et al (54) determined that a CSI score 
of 40 of 100 best distinguished between a group of patients who had a central sensitivity 
syndrome (CSI scores of ≥ 40/100) and a group of patients who did not have a central 
sensitivity syndrome (area under the curve = .86, sensitivity = 81%, specificity = 75%). The 
CSI is a valid instrument for screening patients for the possible presence of central 
sensitization, although the chances of false-positive results are relatively high when 
patients with complex pain disorders are evaluated (55). 
Experimental measures of central sensitization
For investigation of the presence of central sensitization, 2 critical aspects of central pain 
processing were assessed with experimental pain tests: PPTs and conditioned pain 
modulation (CPM). 
Pressure pain hyperalgesia
Pressure pain thresholds were measured unilaterally with a digital pressure algometer 
(FDXTM, Wagner Instruments, Greenwich, Connecticut), both at a symptomatic local region 
(middle trapezius muscle midway between the spinous process of C7 and the lateral 
border of the acromion) to evaluate local hyperalgesia and at asymptomatic distant 
regions (quadriceps muscle midway between the anterior superior iliac spine and the 
basis patellae, the skin web between the thumb and the index finger, and the lumbar level 
5 cm lateral to the spinous process of L3) to evaluate distant hyperalgesia (56, 57) (Fig. 1). 
Pressure pain thresholds were assessed on the more painful side (58). In women who were 
healthy and when participants with CINP and CWAD experienced the same amount of 
neck pain on both sides, PPTs were tested on the dominant side. 
 Pressure pain thresholds were assessed in a randomized order (with Research 
Randomizer; https://www.randomizer.org). During the test procedure, participants were 
comfortably seated and pressure was gradually increased at a rate of 1 kgf/s until the 
participants reported the first sensation of unpleasantness. The PPT was determined as 
the mean of 2 consecutive (30 seconds in between) measurements. This technique was 
found to be reliable (59). In addition, the intratester reliability of PPT measurements is 
satisfactory to good (intraclass correlation coefficient= .78 - .93) (60). 
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Results
Differences between participants with CWAD and CINP and  
healthy controls 
Demographic characteristics and self-reported pain and disability measures
The demographic characteristics and self-reported pain and disability measures are 
shown in Table 1, and test statistics are shown in appendix A. All study groups were 
comparable in age, body height, body weight, body mass index, and education level. 
Furthermore, both groups with chronic neck pain were comparable in neck pain duration, 
current neck pain intensity, and frequency of neck pain complaints per week. 
Disability 
The NDI scores were significantly higher in both groups with chronic neck pain compared to 
healthy controls (p<.001). Participants with CWAD reported significantly more pain-related 
disability compared to participants with CINP (p<.001). Furthermore, compared with 
controls, both groups with chronic neck pain had diminished health-related quality of life 
(SF-36 total) (p<.001). Both physical health-related quality of life and mental health-related 
quality of life were reduced (p<.001). Significantly lower health-related quality of life (lower 
scores on SF-36 total, mental health, and physical health) was observed in participants 
with CWAD compared to participants with CINP (p<.017). 
Cognitive performance
The results for self-reported cognitive deficits (mPDQ total score and subscale scores) and 
the objective cognitive performance test (TMT parts A and B) are shown in Figure 2, Table 1, 
and appendix A.
Compared with women who were healthy, participants with CINP or CWAD reported 
more self-perceived cognitive deficits (mPDQ total score) (p<.017 or p<.001, respectively). 
Compared with controls, participants with CWAD reported more cognitive deficits on all 
mPDQ subscales (p<.001), whereas participants with CINP reported more cognitive 
deficits on only 2 subscales of the mPDQ (attention-concentration and organisation- 
planning) (p<.017). Post hoc paired comparisons indicated significantly more attention- 
concentration problems (p<.001), retrospective memory problems (p<.001), and prospective 
memory problems (p<.017) and more severe deficits in total subjective cognitive 
performance (p<.001) in participants with CWAD compared to those with CINP.
 The time needed to perform TMT part A and TMT part B was significantly longer in 
participants with CWAD compared to women who were healthy (p<.017). In addition, 
the time needed to perform TMT part A was significantly longer in participants with 
CWAD than in those with CINP (p<.017). 
with a 1-way analysis of variance (post hoc Bonferroni) or the Kruskal-Wallis test (post hoc 
Mann-Whitney U test). 
 Finally, correlations among measures of disability, cognitive deficits, and central 
sensitization in both chronic neck pain conditions were investigated with Spearman 
correlation analyses. 
 To correct for multiple comparisons, we deemed only Spearman correlations below 
the .01 level (2-tailed) to be significant. Differences measured with the Mann-Whitney U 
test were assumed to be significant only below the .017 (Bonferroni correction: .05/3) level.
An a priori sample size calculation was conducted in G*Power (version 3.1.9.2; http://www.
gpower.hhu.de/) with a Cohen d effect size of 0.40, a significance level of .05, and a desired 
power of .90 (F tests; 1-way analysis of variance). The Cohen d effect size was calculated on 
the basis of PPT data reported in previous studies (34, 67) for patients with CWAD, patients 
with CINP, and people who were healthy and pain-free. The calculation revealed that a 
total sample size of at least 84 participants, with 28 participants per group, was required.
Figure 1  Top row: the assessment of local and distant hyperalgesia by measuring pressure 
pain thresholds at the trapezius muscle (local hyperalgesia); the web between thumb 
and index finger (= hand), lumbar region (= low back), and quadriceps muscle (distant 
hyperalgesia). Bottom row: the assessment of conditioned pain modulation efficacy at 
the trapezius muscle, and at the quadriceps muscle.
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Pressure pain hyperalgesia
Decreased PPTs were demonstrated at the middle trapezius muscle, quadriceps muscle, 
hand, and lumbar region in participants with CWAD but only at the middle trapezius 
muscle in participants with CINP, relative to the results for women who were healthy 
(p<.017). No significant differences between participants with CWAD and participants 
with CINP were found for PPTs at the 4 locations. 
Conditioned Pain Modulation
The CPM values (PPT during cold pressor test minus PPT before cold pressor test) measured 
at the quadriceps muscle were significantly lower in participants with CWAD than in 
women who were healthy and participants with CINP (p<.017). The CPM values measured 
Executive function, examined by calculating the difference between scores on TMT B and 
scores on TMT A, and cognitive flexibility, examined by calculating the ratio of scores on 
TMT B to scores on TMT A, revealed no significant differences among all study groups 
(p>.05). 
Central sensitization
The outcomes of the measurements of central sensitization are shown in Table 1 and 
appendix A (self-perceived symptoms) and in Table 1, appendix A, and Figures 3 and 4 
(experimental measures).
Self-perceived central sensitization symptoms
Both groups with chronic neck pain reported significantly more self-perceived central 
sensitization symptoms than women who were healthy and pain-free (p<.001), and 
participants with CWAD experienced significantly more central sensitization symptoms 
than participants with CINP (p<.017).
Figure 2  Cognitive performance
 
CON= healthy controls, CINP= chronic idiopathic neck pain, CWAD= chronic whiplash 
associated disorders, IQR= interquartile range, mPDQ= modified Perceived Deficits 
 Questionnaire, TMT= Trail Making Test. 
Median and IQR are presented when the Kruskal-Wallis Test (post-hoc Mann-Whitney U) 
was applied for data observed as not normally distributed; **=p<0.017, ***=p<0.001.
Figure 3  Local and Distant Hyperalgesia 
CON= healthy controls, CINP= chronic idiopathic neck pain, CWAD= chronic whiplash 
associated disorders, PPT= pressure pain thresholds, CPM= conditioned pain modulation, 
kgf = kilogram force (1 kgf = 9,81 N), IQR=interquartile range, **=p<0.017, ***=p<0.001, 
Mean and SD are presented when One-way ANOVA (post-hoc bonferroni) was applied 
for data observed as normally distributed. Median and IQR are presented when Kruskal-
Wallis Test (post-hoc Mann-Whitney U test) was applied for data observed as not normally 
distributed. Results of experimental measures of central sensitization are presented in 
particular pressure pain threshold measurements to examine local hyperalgesia (PPT 
trapezius) and distant hyperalgesia (PPT hand, PPT low back, PPT quadriceps).
**=<0.017: Kruskal-Wallis/Mann-Withney; ***=<0.001: One-way ANOVA (bonferroni);
CON= healthy pain free controls; CINP= chronic idiopathic neck pain;
CWAD= chronic whiplash associated disorders; PPT= pressure pain thresholds
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Interrelationships among disability, cognitive deficits,  
and central sensitization 
Relationships between subjective or objective cognitive performance and 
experimental measures of central sensitization
The results of the Spearman correlation (ρ) analyses of subjective or objective cognitive 
performance and experimental measures of central sensitization are shown in Table 2. 
These analyses revealed significant moderate negative relationships between PPTs at 
local symptomatic or distant asymptomatic locations (ρ= -.456 to ρ= -.688) and 
self-reported cognitive performance in participants with CWAD (p<.001) and between the 
PPT at the local region (ρ= -.463) and self-reported cognitive performance in participants 
with CINP (p<.01). Only in participants with CWAD did Spearman correlation analyses 
demonstrate significant moderate negative relationships (ρ= -.460 to ρ= -.485) between 
PPTs at local or distant locations and objective cognitive performance, in particular visual 
attention and visual-motor speed (TMT part A) (p<.01). In contrast, no significant 
correlations were found between self-perceived or objectively measured cognitive 
performance and CPM efficacy in both groups of participants with chronic neck pain. 
Relationships between disability and experimental measures of central sensitization
The results of the Spearman correlation analyses of self-reported disability characteristics 
and experimental measures of central sensitization are shown in Table 2. In both groups of 
participants with chronic neck pain, no significant correlations were found between PPTs 
or CPM efficacy and neck pain-related disability. Only in participants with CWAD was 
health-related quality of life found to be significantly moderately correlated (ρ= .459) with 
the PPT at the middle trapezius muscle (p<.01). The latter correlation was not observed in 
participants with CINP. 
Relationships between disability and subjective or objective cognitive performance
The results of the Spearman correlation analyses of self-reported disability characteristics 
and cognitive performance are shown in Table 3. Participants with CWAD had significant 
moderate to strong positive relationships (ρ= .486 to ρ= .637) between neck pain-related 
disability and self-perceived cognitive deficits or objectively measured cognitive 
performance. Higher NDI scores correlated with more deficits on the mPDQ (p<.001) and 
more deficits on the TMT parts A and B (p<.01). Furthermore, in participants with CWAD, 
significant moderate to strong negative correlations (ρ= -.470 to ρ= -.701) were observed 
between health-related quality of life and mPDQ total scores (p<.001) or the TMT parts A 
and B (p<.01). 
at the middle trapezius muscle were not significantly different among all study groups 
(p>.017). 
Three participants with CINP and 5 participants with CWAD removed their hands from the 
water before the end of the 2 minutes during the cold pressor test. 
Figure 4  Efficacy of Conditioned Pain Modulation
CON= healthy controls, CINP= chronic idiopathic neck pain, CWAD= chronic whiplash 
associated disorders, CPM= conditioned pain modulation, kgf = kilogram force (1 kgf = 
9,81 N), IQR=interquartile range, CPT= cold pressor test, **=p<0.017, ***=p<0.001, Mean 
and SD are presented when One-way ANOVA (post-hoc bonferroni) was applied for data 
observed as normally distributed. Median and IQR are presented when Kruskal-Wallis Test 
(post-hoc Mann-Whitney U test) was applied for data observed as not normally distributed.
Results of experimental measures of central sensitization are presented, in particular 
measurements of CPM efficacy at the middle trapezius and at the quadriceps muscle.
**=<0.017: Kruskal-Wallis/Mann-Withney; ***=<0.001: One-way ANOVA (bonferroni);
CON= healthy pain free controls; CINP= chronic idiopathic neck pain;
CWAD= chronic whiplash associated disorders; PPT= pressure pain thresholds
144 145
3
Chapter 3 Disability, cognitive deficits, and central sensitization in chronic neck pain
Discussion
The first goal of the present case-control study was to examine differences in disability, 
cognitive deficits, and central sensitization between participants with traumatic chronic 
neck pain and CINP and women who were healthy and pain-free. The second goal was to 
investigate relationships among disability, cognitive deficits, and experimental measures 
of central sensitization in both chronic neck pain conditions. 
The results of the present study provided evidence for pain-related disability, reduced 
physical health- and mental health-related quality of life, and self-perceived cognitive 
deficits in participants with CWAD and CINP, relative to the results for women who were 
healthy. Moreover, participants with CWAD reported more deficits in all of these 
parameters than participants with CINP. Consistent with the findings of the present study, 
several other studies found cognitive deficits in people with CWAD, relative to the results 
for people who were healthy (13, 32, 68). For example, Sullivan et al. observed subjective 
cognitive deficits in patients with CWAD compared to healthy persons (68). Furthermore, 
Table 2   Correlations between cognitive performance and disability 
characteristics, and experimental measures of central sensitization  
in patients with CINP and CWAD.
PPT  
trapezius
PPT  
quadriceps
PPT
low back
PPT
hand
CPM  
trapezius
CPM  
quadriceps
CINP (n=35)
Self-perceived cognitive performance (mPDQ)
Total score 
-.463**
.008
-.238
.189
-.390
.028
-.198
.276
-.033
.867
-.224
.253
Objective cognitive performance (TMT)
Part A 
-.170
.345
-.105
.560
-.126
.486
-.376
.031
-.234
.223
.137
.479
Part B 
-.119
.509
.130
.471
-.003
.987
-.033
.854
.046
.811
.029
.881
Disability characteristics
Pain-related Disability 
-.312
.107
-.379
.046
-.256
.189
-.237
.224
.023
.916
-.085
.694
Health-related QoL total
.301
.088
.290
.090
.299
.307
.183
.101
.148
.455
.097
.619
CWAD (n=32)
Self-perceived cognitive performance (mPDQ)
Total score
-.679***
< .001
-.595***
< .001
-.516**
.003
-.688***
< .001
.042
.837
-.334
.095
Objective cognitive performance (TMT)
Part A
-.485**
.006
-.456**
.010
-.369
.041
-.460**
.009
.069
.739
-.335
.094
Part B
-.265
.149
-.259
.159
-.164
.379
-.344
.058
.179
.382
.223
.272
Disability characteristics
Pain-related Disability
-.337
.060
-.346
.052
-.409
.020
-.366
.039
.126
.530
-.135
.501
Health-related QoL total
.459**
.008
.293
.103
.203
.265
.375
.034
-.126
.532
.089
.657
Significant correlations are presented in bold. Correlations significant at the 0.05 level (2-tailed) were not 
deemed significant in order to correct for multiple comparisons. 
** Spearman correlation is significant at the 0.01 level (2-tailed). *** Spearman correlation is significant at the 
0.001 level (2-tailed). P-values are presented below the correlation coefficient. CINP= chronic idiopathic neck 
pain, CWAD= chronic whiplash associated disorders, mPDQ= modified Perceived Deficits Questionnaire, 
TMT= Trail Making Test, PPT= Pressure Pain Thresholds, CPM= Conditioned Pain Modulation, PPT= Pressure 
Pain Thresholds, CPM= Conditioned Pain Modulation, QoL= quality of life.
Table 3   Correlations between disability characteristics and cognitive 
performance in CINP and CWAD patients.
mPDQ Total TMT Part A TMT Part B
CINP (n=35)
Disability characteristics
Pain-related Disability
.279
.159
.001
.997
.197
.315
Health-related QoL Total
-.345
.057
-.076
.680
-.074
.686
CWAD (n=32)
Disability characteristics
Pain-related Disability
.637***
< .001
.556***
.001
.486**
.006
Health-related QoL Total
-.701***
< .001
-.577***
.001
-.470**
.008
Significant correlations are presented in bold. Correlations significant at the 0.05 level (2-tailed) were not 
deemed significant in order to correct for multiple comparisons. 
** Spearman correlation is significant at or below the 0.01 level (2-tailed). *** Spearman correlation is significant 
at or below the 0.001 level (2-tailed). P-values are presented below the correlation coefficient. CINP= chronic 
idiopathic neck pain, CWAD= chronic whiplash associated disorders, mPDQ= modified Perceived Deficits 
Questionnaire, TMT= Trail Making Test.
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and not in participants with CINP. In accordance with these findings, Chua et al (69) could 
not detect less effective inhibitory modulation in the trigeminal and spinal sensory 
systems in patients with CINP. Furthermore, the lack of signs of central sensitization in 
participants with CINP is consistent with the conclusion of a systematic review that central 
sensitization is not a characteristic feature of CINP (36). 
Remarkably, the results of the self-reported CSI were different from the results of the 
experimental measures of central sensitization because, compared with women who 
were healthy, both participants with CINP and participants with CWAD reported 
significantly more central sensitization symptoms, whereas experimentally measured 
central sensitization was present only in participants with CWAD. The strength and the 
novelty of the present study compared with previous research are that the presence of 
central sensitization was examined by combining 3 important central sensitization 
measures: self-reported central sensitization symptoms (CSI), distant hyperalgesia (PPTs), 
and efficacy of endogenous pain inhibition (CPM). Our results add important evidence 
that central sensitization is present, at a group level, in people with CWAD but not in 
people with CINP. 
 
Regarding the relationships among disability, cognitive performance, and central 
sensitization, the present study revealed that increased local hyperalgesia and distant 
hyperalgesia were moderately to strongly correlated with more subjective and objective 
cognitive deficits in participants with CWAD. On the contrary, CPM efficacy was not 
correlated with cognitive performance. This finding is in contrast to our hypothesis that 
the malfunctioning of endogenous pain inhibition and subsequent chronic pain could be 
associated with decreased cognitive performance. However, another recent study also did 
not reveal significant correlations between decreased cognitive performance and CPM 
efficacy in patients with CWAD (13). Furthermore, consistent with our findings, Meeus et al 
(32) did not find correlations between CPM efficacy and objective cognitive performance in 
people with CWAD. 
In participants with CWAD, higher pain-related disability and reduced health-related 
quality of life were moderately to strongly correlated with increased subjective cognitive 
deficits and decreased performance on the objective cognitive test. However, in 
participants with CINP, positive moderate correlations were observed only for 
self-perceived cognitive deficits and local hyperalgesia at the middle trapezius muscle. 
Furthermore, the results obtained for participants with CWAD were in accordance with a 
recent study that provides evidence for significant correlations between decreased 
attention and working memory capacities (computer-based tests), and reduced 
health-related quality of life in people who were healthy, patients with CWAD, and patients 
with fibromyalgia (13). Our results provide additional evidence for the latter relationship 
we demonstrated decreased objective cognitive performance only in participants with 
CWAD, relative to the results for women who were healthy. Similarly, 2 recent studies 
revealed significant objective cognitive deficits in patients with CWAD, compared with 
the results for volunteers who were healthy (13, 32). To our knowledge, a comparison of 
subjective and objective cognitive deficits in people with CINP and people with CWAD 
has not been reported in the literature. Hence, the present study adds novel and valuable 
insights into the symptomatology of these conditions.
Additionally, as evidenced by the CSI results, significantly more self-perceived symptoms 
suggestive of central sensitization were found in both groups of participants with chronic 
neck pain than in controls. Nevertheless, a CSI score of 40 of 100 best distinguished 
between people who had a central sensitivity syndrome (CSI scores of ≥ 40/100) and 
people who did not have a central sensitivity syndrome (sensitivity = 81%, specificity = 
75%) (54). We found a median CSI score of 49 of 100 for participants with CWAD; this score 
suggested the presence of central sensitization in most participants with CWAD. In 
contrast, participants with CINP had a median CSI score of 39; this score was below the 
cutoff and did not imply the presence of central sensitization in most participants with 
CINP. To the best of our knowledge, the present study is the first to assess these relevant 
self-perceived central sensitization symptoms in people with CINP or CWAD; therefore, 
comparisons with other studies are difficult. 
Pressure pain thresholds measured at the middle trapezius muscle were not different in 
the 2 groups of participants with chronic neck pain. However, compared with women 
who were healthy, participants with CWAD or CINP had increased sensitivity for pressure 
stimuli at the symptomatic middle trapezius muscle, reflecting local hyperalgesia. These 
results are in accordance with those of the study of Scott et al (34), who demonstrated local 
hyperalgesia in both patients with CINP and patients with CWAD, relative to the results for 
volunteers who were healthy. Comparably, Chien and Sterling (35) showed lower PPTs at the 
cervical region in both patients with CWAD and patients with CINP than in controls; in 
addition, they did not observe differences in PPTs at this local region between the 2 
groups with chronic neck pain. 
In the present study, compared with women who were healthy, participants with CWAD 
had increased sensitivity for pressure stimuli at distant regions, reflecting distant 
hyperalgesia and indicating significant signs of central sensitization and, thus, neuroplastic 
changes in the central nervous system. Likewise, Scott et al (34) reported decreased PPTs 
over the tibialis anterior muscle and median and radial nerve trunks in patients with CWAD 
but not in patients with CINP. Additionally, in the present study, decreased CPM efficacy, as 
assessed with the cold pressor test, was observed only in participants with CWAD; this 
finding implied disturbed endogenous pain inhibitory mechanisms in these participants 
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and self-reported cognitive deficits were demonstrated in participants with CWAD and, 
to a significantly lesser extent, in participants with CINP. However, decreased objective 
cognitive performance was present only in participants with CWAD. Local pressure 
hyperalgesia at the middle trapezius muscle was present in both groups of participants 
with chronic neck pain. In contrast, distant hyperalgesia and decreased CPM efficacy were 
present in participants with CWAD but not in those with CINP, indicating the presence of 
central sensitization only in participants with CWAD. Therefore, the results provide preliminary 
evidence for the clinical importance of distinguishing assessment and rehabilitation 
approaches for patients with traumatic chronic neck pain and those with CINP. 
On the basis of the results of the present study, we recommend that disability, self-perceived 
and objective cognitive deficits, signs of central sensitization, and their possible inter-
relationships should be evaluated with the aim of providing more effective and individually 
tailored therapy. In view of the observed correlations with local hyperalgesia and distant 
hyperalgesia in participants with CWAD, targeting the modification of disability and 
cognitive deficits should be an integral part of therapy for patients with CWAD. 
Questionnaires such as the NDI, the SF-36, and the mPDQ could be used to evaluate and 
re-evaluate respectively disability, health-related quality of life, and cognitive deficits in 
both patients with CINP and patients with CWAD. Furthermore, the TMT could be used as 
an objective test to examine cognitive performance in patients with CWAD. 
Additionally, therapists should be aware of the possibility of central sensitization in 
patients with CWAD. Therefore, therapists should be able to recognize central sensitization. 
Clinical guidelines for recognizing and treating central sensitization are available in current 
literature (70, 71). The evaluation of self-reported central sensitization symptoms, distant 
hyperalgesia, and endogenous pain inhibition can contribute to the recognition of central 
sensitization. When the clinical picture is characterized and dominated by central 
sensitization or when maladaptive illness perceptions are present (72), neurophysiological 
pain education should be applied. The goals of such education are to change inappropriate 
pain beliefs, reduce maladaptive attitudes, cognitions, and behavior in relation to pain; 
and subsequent increase participation in active treatment (73, 74). This type of pain education 
will generally be more applicable for patients with CWAD, but it may be relevant for 
patients with CINP because, at an individual patient level, it is still possible that central 
sensitization is present in patients with CINP. Previous research in patients with CWAD 
demonstrated significant decreases in pain-related disability and increases in PPTs after 
pain neurophysiology education (74). 
On the basis of the results of the present study, cognitive deficits, such as attention, 
concentration, and memory problems, should be taken into account in the application of 
pain education. In patients with acute and subacute whiplash injuries, early pain education 
between reduced quality of life and increased objective cognitive deficits in people with 
CWAD. The strength of the present study was the use of the TMT, which can be quickly 
and easily administered in clinical practice, as an objective cognitive test. 
In summary, significant correlations among disability, cognitive performance, and 
experimental measures of central sensitization were demonstrated in participants with CWAD. 
However, in participants with CINP, significant correlations were demonstrated only for 
subjective cognitive deficits and local hyperalgesia. These observations reflected differences 
between the groups of participants with chronic neck pain at the level of interrelation-
ships among the assessed variables and thus indicated different underlying mechanisms. 
Limitations and Strengths 
With regard to interpretation of the results of the present study, the following limitations 
must be taken into account. First, the cross-sectional nature of the study implied that no 
conclusions about the causality of the observed correlations can be drawn. Furthermore, 
the generalizability of the study results may be reduced because only women and only 
those with CWAD classifiable as WAD II A, B, or C were included. Finally, with regard to 
interpretation of the cognitive test results, the possible presence of malingering or feigned 
cognitive deficits in women with CINP and, in particular, women with CWAD must be 
considered. 
However, the present study also had several strengths. First, to our knowledge, this study 
is the first to address these clinically relevant research questions regarding differences 
between CWAD and CINP. Second, numerous significant moderate to strong correlations 
(ρ= .456 to ρ= .70) among disability, cognitive deficits, local hyperalgesia, and distant 
hyperalgesia were observed in this study.
 
An important third strength of the present study was the comparability of the groups in 
age, sex, body mass index, and education level. Neck pain duration and current neck pain 
intensity were comparable for the groups as well. Another important strength of the 
present study was that the researchers anticipated sources of bias, such as use of 
medications, caffeine, alcohol, and nicotine; pregnancy; and performance of heavy 
physical exertion on the assessment day. A final strength was that the sample sizes for 
both groups with chronic neck pain and for controls were large compared with those in 
previous studies in this research domain.
Clinical message and recommendations for further research
The findings of the present study indicate that CWAD and CINP are separate clinical 
conditions, with similar but also prominently different underlying mechanisms. In particular, 
pain-related disability, decreased physical health- and mental health-related quality of life, 
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traumatic chronic neck pain and participants with CINP. Distant hyperalgesia and 
decreased CPM efficacy were shown in participants with CWAD but not in those with 
CINP; this finding was indicative of the presence of central sensitization in participants 
with CWAD. Additionally, this research demonstrated disability and cognitive deficits in 
participants with CWAD and, to a significantly lesser extent, in participants with CINP. 
Furthermore, moderate to strong positive correlations were observed among disability, 
cognitive deficits, and local hyperalgesia and distant hyperalgesia in participants with 
CWAD. However, moderate positive correlations were observed only between 
self-perceived cognitive deficits and local hyperalgesia in participants with CINP.
We recommend that disability, cognitive deficits, central sensitization, and their inter-
relationships should be evaluated with the goal of providing individually tailored therapy 
targeting the observed deficits. 
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and cognitive behavioural therapy are important for preventing the transition to chronicity 
(75). Additionally, cognitive behavioural therapy for patients with CWAD can decrease 
pain-related disability and post-traumatic stress and increase health-related quality of life 
(21, 76).  Furthermore, when treating patients with CINP and, in particular, patients with 
CWAD, physical therapists could apply - as part of their therapy - pain education followed 
by cognition-targeted motor control training (73). 
The results of the present study suggest that the traumatic origin of chronic neck pain in 
patients with CWAD plays a significant negative role in the clinical symptoms of these 
patients, relative to the situatin for patients with CINP. The treatment of cervical 
dysfunctions such as decreased movement control in patients with CWAD or CINP seems 
plausible, but caution is required not to induce or aggravate pain and other symptoms 
during the treatment of patients with CWAD (21). When applying hands-on therapies in 
patients with dominant central sensitization pain, physical therapists should remember 
that therapeutic interventions triggering more pain will serve as a new peripheral source 
of nociceptive input and thus will sustain the central sensitization process (77).
The socioeconomic and psychosocial burdens related to chronic neck pain, the high rate 
of transition to chronicity, and the limited effects of conservative therapy on pain and 
disability make current and future research highly valuable. The results of the present 
study can have implications for health policymakers’ decision-making regarding funding 
and treatment options. Because the present study revealed important correlations, 
longitudinal studies are recommended to unravel the cause-effect relationships among 
disability characteristics, subjective or objective cognitive performance, and (central) pain 
measures in patients with traumatic chronic neck pain and CINP. Additionally, magnetic 
resonance imaging studies investigating the roles of possible structural and functional 
brain alterations in the observed dysfunctions could be highly valuable to increase insight 
into these pain conditions, as it is known that there is an overlap of brain regions involved 
in the processing of cognitive, affective, and nociceptive information (78, 79). It would be 
interesting to explore whether brain alterations are present in these regions in patients 
with CINP or CWAD and whether such alterations are related to disability, cognition, and 
clinical or experimental correlates of pain. 
Conclusion
In conclusion, this research revealed important differences between women with 
traumatic chronic neck pain and women with CINP and thus provided evidence of the 
clinical importance of distinguishing assessment and rehabilitation approaches for these 
chronic neck pain conditions. Local hyperalgesia was demonstrated in participants with 
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Introduction
Chronic neck pain is an enormous healthcare problem and one of the most prevalent 
musculoskeletal pain conditions worldwide (1, 2).  Furthermore, this pain condition is 
associated with unexplained symptoms, reduced quality of life, and poor therapy 
outcomes, thus representing an important source of disability (3-6). Chronic neck pain can 
be subdivided, on the basis of its etiology, into three categories: specific neck pain, 
trauma-induced neck pain, and idiopathic (non-traumatic) neck pain. This article focuses 
on chronic neck pain of a traumatic and an idiopathic non-traumatic nature. 
 Chronic whiplash associated disorders (CWAD) are characterized by trauma-induced 
neck pain lasting more than 3 months resulting from a whiplash injury usually originating 
from a rear-end motor vehicle crash and caused by acceleration-deceleration forces 
acting on the neck, head, and torso (7, 8). Chronic idiopathic non-traumatic neck pain (CINP) is 
characterized by neck pain lasting more than 3 months, without the presence of specific 
pathoanatomical causes. 
 Based on a paucity of studies comparing patients with CINP and CWAD, indications 
for different underlying mechanisms can be found (6, 9). Cognitive deficits (10), maladapted 
pain cognitions (11), and central sensitization (CS) (12) have been demonstrated in patients 
with CWAD. While CS is rare in patients with CINP (13), cognitive deficits, and maladapted 
pain cognitions are present (6, 14), however to a significantly lesser extent compared to 
patients with CWAD (6, 13). 
 Remarkably, although it can be hypothesized that structural brain alterations 
including grey matter volume (GMV) alterations play a role in the persistent and complex 
complaints of patients with CWAD, studies examining the presence of GM morphological 
alterations in patients with CWAD compared to patients with CINP are lacking. 
 Examining the influence of the traumatic acceleration-deceleration injury, the 
presence of GMV alterations, and exploring relationships between regional GMV and 
measures of cognition, pain, and CS is important and could increase our insight into the 
underlying mechanisms of CINP and CWAD, and their possible differences. 
During the past decades, a wide range of Magnetic Resonance Imaging (MRI) techniques 
explored structural brain alterations in-vivo in patients with chronic pain (15-17). This 
neuroimaging research has shown structural neuroplasticity, which refers to the ability of 
the brain to reorganize itself and thereby adapt or maladapt its morphology (18). 
Subsequently, the role of maladapted brain alterations, including GMV alterations (16-18), has 
been gradually elucidated in the persistent pain and associated complaints of various 
chronic pain conditions (e.g. fibromyalgia (19), chronic low back pain (20), temporomandibu-
lar disorders (21), chronic pelvic pain syndrome (22)).  Especially, GMV alterations in regions 
involved in cognitive processing and sensory-discriminative, affective and cognitive pain 
processing have been shown in various chronic pain syndromes, such as fibromyalgia and 
Abstract
Background: Patients with chronic whiplash associated disorders (CWAD) are characterized 
by pain of traumatic origin, cognitive deficits, and central sensitization (CS). Previous 
neuroimaging studies revealed altered grey matter volume (GMV) in mild traumatic brain 
injury patients and chronic pain conditions also characterized by CS. It can therefore be 
hypothesized that GMV alterations also play a role in the persistent complaints of CWAD. 
However, brain alterations remain poorly investigated in these patients. 
Objectives: This study examined regional GMV alterations in patients with CWAD 
compared to patients with non-traumatic chronic idiopathic neck pain (CINP), who 
normally do not show CS at a group level, and healthy controls. Additionally, in both 
patient groups relationships between regional GMV, and measures of cognition as well as 
pain processing were assessed. 
Study design: This was a cross-sectional case-control study.
Setting: This study was performed at the Department of Rehabilitation Sciences and 
Physiotherapy of Ghent University in cooperation with the Ghent Institute for Functional 
and Metabolic Imaging.
Methods: Ninety-three women (28 controls, 34 CINP, 31 CWAD) were enrolled. First, 
T1-weighted Magnetic Resonance Images (MRI) were acquired to examine GMV alterations 
in brain regions involved in processing cognition and pain. Next, cognitive performance, 
pain cognitions, and central sensitization (CS) symptoms were assessed. Finally, 
hyperalgesia and conditioned pain modulation efficacy were examined. 
Results: Regional GMV of the right lateral orbitofrontal cortex, left supramarginal cortex, 
and left posterior cingulate cortex was decreased in CWAD compared to healthy controls 
(p=0.023; p=0.012; p=0.047, respectively). Additionally, GMV of the right superior parietal 
cortex and left posterior cingulate cortex was decreased in CWAD compared to CINP 
patients (p=0.008; p=0.035, respectively). Decreased regional GMV correlated with worse 
cognitive performance, higher maladapted pain cognitions, CS symptoms, and 
hyperalgesia in CWAD (r
s
= -0.515 to -0.657; p<0.01). In CINP, decreased regional GMV 
correlated only with worse cognitive performance (r
s
= -0.499 to -0.619; p<0.01), and no 
GMV differences compared with controls could be revealed. 
Limitations: No conclusions about the causality of the observed relationships can be 
drawn. 
Conclusions: These results provide the first evidence for reduced GMV in cortical regions 
involved in processing cognition and pain in patients with CWAD. Accordingly, it is 
recommended that therapy approaches for CWAD should address the brain and take into 
account neuroplasticity of the central nervous system.
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pain cognitions, and CS symptoms (as described below). Subsequently, assessments to 
investigate cognitive deficits and pain processing were performed. On a separate test day 
(10 +/- 7 days apart), high-resolution T1-weighted MR images and T2*-weighted images of 
the brain were acquired. 
Participants 
Ninety-three female participants - 34 patients with CINP, 31 patients with CWAD and 
28 healthy pain-free controls - were enrolled in the present study. In order to exclude 
the confounding factor of sex, we included only women, as research has demonstrated 
significant differences between men and women regarding GMV, pain sensitivity and pain 
processing in both healthy persons and pain patients (37-41). All participants were Dutch 
native speakers and 18 to 65 years old. Participants were recruited by calls on social media 
and through advertisements on the Ghent University website, placed in health magazines 
and an information brochure of an association for patients with whiplash. Furthermore, 
informative flyers and posters were distributed in different medical institutes and 
associations in Flanders (various hospitals, physical therapist practices, and medical 
physician practices). 
Inclusion criteria for patients with CINP and CWAD were persistent neck pain lasting more 
than 3 months (42) with a mean pain intensity of more than 3 of 10 on the Numeric Rating 
Scale (NRS) during the preceding month. All chronic neck pain patients had to report 
mild/moderate to severe pain-related disability, established by a score of 10 or more of a 
maximum of 50 on the Neck Disability Index (43). Additionally, chronic neck pain patients 
had to report stability of pain medication intake for at least 4 weeks before study 
participation. 
 A specific inclusion criterion for patients with CINP was persistent idiopathic (non-
traumatic) neck pain. Patients with CINP were excluded if they ever experienced a whiplash 
trauma, or any other specific causes of neck pain, e.g. cervical hernia with clinical 
symptoms. 
 Patients with CWAD were included only if they had neck pain resulting from a motor 
vehicle crash or traumatic event and classifiable as WAD II A, B, or C on the modified (44) 
Quebec Task Force Scale (45). Patients with CWAD grades I, III (neurological signs) or IV 
(fracture or dislocation) on the modified Quebec Task Force Scale were excluded. 
Additionally, CWAD patients who lost consciousness as a result of the motor vehicle crash 
or traumatic event, and patients who had suffered posttraumatic amnesia were excluded (46).  
Healthy pain-free women could participate only if they were pain-free on each test day 
(NRS score of <2/10); had no history of neck-shoulder-arm pain for more than 8 consecutive 
days during the preceding year, with a pain intensity of 2 or more on the NRS; no medical 
consultation for neck-shoulder-arm pain during the preceding year; and no history of 
chronic low back pain sharing the common pathophysiology of CS (19, 20). For example, 
altered GM morphology in the cingulate, insula, and orbitofrontal cortex, precuneus, 
amygdala, and thalamus, has been found in these patients. Furthermore, alterations in GM 
morphology are denoted to be related with persistent pain and cognitive symptoms (19-24), 
which are commonly reported complaints in these chronic pain conditions (10, 25-27). Besides, 
these chronic pain patients often show maladapted pain cognitions including pain cata-
strophizing and hypervigilance (28), which seem to be associated with GM morphology (29). 
Research has furthermore demonstrated changes in GMV in patients with mild traumatic 
brain injury (TBI) (30), where chronic pain is also a common sequel (31, 32). In addition, similar 
to patients with chronic pain, mild TBI patients frequently report persistent cognitive 
complaints (33) accompanied with reduced cognitive performance (34-36).
Based on the outlined evidence, due to the trauma, and because of cognitive deficits (10), 
maladapted pain cognitions (11), and CS (12) in CWAD patients, it could be hypothesized that 
alterations in regional GMV are present in patients with CWAD, but not or to a lesser 
degree in patients with CINP. 
 To address the current research gap, the first aim was to examine GMV alterations 
in brain regions involved in cognitive processing, and regions implicated in sensory- 
discriminative, affective and cognitive pain processing in patients with CINP and CWAD 
compared to healthy persons. The second aim was to investigate relationships between 
regional GMV, and cognitive deficits, pain intensity, pain cognitions, local hyperalgesia, 
and measures of CS in both chronic neck pain conditions. 
 Distinct regional GMV alterations and significant relationships with measures of 
cognition, pain, and CS were mainly hypothesized in patients with CWAD compared to 
CINP and healthy persons. Accordingly, important differences between patients with CINP 
and CWAD were hypothesized with a negative mediating role of the trauma in CWAD.
Methods
Study design and procedure
This cross-sectional case-control study took place at the Department of Rehabilitation 
Sciences and Physiotherapy of Ghent University in cooperation with the Ghent Institute 
for Functional and Metabolic Imaging. The study was performed from February 2014 to 
September 2015 and was carried out in accordance with the principles of the Declaration 
of Helsinki. The local Ethics Committee of the Ghent University Hospital (EC/2013/1053) 
approved the research protocol. All participants were thoroughly informed about the 
study procedures and signed an informed consent statement prior to study enrolment.  
First, all participants completed a survey to acquire information on demographics, and 
completed a series of questionnaires to obtain information on disability, pain intensity, 
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participant was instructed to draw lines connecting 25 numbers in ascending order as fast 
as possible, without lifting the pencil from the page. In trail B, the participant had to draw 
lines alternating between numbers and letters in ascending order (going from 1 to A, 
from A to 2, etc.).  The goal of the TMT was to finish part A and part B as quickly and as 
accurate as possible. The researcher explained each part and participants completed a 
practice version containing fewer items. The time taken to complete each part of the test, 
and a switch cost, calculated by subtracting completion time of part A from part B, were 
used as outcome measures. The TMT (B-A) difference minimizes visuoperceptual and 
working memory demands, thus providing an indication of executive function (53). Higher 
scores on completion time and switching cost denote worse cognitive performance. 
The TMT has been demonstrated to be valid for assessing cognitive deficits (53).
Self-reported and experimental measures of pain processing
Pain catastrophizing
The Dutch Pain Catastrophizing Scale (PCS) (0-52) was used to evaluate three components 
of catastrophizing: rumination, magnification, and helplessness (54). Higher scores represent 
higher levels of pain catastrophizing. The Dutch PCS has sufficient test-retest reliability (55, 
56) and the factor structure is confirmed in chronic pain patients and healthy individuals (57). 
Pain hypervigilance
The Dutch Pain Vigilance and Awareness Questionnaire (PVAQ) was administered to assess 
the level of vigilance towards pain (0-80). Higher scores indicate a higher degree of pain 
vigilance and awareness. The PVAQ has been shown to be valid and reliable to measure 
pain vigilance in healthy individuals (58) and chronic pain patients (59). 
Self-reported symptoms of central sensitization
All participants completed the Dutch language version of the Central Sensitization 
Inventory (CSI). The CSI is a self-report screening instrument for the measurement of 
clinical symptoms of CS (0-100) in chronic pain populations (60, 61). Higher CSI scores denote 
a higher degree of CS symptoms. The Dutch CSI has been shown to have good internal 
consistency, excellent test-retest reliability, and good discriminative power to differentiate 
between healthy persons and chronic pain patients (60). Neblett et al (62) determined that a 
CSI score of 40 of 100 best distinguished between a group of central sensitivity syndrome 
patients (CSI scores ≥40/100) and a group of non-central sensitivity syndrome patients 
(sensitivity = 81%, specificity = 75%). 
Local and distant hyperalgesia
The PPTs were measured unilaterally with a digital pressure algometer with a 1 cm2 tip 
(Wagner Instruments, FDX, Greenwich, Connecticut), both at a symptomatic local region 
(middle trapezius muscle midway between the spinous process of C7 and the lateral 
whiplash trauma. Additionally, healthy controls were included only if they had a score of 
less than 8 of 50 on the Neck Disability Index.
 General exclusion criteria for all study groups were the presence of major depression, 
anxiety, psychiatric, neurologic, metabolic, cardiovascular, and inflammatory disorders, 
fibromyalgia, chronic fatigue syndrome, and a history of neck or shoulder girdle surgery. 
Furthermore, all participants completed the MRI safety checklist and participants who 
presented contraindications for MRI were excluded. To preclude confounding factors, all 
participants were asked to discontinue intake of non-opioid analgesics 48 hours before 
study participation. Continuation of intake of narcotic analgesics was allowed and 
medication use of each participant was questioned in detail. In addition, participants were 
asked to avoid heavy physical activities, and to refrain from consuming alcohol, caffeine, 
and nicotine on the day of testing. Finally, brain microhemorrhages related to a traumatic 
event were excluded based on visual inspection of T2*-weighted brain images. 
Self-reported pain and disability measures 
On each test day, participants scored current neck pain intensity on an 11-point verbal 
numeric rating scale (VNRS-11). Scores range from 0 to 10, with 0 reflecting ‘no pain at all’ 
and 10 reflecting ‘the worst pain imaginable’. In addition, patients reported the frequency 
of neck pain complaints in number of days per week. The Dutch Neck Disability Index was 
used to investigate self-reported pain-related disability levels (0-50) (43, 47). Higher scores on 
the Neck Disability Index indicate higher levels of pain-related disability. The Dutch 
language version of the Neck Disability Index has been proven to be reliable and valid to 
assess self-reported disability in patients with chronic neck pain (48-51). 
Cognitive performance
Subjective cognitive performance
Participants completed the Dutch modified Perceived Deficits Questionnaire (mPDQ) to 
investigate subjective cognitive performance (0-72). This questionnaire investigates 
self-perceived cognitive problems in 4 different cognitive subdomains, i.e. prospective 
memory, retrospective memory, attention and concentration, and organization and 
planning, during the preceding 4 weeks. Symptoms are rated on a 5-point Likert scale 
from never (0) to almost always (4). Higher scores represent more self-perceived cognitive 
deficits. The validity and reliability of the English mPDQ have been demonstrated in 
patients with CWAD and healthy persons (52). 
Objective cognitive performance
The Trail Making Test (TMT) was administered in order to objectively obtain an 
instrumented measure of cognitive performance (53). This test consists of two parts, trail A 
and trail B. The TMT part A requires mainly visuoperceptual and processing speed abilities, 
whereas TMT part B reflects working memory and task-switching ability. In trail A, the 
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echo (MP-RAGE) (repetition time [TR] = 2250 ms, echo time [TE]= 4.18 ms, voxel size= 1 x 
1 x 1 mm3, FoV= 256 mm, flip angle= 9°, 176 slices, 1mm slice thickness, acquisition time= 
5’14’’). All T1-weighted anatomical scans were visually checked for overall quality and 
motion artefacts. 
 In addition, axial T2*-weighted brain images were acquired using a T2*-weighted 
acquisition gradient echo with TR= 839 ms, TE= 18.60 ms, voxel size= 1 x 0.7 x 3 mm3, FoV= 
230 mm, flip angle= 20°, 3 mm slice thickness, and acquisition time of 3’ 48”. All 
T2*-weighted images were visually inspected by 2 expert neuroradiologists (KD, EG) to 
evaluate and exclude possible microhemorrhages related to a traumatic event.
MRI data processing 
The high-resolution T1-weighted anatomical scans were analyzed utilizing the FreeSurfer 
v5.3.0 software package, which is documented and freely available (http://surfer.nmr.
mgh.harvard.edu). The analyses were performed utilizing additional computing resources 
from the high performance computing (HPC) TIER1 cluster at the University of Ghent 
(http://www.ugent.be/hpc/). The FreeSurfer analysis suite was used to extract cortical and 
subcortical GM volumes using an automated approach described in detail in prior 
publications (for an overview see Fischl 2012 (73)). Previous research has shown that this 
automated procedure yields accurate and reliable results (74). Briefly, image processing 
included (1) removal of non-brain tissue using a hybrid watershed/surface deformation 
procedure (skull stripping) (75), (2) automated Talairach transformations, (3) segmentation 
of the subcortical white matter and deep GM volumetric structures (74, 76), (4) intensity 
normalization (77), (5) tessellation of the boundary between GM and white matter, 
automated topology correction (78, 79) and (6) surface deformation along intensity gradients 
for optimal placement of the borders between GM, white matter and cerebrospinal fluid 
(80-82). Automated parcellation of the cerebral cortex into units with respect to gyral and 
sulcul structures was performed within each hemisphere using the Desikan atlas (83). 
Furthermore, an automated segmentation (Aseg) of subcortical GM regions within each 
hemisphere was performed in FreeSurfer (74, 76). Also, an estimate of total intracranial 
volume was obtained for each subject. 
 Two independent researchers (IC, RDP) visually checked the data quality of the 
FreeSurfer processing output including the accuracy of skull stripping, registration, 
segmentation, and cortical surface reconstruction. Poor data quality, such as inclusion of 
dura in the pial surface after skull stripping, and surface deformations, was revealed in 12 
participants (healthy controls =3, CINP =3, CWAD =6). These GM volume datasets were 
excluded from all further analyses. All other data was of good quality and was used for 
further analyses. 
border of the acromion) to evaluate local hyperalgesia and at a distant asymptomatic 
region (quadriceps muscle midway between the anterior superior iliac spine and the basis 
patellae) to evaluate widespread or distant hyperalgesia (63, 64). The PPTs were assessed on 
the more painful side (65). In healthy women and when patients experienced the same 
amount of neck pain on both sides, PPTs were tested on the dominant handedness side. 
The PPTs were assessed in a randomized order (with Research Randomizer, https://www.
randomizer.org). During the test procedure, participants were seated and pressure was 
gradually increased at a rate of 1 kgf/s until the participants reported the first sensation of 
unpleasantness. The PPT was determined as the mean of 2 consecutive (30 seconds in 
between) measurements. Decreased PPTs in the patient groups compared to healthy 
controls at the middle trapezius muscle indicate local hyperalgesia, whereas decreased 
PPTs at the quadriceps muscle indicate distant hyperalgesia. This technique has been 
found to be reliable (66). In addition, the intratester reliability of PPT measurements has 
been reported to be satisfactory to good (intraclass correlation coefficient= 0.78-0.93) (67). 
Efficacy of Conditioned Pain Modulation (CPM)
The presence of dysfunctional endogenous pain inhibition was investigated by evaluating 
the efficacy of CPM by applying a CPM paradigm. This paradigm relies on the “pain-inhib-
its-pain” mechanism, in which one noxious stimulus is used as a conditioning stimulus to 
induce a reduction in the perception of pain from another test stimulus (68). The 
conditioning stimulus for eliciting CPM was the cold pressor test. The assessment of PPTs 
was used as the test stimulus. For the conditioning stimulus, the contralateral hand (of the 
PPT side) (69) was first immersed in water maintained at room temperature (22°C) for 1 
minute to standardize the hand temperature (70), before immersing this hand (up to the 
wrist) in a refrigerated bath (VersaCool, Thermo Fisher Scientific, Newington NH, USA) with 
circulating cold water maintained at 12±1°C (71). Participants were asked to keep their hand 
in the water bath for 2 minutes (70). Meanwhile, the PPT was re-evaluated at the quadriceps 
muscle, 45 seconds after immersing the hand (again twice with an interval of 30 seconds) 
(72). If participants removed the hand from the water before the end of the 2 minutes, the 
measurement was registered as missing. For analysis of CPM efficacy, the mean PPT 
measured before the cold pressor test was subtracted from the mean PPT measured 
during the cold pressor test. Hence, a lower CPM value reflected less efficient endogenous 
pain inhibition. The intrasession and intraclass correlation coefficients for the cold pressor 
test have been shown to be excellent (0.85) (72).  
MRI data acquisition
Magnetic Resonance images were acquired on a 3T Siemens Magnetom TrioTim MRI 
scanner (Siemens, Erlangen, Germany) equipped with a 32-channel matrix head coil, at 
the Ghent University Hospital. High-resolution T1-weighted images of the brain were 
acquired using a three-dimensional magnetization prepared rapid acquisition gradient 
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Regions of interest
Grey matter volume was extracted from regions of interest (ROIs). Cortical and subcortical 
regions, which have been reported to be involved in processing pain and cognition in 
previous studies, were selected as ROIs. Furthermore, ROIs were defined based on 
observations from previous studies in patients with chronic pain regarding GMV alterations 
(15, 19, 20, 84), and regarding relationships between GMV alterations, and measures of cognition 
and pain (15, 85-87). The ROIs constituting pain and cognitive processing regions included 
two subcortical GM structures: amygdala and thalamus (see Fig. 1 for subcortical ROIs), 
and 12 cortical regions selected from the Desikan atlas (83): caudal anterior cingulate, rostral 
anterior cingulate, posterior cingulate, rostral middle frontal, medial orbitofrontal, lateral 
orbitofrontal, superior parietal, insula, postcentral, precuneus, pars orbitalis, and 
supramarginal cortex (see Fig. 1 for cortical ROIs). For each ROI, GMV was calculated for 
the right and left hemisphere separately. In addition, the volumes of total subcortical GM 
and total cortical GM were obtained. 
Statistical analyses
All statistical analyses were performed with IBM SPSS Statistics 22.0 (IBM SPSS, Armonk, 
New York). First, the normality of variables was checked with the Shapiro-Wilk test and by 
visual evaluation of quantile-quantile plots and histograms. Additionally, the equality of 
variance was examined with the Levene’s test. Only normally distributed data with an 
equality of variance were analyzed with parametric tests. Otherwise, non-parametric tests 
were applied.
 The comparability of study groups for age, current neck pain intensity, pain duration, 
and other demographics was explored with a one-way ANOVA with post-hoc pairwise 
comparisons using Bonferroni correction (Family Wise Error Rate (FWER) <0.05), or with the 
Kruskal-Wallis test with post-hoc pairwise comparisons using the Mann-Whitney U test. 
Differences measured with the Mann-Whitney U test were assumed to be significant only 
below the 0.017 (Bonferroni correction: 0.05/3) level. Categorical data were analyzed with 
the Fisher’s exact test. 
Subsequently, differences between study groups regarding cognitive performance and 
pain processing were explored using one-way ANOVA (post-hoc pairwise comparisons 
using Bonferroni correction, FWER <0.05) or the Kruskal-Wallis test (post-hoc pairwise 
comparisons using the Mann-Whitney U test, p<0.017). An analysis of covariance (ANCOVA) 
model, controlling for the potentially confounding factor of age, was used to determine 
significant group differences in GMV of the selected ROIs, and total subcortical and cortical 
GMV (post-hoc pairwise comparisons using Bonferroni correction, FWER <0.05).
 Finally, correlations among measures of cognition and pain on one hand, and regional 
GMV on the other hand in both chronic neck pain conditions were investigated with 
group-specific Spearman correlation analyses. To correct for multiple comparisons, we 
deemed only Spearman correlations below the 0.01 level (2-tailed) to be significant. Fi
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Self-reported and experimental measures of pain processing
Pain catastrophizing and pain hypervigilance
As can be seen in Table 1, maladapted pain cognitions including pain catastrophizing and 
hypervigilance were significantly higher in patients with CWAD compared to healthy 
women (p=0.003; p=0.035, respectively). No significant differences between CINP patients 
and healthy controls were found regarding pain catastrophizing and pain hypervigilance 
(p>0.05).
Self-reported central sensitization symptoms
Both patient groups reported significantly more self-perceived CS symptoms compared 
to healthy pain-free women (p<0.001) (Table 1). Moreover, patients with CWAD experienced 
significantly more CS symptoms compared to patients with CINP (p=0.005).
Local and distant hyperalgesia
Decreased PPTs were demonstrated at the middle trapezius muscle and quadriceps 
muscle in patients with CWAD (p=0.001, p=0.008, respectively) but only at the middle 
trapezius muscle in patients with CINP, relative to the results for healthy women (p=0.009) 
(Table 1). 
Efficacy of Conditioned Pain Modulation
The CPM value measured at the quadriceps muscle was significantly lower in patients with 
CWAD compared to healthy women (p=0.010), as presented in Table 1. 
Total cortical and subcortical grey matter volume 
As can be seen in supplementary Table A, the ANCOVA with age as covariate revealed 
no significant differences between all study groups for total intracranial volume (p=0.109), 
total cortical GMV (p=0.198), and total subcortical GMV (p=0.510).  Therefore, we decided 
not to include these metrics in further analyses.
Regional based grey matter volume 
The significant results of the ANCOVA with age as covariate investigating differences in 
GMV of pain and cognitive processing regions between patients with CINP and CWAD, 
and healthy controls are presented in Figure 2 and supplementary Table A. The non- 
significant ANCOVA results for GMV of the ROIs are shown in supplementary Table B.
 The ANCOVA revealed decreased GMV in the left posterior cingulate cortex (p=0.047), 
the right lateral orbitofrontal cortex (p=0.023), and the left supramarginal cortex (p=0.012) 
in patients with CWAD compared to healthy controls (Bonferroni-adjusted p-values). 
Furthermore, decreased GMV in the left posterior cingulate cortex (p=0.035), and the right 
superior parietal cortex (p=0.008) in CWAD patients compared to CINP patients was 
demonstrated with the ANCOVA (Bonferroni-adjusted p-values). No significant differences 
Correlation coefficients were deemed low between 0.30 to 0.50, moderate between 0.50 
to 0.70, high between 0.70 to 0.90, and very high between 0.90 to 1.00 (88).
Results
Differences between patients with idiopathic and traumatic chronic 
neck pain compared to healthy controls
Demographic characteristics and self-reported pain and disability measures
The results of demographic characteristics and self-reported pain and disability measures 
of 81 female participants (25 healthy controls, 31 patients with CINP, 25 patients with 
CWAD) are shown in Table 1. All study groups were comparable in age, body height, body 
weight, body mass index, education level, smoking status, menstrual phase, and 
handedness (p>0.05). Furthermore, both groups with chronic neck pain were comparable 
in medication use, neck pain duration, and frequency of neck pain complaints per week 
(p>0.05). Participants with CWAD reported significantly higher current neck pain intensity 
on the clinical and MRI test day, and significantly more pain-related disability than 
participants with CINP (p<0.01). 
 Ninety-one percent of all participants were right-handed. This is a representative 
sample regarding handedness because approximately 10 percent of the general 
population is ambidextrous or left-handed (89). The ANCOVA with age as covariate and 
handedness as fixed-factor, revealed no significant main effect of handedness on total 
and regional GMV. Therefore, the GMV results of the left- and right-handed women were 
analyzed together.
Cognitive performance
Subjective cognitive performance
Compared with healthy controls, patients with CINP (p=0.009) and patients with CWAD 
(p<0.001) reported more self-perceived cognitive deficits, as presented in Table 1. 
Moreover, CWAD patients reported more self-perceived cognitive deficits compared to 
patients with CINP (p=0.001). 
Objective cognitive performance
The time needed to perform TMT part A (p=0.002) and TMT part B (p=0.004) was 
significantly longer in the CWAD group compared to the healthy control group, denoting 
worse objective cognitive performance in patients with CWAD (Table 1). In addition, the 
time needed to perform TMT part A (p=0.003) and TMT part B (p=0.009) was significantly 
longer in CWAD patients compared to CINP patients. Despite the differences in completion 
time, no significant group differences were revealed for executive control or switching 
cost (TMT (B-A) difference), (p’s>0.05). 
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Chapter 4 Decreased regional grey matter volume in CWAD
in regional GMV were found between patients with CINP and healthy women (p’s>0.05). 
In addition, no significant subcortical GMV differences were found in the amygdala and 
thalamus between all study groups (p>0.05). 
Relationships between regional grey matter volume, and cognitive deficits, pain 
intensity, and pain processing in patients with idiopathic and traumatic chronic 
neck pain 
CINP
The results of the Spearman correlation (r
s
) analyses between GMV of regions involved in 
pain and cognitive processing, and cognitive deficits, pain intensity, and pain processing 
in patients with CINP are shown in Tables 2a and 2b.
 In the CINP group, only 4 significant correlations were revealed. A moderate relationship 
was found between increased severity of self-reported cognitive deficits, and decreased 
GMV of the left rostral anterior cingulate cortex (r
s
= -.499; p=0.008). Furthermore, lower 
visuoperceptual abilities were moderately correlated with decreased GMV of the right 
thalamus (r
s
= -0.529; p=0.003). Also, decreased task-switching capacity was moderately 
correlated with decreased GMV of the left medial orbitofrontal cortex (r
s
= -.565; p=0.001). 
A moderate relationship was observed between decreased GMV of the left medial 
orbitofrontal cortex, and worse executive control (r
s
= -.619; p<0.001).
 No significant correlations among pain intensity, maladapted pain cognitions, CS 
symptoms, and experimental measures of pain processing, and regional GMV were 
demonstrated (p>0.01). 
CWAD
The results of the Spearman correlation (r
s
) analyses between GMV of regions involved in 
pain and cognitive processing, and cognitive deficits, pain intensity, and pain processing 
in patients with CWAD are displayed in Tables 3a and 3b. 
 In the CWAD group, more robust correlations were found compared to the CINP 
group. Moderate correlations were revealed between increased severity of self-reported 
cognitive deficits, and decreased GMV of the left pars orbitalis (r
s
= -.543; p=0.006), the left 
amygdala (r
s
= -0.598; p=0.002), and the right medial orbitofrontal cortex (r
s
= -0.548; 
p=0.006). Furthermore, decreased task-switching capacity was moderately correlated 
with decreased GMV of the right rostral anterior cingulate cortex (r
s
= -.588; p=0.002), the 
right posterior cingulate cortex (r
s
= -0.538; p=0.007), the left rostral middle frontal cortex 
(r
s
= -0.604; p=0.002), and the left insula (r
s
= -0.539; p=0.007). In addition, worse executive 
control was moderately correlated with decreased GMV of the left rostral middle frontal 
cortex (r
s
= -0.617, p=0.001), the left lateral orbitofrontal cortex (r
s
= -0.539, p=0.007), the left 
insula (r
s
= -0.634, p=0.001), the right posterior cingulate cortex (r
s
= -0.594, p=0.002), and 
the right lateral orbitofrontal cortex (r
s
= -0.569, p=0.004). Fi
gu
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Chapter 4 Decreased regional grey matter volume in CWAD
Table 2a   Spearman correlations between regional cortical and subcortical  
grey matter volume (LH), and self-reported and experimental measures  
of pain and cognition in patients with CINP.
Caudal  
ACC
Rostral  
ACC
PCC Rostral 
middle 
frontal 
Medial  
OBF
Lateral  
OBF
Superior 
Parietal
Insula Postcentral Precuneus Pars 
Orbitalis
Supra-
marginal
Amygdala Thalamus
CINP (n=31)
Self-perceived cognitive performance (mPDQ)
Total score -0.378 -0.499 -0.356 -0.201 -0.084 -0.177 -0.100 -0.335 -0.171 -0.067 -0.066 -0.179 0.006 -0.017
0.052 0.008 0.068 0.315 0.678 0.377 0.619 0.088 0.394 0.739 0.745 0.372 0.978 0.932
Objective cognitive performance (TMT)
Part A -0.229 -0.208 -0.307 -0.196 -0.293 -0.269 0.030 -0.398 -0.005 0.044 -0.105 -0.337 0.092 -0.120
0.233 0.279 0.105 0.309 0.123 0.158 0.879 0.033 0.98 0.819 0.588 0.073 0.636 0.536
Part B -0.044 -0.078 -0.334 -0.324 -0.565 -0.299 0.158 -0.385 -0.178 0.041 -0.290 -0.38 -0.037 -0.009
0.821 0.686 0.077 0.086 0.001 0.116 0.414 0.039 0.355 0.834 0.127 0.042 0.847 0.964
B – A -0.041 -0.088 -0.252 -0.369 -0.619 -0.250 0.145 -0.366 -0.335 -0.004 -0.308 -0.344 -0.083 -0.010
0.833 0.651 0.188 0.049 <0.001 0.190 0.454 0.051 0.075 0.983 0.104 0.068 0.668 0.961
Self-reported pain measures
neck pain 
intensity_M
-0.217 0.120 0.014 0.036 -0.066 0.181 -0.001 0.092 0.227 -0.140 0.108 -0.256 -0.042 0.293
0.241 0.520 0.939 0.847 0.723 0.329 0.994 0.623 0.219 0.453 0.564 0.164 0.823 0.109
Maladaptive pain cognitions
PCS 0.012 -0.001 -0.076 -0.051 -0.343 -0.068 -0.066 -0.122 0.227 0.056 0.039 0.166 0.274 -0.192
0.950 0.997 0.697 0.792 0.069 0.724 0.734 0.529 0.237 0.771 0.843 0.390 0.150 0.319
PVAQ -0.303 -0.246 -0.294 -0.399 -0.375 -0.227 -0.128 -0.224 -0.134 -0.252 -0.112 -0.084 0.171 -0.124
0.110 0.197 0.122 0.032 0.045 0.237 0.508 0.244 0.487 0.187 0.562 0.666 0.375 0.523
Self-reported symptoms of central sensitization
CSI 0.152 0.145 0.078 0.027 0.045 -0.002 0.044 0.124 0.113 0.104 0.036 0.249 0.001 0.150
0.432 0.452 0.688 0.889 0.816 0.993 0.819 0.523 0.559 0.593 0.853 0.193 0.996 0.438
Local hyperalgesia
PPT trapezius -0.122 0.106 0.116 0.047 -0.091 -0.040 -0.015 0.009 -0.068 -0.310 -0.130 -0.026 -0.238 -0.127
0.512 0.570 0.533 0.804 0.627 0.832 0.936 0.963 0.717 0.090 0.484 0.889 0.198 0.497
Distant hyperalgesia
PPT quadriceps 0.090 0.225 0.088 0.060 -0.052 -0.084 0.310 0.125 0.140 -0.095 -0.074 0.004 -0.159 -0.230
0.630 0.224 0.640 0.750 0.779 0.653 0.089 0.501 0.453 0.610 0.691 0.981 0.393 0.214
CPM efficacy
CPM quadriceps -0.057 -0.043 0.089 0.023 -0.038 0.067 -0.165 -0.072 -0.037 -0.017 -0.152 -0.001 -0.236 -0.132
0.776 0.832 0.661 0.911 0.849 0.738 0.411 0.721 0.854 0.934 0.450 0.998 0.235 0.512
Significant correlations are presented in bold. Correlations significant at the 0.05 level (2-tailed) were not 
deemed significant in order to correct for multiple comparisons. Correlations significant at the 0.01 level 
(2-tailed) were deemed significant. P-values are presented below the correlation coefficient. 
Abbreviations: ACC= anterior cingulate cortex, PCC= posterior cingulate cortex, OBF= orbitofrontal, CINP= chronic 
idiopathic neck pain, mPDQ= modified perceived deficits questionnaire, TMT= trail making test, M= MRI test moment, 
PCS= pain catastrophizing scale, PVAQ= pain vigilance and awareness questionnaire, CSI= central sensitization 
inventory, PPT= pressure pain thresholds, CPM= conditioned pain modulation, LH= left hemisphere.
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Table 2b   Spearman correlations between regional cortical and subcortical  
grey matter volume (RH), and self-reported and experimental measures  
of pain and cognition in patients with CINP.
Caudal  
ACC
Rostral  
ACC
PCC Rostral 
middle 
frontal
Medial  
OBF
Lateral  
OBF
Superior 
Parietal
Insula Postcentral Precuneus Pars 
Orbitalis
Supra-
marginal
Amygdala Thalamus
CINP (n=31)
Self-perceived cognitive performance (mPDQ)
Total score 0.151 0.151 -0.223 -0.135 -0.198 -0.188 -0.219 -0.358 -0.109 -0.218 0.168 -0.331 -0.083 -0.165
0.453 0.453 0.263 0.504 0.322 0.348 0.272 0.067 0.589 0.274 0.403 0.091 0.682 0.411
Objective cognitive performance (TMT)
Part A 0.042 -0.084 0.011 -0.230 -0.218 -0.288 -0.034 -0.285 -0.270 0.05 -0.363 -0.330 0.140 -0.529
0.829 0.664 0.954 0.231 0.255 0.130 0.861 0.134 0.157 0.796 0.053 0.081 0.468 0.003
Part B -0.096 -0.200 -0.061 -0.318 -0.175 -0.268 -0.158 -0.292 -0.377 0.026 0.027 -0.148 0.056 -0.314
0.622 0.298 0.753 0.093 0.363 0.159 0.414 0.124 0.044 0.895 0.888 0.443 0.772 0.097
B – A -0.088 -0.176 -0.099 -0.288 -0.210 -0.222 -0.238 -0.297 -0.379 -0.065 0.245 -0.100 -0.054 -0.182
0.649 0.362 0.611 0.130 0.273 0.248 0.214 0.118 0.042 0.739 0.201 0.606 0.782 0.345
Self-reported pain measures
neck pain 
intensity_M
0.145 -0.163 0.105 -0.190 0.013 0.123 0.170 0.036 0.160 -0.034 -0.075 -0.084 0.133 0.326
0.437 0.381 0.572 0.306 0.945 0.511 0.36 0.846 0.389 0.857 0.688 0.653 0.474 0.073
Maladaptive pain cognitions
PCS 0.174 0.108 0.051 -0.087 -0.156 -0.04 -0.010 -0.158 0.188 0.112 0.288 -0.069 0.109 0.022
0.365 0.577 0.793 0.655 0.420 0.839 0.958 0.412 0.329 0.564 0.129 0.720 0.574 0.908
PVAQ -0.218 -0.07 -0.138 -0.342 -0.293 -0.157 -0.177 -0.210 -0.085 -0.161 -0.009 0.236 0.022 -0.092
0.256 0.718 0.475 0.070 0.123 0.416 0.359 0.273 0.662 0.404 0.964 0.218 0.910 0.635
Self-reported symptoms of central sensitization
CSI 0.198 0.184 0.142 0.090 -0.051 0.194 -0.025 0.028 0.223 0.183 0.135 -0.031 -0.057 0.222
0.302 0.339 0.461 0.642 0.794 0.313 0.896 0.886 0.245 0.342 0.486 0.874 0.770 0.248
Local hyperalgesia
PPT trapezius 0.001 -0.185 0.255 -0.104 -0.037 0.061 0.283 0.030 -0.111 -0.273 -0.180 -0.207 -0.182 0.132
0.995 0.320 0.165 0.578 0.844 0.743 0.123 0.873 0.552 0.137 0.332 0.263 0.327 0.477
Distant hyperalgesia
PPT quadriceps 0.108 -0.045 0.238 -0.089 0.045 0.022 0.439 0.113 0.027 -0.007 -0.042 -0.052 0.000 -0.032
0.563 0.812 0.197 0.635 0.809 0.906 0.013 0.544 0.885 0.971 0.824 0.781 0.998 0.865
CPM efficacy
CPM quadriceps -0.053 0.013 0.220 -0.027 -0.007 0.008 0.092 -0.142 -0.292 -0.07 -0.324 -0.229 -0.136 -0.030
0.795 0.949 0.271 0.892 0.971 0.969 0.647 0.481 0.140 0.730 0.099 0.251 0.500 0.882
Significant correlations are presented in bold. Correlations significant at the 0.05 level (2-tailed) were not 
deemed significant in order to correct for multiple comparisons. Correlations significant at the 0.01 level 
(2-tailed) were deemed significant. P-values are presented below the correlation coefficient.  
Abbreviations: ACC= anterior cingulate cortex, PCC= posterior cingulate cortex, OBF= orbitofrontal, CINP= chronic 
idiopathic neck pain, mPDQ= modified perceived deficits questionnaire, TMT= trail making test, M= MRI test moment, 
PCS= pain catastrophizing scale, PVAQ= pain vigilance and awareness questionnaire, CSI= central sensitization 
inventory, PPT= pressure pain thresholds, CPM= conditioned pain modulation, RH= right hemispere. 
182 183
4
Chapter 4 Decreased regional grey matter volume in CWAD
Table 3a   Spearman correlations between regional cortical and subcortical  
grey matter volume (LH), and self-reported and experimental measures  
of pain and cognition in patients with CWAD.
Caudal  
ACC
Rostral  
ACC
PCC Rostral 
middle 
frontal 
Medial  
OBF
Lateral  
OBF
Superior 
Parietal
Insula Postcentral Precuneus Pars 
Orbitalis
Supra-
marginal
Amygdala Thalamus
CWAD (n=25)
Self-perceived cognitive performance (mPDQ)
Total score -0.154 -0.158 -0.389 -0.394 -0.170 -0.324 -0.375 -0.235 -0.427 -0.462 -0.543 0.078 -0.598 -0.355
0.474 0.460 0.060 0.057 0.428 0.123 0.071 0.268 0.037 0.023 0.006 0.718 0.002 0.089
Objective cognitive performance (TMT)
Part A -0.122 -0.214 -0.326 -0.243 -0.016 -0.016 0.014 -0.151 -0.333 -0.129 -0.218 0.350 -0.445 0.065
0.569 0.314 0.120 0.252 0.942 0.941 0.947 0.482 0.112 0.549 0.305 0.094 0.029 0.764
Part B -0.145 -0.326 -0.505 -0.604 -0.314 -0.446 -0.365 -0.539 -0.155 -0.354 -0.498 -0.197 -0.513 -0.358
0.498 0.120 0.012 0.002 0.135 0.029 0.080 0.007 0.470 0.089 0.013 0.355 0.010 0.086
B – A -0.063 -0.158 -0.398 -0.617 -0.374 -0.539 -0.349 -0.634 0.041 -0.341 -0.451 -0.343 -0.417 -0.457
0.771 0.460 0.054 0.001 0.072 0.007 0.095 0.001 0.850 0.103 0.027 0.100 0.043 0.025
Self-reported pain measures
neck pain 
intensity_M
-0.410 -0.214 -0.193 -0.263 0.024 -0.426 -0.216 -0.179 -0.057 -0.484 -0.387 -0.086 -0.335 -0.360
0.042 0.305 0.356 0.204 0.908 0.034 0.301 0.393 0.786 0.014 0.056 0.683 0.101 0.078
Maladaptive pain cognitions
PCS 0.150 0.021 -0.016 -0.389 -0.228 -0.450 -0.207 -0.373 -0.291 -0.522 -0.56 -0.010 -0.252 -0.361
0.474 0.92 0.939 0.054 0.274 0.024 0.320 0.066 0.158 0.007 0.004 0.961 0.224 0.076
PVAQ -0.169 -0.336 -0.458 -0.576 -0.23 -0.365 -0.167 -0.358 -0.204 -0.293 -0.457 -0.254 -0.303 -0.572
0.419 0.100 0.021 0.003 0.268 0.073 0.426 0.079 0.327 0.155 0.022 0.221 0.141 0.003
Self-reported symptoms of central sensitization
CSI 0.054 -0.135 -0.389 -0.455 -0.143 -0.284 -0.261 -0.081 -0.351 -0.324 -0.491 0.16 -0.636 -0.333
0.802 0.529 0.06 0.026 0.506 0.179 0.218 0.708 0.093 0.123 0.015 0.455 0.001 0.112
Local hyperalgesia
PPT trapezius 0.165 0.222 0.317 0.304 0.015 0.209 0.257 0.115 0.551 0.354 0.482 -0.079 0.302 0.402
0.429 0.287 0.123 0.14 0.942 0.317 0.215 0.583 0.004 0.083 0.015 0.707 0.143 0.047
Distant hyperalgesia
PPT quadriceps 0.208 0.234 0.318 0.162 0.002 0.095 0.125 -0.043 0.200 0.156 0.240 -0.074 0.370 0.306
0.317 0.261 0.121 0.440 0.994 0.65 0.553 0.838 0.338 0.456 0.248 0.726 0.069 0.137
CPM efficacy
CPM quadriceps 0.064 -0.099 0.029 0.278 -0.157 -0.077 0.195 -0.186 0.468 0.372 0.024 -0.079 0.311 0.264
0.782 0.668 0.902 0.222 0.498 0.741 0.397 0.420 0.033 0.097 0.918 0.733 0.170 0.248
Significant correlations are presented in bold. Correlations significant at the 0.05 level (2-tailed) were not 
deemed significant in order to correct for multiple comparisons. Correlations significant at the 0.01 level 
(2-tailed) were deemed significant. P-values are presented below the correlation coefficient.  
Abbreviations: ACC= anterior cingulate cortex, PCC= posterior cingulate cortex, OBF= orbitofrontal, CWAD= chronic 
whiplash associated disorders, mPDQ= modified perceived deficits questionnaire, TMT= trail making test, M= MRI test 
moment, PCS= pain catastrophizing scale, PVAQ= pain vigilance and awareness questionnaire, CSI= central 
sensitization inventory, PPT= pressure pain thresholds, CPM= conditioned pain modulation, LH= left hemisphere.
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Table 3b   Spearman correlations between regional cortical and subcortical grey  
matter volume (RH), and self-reported and experimental measures of  
pain and cognition in patients with CWAD.
Caudal  
ACC
Rostral  
ACC
PCC Rostral  
middle  
frontal
Medial  
OBF
Lateral  
OBF
Superior 
Parietal
Insula Postcentral Precuneus Pars 
Orbitalis
Supra-
marginal
Amygdala Thalamus
CWAD (n=25)
Self-perceived cognitive performance (mPDQ)
Total score -0.186 -0.329 -0.277 -0.171 -0.548 -0.091 -0.271 -0.401 -0.402 -0.452 -0.272 -0.303 -0.351 -0.072
0.384 0.117 0.191 0.426 0.006 0.673 0.201 0.052 0.051 0.026 0.198 0.150 0.093 0.737
Objective cognitive performance (TMT)
Part A -0.190 -0.354 -0.115 -0.014 -0.242 0.063 -0.038 -0.144 -0.069 -0.160 -0.272 0.092 -0.216 0.275
0.375 0.090 0.592 0.949 0.255 0.770 0.861 0.502 0.748 0.455 0.198 0.668 0.311 0.193
Part B -0.262 -0.588 -0.538 -0.319 -0.485 -0.421 -0.364 -0.284 -0.299 -0.477 -0.419 -0.174 -0.356 -0.168
0.216 0.002 0.007 0.128 0.016 0.041 0.08 0.179 0.156 0.018 0.042 0.415 0.088 0.433
B – A -0.227 -0.495 -0.594 -0.342 -0.489 -0.569 -0.241 -0.312 -0.194 -0.45 -0.432 -0.213 -0.373 -0.302
0.286 0.014 0.002 0.102 0.015 0.004 0.257 0.138 0.364 0.028 0.035 0.318 0.073 0.152
Self-reported pain measures
Neck pain 
intensity_M
0.112 -0.109 -0.081 -0.186 -0.392 -0.397 -0.104 -0.249 -0.125 -0.285 -0.384 -0.317 -0.222 -0.102
0.593 0.605 0.701 0.374 0.053 0.049 0.619 0.230 0.550 0.168 0.058 0.122 0.285 0.628
Maladaptive pain cognitions
PCS -0.024 -0.400 -0.397 -0.232 -0.535 -0.355 -0.215 -0.515 -0.153 -0.412 -0.482 -0.322 -0.221 -0.210
0.91 0.047 0.049 0.265 0.006 0.082 0.303 0.008 0.466 0.041 0.015 0.116 0.287 0.313
PVAQ -0.277 -0.501 -0.657 -0.243 -0.441 -0.249 -0.088 -0.420 -0.152 -0.384 -0.325 -0.265 0.101 -0.199
0.18 0.011 <0.001 0.241 0.027 0.230 0.676 0.037 0.468 0.058 0.113 0.200 0.631 0.340
Self-reported symptoms of central sensitization
CSI -0.246 -0.436 -0.317 -0.283 -0.406 -0.137 -0.154 -0.212 -0.365 -0.440 -0.421 -0.123 -0.444 -0.105
0.247 0.033 0.131 0.181 0.049 0.524 0.471 0.320 0.080 0.031 0.040 0.568 0.030 0.625
Local hyperalgesia
PPT trapezius 0.232 0.271 0.202 -0.012 0.437 -0.066 0.002 0.345 0.409 0.336 0.107 0.361 0.035 0.091
0.265 0.190 0.334 0.953 0.029 0.753 0.994 0.091 0.042 0.100 0.610 0.076 0.870 0.666
Distant hyperalgesia
PPT quadriceps 0.063 0.022 0.187 0.098 0.427 -0.053 -0.114 0.004 0.252 0.139 0.113 0.154 0.168 0.094
0.763 0.919 0.371 0.642 0.033 0.801 0.588 0.985 0.225 0.507 0.592 0.463 0.421 0.655
CPM efficacy
CPM quadriceps -0.093 0.086 -0.041 -0.003 -0.026 -0.205 -0.063 0.232 0.409 0.349 0.084 0.253 -0.097 0.177
0.689 0.712 0.860 0.989 0.910 0.372 0.786 0.312 0.066 0.120 0.717 0.268 0.676 0.442
Significant correlations are presented in bold. Correlations significant at the 0.05 level (2-tailed) were not 
deemed significant in order to correct for multiple comparisons. Correlations significant at the 0.01 level 
(2-tailed) were deemed significant. P-values are presented below the correlation coefficient.  
Abbreviations: ACC= anterior cingulate cortex, PCC= posterior cingulate cortex, OBF= orbitofrontal, CWAD= chronic 
whiplash associated disorders, mPDQ= modified perceived deficits questionnaire, TMT= trail making test, M= MRI test 
moment, PCS= pain catastrophizing scale, PVAQ= pain vigilance and awareness questionnaire, CSI= central 
sensitization inventory, PPT= pressure pain thresholds, CPM= conditioned pain modulation, RH= right hemisphere.
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One previous study in patients who developed chronic headache after a whiplash injury, 
also observed regional GMV decrease however in the anterior cingulate cortex and the 
dorsolateral prefrontal cortex in the patient group compared to healthy controls (96). To our 
knowledge, only one previous study has examined GMV alterations in patients with 
non-traumatic chronic neck pain, more specifically in patients with chronic myofascial 
pain resulting from active trigger points in the trapezius muscle. The authors found 
decreased GMV in the left parahippocampal cortex, and the right fusiform cortex in 
the patient group compared to healthy persons (97). Despite these promising results, 
the authors did not correct for multiple comparisons. 
 Nevertheless, contrary to previous evidence regarding GMV alterations in regions 
such as the insula, anterior cingulate cortex, and amygdala in other chronic pain patients, 
we could not find GMV alterations in all other ROIs. Although, this can be due to 
methodological factors (e.g. MRI acquisition parameters, MRI processing, poor control in 
previous studies for age, pain duration, and comorbidities (98)), unique pathology-specific 
GM morphology alterations in different chronic pain types (86, 92) may also account for these 
differences. 
 On the basis of the results of a quantitative meta-analysis investigating GMV alterations 
in patients with chronic pain, the observed estimated mean differences in regional GMV 
(mm3) of the present study in patients with CWAD compared to healthy controls are rather 
comparable with the results of GMV changes in other chronic pain patients (84). However, 
caution is warranted when comparing results of studies that applied different MRI 
acquisition, analyzing, and processing techniques (e.g. FreeSurfer versus voxel-based 
morphometry). 
Group differences in measures of cognition, pain, and CS
Furthermore, patients with CWAD displayed higher neck pain intensity, more severe 
pain-related disability, more pronounced cognitive deficits, and more signs of CS 
compared to patients with non-traumatic CINP. One previous study comparing CINP and 
CWAD patients, also observed significant features of CS in CWAD patients and not in 
patients with CINP (99). Moreover, higher levels of pain catastrophizing and hypervigilance 
were only present in the CWAD group compared to healthy persons. Accordingly, based 
on the present study results, it is plausible that more severe cognitive deficits and 
disturbed pain processing in CWAD patients are associated with a larger extent of 
maladapted GM morphology reorganization compared to patients with CINP. 
Relationships between regional GMV and measures of cognition,  
pain, and CS
The results of our correlation analyses have demonstrated relationships between 
decreased regional GMV and debilitating symptoms in CWAD patients. In particular, we 
revealed that decreased GMV in cognitive and pain processing regions (left pars orbitalis, 
Moderate correlations were demonstrated between higher levels of pain catastrophizing, 
and decreased GMV of the left precuneus (r
s
= -0.522; p=0.007), the left pars orbitalis 
(r
s
= -0.560; p=0.004), the right medial orbitofrontal cortex (r
s
= -0.535; p=0.006), and the 
right insula (r
s
= -0.515; p=0.008). Furthermore, moderate correlations were found between 
higher levels of pain hypervigilance, and decreased GMV of the left rostral middle frontal 
cortex (r
s
= -0.576; p=0.003), the left thalamus (r
s
= -0.572; p=0.003), and the right posterior 
cingulate cortex (r
s
= -0.657; p<0.001). A moderate relationship was observed between 
more self-perceived CS symptoms, and decreased GMV of the left amygdala (r
s
= -0.636; 
p=0.001). 
 Moreover, a moderate relationship was found between lower PPTs at the trapezius 
muscle, and decreased GMV of the left postcentral cortex (r
s
= 0.551; p=0.004). Finally, no 
significant correlations were detected between regional GMV and efficacy of CPM (p>0.01).
Discussion
The results of the present innovative study provided evidence for decreased GMV in 
cortical regions known to be associated with processing cognition and pain in patients 
with CWAD compared to CINP patients and healthy persons. In contrast, regional GMV 
alterations were not observed in CINP patients compared to healthy persons. Furthermore, 
this study revealed for the first time that increased cognitive deficits, maladapted pain 
cognitions, CS symptoms, and local hyperalgesia were moderately correlated with 
decreased regional GMV in CWAD patients. In CINP patients, regional GMV was only 
correlated with cognitive deficits. 
Group differences in regional GMV
The observed cortical GMV decrease in patients with CWAD compared to CINP patients 
and healthy controls was in line with our hypothesis and could be explained because 
CWAD patients have a traumatic origin of neck pain and are characterized by CS in contrast 
to CINP patients, who have a non-traumatic origin of neck pain, and do not show CS at a 
group level. In the present study, decreased GMV was demonstrated in the left posterior 
cingulate cortex, and the right superior parietal cortex in patients with CWAD compared 
to CINP. This is the first study investigating and revealing these regional GMV differences 
between women with CINP and CWAD. Compared to healthy women, decreased GMV 
could also be revealed in the left posterior cingulate cortex, right lateral orbitofrontal 
cortex, and left supramarginal cortex in women with CWAD. These findings are in line with 
accumulating evidence of decreased regional GMV in other chronic pain populations 
characterized by CS such as fibromyalgia and chronic low back pain (19-21, 90, 91). In particular, 
decreased GMV has previously been observed in the posterior cingulate cortex, lateral 
orbitofrontal cortex, and supramarginal cortex in the latter chronic pain populations 
compared to healthy persons (19, 20, 84, 92-95).
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Lastly, our study found that increased self-reported symptoms of CS were correlated with 
decreased GMV in the left amygdala in CWAD. Interestingly, the amygdala is a key region 
involved in pain processing and cognitive factors of pain anticipation (105), and has a crucial 
role in negative emotions and pain-related memories (106)
. 
Limitations and Strengths 
With regard to interpretation of the present study results, the following limitations must 
be taken into account. First, the cross-sectional nature of this study implies that no 
conclusions about the causality of the observed relationships can be drawn. Second, the 
generalizability of the study results might be reduced because only women were included 
and only CWAD patients classified as WAD II A, B or C, but, this results in less heterogeneity 
in the included study sample which is also a strength. 
 However, the present study also had several strengths. First, this study is the first to 
address the relationships between GMV alterations on one hand, and self-reported and 
experimental features of cognition, pain, and CS on the other hand in CINP and CWAD. 
Second, all groups were comparable in age, body mass index, education level, smoking 
status, menstrual phase, medication use, neck pain duration, and frequency of neck pain 
(for the patient groups). In addition, the researchers anticipated sources of bias such as use 
of medications, caffeine, alcohol, and nicotine on the assessment days. A final strength is 
the use of FreeSurfer, which has some advantages over voxel-based morphometry. 
Clinical message 
Our results indicated that chronic pain in CWAD patients should be interpreted, at least in 
part, as a result of neural reorganization of the CNS associated with alterations in GMV of 
regions involved in various aspects of pain and cognitive processing. 
 Importantly, increased cognitive deficits, maladapted pain cognitions, and CS 
symptoms were found to be associated with decreased GMV in regions implicated in 
processing cognition and pain in CWAD patients. Therefore, it can be recommended that 
therapy approaches for CWAD should address the brain and take into account neuroplas-
ticity of the CNS. Cognitive behavioral therapy can be advocated and has been 
demonstrated to reverse regional GMV decreases associated with reduced pain catastro-
phizing and decreased cognitive deficits in other chronic pain patients characterized by 
CS (107, 108). 
 In CINP patients, only cognitive deficits were related to decreased regional GMV, and 
no GMV alterations or CS could be revealed. Accordingly, fewer indications are currently 
available for a role of brain alterations and CNS reorganization in the pathophysiology of 
CINP at a group level. Nevertheless, at the individual patient level it is still possible that 
CNS mechanisms play a role, and subsequently the therapeutic approach should be 
personalized for each specific patient regardless of diagnosis. 
left amygdala, left rostral middle frontal cortex, lateral orbitofrontal cortex bilateral, insula 
bilateral, left precuneus, left thalamus, left postcentral cortex, right medial orbitofrontal 
cortex, right rostral anterior cingulate cortex, right posterior cingulate cortex) coincided 
with increased cognitive deficits, maladapted pain cognitions, CS symptoms, and local 
hyperalgesia in CWAD. Noteworthy, in CINP patients decreased GMV (left rostral anterior 
cingulate cortex, left medial orbitofrontal cortex, right thalamus) was only associated with 
increased cognitive deficits but not with pain cognitions, CS symptoms, and local 
hyperalgesia. The present study could not detect relationships between CPM efficacy and 
regional GMV in both chronic neck pain groups, in contrast to a previous morphological 
MRI study in patients with irritable bowel syndrome (100). This study revealed a relationship 
between endogenous pain inhibition and cortical thickness in the lateral orbitofrontal 
cortex. This inconsistent result could be, however, explained by a different CPM paradigm 
and a different macrostructural metric (cortical thickness versus GMV) (100). 
 Remarkably, only GMV of the right lateral orbitofrontal cortex was sensitive in 
detecting significant group differences and was also correlated with measures of cognition 
and pain. Specifically, decreased GMV in the right lateral orbitofrontal cortex in CWAD 
patients correlated with worse executive control. Functional neuroimaging combined 
with neuropsychological data have provided evidence which indicates an important role 
of the orbitofrontal cortex in decision-making (101) and executive control of information 
processing by inhibiting neural activity associated with painful sensations (102). 
 Furthermore, the present study showed associations between increased self-reported 
cognitive deficits and worse objective cognitive performance (working memory capacity, 
task-switching capacity, and executive control), and decreased regional GMV in CINP and 
CWAD patients. Similarly, Luerding et al (24) demonstrated associations between reduced 
working memory performance and decreased GMV in the left dorsolateral prefrontal 
cortex in fibromyalgia patients. 
 Higher levels of pain catastrophizing and pain hypervigilance were correlated with 
decreased GMV in the precuneus, inferior frontal gyrus (pars orbitalis), medial orbitofrontal 
cortex, insula, thalamus, posterior cingulate cortex, and rostral middle frontal cortex in 
patients with CWAD. Our results are consistent with previous studies exploring associations 
between pain catastrophizing and GM morphology. For example, Hubbard et al (103) 
observed associations between higher pain catastrophizing and lower GMV in pain 
processing regions in migraine patients. 
 Furthermore, increased local hyperalgesia as revealed by lower PPTs at the trapezius 
muscle in CWAD was correlated with decreased GMV in the left postcentral cortex, which 
is a region involved in pain perception and processing nociceptive stimuli (104). Recently, 
Niddam et al (97) demonstrated an association between decreased PPTs at the trapezius 
muscle (local hyperalgesia) and decreased GMV in the right middle frontal cortex in 
patients with chronic myofacial pain. 
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In women with CINP, decreased GMV was only associated with increased cognitive deficits 
but compared with healthy controls no GMV alterations could be revealed. These findings 
indicate a possible negative mediating role of the trauma in patients with CWAD. The 
underlying neurobiological mechanisms of these GMV alterations remain to be elucidated 
and no conclusions about the causality of the observed relationships can be drawn. 
Accordingly, longitudinal research is warranted to unravel whether these GMV alterations 
occur as a result of chronic pain or vice versa.  Based on the present study results, it can be 
recommended that therapy approaches for CWAD should take into account the role of 
CNS neuroplasticity. 
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Encouragingly, multiple studies have shown in other chronic pain conditions that decrease 
in GM morphology including GMV is at least partially reversible when underlying pain is 
adequately treated (96, 109, 110). These studies are clinically relevant as they suggest that at 
least some of the morphological GM changes must be a direct consequence of the 
presence of pain, and related sequel, and possibly the underlying mechanism is based on 
synaptic plasticity (93).
 To summarize, the current study results pave the way for the development of novel 
and more effective treatment approaches for patients with chronic neck pain. 
Recommendations for further research
The exact underlying mechanisms responsible for decreased regional GMV in CWAD 
patients remain unclear. The potential underlying mechanisms for GMV changes include 
changes in synaptic density and dendritic spine structure, among others (111). It is possible 
that the observed GMV decrease reflects tissue shrinkage, which can be caused by 
affected neural tissue or extracellular and microvascular volume without substantially 
impacting neuronal properties (112). Further research should investigate the underlying 
neurobiological mechanisms of the observed GMV alterations. In addition, future research 
should investigate possible alterations in white matter microstructure in patients with 
CWAD compared to CINP. 
 The regional GMV decrease can also be interpreted in the light of maladapted neuro-
plasticity (113). This is relevant when considering the dynamic features of GMV alterations 
associated with persistent pain. Neural reorganization can range from synaptic plasticity 
to changes in neural circuitry (e.g. long-term potentiation, synaptic sprouting, neurogenesis 
(114), and glial reorganization).  
Whether these GMV changes are the consequence of pain or whether pre-existent 
alterations of these regions make patients more susceptible to the development of CWAD 
remains to be elucidated. Longitudinal research is warranted and research should unravel 
if therapy can re-shape the brain and diminish the associated burden in CWAD. Noteworthy, 
the current study has investigated only one piece of the puzzle regarding possible brain 
alterations in patients with CINP and CWAD. Accordingly, future brain imaging research 
has to further disentangle possible structural and functional brain changes in patients 
with chronic neck pain.  
Conclusion
The present innovative study provided evidence for decreased GMV in cortical regions 
associated with pain and cognitive processing in women with CWAD compared to 
women with CINP and healthy women. Additionally, in women with CWAD, decreased 
GMV in cognitive and pain processing regions was associated with increased cognitive 
deficits, maladapted pain cognitions, self-perceived CS symptoms, and local hyperalgesia. 
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Supplementary Table B  Non-significant differences in GMV of ROIs involved in 
processing of cognition and pain in CWAD patients, CINP patients and healthy women.
Estimated means Tests of  between-
Subjects Effects
Mean* Std. Error 95% Confidence Interval  F-value (P-value)
 Lower Bound Upper Bound
Caudal anterior cingulate volume (left hemisphere) (mm3)
HCON 2022.697 84.968 1853.504 2191.890
 1.146 (0.323)CINP 1849.925 75.519 1699.546 2000.303
CWAD 1933.957 84.169 1766.356 2101.558
Caudal anterior cingulate volume (right hemisphere) (mm3)
HCON 2238.221 88.037 2062.916 2413.526
 0.662 (0.519)CINP 2103.819 78.247 1948.008 2259.629
CWAD 2182.124 87.209 2008.469 2355.779
Rostral anterior cingulate volume (left hemisphere) (mm3)
HCON 2815.528 95.081 2626.197 3004.859
1.857 (0.163)CINP 2595.038 84.508 2426.761 2763.314
CWAD 2592.465 94.187 2404.916 2780.015
Rostral anterior cingulate volume (right hemisphere) (mm3)
HCON 2223.509 78.969 2066.262 2380.756
1.058 (0.352)CINP 2148.890 70.187 2009.129 2288.650
CWAD 2061.148 78.226 1905.381 2216.915
Posterior cingulate volume (right hemisphere) (mm3)
HCON 3239.293 87.813 3064.435 3414.151
1.755 (0.180)CINP 3080.014 78.048 2924.600 3235.427
CWAD 3012.570 86.987 2839.357 3185.782
Rostral middle frontal volume (left hemisphere) (mm3)
HCON 15797.621 340.979 15118.645 16476.597
1.027 (0.363)CINP 15447.520 303.061 14844.048 16050.992
CWAD 15105.454 337.771 14432.867 15778.042
Rostral middle frontal volume (right hemisphere) (mm3)
HCON 15021.037 343.129 14337.780 15704.294
0.347 (0.708)CINP 14776.898 304.972 14169.621 15384.174
CWAD 14618.770 339.900 13941.942 15295.598
Medial orbitofrontal volume (left hemispere) (mm3)
HCON 4624.112 108.906 4407.251 4840.973
2.305 (0.107)CINP 4540.005 96.796 4347.260 4732.750
CWAD 4307.561 107.882 4092.741 4522.381
Medial orbitofrontal volume (right hemispere) (mm3)
HCON 4786.377 97.557 4592.116 4980.637
1.228 (0.298)CINP 4583.517 86.708 4410.859 4756.175
CWAD 4701.462 96.639 4509.030 4893.895
Supplementary Table B  Continued.
Estimated means Tests of  between-
Subjects Effects
Mean* Std. Error 95% Confidence Interval  F-value (P-value)
 Lower Bound Upper Bound
Lateral orbitofrontal volume (left hemisphere) (mm3)
HCON 7556.569 150.887 7256.115 7857.023
1.161 (0.319)CINP 7396.945 134.108 7129.902 7663.988
CWAD 7230.979 149.467 6933.351 7528.606
Insula volume (left hemisphere) (mm3)
HCON 6650.029 135.783 6379.651 6920.407
1.807 (0.171)CINP 6619.807 120.683 6379.495 6860.118
CWAD 6326.050 134.505 6058.216 6593.884
Insula volume (right hemisphere) (mm3)
HCON 6759.804 131.606 6497.743 7021.865
1.419 (0.248)CINP 6677.191 116.971 6444.272 6910.110
CWAD 6458.759 130.368 6199.164 6718.355
Postcentral volume (left hemisphere) (mm3)
HCON 9350.764 227.937 8896.884 9804.645
0.590 (0.557CINP 9683.044 202.590 9279.637 10086.452
CWAD 9517.861 225.792 9068.251 9967.471
Postcentral volume (right hemisphere) (mm3)
HCON 9045.141 267.322 8512.835 9577.447
0.028 (0.973)CINP 8984.258 237.595 8511.146 9457.370
CWAD 8958.659 264.807 8431.362 9485.957
Precuneus volume (left hemisphere) (mm3)
HCON 9579.739 220.170 9141.325 10018.153
1.011 (0.369)CINP 9593.422 195.686 9203.761 9983.083
CWAD 9214.218 218.098 8779.929 9648.506
Precuneus volume (right hemisphere) (mm3)
HCON 992.580 200.089 9530.152 10327.008
2.240 (0.113)CINP 10015.495 177.838 9661.373 10369.617
CWAD 9478.566 198.206 9083.887 9873.245
Pars Orbitalis volume (left hemisphere) (mm3)
HCON 2201.797 56.529 2089.233 2314.361
1.609 (0.207)CINP 2218.293 50.243 2118.247 2318.340
CWAD 2091.079 55.997 1979.574 2202.584
Pars Orbitalis volume (right hemisphere) (mm3)
HCON 2649.025 71.052 2507.542 2790.509
1.406 (0.251)CINP 2580.656 63.151 2454.906 2706.406
CWAD 2481.601 70.384 2341.449 2621.753
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Introduction
Extensive Magnetic Resonance Imaging (MRI) research has uncovered alterations in grey 
matter (GM) volume, cortical thickness, and white matter (WM) microstructure in regions 
and tracts involved in processing of pain and cognition in various chronic musculoskeletal 
pain conditions such as fibromyalgia (1-4) and chronic low back pain (5-7). In addition, these 
brain alterations have been reported in mild traumatic brain injury (TBI) patients (8-11). 
Also, in mild TBI patients evidence is available for brain microhemorrhages related to the 
trauma or diffuse axonal injury (12). Yet, despite this huge body of work, there have been 
few attempts to investigate these findings in more detail and to examine alterations in 
both GM and WM, as well as associations with clinical features in patients with chronic 
musculoskeletal pain.
 Remarkably, structural brain MRI research is limited in two prevalent musculoskeletal 
pain conditions namely chronic whiplash-associated disorders (CWAD), who have trauma- 
induced persistent neck pain (13), and chronic idiopathic neck pain (CINP), who have 
persistent neck pain of non-traumatic origin. However, due to the trauma inducing 
possible shearing forces through acceleration-deceleration of the brain (14), it could be 
hypothesized that subtle structural brain alterations in GM morphology and WM 
microstructure are present in CWAD, but not or to a lesser degree in CINP patients. 
To investigate this hypothesis and to unravel the underlying mechanisms of a wide 
range of possible structural brain alterations, it seemed valuable to compare patients 
with CINP and CWAD, a priori different from each other in the origin of pain. Furthermore, 
this research could explore pathophysiological differences between both chronic neck 
pain groups which is necessary to improve their treatment outcome.
 Intriguingly, many chronic musculoskeletal pain disorders are characterized by central 
sensitization (CS) as overlapping pathophysiological mechanism, and often experience 
cognitive problems (15, 16). In addition, similar to chronic pain patients, mild TBI patients 
often report cognitive complaints (17) and chronic pain (18). These findings indicate that 
chronic pain is associated with structural brain plasticity, and suggest that cognitive 
deficits and CS are related to this plasticity (19, 20). Also, it has been shown that GM and WM 
neuroplasticity is associated with the traumatic factor in mild TBI (8-11).
 Compelling evidence has shown CS in patients with CWAD (21). In contrast, CS is not a 
characteristic feature in CINP patients (22, 23), and cognitive deficits are observed to a lesser 
extent compared to CWAD (24). A recent systematic review concerning brain alterations in 
WAD and INP, only found 3 studies investigating structural brain alterations exclusively in 
WAD (25), and one study reported altered GM volume in CWAD. However, alterations in 
cortical thickness and WM microstructure, and their association with cognitive deficits 
and CS, have never been investigated in patients with CWAD compared to CINP, which is 
a prominent research gap. 
Abstract
Background: Alterations in grey matter (GM) and white matter (WM) are hypothesized to 
be present in patients with chronic whiplash-associated disorders (CWAD). These 
alterations are possibly associated with the traumatic whiplash injury. Furthermore, these 
brain alterations are presumed to be associated with more severe cognitive deficits and 
central sensitization (CS) in CWAD compared to chronic idiopathic neck pain (CINP) 
patients. 
Objectives: To examine alterations in cortical thickness and WM microstructure, and the 
presence of brain microhemorrhages in a patient group encountering chronic neck pain 
of traumatic origin (i.e. CWAD) compared to a patient group characterized by non-traumatic 
chronic neck pain (i.e. CINP), and healthy controls. Furthermore, we aimed to investigate 
associations between brain structure on one hand and cognitive performance and CS on 
the other hand.
Methods: T1-weighted, diffusion-weighted and T2*-weighted Magnetic Resonance images 
of the brain were acquired in 105 women (31 controls, 37 CINP, 37 CWAD) to investigate 
regional cortical thickness, WM microstructure, and microhemorrhages, respectively. 
Next, cognitive performance, and CS encompassing distant hyperalgesia and conditioned 
pain modulation (CPM) efficacy were examined.
Results: We demonstrated worse cognitive performance and decreased CPM efficacy in 
CWAD compared to CINP patients and controls. Cortical thinning in the left precuneus 
was revealed in CWAD compared to CINP patients. Also, decreased fractional anisotropy, 
together with increased values of mean diffusivity and radial diffusivity could be observed 
in the left cingulum hippocampus and tapetum in CWAD compared to CINP patients, 
and in the left tapetum in CWAD patients compared to controls. Moreover, the extent of 
WM microstructural deficits in the left tapetum coincided with decreased CPM efficacy 
(denoting CS) in the CWAD group. 
Conclusion: Alterations in precuneus cortical thickness, and regional WM microstructure 
were found in women with CWAD, characterized by trauma-induced neck pain. Together, 
our results provide evidence for associations between decreased endogenous pain 
inhibition, and the degree of regional WM deficits in CWAD. This yields evidence for 
underlying WM microstructural correlates of CS, and emphasizes the role of structural 
brain alterations in women with CWAD compared to CINP. Accordingly, it can be 
recommended that therapy approaches for CWAD should take into account structural 
neuroplasticity of the central nervous system.
Keywords: chronic whiplash-associated disorders, chronic idiopathic neck pain, cortical 
thickness, white matter microstructure, magnetic resonance imaging, central sensitization, 
cognitive performance
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(unpublished), and concerning clinical differences between women with CINP and CWAD 
(24). In order to exclude the confounding factor of gender on brain structure and pain 
modulation, only women were included, as research has demonstrated differences 
between men and women regarding brain structure, pain sensitivity and processing in 
healthy persons and pain patients (37-39). All participants were Dutch native speakers 
between 18 to 65 years old. Participants were recruited by calls on social media and 
through advertisements placed in health magazines and a patient information brochure, 
on the Ghent University website, and via local radio. Furthermore, informative flyers and 
posters were distributed in different medical institutes and associations in Flanders, 
Belgium (various hospitals, medical physician practices, and physical therapist practices). 
As general inclusion criteria, approximately 90 percent of all participants were right-handed 
and 10 percent left-handed. This is a representative sample, because approximately 10 
percent of the general population is ambidextrous or left-handed (40).
Inclusion criteria for patients with CINP and CWAD were persistent neck pain lasting more 
than 3 months (41), with a mean pain intensity of more than 3 of 10 on a Numeric Rating 
Scale (NRS) during the preceding month. All chronic neck pain patients had to report 
mild/moderate to severe pain-related disability, established by a score of 10 or more of a 
maximum of 50 on the Neck Disability Index (42). Additionally, patients with chronic neck 
pain had to report stability of pain medication intake for at least 4 weeks before study 
participation. 
 A specific inclusion criterion for CINP patients was persistent idiopathic neck pain. 
Patients with CINP were excluded if they ever experienced whiplash trauma, or any other 
specific cause of neck pain, e.g. cervical hernia with clinical symptoms. Patients with 
CWAD were included only if they had neck pain resulting from a motor vehicle crash or 
traumatic event and classifiable as WAD II A, B, or C on the modified Quebec Task Force 
Scale (43). Patients with CWAD grades I, III (neurological signs), or IV (fracture or dislocation) 
on the modified Quebec Task Force Scale were excluded. Additionally, CWAD patients 
who lost consciousness as a result of the traumatic event, and who had suffered distinct 
posttraumatic amnesia were excluded.   
 Healthy women could participate only if they were pain-free on each test day (NRS 
score of <2/10), had no history of neck-shoulder-arm pain for longer than 8 consecutive 
days during the preceding year, with a pain intensity of 2 or more of 10 on the NRS, no 
medical consultation for neck-shoulder-arm pain during the preceding year, and no 
history of whiplash trauma. Additionally, healthy controls were included only if they had a 
score of less than 8 of 50 on the Neck Disability Index.
 General exclusion criteria for all study groups were the presence of major depression 
or psychiatric illness; neurologic, or cardiovascular disorders; inflammatory disorders; 
fibromyalgia; chronic fatigue syndrome; and a history of neck or shoulder girdle surgery. 
All participants completed the MRI safety checklist and participants who presented con-
In order to disentangle subtle structural brain alterations in patients with CWAD compared 
to non-traumatic CINP, innovative advanced MRI, in particular, Diffusion-Weighted 
Imaging (DWI) acquisition techniques, and Diffusion Tensor Imaging (DTI) analyses 
offer opportunities to investigate the brain’s WM tissue at a microstructural level (26-31). 
Hence, these techniques will probably be more sensitive for detecting subtle structural 
brain changes in CWAD (32). In particular, DWI examines WM microstructural organization 
by quantifying the directionality and degree of diffusion of water within tissues (26-31). 
In addition, T2*-weighted MRI could gain insight in the presence or absence of brain 
 microhemorrhages related to the trauma in CWAD. Furthermore, MRI techniques 
investigating cortical thickness could be valuable to extract additional information of the 
brain’s GM morphology. It is suggested that cortical thickness and GM volume reflect 
different aspects of the neural architecture (33). Examining cortical thickness could therefore 
provide additional insights into the structural neural underpinnings of CWAD and CINP. 
The first study objective was to investigate alterations in cortical thickness in brain regions 
involved in processing of cognition or pain in patients with CWAD compared to CINP and 
healthy controls. The second objective was to examine deficits in WM microstructure, 
including alterations in fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity 
(AD), and radial diffusivity (RD) in predefined WM regions/tracts carrying information 
between regions involved in processing of cognition or pain in patients with CWAD 
compared to CINP, and healthy controls. The third objective was to examine the presence 
or absence of microhemorrhages related to trauma in CWAD patients compared to the 
other study groups. The final objective was to explore in each group separately whether 
alterations in regional cortical thickness and WM microstructure were associated with 
cognitive performance and CS.
 Based on a-priori cortical thickness and WM anatomical hypotheses, cortical thinning, 
and deficits in WM microstructure of predefined regions/tracts were hypothesized in 
CWAD due to the trauma, and because of cognitive deficits (34) and CS (21), compared to 
CINP patients and healthy controls. Also, previous MRI studies revealed associations 
between altered cortical thickness and WM microstructure, and measures of cognition 
and pain in various chronic pain conditions (35, 36). Therefore, it is hypothesized that 
alterations in cortical thickness and WM microstructure in CWAD are associated with 
worse cognitive performance and signs of CS in CWAD compared to CINP patients.
Methods
Participants
Hundred-five female participants - 37 patients with CINP, 37 patients with CWAD, and 31 
healthy pain-free controls - were enrolled. A subject sample presenting overlap with the 
current study sample was used in our recent study with regard to GM volume alterations 
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sequencing, mental double tracking, and alternation (i.e. shifting between number and 
letter series) (48). The TMT has been proven to be valid for assessing cognitive deficits (46), 
and is a quickly administered, widely used neuropsychological test that provides 
information on a broad range of cognitive skills (49).
Measures of central sensitization
Distant hyperalgesia
Pressure pain thresholds (PPTs) were measured unilaterally with a digital manual algometer 
(Wagner Instruments, FDX, Greenwich, Connecticut) at a distant asymptomatic region 
(quadriceps muscle midway between the anterior superior iliac spine and the basis 
patellae) to evaluate secondary or distant hyperalgesia (50). The PPTs were assessed at the 
most painful side (51) and in a randomized order (with research randomizer, https://www.
randomizer.org). If patients experienced the same amount of neck pain at both sides, and 
in healthy women, PPTs were tested at the dominant handedness side. The participant 
was seated and pressure was gradually increased at a rate of 1 kgf/s until the participant 
reported the first sensation of unpleasantness. The PPT was determined as the mean of 2 
consecutive (30 seconds in between) measurements. Decreased PPTs in the patient 
groups compared to controls at the quadriceps muscle indicate distant hyperalgesia, and 
are suggestive for the presence of CS. The described PPT technique has been demonstrated 
to be reliable (52). 
Efficacy of Conditioned Pain Modulation (CPM)
Endogenous pain inhibition was investigated by applying a CPM paradigm. This paradigm 
relies on the “pain-inhibits-pain” mechanism in which one noxious stimulus is used as a 
conditioning stimulus to induce a reduction in pain perception from another test stimulus 
(53). The conditioning stimulus for eliciting CPM was the cold pressor test. The PPT 
assessment was used as test stimulus. For the conditioning stimulus, the contralateral 
hand (of the PPT side) was first immersed in water maintained at room temperature (22°C) 
for 1 minute to standardize hand temperature (54), before immersing this hand (up to the 
wrist) in a refrigerated circulating bath (Versacool, Thermo Fisher Scientific, Waltham, 
Massachusetts) with cold water maintained at 12±1°C (55). Participants were asked to keep 
their hand in the water bath for 2 minutes (54). Meanwhile, the PPT was re-evaluated at the 
quadriceps muscle, approximately 45 seconds after immersing the hand (again with an 
interval of 30 seconds) (56). If the participant removed the hand from the water before the 
end of the 2 minutes, the measurement was registered as missing. For analysis of CPM 
efficacy, the mean PPT measured before the cold pressor test was subtracted from the 
mean PPT measured during the cold pressor test. Hence, a lower CPM value reflected less 
efficient endogenous pain inhibition. The cold pressor test with cold water of 12°C and 
immersion of the hand for 2 minutes is sufficient to induce an endogenous pain inhibitory 
response (57). 
tra-indications for MRI were excluded. To preclude confounding factors, all participants 
were asked to discontinue intake of non-opioid analgesics 48 hours before study 
participation. In addition, participants were asked to avoid heavy physical exertion and to 
refrain from consuming alcohol, caffeine, and nicotine on each testing day. 
Study design and procedure 
This cross-sectional case-control study took place at Ghent University in cooperation with 
the Ghent Institute for Functional and Metabolic Imaging. The study was performed from 
February 2014 to September 2015 and was carried out in accordance with the principles of 
the Declaration of Helsinki. The Ethics Committee of the Ghent University Hospital 
(EC/2013/1053) approved the research protocol. All participants were informed about the 
study procedures and signed an informed consent form prior to study enrolment. 
 First, all participants completed a survey to acquire information on demographics, 
and completed a series of questionnaires to obtain information on pain-related disability, 
pain intensity and frequency (as described below). Subsequently, experimental assessments 
to investigate cognitive performance and CS were performed. On a separate test day 
(10 +/- 7 days apart), T1-weighted MR images, diffusion-weighted MR images, and 
T2*-weighted gradient echo MR images of the brain were acquired. 
Self-reported pain and disability measures 
On each test day, participants scored current neck pain intensity on a NRS. Scores ranged 
from 0 to 10, with 0 reflecting ‘no pain’ and 10 reflecting ‘the worst pain imaginable’. 
Patients reported their neck pain frequency in number of days per week. The Dutch Neck 
Disability Index was used to investigate self-reported pain-related disability levels (0-50) 
(42). Higher scores on the Neck Disability Index indicate higher levels of pain-related 
disability. The Dutch language version of the Neck Disability Index has been proven to be 
valid and reliable to assess self-reported disability in patients with chronic neck pain (44, 45). 
Cognitive performance
In order to obtain an objective measure of cognitive performance the Trail Making Test 
(TMT) was administered. This test consists of two parts, trail A and trail B. TMT part A 
requires mainly visuo-perceptual (46) and processing speed (47) abilities, whereas TMT part B 
reflects primarily working memory and secondarily task-switching ability (46). In trail A, the 
participant had to draw lines connecting 25 numbers in ascending order as fast as 
possible, without lifting the pencil from the paper. In trail B, the participant was instructed 
to draw lines alternating between numbers and letters in ascending order (going from 1 
to A, from A to 2, etc.).  The goal of the TMT was to finish part A and part B as accurate and 
as quickly as possible. The time taken to complete each part of the test was used as 
outcome measure. Both subtests necessitate graphomotor speed, visual scanning ability, 
sufficient attention, and numeric sequencing (46-48). The TMT part B further requires letter 
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The T1.mgz (i.e. the FreeSurfer T1 image) and aparc+aseg.mgz (i.e. image containing ROIs 
constructed by the FreeSurfer pipeline) files were converted to the Neuroimaging 
Informatics Technology Initiative (NIfTI) format (T1.nii and aparc+aseg.nii) to be used in 
the further DWI analyses.
 Two independent researchers (IC, RDP) visually checked the data quality of the 
FreeSurfer processing output including the accuracy of skull stripping, registration, 
segmentation, and cortical surface reconstruction. Poor data quality, such as inclusion of 
dura in the pial surface after skull stripping, and surface deformations, was revealed in 
12 participants (controls =3, CINP =3, CWAD =6). These cortical thickness datasets were 
excluded from further analyses. 
Cortical regions of interest
Cortical thickness was extracted from 9 ROIs from the Desikan atlas (66) reported to be 
involved in processing of pain and/or cognition. These ROIs were also based on our 
systematic review appraising the evidence for brain alterations in INP and WAD (25), on 
previous studies in patients with chronic pain examining GM morphology alterations (1, 5, 67), 
and regarding studies exploring associations between cortical thickness, and measures 
of cognition and pain (35, 68-70). Specifically, the following 9 ROIs were selected from the 
Desikan atlas (66): caudal anterior cingulate cortex, posterior cingulate cortex, lateral 
orbitofrontal cortex, superior parietal cortex, postcentral cortex, precuneus, pars orbitalis 
of the inferior frontal gyrus, parahippocampal cortex and supramarginal cortex (see fig. 1 
for cortical ROIs). For each ROI, cortical thickness was calculated for the right and left 
hemisphere separately. 
DWI processing
The DWI data were analyzed and processed in ExploreDTI v4.8.6 with MATLAB (71) using the 
following procedure:  DWI volumes were looped at a high frame rate to check for obvious 
artefacts in the data, such as large signal dropouts and geometric distortions. Next, we 
toggled between the views of the first and last acquired DW image to observe subtle 
system drifts. Furthermore, we inspected the images in different orthogonal views 
(coronal, sagittal, axial) to check for interslice and intravolume instabilities, and visualized 
various image maps to check for artefacts. Then, we checked the residual map for outliers, 
reflecting the difference between the modelled and the measured signal (29). Next, the DW 
data were corrected for distortions induced by the DW gradients, artefacts due to head 
motion, eddy current–induced geometric distortions, and EPI distortions (72). EPI distortions 
were corrected by co-registering the DW images to the T1-weighted anatomical images, 
which were normalized for intensity using FreeSurfer. Moreover, we performed appropriate 
reorientation of the encoding vectors. Next, a tensor estimation procedure was performed 
on the preprocessed DW data. 
MRI data acquisition
MR images were acquired on a 3T Siemens Magnetom TrioTim MRI scanner (Siemens, 
Erlangen, Germany) equipped with a 32-channel matrix head coil, at the Ghent University 
Hospital. First, high-resolution T1-weighted images of the brain were acquired using a 
three-dimensional magnetization prepared rapid acquisition gradient echo (MP-RAGE) 
(repetition time [TR] = 2250 ms, echo time [TE]= 4.18 ms, voxel size= 1 x 1 x 1 mm3, field 
of view (FoV)= 256 x 256 mm, flip angle= 9°, 176 slices, 1 mm slice thickness, acquisition 
time = 5’14’’). All T1-weighted anatomical scans were visually checked for overall quality 
and motion artefacts. 
 Second, DW images of the brain were acquired using single-shot echo planar imaging 
with a twice-refocused spin echo sequence with FoV = 240 x 240 mm, TR = 10800 ms, TE 
= 83 ms, and 60 contiguous sagittal slices (slice thickness = 2.5 mm; voxel size = 2.5 x 2.5 x 
2.5 mm3), and an acquisition time of 12’ 36”. Diffusion sensitizing gradients were applied at 
a b-value of 1200 s/mm2, along 64 noncollinear directions. Additionally, 1 set of images 
with no diffusion weighting (b-value= 0 s/mm2) was acquired as a reference image.
 Finally, axial T2*-weighted brain images were acquired using a T2*-weighted 
acquisition gradient echo with TR= 839 ms, TE= 18.60 ms, voxel size= 1 x 0.7 x 3 mm3, FoV= 
230 x 230 mm, flip angle= 20°, 3 mm slice thickness, and an acquisition time of 3’ 48”.  All 
T2*-weighted images were visually inspected by 2 expert neuroradiologists (KD, EG) to 
evaluate possible microhemorrhages or hemorrhagic shearing lesions related to trauma 
or diffuse axonal injury. 
T1-weighted MRI data processing 
T1-weighted anatomical scans were analyzed utilizing the FreeSurfer v5.3.0 software 
package (http://surfer.nmr.mgh.harvard.edu). The analyses were performed using 
additional computing resources from the high performance computing TIER1 cluster at 
the University of Ghent (http://www.ugent.be/hpc/). The FreeSurfer analysis suite was 
used to extract cortical thickness using an automated approach described in detail in 
prior publications (see Fischl 2012 (58)). Previous research has shown that this automated 
procedure yields accurate and reliable results (59). Briefly, image processing included (1) 
removal of non-brain tissue using a hybrid watershed/surface deformation procedure 
(skull stripping) (60), (2) automated Talairach transformations, (3) segmentation of the 
subcortical WM and deep GM volumetric structures (59), (4) intensity normalization (61), (5) 
tessellation of the boundary between GM and WM, automated topology correction (62, 63) 
and (6) surface deformation along intensity gradients for optimal placement of the 
borders between GM, WM and cerebrospinal fluid (64, 65). Automated parcellation of the 
cerebral cortex into units with respect to gyral and sulcul structures, and calculation of 
cortical thickness from all vertices within the cortical parcellations was performed per 
hemisphere using the Desikan atlas (66). Also, estimates of total intracranial volume, and 
mean total thickness of the left and right hemisphere were obtained for each subject. 
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Based on our anatomical hypotheses, we selected WM atlas-labels that are mainly 
involved in pain or cognition or the combination thereof. The selection of these ROIs was 
furthermore based on previous MRI research demonstrating WM structural alterations in 
chronic pain or mild TBI patients, or revealing associations between WM structure, and 
measures of cognition and pain. Hereby, the following 10 WM regions/tracts were defined: 
projection fibers namely (1) the superior cerebellar peduncle (74, 75) (2) the anterior corona 
radiata, (3) the posterior corona radiate (11, 76-80), (4) the anterior limb of internal capsule, (5) 
the posterior limb of internal capsule (3). Association fibers, namely (6) the cingulum 
cingulate gyrus (i.e. subgenual and retrosplenial part of the cingulum) and (7) the cingulum 
hippocampus (i.e. parahippocampal part of the cingulum) (3, 73) and (8) fornix and stria 
terminalis (81-83). Finally, commissural fibers i.e. (9) the tapetum of the corpus callosum (2, 84) 
and (10) the splenium of the corpus callosum (3).  Acceleration-deceleration of the brain is 
believed to affect the superior cerebellar peduncles, and periventricular WM (84), e.g. 
tapetum of the corpus callosum (2, 85, 86). For visualization purposes, masks of these ROIs are 
displayed on MD maps of the WM Mori atlas (73) in fig. 2. To examine WM microstructural 
organization, average FA, MD, AD and RD values were computed in all WM ROI for each 
subject for the right and left hemisphere separately.
Statistical analyses
All statistical analyses were performed with IBM SPSS Statistics 22.0. First, normality of 
variables was assessed with the Shapiro-Wilk test and by visual evaluation of histograms 
and quantile-quantile plots. Additionally, the equality of variance was examined with the 
Levene’s test. If the assumptions of normality and equal between-group variances were 
met, data were analyzed with parametric tests. Otherwise, non-parametric tests were 
applied.
 The comparability of study groups for demographics was explored with a one-way 
ANOVA with post-hoc pairwise comparisons using Bonferroni correction (Family Wise Error 
Rate (FWER) < 0.05), or with the Kruskal-Wallis test with post-hoc pairwise comparisons 
using the Mann-Whitney U test. Differences measured with the Mann-Whitney U test 
were only assumed significant below the significance threshold of 0.017 (Bonferroni 
correction: 0.05/3) to correct for the number of groups. Categorical data were analyzed 
with the Fisher’s exact test. Group differences for cognitive performance and CS were 
explored with one-way ANOVA (post-hoc pairwise comparisons using Bonferroni 
correction, FWER < 0.05) or the Kruskal-Wallis test (post-hoc pairwise comparisons using 
the Mann-Whitney U test, p < 0.017). 
 An ANCOVA model was fitted, controlling for age, to examine differences in total 
intracranial volume and total mean thickness of the left and right hemisphere (post-hoc 
pairwise comparisons using Bonferroni correction, FWER < 0.05).
 A MANCOVA model controlling for age was performed to determine group differences 
in cortical thickness of the 9 ROIs if the assumptions for performing MANCOVA were 
Each scan was visually checked for accuracy after both the motion correction and co- 
registration steps by 2 independent researchers. To check the accuracy of the co-registration, 
the preprocessed DWI was overlaid on the normalized T1-weighted anatomical image. 
Poor data quality was observed in 1 healthy subject because of too much head translation 
due to severe head motion (exceeding the size of 1 voxel), and 2 patients with CINP, 1 due 
to a too high percentage of outliers in the preprocessed DW images and 1 because of a 
general low data quality profile (ghosting, spikes). These WM microstructural data were 
excluded from further analyses. 
 Translational motions (average of axial, coronal and sagittal) did not exceed the size 
of 1 voxel, i.e. 2.5 x 2.5 x 2.5 mm3 (mean +/- SE: controls: 0.85 +/- 0.03 mm; CINP patients: 
0.79 +/- 0.03 mm; 0.87 +/- 0.03 mm for CWAD patients). We re-inspected the data in 3 
orthogonal planes to ensure that the motion/distortion correction was performed 
correctly and that no additional artefacts were introduced into the data. Finally, DWI 
derived metrics FA, MD, AD, and RD were extracted from the preprocessed DWI data using 
an automated approach based on the ICBM DTI-81 WM atlas, which will be further 
explained in the following paragraph (73). 
White matter regions of interest
The ICBM-DTI-81 WM labels atlas, developed by Mori et al. (73), was used for automated 
parcellation of the ROIs. This is a stereotaxic probabilistic WM atlas that fuses DTI-based 
WM information with the standard MNI anatomical template (ICBM-152).  The WM 
parcellations were applied to the preprocessed images and the DWI derived metrics were 
calculated in each ROI, by warping the atlas template to each individual data set. 
Figure 1  Lateral (left fig.) and medial (right fig.) view of the cortical parcellation of the 
Desikan atlas (68) displayed on an inflated template (https://surfer.nmr.mgh.harvard.edu). 
Numbered regions indicate the cortical regions of interest: 1) lateral orbitofrontal cortex; 
2) pars orbitalis; 3) postcentral cortex; 4) superior parietal cortex; 5) supramarginal cortex; 
6) precuneus; 7) posterior cingulate cortex; 8) caudal anterior cingulate cortex; 9) para-
hippocampal cortex.
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Because there were significant effects of age on various diffusion metrics in WM regions, 
age was included as covariate in the MANCOVA model. For each MANCOVA model, 
the partial eta square (η2) was calculated. This measure shows how much variance is 
explained by the independent variable (study group) and is used as the effect size for the 
MANCOVA model. 
 Finally, group-specific partial correlations (controlling for age) were conducted 
between cognitive performance and CS measures on one hand, and cortical thickness or 
WM microstructure on the other hand in cortical regions or WM tracts displaying 
significant group differences. To correct for multiple comparisons (for the number of 
clinical variables), partial correlations were deemed significant only below the 0.0125 
(0.05/4) level. 
Results
Demographic characteristics and self-reported pain and  
disability measures
The results of demographic characteristics and self-reported pain and disability measures 
of 102 participants (30 healthy controls, 35 CINP, 37 CWAD) are presented in table 1. 
No significant differences in demographic characteristics were found between all study 
groups (p > 0.05), except for age (healthy controls were younger compared to CINP; 
p = 0.010). Furthermore, both patient groups were comparable in use of medications, neck 
pain duration, and frequency of neck pain complaints (p > 0.05). In contrast, higher neck 
pain intensity at the MRI test day (p < 0.001), and higher pain-related disability were 
reported by patients with CWAD compared to CINP (p = 0.001). 
Control analyses
The MANCOVA with age and handedness as covariates, revealed no significant main effect 
of handedness on regional cortical thickness (p = 0.284) or WM microstructure (p = 0.349 
for FA; p = 0.215 for MD; p = 0.170 for AD; p = 0.094 for RD). Therefore, the cortical thickness 
and WM microstructure results of the left- and right-handed women were analyzed 
together. The ANCOVA controlling for age showed no significant group differences for 
total intracranial volume (p = 0.137), and total mean thickness of the left (p = 0.563) and 
right (p = 0.404) hemisphere. 
 The assumptions for all applied models were verified. 
Group differences in cognitive performance and central sensitization 
As shown in table 1, the completion time of TMT part A (p < 0.001) and part B (p = 0.002) 
was significantly longer in the CWAD group compared to healthy controls, denoting 
worse performance in CWAD patients. In addition, the time needed to perform TMT part 
A (p < 0.001) was significantly longer in patients with CWAD compared to CINP.
verified (multivariate normality in the data, homogeneity of variance between groups, 
absence of multicollinearity). Four MANCOVA models including age as covariate were 
performed investigating WM microstructure with respectively FA, MD, AD and RD of 10 
WM ROIs in separate models each, as dependent variables, in patients with CWAD, CINP, 
and controls, as independent variables. The significance threshold was Bonferroni 
corrected for the number of DWI derived metrics, resulting in an adjusted p-value of 
< 0.0125 (0.05/4) for the multivariate test and for the individual WM tracts. Next, post-hoc 
pairwise comparison using Bonferroni correction was applied for the group comparisons. 
Figure 2  White matter regions of interest masks. 
Regions are depicted on mean diffusivity maps of the white matter atlas of Mori et al. (73)
a= Axial view of bilateral anterior limb of internal capsule (red), bilateral posterior limb of 
internal capsule (blue), bilateral anterior corona radiate (green), bilateral posterior corona 
radiate (violet); (projection fibers) 
b= Axial view of bilateral tapetum (green) (commissural fibers), and bilateral cingulum 
cingulate gyrus (yellow)
c= Axial view of bilateral superior cerebellar peduncles (blue); (tract in the brain stem)
d= Sagittal view of the cingulum cingulate gyrus (yellow), and the cingulum hippocampus 
(cyan); (association fibers)
e= Sagittal view of the fornix (green) (association fibers) and superior cerebellar peduncle 
(blue).
f= Splenium of the corpus callosum (green) (commissural fibers).
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detected a small round T2* hypointensity in the left thalamus and left globus pallidus 
suggesting microhemorrhages related to hypertension.
Associations between cortical thickness alterations, and cognitive 
performance and central sensitization 
Associations (partial correlations corrected for age) between cognitive performance 
and CS, and cortical thickness were investigated only in ROIs showing significant group 
differences (table 2). The time to complete TMT part B was negatively correlated with 
cortical thickness of the left precuneus (r = - 0.520, p = 0.005) within the CINP group (n = 27). 
Specifically, worse performance on the TMT part B coincided with decreased cortical 
thickness in the left precuneus in patients with CINP, however worse TMT performance 
could not be revealed in CINP patients compared to healthy controls. In the CWAD (n = 26), 
and control group (n = 26), no significant correlations could be found (p > 0.017). 
Decreased PPTs were demonstrated at the quadriceps muscle, reflecting distant 
hyperalgesia in patients with CWAD compared to healthy controls (p = 0.002). The CPM 
value, measured at the quadriceps muscle, was significantly lower in CWAD patients 
compared to controls (p = 0.005), indicating diminished endogenous pain inhibition in 
patients with CWAD (table 1). 
Group differences in cortical thickness
The MANCOVA model examining cortical thickness in 9 ROIs between individuals with 
CWAD, CINP, and healthy controls, including age as covariate, demonstrated significant 
differences for cortical thickness (p = 0.015, η2 = 0.312), based on the multivariate test 
(supplementary table A). Only the left precuneus showed significant group differences 
in cortical thickness (p = 0.037). Post-hoc pairwise comparisons between study groups 
using Bonferroni correction revealed significant decreased cortical thickness in the left 
precuneus (p = 0.032) (fig. 3, supplementary table A) in patients with CWAD compared 
to CINP.
Group differences in white matter microstructure
As can be seen in supplementary table B, four MANCOVA models with age as covariate 
investigating WM microstructure with respectively FA, MD, AD, and RD of 10 WM tracts in 
separate models in patients with CWAD, CINP, and controls, showed significant differences 
for FA (p = 0.010, η2 = 0.293), MD (p = 0.007, η2 = 0.274), and RD (p = 0.007, η2 = 0.297) based 
on the multivariate tests. The MANCOVA of AD could not detect significant differences 
between study groups (p = 0.499), hence regional WM differences in AD were not further 
analysed. 
 The following WM tracts did retain significance after correcting for multiple comparisons 
(p < 0.0125 (0.05/4)): left cingulum hippocampus (p = 0.002 for FA, p = 0.004 for MD, 
p = 0.002 for RD) and left tapetum (p = 0.003 for FA, p = 0.005 for MD, p = 0.004 for RD) 
(supplementary table B). Subsequent, post-hoc pairwise comparisons between study 
groups, using Bonferroni correction, revealed significantly decreased FA (p = 0.007 and 
p = 0.013), increased MD (p = 0.010 and p = 0.025), and increased RD (p = 0.009 and 
p = 0.020) in the left tapetum in CWAD patients compared to controls and CINP patients 
respectively (fig. 4, supplementary table B). Also, significantly decreased FA (p = 0.002), 
increased MD (p = 0.004), and increased RD (p = 0.001) in the left cingulum hippocampus 
were found in CWAD patients compared to CINP patients (fig. 4, supplementary table B). 
Results of T2*-weighted brain imaging analyses 
Based on detailed visual inspection of the axial T2*-weighted brain images, no hemorrhagic 
shearing lesions or microhemorrhages related to trauma or diffuse axonal injury were 
detected. In one CWAD patient a small a-specific T2* hypointensity left parietal without 
clinical relevance was observed. Furthermore, in one CINP patient the neuroradiologists 
Figure 3  Significant differences in cortical thickness of grey matter ROIs between patients 
with CWAD (n= 31), CINP (n= 32) and healthy controls (n= 26).
Abbreviations: HCON= healthy pain-free controls, CINP= chronic idiopathic neck pain, 
CWAD= chronic whiplash associated disorders, SE= standard error, ROIs= regions of 
interest. Data were analyzed using MANCOVA with age as covariate and post-hoc pairwise 
comparisons were applied using Bonferroni correction. *= p=0.032
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Associations between white matter microstructural alterations,  
and cognitive performance and central sensitization 
As presented in table 3, associations (partial correlations corrected for age) between WM 
microstructure (only FA, MD, RD), and cognitive performance and CS measures were 
investigated only in WM tracts demonstrating significant group differences. In the CWAD 
group (n = 34), efficacy of CPM was negatively correlated with MD (r = - 0.478, p = 0.010) 
and RD (r = - 0.477, p = 0.010) in the left tapetum. In other words, decreased efficacy of CPM 
was moderately correlated with increased MD and RD in the left tapetum in CWAD 
patients. In the CINP (n = 33) and control group (n = 28), no significant correlations could 
be revealed (p-value > 0.0125 (0.05/4)). 
 
Figure 4  Significant differences in DTI-derived metrics of white matter ROIs between 
CWAD patients (n= 37), CINP patients (n= 35) and healthy women (n= 30).
Abbreviations: HCON= healthy pain-free controls, CINP= chronic idiopathic neck pain, 
CWAD= chronic whiplash associated disorders, SE= standard error, DTI= diffusion tensor 
imaging, ROIs= regions of interest. Data were analyzed using MANCOVA with age as 
covariate (p<0.0125 (0.05/4)) and post-hoc pairwise comparisons were applied using 
Bonferroni correction. *= p<0.05, **= p<0.01.
Table 2   Partial correlations (controlling for age) between grey matter ROIs with 
significant group differences, and experimental measures of pain and 
cognition in patients with CINP and CWAD.
GM ROI cortical 
thickness (mm)
visuo-perceptual  
and processing speed 
abilities
working 
memory and 
task-switching 
ability
Distant 
hyperalgesia
CPM efficacy
TMT A TMT B PPT quadriceps CPM quadriceps
CINP (n= 27)
Precuneus left
-0,164 -0,520 -0,241 0,030
0,414 0,005 0,208 0,886
CWAD (n= 26)
Precuneus left
-0,022 -0,107 0,154 0,411
0,914 0,596 0,433 0,051
To correct for multiple comparisons, correlations significant at a statistical threshold level of P< 0.0125 level 
(0.05/4) (2-tailed) were deemed significant, and are presented in bold and in green. P-values are presented 
below the correlation coefficient. In healthy pain-free controls, no significant correlations could be revealed 
(data not presented). Abbreviations: CINP= chronic idiopathic neck pain, CWAD= chronic whiplash associated 
disorders, TMT= trail making test, PPT= pressure pain thresholds, CPM= conditioned pain modulation, ROIs= 
regions of interest.
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Discussion
The present study has demonstrated cortical thinning in the left precuneus, a region 
crucially involved in cognitive functioning, in patients with CWAD compared to CINP. 
Furthermore, abnormalities in WM microstructure encompassing decreased FA coinciding 
with increased MD and RD in the left cingulum hippocampus were revealed in patients 
with CWAD compared to CINP, and in the left tapetum in patients with CWAD compared 
to CINP and healthy controls. Interestingly, brain microhemorrhages related to trauma 
were not observed. This is the first study revealing alterations in cortical thickness and WM 
microstructure in women with CWAD compared to CINP or healthy women, indicating a 
potential association between these brain alterations and the signs and symptoms 
induced by the traumatic event in patients with CWAD. Moreover, decreased CPM efficacy 
(denoting CS) was associated with the extent of WM deficits in the left tapetum in CWAD 
patients. The latter yields novel evidence for underlying microstructural neural correlates 
of disturbed endogenous pain inhibition. 
Group differences in cognitive performance and central sensitization
CWAD patients displayed worse processing speed abilities compared to CINP patients 
and controls based on the results of the TMT part A. Decreased working memory span 
was revealed in the CWAD group compared to controls, utilizing the TMT part B. Consistent 
with these findings, 2 recent studies revealed worse cognitive performance in CWAD 
patients compared to healthy volunteers, specifically on domains of sustained attention 
and working memory evaluated with computer-based cognitive tasks (34, 87). Hence, our 
study highlights the importance of evaluating cognitive performance in patients with 
CWAD in clinical practice. 
 Furthermore, CWAD patients showed decreased PPTs at the quadriceps muscle 
compared to healthy controls reflecting distant hyperalgesia. This indicates significant 
indirect signs of CS and thus enhanced central pain sensitivity in CWAD. In accordance 
with our expectations, distant hyperalgesia was not demonstrated in CINP patients. 
Likewise, Scott and colleagues reported decreased PPTs at distant regions in CWAD but 
not in CINP patients (23). Furthermore, decreased CPM efficacy was only observed in the 
CWAD group, implying disturbed endogenous pain inhibitory mechanisms in CWAD but 
not in CINP patients. Consistent with these findings, reduced endogenous pain inhibition 
has previously been reported in CWAD (88, 89) but could not be found in patients with CINP 
(90). The lack of signs for CS in CINP patients is furthermore in line with the results of a recent 
systematic review concluding that CS is not a characteristic feature of CINP (22). Our results 
add evidence to support that CS is present, at a group level, in CWAD and usually not in 
CINP patients, which further elucidates difference in underlying mechanisms. 
Table 3   Partial correlations (controlling for age) between DTI-derived metrics in  
WM ROIs with significant group differences, and measures of cognition  
and central sensitization in patients with CINP and CWAD.
WM ROI DTI-
derived 
metric
visuo-perceptual 
and processing 
speed abilities
working memory 
and task-
switching ability
Distant 
hyperalgesia
CPM efficacy
TMT A TMT B PPT quadriceps CPM quadriceps
CINP (n= 33)
CgH left FA -0,113 -0,212 0,068 -0,038
0,552 0,260 0,712 0,848
MD 0,330 0,356 -0,093 -0,082
0,075 0,053 0,612 0,679
RD 0,304 0,364 -0,103 -0,042
0,102 0,048 0,576 0,831
TAP left FA -0,376 -0,330 -0,093 0,068
0,040 0,075 0,614 0,730
MD 0,001 0,197 0,059 -0,076
0,998 0,297 0,748 0,700
RD 0,078 0,245 0,079 -0,081
0,684 0,193 0,668 0,682
CWAD (n= 34)
CgH left FA -0,198 -0,025 0,213 -0,021
0,278 0,891 0,235 0,915
MD -0,006 -0,077 -0,142 0,418
0,974 0,677 0,432 0,027
RD 0,022 -0,065 -0,15 0,379
0,903 0,725 0,405 0,047
TAP left FA -0,295 -0,240 0,197 0,397
0,102 0,187 0,272 0,037
MD 0,332 0,287 -0,152 -0,478
0,063 0,112 0,397 0,010
RD 0,342 0,290 -0,171 -0,477
0,055 0,107 0,340 0,010
Correlations significant at a statistical threshold level of P< 0.0125 level (0.05/4) (2-tailed) were deemed 
significant, and are presented in bold and in green. P-values are presented below the correlation coefficient. In 
healthy pain-free controls, no significant correlations could be revealed (data is not presented). Abbreviations: 
CINP= chronic idiopathic neck pain, CWAD= chronic whiplash associated disorders, DTI= diffusion tensor 
imaging, TMT= trail making test, PPT= pressure pain thresholds, CPM= conditioned pain modulation, WM= 
white matter, ROI= region of interest, CgH= Cingulum hippocampus, TAP= Tapetum, FA= fractional anisotropy, 
MD= mean diffusivity, RD= radial diffusivity.
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region. The tapetum is the temporal component of the corpus callosum (73) formed by 
decussating fibers in the splenium that arch over the atrium of the lateral ventricle and 
course inferiorly in the posterior and temporal horns of this ventricle (85).  In contrast, more 
evidence exists for WM deficits in the corpus callosum (genu, rostrum, body, splenium, 
tapetum) in chronic musculoskeletal pain patients (3) and mild TBI patients (102). 
 The revealed pattern of WM microstructural deficits encompassing decreased FA, 
increased MD and increased RD in CWAD is consistent with results in other chronic 
musculo skeletal pain conditions. For example, Lieberman et al (3) observed decreased FA 
and increased RD in the left cingulum hippocampus in chronic musculoskeletal pain 
patients compared to healthy volunteers. In patients with complex regional pain syndrome 
decreased FA in the left cingulum bundle has also been demonstrated (103). Furthermore, 
the observed WM abnormalities are in accordance with findings of increased MD in the 
cingulum in mild TBI patients compared to healthy persons (104). In literature, studies tend 
to show decreased FA associated with numerous neurological and neurodegenerative 
diseases (105, 106).
 Additionally, WM microstructural abnormalities were found in the cingulum 
hippocampus in CWAD compared to CINP patients but not compared to healthy persons. 
The cingulum bundle is a prominent WM tract extending longitudinally above the corpus 
callosum (107), and carrying information from the cingulate gyrus to the hippocampus. 
Specifically, the cingulum contains many afferent and efferent fibers associated with the 
cingulate cortices (108-110). These fibers include connections with the thalamus, dorsolateral 
prefrontal cortex, and insula (108). Other cingulum fibers are connected to the parahippo-
campal cortices, the inferior component of the hippocampal formation, and amygdala (108, 110). 
 We can very carefully suggest that our findings are indicative of WM microstructural 
abnormalities in the left tapetum and the left cingulum hippocampus in the CWAD group, 
maybe to some extent reflecting WM demyelination evidenced by the unchanged AD 
together with increased RD (111-113).  Interestingly, in mild TBI patients research has 
demonstrated that long associative WM tracts such as the cingulum bundle are frequently 
affected (114, 115). As such, the underlying mechanisms of the revealed WM deficits in CWAD 
patients could be associated with the traumatic whiplash injury, which perhaps induced a 
cascade of events eventually leading to WM microstructural deficits. Noteworthy, FA 
differences in WM have been shown to predict transition to chronic pain in subacute low 
back pain patients (6). Nevertheless, based on visual inspection of the T2*-weighted brain 
images, microhemorrhages related to trauma or diffuse axonal injury were not observed 
in patients with CWAD. In patients with mild TBI, previous studies could detect subtle 
 microhemorrhagic lesions suggesting differences in underlying pathophysiological 
mechanisms between patients with chronic WAD and mild TBI (116). However, in future 
research we should include Susceptibility Weighted Imaging or Quantitative Susceptibility 
Mapping to detect possible microhemorrhages related to trauma in chronic WAD patients. 
Group differences in cortical thickness
The cortical thinning in the left precuneus in CWAD supports our hypothesis of decreased 
regional cortical thickness in patients with traumatic compared to non-traumatic chronic 
neck pain. The observed cortical thinning in the precuneus in CWAD compared to CINP 
patients has a valuable meaning because it demonstrates macrostructural differences 
between both patient groups. Moreover, this region plays a crucial role in a wide range of 
cognitive and mental processes, and is involved in neurodegenerative processes (91, 92). The 
precuneus is part of the structural core of the brain (93), and is a core hub (i.e. highly 
interconnected nodes) of the default mode network (94). The latter network is a constellation 
of brain regions involved in self-referential mental activity, emotional processing, and 
recollection of prior experiences, and is deactivated during externally focused tasks (95). It 
is reported that damage to network hub regions connecting different subnetworks, such 
as the precuneus, causes the largest disturbances in network organization (96). Also, 
functional MRI studies have demonstrated altered resting-state functional connectivity in 
the precuneus in patients with chronic musculoskeletal pain (97), and in mild TBI patients 
(98). Furthermore, Baliki et al. (99) have demonstrated reorganization of the default mode 
network dynamics in different chronic pain conditions including alterations in precuneus 
connectivity. Interestingly, Kucyi et al. (100) found that functional connectivity fluctuations 
between the default mode network and periaqueductal grey dynamically tracked 
spontaneous attention away from pain in healthy people. 
 Nevertheless, opposite to our hypothesis, we could not detect significant correlations 
between cortical thinning in the precuneus and cognitive performance or experimental 
CS measures in CWAD patients. Also, in contrast to our hypothesis and to the results of 
previous studies in patients with chronic musculoskeletal pain (5, 101) and mild TBI (9), 
differences in cortical thickness between CWAD patients and healthy controls could not 
be demonstrated. Yet, the cortical thickness MANCOVA model comprising all ROIs showed 
a partial eta squared of 0.31, which means that 31% of the variance in cortical thickness in 
the 9 ROIs can be explained by study group, which corresponds with a large effect size. 
Group differences in white matter microstructure
Results showed a consistent pattern of decreased FA coinciding with increased MD and 
RD in the left cingulum hippocampus, and in the left tapetum in patients with CWAD 
compared to healthy controls (tapetum) or compared to CINP patients (cingulum and 
tapetum). In contrast, AD values were not different between all study groups. 
 The observed WM microstructural differences between CWAD patients compared to 
healthy controls were in line with our hypothesis. In addition, differences in WM 
microstructure were revealed between CINP and CWAD patients in the left cingulum 
hippocampus and the left tapetum. The tapetum of the corpus callosum is periventricular 
WM, which is believed to be affected by traumatic acceleration-deceleration of the brain 
(85, 86). To date, limited studies are available on WM abnormalities in the tapetum as separate 
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Strengths, limitations and recommendations for further research
Several strengths can be outlined. This is the first study examining alterations in cortical 
thickness and WM microstructure, and their relationships with cognitive performance and 
CS in patients with a traumatic origin of pain (CWAD) compared to patients with 
non-traumatic CINP and healthy controls. This research is important because it unraveled 
differences between both pain conditions, and provided evidence for CS and structural 
brain alterations as underlying pathophysiological mechanisms in CWAD. Another 
strength is the evaluation of alterations in both GM macrostructure (cortical thickness) and 
WM microstructure (FA, MD, AD, RD). 
 The following limitations have to be taken into account when interpreting our results. 
Metrics derived from DWI data using the tensor model are indirect measures that relate to 
but do not directly quantify tissue features and are influenced by various methodological 
and biological factors (105). These metrics cannot disentangle the individual microscopic 
contributions at the voxel level and therefore should be interpreted with caution. It 
remains unclear whether decreased FA is due to changes in membrane permeability, 
organelles, axon thickness, fiber density, or degree of myelination (105). It has been 
suggested that alterations in RD combined with unchanged AD reflect demyelination (112), 
but the interpretation of these metrics has been a topic of controversy (119). 
 A second limitation of DTI analyses is the inability of the tensor model to adequately 
characterize diffusion in regions of complex fiber architecture. Single-shell data reconstructed 
with the diffusion tensor model assumes a single straight fiber orientation within each 
voxel and is inadequate to model more than one fiber orientation per voxel. In the brain 
however voxels often contain fiber populations with more than one dominant orientation, 
such as crossing fibers (105). Therefore, advanced models based on the high angular resolution 
DWI acquisition strategy to provide more robust estimates of the fiber orientation are 
recommended for further research in CINP and CWAD. 
 A final limitation pertains to the cross-sectional nature of this study implying that no 
conclusions can be drawn on the causality of the observed associations. To test causal 
inference, future longitudinal studies are necessary.
 Further research investigating associations between abnormalities in WM microstructure 
in CWAD, and other experimental features of CS such as temporal summation of second 
pain could add valuable insights into the brain structural correlates of CS. Finally, it could 
be recommended to disentangle possible functional brain alterations using (resting-state) 
functional MRI techniques and perform network analyses in patients with CWAD and 
CINP compared to healthy controls.  
Decreased cortical thickness in the precuneus: associations with 
cognitive performance and central sensitization
In CINP patients, decreased precuneus thickness coincided with worse performance on 
the TMT part B, however decreased cortical thickness and worse cognitive performance 
could not be revealed in CINP patients compared to controls. The observed association 
between working memory capacity and cortical thickness in CINP patients is in line with 
studies reporting associations between regional GM morphology and working memory 
capacity or other features of cognition in patients with fibromyalgia (36), patients with 
complex regional pain syndrome (117), and in mild TBI patients (118). 
Microstructural white matter abnormalities in the cingulum 
hippocampus and tapetum: associations with cognitive performance 
and central sensitization
Consistent with our hypothesis, deficits in WM microstructure in the left tapetum, 
encompassing increased MD and RD, were associated with decreased CPM efficacy 
(denoting CS) in the CWAD group. However, associations between cognitive performance 
or CS, and the observed WM alterations in the cingulum hippocampus could not be 
detected. Also, no associations were demonstrated between cognitive performance or 
distant hyperalgesia, and WM microstructural abnormalities in CWAD patients, which was 
in contrast with our expectations. Interestingly, we provide novel evidence for associations 
between microstructural WM deficits and decreased CPM efficacy in CWAD. Recently, a 
longitudinal MRI study uncovered microstructural WM vulnerabilities to develop chronic 
back pain (6). Also, moderate evidence exists to support that higher pain intensity is 
associated with FA alterations in WM tracts involved in pain and cognition (35). 
Clinical implications
Our findings support a role of WM microstructural abnormalities in the left tapetum in the 
observed dysfunctional CPM response in CWAD. This yields innovative evidence for 
underlying WM microstructural correlates of disturbed endogenous pain inhibition in 
CWAD but not in CINP patients. Accordingly, these results emphasize the role of WM 
abnormalities in patients with CWAD compared to CINP and maybe reflect one piece of the 
puzzle underlying the observed clinical differences between both neck pain conditions 
with possibly a role of the traumatic injury mediating the structural brain differences. 
 Our results furthermore indicate that chronic pain in CWAD patients should be 
interpreted, at least in part, as a result of structural plasticity of the central nervous system, 
associated with alterations in cortical thickness and WM microstructure in regions involved 
in various aspects of pain and cognitive processing. Accordingly, it can be recommended 
that therapy approaches for CWAD should address the brain and take into account neuro-
plasticity of the central nervous system. As such, clinicians should take into account the 
observed structural brain differences when treating patients with CINP and CWAD. 
228 229
5
Chapter 5 Alterations in white matter microstructure and cortical thickness in CWAD
Conclusion
In conclusion, cortical thinning in the left precuneus, a core hub of the default mode 
network and part of the structural brain core, was found in women with CWAD compared 
to CINP. Additionally, abnormalities in WM microstructure were revealed in 2 WM tracts 
carrying information between regions involved in affective-cognitive dimensions of pain 
processing and cognition in women with CWAD compared to CINP or healthy women. 
This study provided novel evidence for associations between dysfunctional CPM and the 
degree of WM deficits in the left tapetum in patients with CWAD. This yields innovative 
evidence for underlying WM microstructural correlates of CS and in particular of disturbed 
endogenous pain inhibition in CWAD. Accordingly, these results emphasize the role of 
structural brain alterations in patients with CWAD compared to CINP. 
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the clinical importance of objectively measured cognitive deficits in patients with chronic 
WAD and FM. 
Key words: Chronic pain, fibromyalgia, whiplash, central sensitization, conditioned pain 
modulation, temporal summation, cognition, quality of life
1.  Introduction
A whiplash injury is caused by a sudden acceleration-deceleration of the head, mostly due 
to motor vehicle collisions (1, 2).  Up to 50% of whiplash patients develop chronic neck pain 
and disability (3, 4). The term chronic whiplash-associated disorders (WAD) is used to describe 
the various symptoms that are experienced by whiplash patients beyond 3 months after 
the accident (1). These symptoms include persistent neck pain, referred pain, headache, 
dizziness, emotional and cognitive disturbance, and physical dysfunctions (5-7). Fibromyalgia 
(FM) is another condition characterized by various persistent symptoms (8). 
 The diagnosis of FM is based upon the 1990 or 2010 American College of Rheumatology 
(ACR) criteria (9). According to these criteria, FM patients are characterized by chronic 
widespread musculoskeletal pain. Additionally, FM patients experience a variety of 
symptoms, including sleep disturbances, fatigue, cognitive dysfunctions, and limitations 
in activities of daily living (8, 10). Chronic pain is a predominant and common debilitating 
symptom in both patients with WAD and FM (11-13).
 Nowadays, there is compelling evidence for impaired central pain modulation or 
central sensitization (CS) in both patients with chronic WAD and FM as the underlying 
mechanism of their pain complaints (11, 13-17). CS is defined as an exaggerated responsiveness 
of the central nervous system to a variety of stimuli, like pressure, temperature, light, and 
medication among others (18, 19). The CS mechanism causes hyperalgesia, allodynia, 
temporal summation (TS), and referred pain across multiple spinal segments, leading to 
chronic widespread pain (11). The augmented excitability results in a largely decreased load 
tolerance of the neuromusculoskeletal system. Contiguously, it has been shown that 
alterations in descending pain pathways are involved in the CS process (20). Malfunctioning 
of descending neuronal pathways can lead to more facilitation and less inhibition of the 
transmitted nociceptive signals to the brain. 
 The conditioned pain modulation (CPM) paradigm is often used to evaluate the 
efficacy of endogenous pain inhibition, and relies on the “pain-inhibits-pain” mechanism (21). 
Earlier studies provided evidence for inefficient CPM activation in patients with chronic 
WAD and FM (13, 22-24). In addition, TS, defined as the increase in pain ratings after repetitive 
stimulation at a constant intensity, is widely used in pain research to assess hyperexcitability 
of the central nervous system (21, 25). Interestingly, it seems that activation of CPM is able to 
reduce TS among healthy pain-free individuals (26). By measuring both CPM, combined 
Abstract
Background: A growing body of research has demonstrated that impaired central pain 
modulation or central sensitization (CS) is a crucial mechanism for the development of 
persistent pain in chronic whiplash-associated disorders (WAD) and fibromyalgia (FM) 
patients. Furthermore, there is increasing evidence for cognitive dysfunctions among 
these patients. In addition, chronic WAD and FM patients often report problems with 
health-related quality of life (QoL). Yet, there is limited research concerning the interrelations 
between cognitive performance, indices of CS and health-related QoL in these patients. 
Objectives: (1) Examining the presence of cognitive impairment, CS, and limitations on 
health-related QoL in patients with chronic WAD and FM compared to healthy controls. (2) 
Examining interrelations between performance-based cognitive functioning, CS, and 
self-reported health-related QoL in these 3 study groups. 
Study design: A case-control study was conducted. 
Setting: The present study took place at the University Hospital Brussels, the University of 
Brussels, and the University of Antwerp.
Methods: Fifty-nine participants (16 chronic WAD patients, 21 FM patients and 22 pain-free 
volunteers) filled out the Short Form 36 item Health Survey (SF-36), a self-reported 
psychosocial questionnaire, to assess health-related QoL. Next, they were subjected to 
various pain measurements (pressure hyperalgesia, deep-tissue hyperalgesia, temporal 
summation (TS), and conditioned pain modulation (CPM)). Finally, participants completed 
a battery of performance-based cognitive tests (Stroop task, psychomotor vigilance task 
(PVT), and operation span task (OSPAN)).
Results: Significant cognitive impairment, bottom-up sensitization, and decreased 
health-related QoL were demonstrated in patients with chronic WAD and FM compared 
to healthy controls (p<0.017). CPM was comparable between the 3 groups. Cognitive 
performance was significantly related to central pain modulation (deep-tissue hyperalgesia, 
TS, CPM) as well as to self-reported health-related QoL (p<0.05). Decreased cognitive 
performance was related to deficient central pain modulation in healthy controls. Further, 
significant correlations between decreased cognitive performance and reduced health- 
related QoL were revealed among all study groups. Additionally, FM patients showed 
correlations between cognitive impairment and increased health-related QoL. Remarkably, 
impaired selective attention and working memory were related to less TS, whereas 
impaired sustained attention was correlated with dysfunctional CPM in FM patients.
Limitations: Based on the current cross-sectional study no firm conclusions can be drawn 
on the causality of the relations.
Conclusion: In conclusion, this paper has demonstrated significant cognitive deficits, 
signs of CS, and reduced health-related QoL in chronic WAD and FM patients compared to 
healthy individuals. Significant relations between cognitive performance and CS as well as 
health-related QoL were demonstrated. These results provide preliminary evidence for 
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friends, relatives, or acquaintances of students, researchers, patients, and university staff. 
Each study participant had to be Dutch speaking and aged between 18 and 65 years. 
The chronic WAD group fulfilled the criteria of the Quebec Task Force (grade II to III) (1). 
Chronic neck pain due to a whiplash event was defined as pain lasting longer than 3 
months. The FM group complied with the diagnostic criteria for FM as defined by the 1990 
ACR (9). FM patients reporting a history of a whiplash trauma and chronic WAD patients 
fulfilling the diagnostic criteria for FM were excluded from the study. At the time of study 
participation, healthy individuals were not allowed to suffer from any pain complaints or 
any (chronic) disease. 
 General exclusion criteria were neurologic, metabolic, cardiovascular, or inflammatory 
disorders. In order to preclude confounding factors, pregnant women and women one 
year postnatal were excluded. Furthermore, all participants were asked to stop analgesics 
48 hours prior to study participation, not to undertake physical exertion, and to refrain 
from consuming alcohol, caffeine, and nicotine on the day of the experiments.
2.3.  Central sensitization 
To investigate central pain modulation and the presence of CS, 4 critical aspects of the 
central pain system were assessed (36-39). First, in order to evaluate local and widespread 
hyperalgesia, pressure pain thresholds (PPTs) were measured with a digital algometer 
(Wagner Instruments, Greenwich, CT, USA) at symptomatic and remote areas. Secondly, 
deep-tissue hyperalgesia was evaluated. Thirdly, TS of pressure pain was examined. Finally, 
a CPM paradigm was conducted to assess the efficacy of endogenous pain inhibition.
2.3.1.  Pressure hyperalgesia
The PPT was measured at 2 different sites: the dorsal side of the intermediate phalanx of 
the right middle finger and the middle of the right trapezius belly, midway between the 
processus spinosus of the seventh cervical vertebra and the lateral edge of the acromion 
(40, 41). On each site, 2 PPT measurements (interval 30 seconds) were performed, generating 
a mean PPT value per site. To determine the PPT, pressure was increased at a rate of 
approximately 1 kg/s and participants were asked to say “stop” at the moment the 
sensation became unpleasant. Consequently, the pressure was immediately released. The 
pressure established on that moment was determined as the PPT, measured in kg/cm2. 
The use of pressure algometry has been found to be an efficient and reliable technique in 
the determination of PPTs and subsequently the examination of hyperalgesia (22, 42, 43).
2.3.2.  Deep-tissue hyperalgesia
Deep-tissue hyperalgesia was investigated by inflating an occlusion cuff placed around 
the left arm. The cuff served also as the conditioned stimulus in the CPM paradigm (see 
further). Cuff inflation rate was constant (20 mmHg/s) and manually increased until the 
participant reported pain. The pressure at this moment was registered (cuff pressure) and 
with the evaluation of enhanced TS, important information regarding central nervous 
systems’ pain modulation can be obtained. 
 Apart from persistent pain, chronic WAD and FM patients often experience cognitive 
deficits, including concentration difficulties and working memory deficits (1, 9, 10, 27). More 
specifically, the cognitive deficits encompass longer reaction times, short-term memory 
deficits and attention problems (28-30). Decreased cognitive function seems to be related to 
pain severity in various chronic pain populations (29, 31), and is presumed to be a feature of 
CS (19). Accordingly, it is hypothesized that malfunctioning of endogenous pain inhibition 
and subsequent chronic pain precludes optimal cognitive performance. This hypothesis is 
supported by the findings of altered brain morphology (32, 33) and brain activity (34, 35) in 
patients with chronic WAD and FM. 
 Besides the growing evidence for the above mentioned dysfunctions, studies 
examining the relation between objectively measured cognitive performance, CS, and 
health-related quality of life (QoL) in patients with chronic WAD and FM are limited (28). 
Accordingly, it is necessary to further investigate the possible relations between cognitive 
performance, CS, and health-related QoL in patients with chronic CS pain, like those with 
chronic WAD or FM. It is hypothesized that cognitive impairment is related to CS and 
increased limitations on health-related QoL.
 Therefore, the aims of the current study are: 1) to compare these aspects between 2 
patients groups characterized by CS, chronic WAD and FM, and healthy controls; and 2) to 
investigate the interrelations between cognitive performance, CS, and self-reported 
health-related QoL in patients with chronic WAD and FM, and healthy pain-free controls. 
2.  Methods
2.1.  Study design and setting
The present case-control study took place at the University Hospital Brussels, the University 
of Brussels, and the University of Antwerp. Participants received detailed study information 
and gave written informed consent prior to study enrollment. All patients and healthy 
control subjects were unpaid volunteers. This research was approved by the Ethics 
committee of the University Hospital Brussels.
2.2.  Participants and assessments
The present study took place from July 2010 until December 2013. Sixteen patients with 
chronic WAD, 21 patients with FM, and 22 healthy pain-free controls were included. 
Chronic WAD and FM patients were recruited in cooperation with rheumatologists and 
physical medicine physicians. Eligible patients, men and women, were contacted by 
phone and/or email. In addition, patients were contacted using social network and 
Internet sites of chronic WAD and FM associations. Healthy controls were recruited through 
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2.4.1  The Stroop Task
The Stroop Task was used to evaluate selective attention, cognitive inhibition, and choice 
reaction time (46). Three different conditions were used, namely, “incongruent” (word and 
ink color are different), “non word” (XXX in a specific color), and “negative priming” (e.g., 
the word green displayed in red immediately followed by the word blue displayed in 
green). 
 Stroop reaction times for correct responses were taken into account for further 
analyses. Stroop interference effect was calculated by subtracting Stroop reaction time 
non-word from Stroop reaction time incongruent. Stroop interference seems to reflect 
one’s ability to inhibit irrelevant information, and is therefore a measure of cognitive 
inhibitory capacity.
 Negative priming is defined as the condition where the to-be-ignored response in 
the first presentation becomes the subsequent relevant dimension. Furthermore, negative 
priming is believed to rely on one of the mechanisms of selective attention (47). Hence, 
negative priming can provide more information about the quality of cognitive control to 
select relevant information. 
2.4.2.  The Psychomotor vigilance task
The PVT has been validated as a measure of sustained attention, alertness and simple 
reaction time (48). Participants were instructed to respond as quickly as possible to a visual 
stimulus (red spot on a black screen) presented at a variable time-interval (2,000 - 10,000 
ms). The trial was stored as a lapse, if a response had not been made within 500 ms. The 
PVT reaction time of correct responses and number of lapses were registered and used for 
statistical analyses. The PVT has good test-retest reliability for median response times 
(ICC=0.89, p<0.0001) and number of PVT lapses (ICC=0.83, p<0.0001) (49).
2.4.3.  The Operation Span Task
The OSPAN task was used to assess working memory capacity (50). The OSPAN task 
consisted of exercises on letter recall and math operation. The “Operation span” is the 
maximum number of letters that can be recalled. When the test was terminated, the 
“OSPAN total score” was retrieved and used for further statistical analyses. The “OSPAN 
total score” is the sum of all perfectly recalled exercise sets. This score measures working 
memory capacity as it indicates the number of letters recalled in the correct position.
2.5.  Self-reported health-related QoL
The Short Form 36-item Health Survey (SF-36) was used to assess physical function, mental 
health, and health-related QoL (51). This self-reported questionnaire examines 2 main 
domains of health, namely the physical and mental component. Higher scores represent 
better health for that particular subitem. 
used for further data analyses. Participants then adapted to the stimulus for 30 seconds 
and rated the pain on the verbal numeric rating scale (VNRS).  Cuff inflation was then 
adjusted until participants indicated pain at a level 3 of 10 on the VNRS. Subsequent, this 
pressure (cuff pressure VNRS3) was stored and used for further data analyses.
2.3.3.  Temporal summation
TS was induced by means of a digital algometer (Wagner Instruments, Greenwich, CT, 
USA). TS was elicited by 10 consecutive pressure pulses at PPT intensity on the same 
places. For each pulse of the TS procedure, the pressure was increased at a rate of 2 kg/s 
until the previously determined PPT, where it was maintained for one second before 
being released. Pressure pulses were presented with an inter-stimulus interval of one 
second. Participants were instructed to rate the pain intensity of the first, fifth and tenth 
pressure pulse according to the VNRS. TS score was obtained by subtracting the first VNRS 
score from the last VNRS. The higher the TS score, the more efficient the nociceptive 
signaling to the brain. The TS procedure is found to be reliable and valid, and is supported 
to use in chronic pain patients (36).
2.3.4.  Conditioned Pain Modulation
CPM was induced by inflating an occlusion cuff (conditioning stimulus) on the left arm, 
opposite of the test stimulus, to a painful intensity (see 2.3.2), being the TS procedure 
repeated while wearing the cuff. 
 The CPM procedure started when cuff inflation was adjusted equal to a level 3 of 10 
on the VNRS. The left arm was then rested on a table while TS assessment was repeated at 
the right side as described above (36). 
 Efficacy of CPM is examined by subtracting the VNRS at the first pressure pulse prior 
to and during cuff inflation (CPM). The efficacy of CPM on TS was assessed by subtracting 
TS of pressure pain (VNRS tenth pressure pulse) prior to and during cuff inflation (CPM on 
TS) (28). This CPM procedure is found to be reliable, and CPM induced by ischemic cuff 
inflation is able to reduce TS in healthy controls (36). 
2.4.  Cognitive performance
Cognitive performance was assessed using a battery of 3 consecutive computer tests: the 
Stroop task, the psychomotor vigilance task (PVT), and the operation span task (OSPAN). In 
order to standardize the procedure, each test began with the presentation of written 
instructions for that particular test. All study participants performed the cognitive tasks on 
the same computer and in a fixed order (i.e., Stroop task, PVT, and OSPAN). These cognitive 
tests are selected based on the outcome of a systematic review addressing cognitive 
performance in chronic pain patients (27). Each of the 3 tests has been used and described 
in detail in 3 of our previous studies in patients with chronic CS pain (28, 44, 45).
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The SF-36 has been demonstrated to have good reliability and validity in chronic pain 
patients (51). 
2.6.  Data analysis
All statistical analyses were performed using IBM® SPSS® Statistics 22.0. Normality of 
variables was tested with the Shapiro-Wilk test and by visual evaluation of the histograms 
and QQ-plots. In addition, the Levene’s test examined equality of variance. The assumption 
of data normality and equality of variance was not fulfilled. Accordingly, non-parametric 
tests were used for further data analyses. Comparability of groups for age, gender 
distribution, and disease duration was examined with the one-way ANOVA test and 
Chi-square test. 
 First, the median values of the SF-36 questionnaire, pain measurements, and perfor-
mance-based cognitive tests were compared between the 3 study groups using the 
Kruskal-Wallis test. When a significance level of p<0.05 was found, the Mann-Whitney U 
test was performed for post-hoc comparisons. A significance level of p<0.017 (α<0.05/3) 
was used (Bonferroni correction was applied to compensate for the multiple testing 
problem) and to maintain the initial significance level of α<0.05. 
 To determine the relationship between cognitive performance, CS, and health-related 
QoL, Spearman correlation coefficients were calculated between the results of the 
cognitive tests and central pain measures and SF-36 scores, respectively. 
3.  Results
3.1.  Group characteristics
The demographic characteristics of the 3 study groups are presented in Table 1. All study 
groups were comparable for age and gender distribution. Further, disease duration was 
not significantly different between the 2 patient groups. 
3.2   Comparison between patients with chronic WAD, FM,  
and healthy controls
3.2.1  Central sensitization
Pressure hyperalgesia and deep-tissue hyperalgesia
Results of pressure and deep-tissue hyperalgesia are displayed in Table 2. PPTs at the 
shoulder and finger were significantly lower in FM patients compared to chronic WAD 
patients and controls. In addition, cuff pressures at the arm were significantly lower in the 
FM group compared to healthy participants. 
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Chapter 6 Cognitive performance related to central sensitization and quality of life
3.2.2  Cognitive performance
Table 3 presents the median and interquartile ranges (IQR) of the 3 performance-based 
cognitive tests and their subscales for the patients and controls. FM patients presented 
impaired cognitive performance on all cognitive tests compared to healthy individuals. 
Chronic WAD patients only demonstrated impaired performance on the PVT test 
(significant longer PVT reaction times and more PVT lapses) compared to healthy pain-free 
controls. 
Temporal summation and conditioned pain modulation 
Results of TS prior to cuff inflation are shown in Table 2. No significant differences in TS 
were observed between chronic WAD and FM. In contrast, TS was significantly higher in 
both patient groups in comparison with healthy controls. The 3 study groups displayed no 
significant differences for the efficacy of endogenous pain inhibition (CPM). 
Table 2   Comparison of pressure hyperalgesia, deep-tissue hyperalgesia, temporal 
summation, and conditioned pain modulation between patients (cWAD and 
FM) and healthy controls.
PAIN MEASURES cWAD (n=16) FM (n=21) CON (n=22) Kruskal-Wallis Mann-
Whitney U
Median 
(IQR)
Median 
(IQR)
Median 
(IQR)
p value 
<0.05
p value 
< 0.017
Pressure and deep tissue hyperalgesia
PPT finger 7.70
(5.40 – 9.60)
3.00
(1.89 – 5.68)
6.65
(4.47 – 9.35)
0.002 FM < cWAD°;
FM < CON*
PPT shoulder 4.00
(2.50 –  5.20)
1.32
(1.08 – 2.60)
4.22
(2.99 – 5.80)
< 0.001 FM < cWAD°;
FM < CON*
Cuff pressure 160.00
(90.00 – 200.00)
80.00
(63.00 – 145.00)
170 .00
(97.5 – 215)
0.018 FM < CON*
Cuff pressure 
(VNRS3)
110.00
(60.00 – 200.00)
63.00
(42 – 90)
100.00
(80 – 172)
0.020 FM < CON*
Temporal summation
TS finger 3.50
(2.00 – 5.00)
2.00
(1.00 – 3.00)
2.00
(1.00 – 3.00)
0.025 cWAD > CON**
TS shoulder 3.00
(2.00 – 4.00)
3.00
(2.00 – 5.00)
1.00
(0.00 – 3.00)
0.009 FM > CON*;
cWAD > CON**
Conditioned pain modulation
CPM finger 
(VNRS1)
0.00
(0.00 – 2.00)
0.00
(0.00 – 1.00)
0 .00
(0.00 – 1.00)
0.620 ns
CPM shoulder  
(VNRS1)
1.00
(0.00 – 2.00)
0.00
(- 0.75 – 1.00)
1.00
(0.00 – 2.00)
0.080 ns
CPM on TS finger  
(VNRS10)
1.00
(0.00 – 3.00)
0.00
(-0.37 – 1.00)
2.00
(0.00 – 2.00)
0.070 ns
CPM on TS shoulder 
(VNRS10)
1.00
(0.00 – 2.50)
1.00
(0.00 – 1.75)
1.00
(0.00 – 2.00)
0.600 ns
Values are presented as median value and interquartile range (IQR). Significant differences are presented in bold 
font. PPT: Pressure pain threshold, VNRS: Verbal numeric rating scale, TS: Temporal summation, CPM: Conditioned 
pain modulation, ns= not significant, cWAD: chronic whiplash-associated disorders, FM: fibromyalgia, CON: 
healthy controls. Significant differences (p<0.017) between cWAD and FM are presented as (°) between CON 
and FM are presented as (*) between CON and cWAD are presented as (**).
Table 3   Comparison of cognitive performance (Stroop Task, PVT, OSPAN) between 
patients (cWAD and FM) and healthy controls.
COGNITIVE 
TESTS
cWAD (n=16) FM (n=21) CON (n=22) Kruskal-Wallis Mann-
Whitney U
Median 
(IQR)
Median 
(IQR)
Median 
(IQR)
p value
< 0.05
p value  
< 0.017
Stroop reaction times (ms)
Incongruent 1082.63
(977.52 – 1326.83)
1329.17
(1134.53 – 1605.71)
998.53
(886.49 – 1157.48)
0.006 FM > CON*
Non-word 1014.61
(859.03 – 1134.20)
1226.52
(1017.99 – 1384.80)
903.39
(852.98 – 1095.35)
0.016 FM > CON*
Stroop 
Interference
127.79
(29.20 – 223.60)
143.53
(65.14 – 194.91)
39.17
(6.05  – 114.59)
0.025 FM > CON*
Priming negative 1063.11
(954.06 – 1572.11)
1333.89
( 1168.65 – 1735.66)
983.55
(884.11 – 1203.07)
0.018 FM > CON*
Psychomotor Vigilance Task
Reaction time 
(ms)
342.92
(319.50 – 382.43)
328.20
(315.34 – 362.98)
298.05
(281.96 – 315.88)
< 0.001 FM > CON;
cWAD > CON
Lapses 12.50
(3.50 – 25.75)
10.50
(6.00 – 15.00)
3.00
(1.50 – 4.50)
0.001 FM > CON;
cWAD > CON
Operation Span Task
OSPAN Total score 46.50
(15.50 – 55.50)
41.00
(28.50 – 55.00)
55.00
(49.00 – 64.00)
0.011 FM < CON*
Values are presented as median values and interquartile range (IQR). Significant differences are presented in 
bold font. cWAD: chronic whiplash-associated disorders, FM: fibromyalgia, CON: healthy controls.
Significant differences (p<0.017) between cWAD and FM are presented as (°) between CON and FM are 
presented as (*) between CON and cWAD are presented as (**).
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3.2.3  Self-reported health-related QoL
Median values and interquartile ranges (IQR) of the SF-36 total score, mental and physical 
health summary score are presented in Table 4. 
 FM patients demonstrated higher limitations on all the SF-36 physical health domains 
compared to chronic WAD patients. In addition, both patient groups reported significantly 
more problems on physical and mental health compared to healthy participants.
3.3   Relations between cognitive performance, CS, and health-related QoL
3.3.1. Cognitive performance and central sensitization
In the chronic WAD group, deep-tissue hyperalgesia was the only variable that significantly 
correlated (r= 0.517, p< 0.05) with cognitive performance, i.e. Stroop interference (data not 
shown). 
 FM patients showed significant relations between cognitive performance and 4 measures 
of CS, as presented in Table 5. Longer Stroop reaction times and decreased recall capacities 
on the OSPAN were significantly correlated with lower TS scores. Further, an increased 
number of PVT lapses was significantly correlated with lower tolerable cuff pressure 
(VNRS3) and less efficient endogenous pain inhibition (CPM). 
 In the healthy control group, longer Stroop and PVT reaction times were significantly 
related with respectively, less CPM efficiency and lower cuff pressure (VNRS3) as demonstrated 
in Table 5.
Table 4   Comparison of self-reported health-related QoL (SF-36) between patients 
(cWAD and FM) and healthy controls
SF-36 
QUESTIONNAIRE
cWAD
(n=16)
FM
(n=21)
CON
(n=22)
Kruskal-
Wallis
Mann-Whitney U
Median
(IQR)
Median
(IQR)
Median
(IQR)
p value  
< 0.05
p value  
< 0.017
Quality of life
Physical  
health total
167.50
(134.25 – 249.50)
116.00
(76.00 – 152.50)
371.00
(336.00 – 387.75)
< 0.001 FM < cWAD°;  
FM < CON*;  
cWAD < CON**
Mental  
health total
242.25
(150.96 – 291.50)
220.50
(159.83 – 264.00)
354.50
(337.87 – 373.54)
< 0.001 FM < CON*;
cWAD < CON **
SF-36 total 
score
414.25
(274.25 – 546.25)
338.00
( 271.83 – 382.25)
728.00
(662.25 – 748.25)
< 0.001 FM < CON*;
cWAD < CON **
Values are presented as median values and interquartile range (IQR). Significant differences are presented in 
bold. SF-36: 36-Item Short-Form Health Survey, cWAD: chronic whiplash-associated disorders, FM: fibromyalgia, 
CON: healthy controls. Significant differences (p<0.017) between cWAD and FM are presented as (°); between 
CON and FM are presented as (*); between CON and cWAD are presented as (**).
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Chapter 6 Cognitive performance related to central sensitization and quality of life
No significant relations were detected between cognitive performance and PPTs in the 
3 study groups (data not shown).
3.3.2.  Cognitive performance and health-related QoL
The correlations between cognitive performance and SF-36 scores are presented in Table 
6. In the chronic WAD group decreased cognitive performance was significantly related 
with reduced health-related QoL (SF-36). 
 In the FM group a different pattern of correlations was seen. Stroop reaction times 
and interference were positively correlated with reduced QoL, whereas negative 
correlations were found between reduced QoL and PVT reaction times. 
 In the healthy control group decreased performance on the Stroop was correlated 
with increased limitations on health-related QoL (SF-36). 
4.  Discussion
The current study examined the presence of cognitive impairment, signs of CS, and 
health-related QoL in chronic WAD and FM patients, compared to healthy controls. 
Secondly, this study is the first to examine interrelations between cognitive performance, 
indices of CS, and self-reported health-related QoL in these 2 chronic pain populations. 
Central sensitization
Remarkably, efficacy of endogenous pain inhibition (CPM) was comparable between the 
3 study groups. Yet, previous studies have revealed dysfunctional CPM in patients with 
chronic WAD compared to healthy controls (26). Nevertheless, significant other features of 
CS were demonstrated in chronic WAD and FM patients compared to controls. First, 
enhanced TS was shown in both patient groups. These findings of enhanced TS in chronic 
WAD and FM are similar to previous studies (52, 53). Second, significant lower PPTs and 
decreased tolerable cuff pressures were revealed in FM patients compared to the other 
study groups, representing deep-tissue hyperalgesia at the arm in patients with FM but 
not in chronic WAD patients. In line with the results in the FM group, previous research has 
observed deep-tissue hyperalgesia among FM patients (48, 54). The fact that no deep-tissue 
hyperalgesia was found among chronic WAD patients is in contrast with the results of 
Lemming et al (52), who demonstrated widespread deep-tissue hyperalgesia in patients 
with chronic WAD. However, the chronic WAD patients in the study of Lemming et al (52) 
experienced neck pain for at least 6 months and were recruited from a specific Pain and 
Rehabilitation Centre. Furthermore, deep-tissue hyperalgesia was measured with a 
computerized pneumatic cuff. Increased bottom-up sensitization, demonstrated by 
enhanced TS, was present in chronic WAD and FM patients compared to healthy controls. 
However, no significant differences were found between the 3 study groups regarding T
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Chapter 6 Cognitive performance related to central sensitization and quality of life
Self-reported health-related QoL
The current study established significant limitations on health-related QoL in patients 
with chronic WAD and FM compared to healthy controls. In particular, physical and mental 
health were impaired in these patients. Our results confirm current evidence of impaired 
physical and mental health in patients with chronic WAD and FM (58, 59). Significantly worse 
scores in the FM group on domains of physical health were detected in comparison with 
chronic WAD patients. These results are in line with the literature, as FM patients score 
lower than other chronic pain conditions on health domains of bodily pain and vitality (58). 
 In summary, FM patients demonstrated more signs of CS, higher cognitive impairment, 
and more physical health problems compared with chronic WAD patients. Possible 
explanations for the latter findings are the fact that the included FM patients experienced 
on average 3 years longer disease symptoms compared to the chronic WAD patients. 
Additionally, it is reported that the medical diagnosis of FM most often implies the 
presence of CS (11, 60). In contrast, chronic WAD is associated but not uniformly characterized 
by CS (19).
Interrelations
Table 7 depicts a clinical useful translation of the observed correlations between cognitive 
impairment and respectively, impaired central pain modulation and health-related QoL 
limitations in the 3 study groups. 
Cognitive performance and central sensitization
In the chronic WAD group, deep-tissue hyperalgesia was the only variable that significantly 
correlated to cognitive performance, i.e., cognitive inhibition. This finding suggests that 
deficits in cognitive inhibition are related to less deep-tissue hyperalgesia. However, 
malingering, headache, intelligence, and the degree of vigilance are possible factors 
influencing cognitive performance in chronic WAD patients, and may explain the 
observed opposite relations (61). Possible explanations for the scarcely observed relations 
between cognitive performance and CS in chronic WAD patients are obscure and merit 
further detailed research. 
 In contrast, FM patients showed much more significant relations between cognitive 
performance and various indices of CS. In summary, impairment on the Stroop and OSPAN 
in FM patients was unexpectedly related to lower TS values, hence less bottom-up 
sensitization. Possibly, these results are due to an overall decreased vigilant state in FM 
patients for a variety of sensory input, e.g., pressure pulses. Subsequently, the sensory and 
nociceptive transmission to the brain during the TS experiment could be delayed. On the 
other hand, in accordance with our expectations, impairment on the PVT was related to 
deficient CPM and increased deep-tissue hyperalgesia.  Previous research has reported 
that working memory deficits in FM patients are related to gray matter volume changes in 
specific brain regions, which may indicate structural correlates of pain-cognition 
CPM; hence the present study could not unravel impaired endogenous pain inhibition. In 
addition, FM patients demonstrated more pressure and deep-tissue hyperalgesia 
compared to chronic WAD patients. 
 Further, prior research has established both primary and secondary hyperalgesia, 
demonstrated by decreased electrical pain thresholds at the neck and lower limb in 
chronic WAD patients (55). 
Cognitive performance
The results of the current study showed longer choice and simple reaction times in 
patients with FM compared to controls, as evidenced by slower response times on the 
Stroop and PVT, respectively. Hence, FM patients demonstrated reduced selective and 
sustained attention. Furthermore, we revealed longer simple reaction times in the chronic 
WAD group compared to controls. In addition, both patient groups showed significantly 
more PVT lapses in comparison with healthy individuals. This indicates that chronic WAD 
and FM patients tend to make more errors of omission during the PVT cognition task. 
In addition, longer PVT reaction times point to the failure of sustained attention. 
 An increased Stroop interference effect could not be demonstrated in the chronic 
WAD group, but the current study did however find significant increased interference and 
priming effect in FM patients relative to healthy controls. These results imply that chronic 
WAD patients are capable to inhibit irrelevant information, whereas FM patients seem to 
have problems with this attending ability. Increased interference effect or impaired 
cognitive inhibition has been demonstrated before in FM patients (56). In addition, 
significantly higher negative priming effects in FM patients were observed compared to 
controls. Therefore, this study provides preliminary evidence that FM patients experience 
problems with inhibiting distraction stimuli. 
 Furthermore, no differences were found between chronic WAD patients and controls 
regarding Stroop reaction times. This indicates that chronic WAD patients have normal 
selective attention. As reported previously, chronic WAD patients presented only delayed 
information processing when there was attentional bias, i.e., when sleep-related words 
were shown (28). On the contrary, the present study did demonstrate significantly longer 
Stroop reaction times in FM patients compared to healthy controls. The latter may indicate 
a general slowing down of information processing in patients with FM.
 Regarding the OSPAN, chronic WAD patients showed normal working memory 
capacity. In contrast, FM patients established significant lower OSPAN scores compared to 
controls, illustrating reduced working memory capacity in FM patients. These findings are 
in line with accumulating evidence showing reduced working memory capacity in FM 
patients (57).
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Consequently, further research is warranted to investigate if CS and reduced health-related 
QoL lead to cognitive impairment or vice versa. 
5.  Conclusion
In conclusion, chronic WAD and FM patients encounter significant cognitive impairment, 
signs of CS, and decreased health-related QoL compared to healthy pain-free individuals. 
The current study revealed more indices of CS, higher cognitive impairment, and more 
limitations on health-related QoL in FM patients compared with chronic WAD patients. In 
particular, FM patients showed higher impairment of self-reported physical health, 
pressure and deep-tissue hyperalgesia, hampered selective attention, and reduced 
working memory capacity in comparison with chronic WAD patients.  
 Significant correlations between cognitive impairment and indices of CS and 
self-reported health-related QoL, respectively, were demonstrated among the 3 study 
groups. Especially in FM patients cognitive impairment appeared to be related to indices 
of CS. Reduced selective and sustained attention, as well as reduced working memory 
were correlated with less TS, so less bottom-up sensitization in FM. However, impaired 
sustained attention was related to increased deep-tissue hyperalgesia, deficient CPM, and 
reduced QoL in FM patients. 
 Accordingly, these results provide preliminary evidence for the clinical importance of 
objectively measured cognitive deficits in patients with chronic WAD and FM and the 
interaction (33). In addition, it seems that chronic pain in FM patients disrupts attention and 
induces neuroplasticity in the central nervous system (62).
 In the healthy control group, less efficient pain inhibition was related to slower 
reaction times on the Stroop task. Furthermore, this is the first study finding a negative 
relation between PVT reaction times and deep-tissue hyperalgesia. 
 The observations in healthy controls and part of the findings in FM patients are in line 
with our study hypothesis of expected correlations between decreased cognitive 
performance and increased indices of CS.
Cognitive performance and health-related QoL
In chronic WAD patients, correlations between impaired selective attention and lower 
health-related QoL, in particular mental health, were demonstrated. These results are in 
line with our hypothesis and consistent with earlier research that observed relations 
between psychological functioning and cognitive performance in patients with chronic 
WAD (63).
 A different pattern of correlations was obtained in the FM group. Remarkably, impaired 
selective attention and deficient cognitive inhibition were correlated with higher health- 
related QoL, whereas impaired sustained attention was related to increased QoL limitations. 
 In the healthy control group, decreased selective attention and cognitive inhibition 
were related to lower health-related QoL. 
4.1.   Study strengths, limitations and recommendations  
for further research
The strengths of the present study are the innovative aspect and the numerous observed 
significant correlations. Correlation coefficients which range from 0.36 to 0.67 are generally 
believed to represent moderate correlations (≤0.35 = weak correlation and 0.68 - 1.0 = 
strong correlation) (64). In this study, all significant correlations (p<0.05) were situated 
between the range of 0.42 and 0.82, thus moderate to strong correlations. 
 When interpreting the results, the following study limitations have to be taken into 
account. Firstly, based on the current cross-sectional study, no firm conclusions can be 
drawn on the causality of the relations. In the 3 study groups, longer reaction times were 
correlated with lower health-related QoL. However, it is uncertain if cognitive deficits lead 
to impaired QoL or vice versa. Moreover, malingering, concentration, education level, and 
IQ could have influenced the cognitive study results. Secondly, when conducting this 
study various confounders, including medication use were taken into account. However, 
it has to be noticed that antidepressiva use was significantly different between the 3 study 
groups. In addition, we cannot exclude possible differences in education level or other 
biopsychosocial characteristics between the patients and controls and that this may have 
created bias in the results. Thirdly, only non-parametric statistical analyses were performed 
because the sample size of the current study was rather small. 
Table 7   Direction of the correlations between cognitive impairment and respectively, 
impaired central pain modulation, and self-reported health-related QoL.
Impaired selective 
attention 
(Stroop)
Impaired sustained 
attention and reaction 
time (PVT)
Impaired working 
memory (OSPAN)
WAD FM CON WAD FM CON WAD FM CON
Deep-tissue 
hyperalgesia
1/~ ~ ~
Increased TS 1/~ 1/~
Deficient CPM ~ ~
Reduced QoL 
(SF-36) 
~ 1/~ ~ ~ ~ ~ ~
1/~: measurements are oppositely correlated, ~: measurements are correlated in the same direction,  
QoL: Quality of Life.
All measurements are presented in the impaired form. 
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Introduction
Nowadays, there is compelling evidence for impaired central pain modulation or central 
sensitization (CS) as the common underlying pathophysiological mechanism of chronic 
pain in conditions such as chronic whiplash associated disorders (WAD) and fibromyalgia 
(FM) (1-3). CS is defined as an exaggerated responsiveness of the central nervous system to 
nociceptive and non-nociceptive stimuli, like pressure, electrical stimuli, temperature, 
light, and medication (4-8). 
 Enhanced bottom-up sensitization, being an exaggerated efficient nociceptive 
transmission, is a possible feature in CS (9,10). To assess the efficacy of this bottom-up 
sensitization, evaluation of temporal summation (TS), characterized by the increase in pain 
ratings after repetitive noxious stimulation at a constant intensity, has frequently been 
performed (11,12). In addition, it has been shown that malfunctioning of descending pain-in-
hibitory pathways is involved in the CS process (13). This can lead to increased nociceptive 
transmission to the brain because of the lack of dampening or filtering of the incoming 
information. The conditioned pain modulation (CPM) paradigm is often used to evaluate 
the efficacy of endogenous pain inhibition, and relies on the “pain-inhibits-pain” 
mechanism (12). Enhanced TS of pain (14,15), impaired endogenous pain inhibition (16-19), and 
inefficient CPM (20,21) have been demonstrated in patients with chronic WAD and FM.
 Furthermore, a growing body of research shows abnormalities in stress-regulating 
systems in chronic pain patients, including WAD and FM (22-24). It has been demonstrated 
that stress can have a major impact on pain perception (25,26) by either suppressing pain 
(stress-induced analgesia) or exacerbating it (stress-induced hyperalgesia) (25,27-29). Stress- 
induced analgesia during exercise is presumed to result from the release of endogenous 
opioids and growth factors (30,31) and activation of nociceptive inhibitory mechanisms 
orchestrated by the brain (32,33). Previous research has demonstrated dysfunctional exercise- 
induced analgesia in chronic WAD and FM patients (17-19). 
 The exact mechanisms involved in stress-induced hyperalgesia have to be further 
unravelled (34). To date, it is suggested that neurotransmitters and neuroendocrine alterations 
play a role in this phenomenon. In addition, alterations in brain pathways mediating 
excitatory and inhibitory systems likely give rise to stress-induced hyperalgesia (34).
 Apart from persistent pain, chronic WAD and FM patients frequently complain of 
cognitive disturbances, including concentration and memory problems (35-40). Decreased 
cognitive function seems to be related to pain severity in patients with chronic WAD and 
FM (40-42), and is presumed to be a feature of CS (3,5). 
 Interestingly, an overlap exists in brain regions involved in cognitive function and 
areas of the pain matrix (e.g., periaqueductal gray, anterior cingulate cortex) (40). However, 
the influence of cognitive stress on central pain modulation has not yet been clearly 
described in patients with CS pain. 
Abstract
Background: Compelling evidence has demonstrated that impaired central pain 
modulation contributes to persistent pain in patients with chronic whiplash associated 
disorders (WAD) and fibromyalgia (FM). However, there is limited research concerning the 
influence of stress and relaxation on central pain modulation in patients with chronic 
WAD and FM. 
Objectives: The present study aims to investigate the effects of acute cognitive stress and 
relaxation on central pain modulation in chronic WAD and FM patients compared to 
healthy individuals. 
Study Design: A randomized crossover design was employed.
Setting: The present study took place at the University of Brussels, the University Hospital 
Brussels, and the University of Antwerp.
Methods: Fifty-nine participants (16 chronic WAD patients, 21 FM patients, 22 pain-free 
controls) were enrolled and subjected to various pain measurements. Temporal 
summation (TS) of pain and conditioned pain modulation (CPM) were evaluated. 
Subsequently, participants were randomly allocated to either a group that received 
progressive relaxation therapy or a group that performed a battery of cognitive tests (= 
cognitive stressor). Afterwards, all pain measurements were repeated. One week later 
participant groups were switched.
Results: A significant difference was found between the groups in the change in TS in 
response to relaxation (p=0.008) and cognitive stress (p=0.003). TS decreased in response 
to relaxation and cognitive stress in chronic WAD patients and controls. In contrast, TS 
increased after both interventions in FM patients. CPM efficacy decreased in all 3 groups 
in response to relaxation (p=0.002) and cognitive stress (p=0.001).
Limitations: The obtained results only apply for a single session of muscle relaxation 
therapy and cognitive stress, whereby no conclusions can be made for effects on pain 
perception and modulation of chronic cognitive stress and long-term relaxation therapies.
Conclusions: A single relaxation session as well as cognitive stress may have negative 
acute effects on pain modulation in patients with FM, while cognitive stress and relaxation 
did not worsen bottom-up sensitization in chronic WAD patients and healthy persons. 
However, endogenous pain inhibition, assessed using a CPM paradigm, worsened in 
chronic WAD and FM patients, as well as in healthy people following both interventions. 
Key words: Chronic pain, central sensitization, endogenous pain inhibition, temporal 
summation of pain, cognitive stressor, relaxation, fibromyalgia, whiplash-associated 
disorders
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not eligible for study participation. Healthy individuals were pain-free at the time of study 
participation. In addition, participants suffering metabolic, cardiovascular, or inflammatory 
disorders were excluded.
 In order to preclude confounding factors, pregnant women and women less than 
one year postnatal were excluded. Furthermore, all participants were asked to stop 
analgesics 48 hours prior to study participation, not to undertake physical exertion, and to 
refrain from consuming caffeine, alcohol, and nicotine on the day of the experiments.
 Based on an a priori power calculation, we aimed at recruiting a total sample size of 
at least 45 participants (G*Power 3.1.2). This a priori power analysis was performed for the 
within-between interaction in repeated measures ANOVA with 3 groups, 3 measurements 
(baseline mean pain measures, pain measures after relaxation, pain measures after 
cognitive tests), an effect size of 0.25, a significance level of 0.05, and a minimum power 
of 0.90. 
Inversely, there is conflicting evidence regarding the effects of relaxation therapy on pain 
ratings (43). There is a lack of research concerning the effects of relaxation on central pain 
modulation in chronic pain patients. Further it is unclear whether stress and relaxation 
have similar or different effects on pain modulation in these patients. An example for a 
non-stressful intervention is the progressive muscle relaxation therapy (PRT) (44). 
 Possibly, performing cognitive challenging tasks may serve as a stressor for patients 
already suffering concentration and memory problems, which may further burden the 
central nervous system leading to enhanced disinhibition and more pain. On the contrary, 
it is hypothesized that cognitive stress, caused by cognitive tasks, can diminish pain ratings 
as a result of the so-called “distraction effect”, described by Eccleston and Crombez (45). 
 Further, it is hypothesized that muscles are more relaxed after the PRT, leading to 
temporary pain relief (46). On the contrary, another hypothesis is that the PRT leads to more 
body awareness, leading to more pain. 
 The present study aimed at investigating the effects of cognitive tasks (to induce 
cognitive stress) and a single relaxation session on central pain modulation in patients 
with chronic WAD and FM compared to healthy pain-free individuals.
Methods
Study design and setting
A randomized crossover design was employed as illustrated in Fig. 1. The present 
experimental study took place from July 2010 until December 2013 at the University of 
Antwerp, the University of Brussels, and the University Hospital Brussels. Participants 
received detailed study information and gave written informed consent prior to study 
enrollment. This research was approved by the Ethics Committee of the University Hospital 
Brussels. The current study is registered with the ClinicalTrials.gov Identifier number 
NCT01172795.
Participants 
Sixteen patients with chronic WAD, 21 patients with FM, and 22 healthy pain-free controls 
were included. Chronic WAD and FM patients were recruited in cooperation with rheuma-
tologists and physical medicine and rehabilitation physicians. Healthy controls were 
recruited through acquaintances of patients, students, researchers, and university staff. 
Each study participant had to be Dutch speaking and aged between 18 and 65 years. 
The chronic WAD group fulfilled the criteria of the Quebec Task Force (grade II to III) (35). 
Chronic neck pain due to a whiplash event was defined as pain lasting longer than 
3 months. The FM group complied with the diagnostic criteria for FM as defined by the 
1990 American College of Rheumatology (ACR) (36,47). Chronic WAD patients fulfilling the 
diagnostic criteria for FM and FM patients reporting a history of a whiplash trauma were 
Figure 1  Flow diagram showing the study protocol.
CWAD: chronic whiplash associated disorders, CON: pain-free controls, FM: fibromyalgia, 
PPTs: pressure pain thresholds, TS: temporal summation, CPM: conditioned pain modulation.
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during cuff inflation. Therefore, the cuff was inflated at a constant rate (20 mmHg/s) until 
the participant reported pain. Participants then adapted to the stimulus for 30 seconds 
and rated the pain on the VNRS. Subsequently, the cuff inflation was adjusted until 
participants indicated a pain intensity of 3 out of 10 on the VNRS. The CPM procedure 
started as soon as the cuff inflation was adjusted. During the CPM procedure the left arm 
rested on a table and the TS assessment was repeated at the right trapezius as described 
above (48). Efficacy of CPM was examined by subtracting the VNRS from the first pressure 
pulse prior to and during cuff inflation. This CPM procedure has been found reliable, and 
CPM induced by ischemic cuff inflation is able to reduce TS in healthy controls (48) and has 
been previously used to examine CPM efficacy in CWAD (55,56) and FM (57).
Interventions
Progressive muscle relaxation therapy
The relaxation intervention consisted of PRT. The participant was positioned in a 
comfortable supine position on a treatment table. A Dutch audio fragment was played 
and the participant listened to the instructions that were given. The participants were 
instructed to alternately contract and relax different skeletal muscle groups in order to 
create awareness of muscle tension and relaxation. The participant was guided to 
progressively proceed through all major muscle groups, relaxing them one at a time, and 
eventually leading to total muscle relaxation (44,58). The relaxation session had a duration of 
30 minutes.
Cognitive stress
The cognitive stress intervention encompassed the performance of 3 cognitive tests, the 
Stroop task, Psychomotor vigilance task (PVT), and Operation span (OSPAN) task. In order 
to standardize the procedure, all tests were conducted on the same computer and in a 
fixed order (Stroop, PVT, OSPAN). The cognitive tests were quite challenging and had a 
total duration of approximately 30 to 45 minutes. Each of the 3 tests has been used and 
described in detail in 3 of our previous studies in patients with chronic CS pain (59-61). 
Statistical analyses
Statistical analyses were performed using the Statistical Package for Social Sciences 22.0 
(SPSS Inc. Headquarters, Chicago, Illinois, USA). Statistical significance was set a priori at α 
= 0.05. 
 Comparability of groups for age, gender distribution, disease duration, and medication 
use was examined with the one-way ANOVA or Chi-square test. First, a paired-samples 
t-test was performed to ensure there were no significant differences between the baseline 
pain measurements at the day of the relaxation and cognitive intervention. Then, the mean 
of the two baseline measures (before relaxation and before cognitive intervention) of 
each pain measurement was calculated and used for further data analyses.
Research procedure
First, participants were subjected to various pain measurements. Pressure pain thresholds 
(PPTs), TS, and CPM were evaluated. Subsequently, participants were randomly allocated 
(by lottery) to either a group that performed a battery of cognitive tests or a group that 
received PRT. To randomize, each participant chose a folded ticket, which indicated the 
order of the intervention, on the first test day. Afterwards, all pain measurements were 
repeated. One week later participant groups were switched.
Experimental pain measures 
To investigate the presence of CS, 3 critical aspects of the central pain system were 
assessed (48-51). First, PPTs were measured with a digital algometer (Wagner Instruments, 
Greenwich). Secondly, TS of pain was examined. Finally, a CPM paradigm was conducted 
to assess the efficacy of endogenous pain inhibition. All pain measurements were 
performed by a researcher blinded to the group allocation. 
Pressure pain thresholds and temporal summation of pressure pain
The PPT was measured at the middle of the right trapezius belly, midway between the 
processus spinosus of the seventh cervical vertebra and the lateral edge of the acromion 
using a digital algometer (Wagner Instruments, Greenwich). The pressure was increased at 
a rate of approximately 1 kg/s until participants said “stop” at the moment the sensation 
became uncomfortable. Consequently, the pressure was immediately released. The 
pressure established on that moment was determined as the PPT, measured in kg/cm2. 
Two PPT measurements (interval 30 seconds) were performed, from which a mean PPT 
value was calculated. The use of pressure algometry has been found to be an efficient and 
reliable technique in the determination of PPTs and subsequently the examination of 
hyperalgesia (52-54).
 TS of pressure pain was elicited at the trapezius by administering 10 consecutive 
pressure pulses using the algometer. For each pulse of the TS procedure, the pressure was 
increased at a rate of approximately 2 kg/s until the previously determined PPT was 
reached and maintained for one second (48). Pressure pulses were presented with an 
inter-stimulus interval of one second. Participants were instructed to rate their perceived 
pain intensity during the first, fifth and tenth pressure pulse using a verbal numeric rating 
scale (VNRS). The TS pain score was obtained by subtracting the first VNRS score from the 
last VNRS. The higher the TS score, the more extensive/efficacious the nociceptive 
transmission to the brain. This TS procedure has been found to be reliable and valid (48).
Conditioned pain modulation
CPM was induced by inflating an occlusion cuff (conditioning stimulus) placed around the 
left arm, opposite of the test stimulus, to a painful intensity. The test stimulus was applied 
at the contralateral body side and consisted of the TS procedure, which was repeated 
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Repeated measures ANOVA were performed using 3 levels. The first level was the mean 
baseline pain measure, calculated as described above. The second level was the pain 
measure after relaxation. The third level was the same pain measure, however acquired 
after the cognitive tests. 
 First, possible interaction effects between each pain measure and “study group” were 
explored. If there was no significant interaction effect, the main within and between subject 
effects were inspected. To see the nature of the effects, a simple contrast was examined 
and the first level was set as the reference category. Group differences were further 
explored with a one-way ANOVA test. Bonferroni correction was used as post-hoc test. 
Results
Baseline characteristics
Demographic characteristics, medication use, and baseline pain measures of the participants 
are presented in Table 1. Fifty-nine participants (16 chronic WAD patients, 21 FM patients, 
and 22 pain-free controls), comparable for age and gender distribution, were included for 
the baseline measures on the first session day and were randomly assigned. Fifty-seven 
participants (15 chronic WAD patients, 20 FM patients and 22 controls) were included 
on the second session day and were subjected to the pain measures and intervention. 
Two patients (1 chronic WAD, 1 FM) were lost to follow-up because they did not show up 
at the second intervention day. Consequently, there are 2 missing values for the TS and 
CPM measurements.
 The paired-samples t-test in each study group displayed no significant differences 
between the baseline pain measurements at the experimental day of the relaxation and 
cognitive intervention (p>0.05) (Table 1). 
Effects of relaxation and cognitive stress on central pain modulation
Temporal summation of pressure pain
A significant interaction effect was found for the change in TS between study groups 
(Table 2) after relaxation (p=0.008) and after the cognitive tests (p=0.003) (Table 3 and Fig. 2). 
 TS, measured at the trapezius muscle, decreased significantly in response to the 
relaxation and cognitive stress intervention in healthy persons (p<0.01). Additionally, 
chronic WAD patients displayed a trend for reduced TS scores after both interventions. In 
contrast, TS showed a trend to increase in response to the relaxation and cognitive stress 
intervention in the FM group. 
Conditioned pain modulation
A significant main within-subjects time effect was found for CPM in every study group 
(Table 2), being a decreased CPM efficacy after relaxation (p=0.002) and after the cognitive 
tests (p=0.001) (Table 3 and Fig. 3). T
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Discussion
The present study is the first to examine the effects of a single relaxation session and a 
cognitive stressor on central pain modulation in chronic WAD and FM patients compared 
to healthy individuals. The study results indicate that both types of interventions enhance 
TS of pain in FM, indicating an increased nociceptive transmission to the brain in these 
patients (bottom-up sensitization). In contrast, chronic WAD patients and healthy controls 
experienced acute positive effects on bottom-up sensitization, as both relaxation and 
cognitive stress reduced TS of pain. However, both interventions resulted in decreased 
CPM efficacy in healthy people as well as in those suffering from chronic pain (chronic 
WAD and FM), indicating that they have a detrimental effect on endogenous pain 
inhibition.
 Possibly, performing the cognitive tasks served as a high cognitive stressor for FM 
patients, already suffering attention and memory problems (62,63), which further burdened 
the central nervous system leading to further disinhibition and more pain (self-reported 
hyperalgesia). In line with these results, Crettaz and colleagues (28) reported enhanced pain 
sensitivity to pressure stimuli in FM patients, but not in healthy participants following 
psychological stress, induced using the Trier Social stress test. Stress-induced hyperalgesia 
has been demonstrated in FM in other studies as well (64,65). However, these studies have 
not investigated the effect of stress on TS and CPM. 
CPM efficacy diminished significantly after both interventions in healthy persons (p<0.05). 
Furthermore, chronic WAD patients demonstrated significantly decreased CPM efficacy 
after the PRT (p<0.05).
Table 2  Main effects: Repeated measures analysis of variance (3 study groups).
Outcome measure Interaction effect 
(outcome time & group)
Within-subjects:
time effect
Between-subjects:
group effect
TS trapezius p= 0.003 p= NA p= NA
CPM trapezius p= 0.755 p= 0.002 p= 0.639
TS: temporal summation, CPM: conditioned pain modulation, NA: not applicable
Table 3   Contrasts: Repeated measures analysis of variance (3 study groups).
Within-subjects contrasts 
(simple first)
After relaxation vs. 
baseline mean
After cognition vs. 
baseline mean
TS trapezius*group p= 0.008 p= 0.003
CPM trapezius p= 0.002 p= 0.001
TS: temporal summation, CPM: conditioned pain modulation
Figure 2   Effects of relaxation and cognitive stress on TS in patients with chronic WAD, 
FM and healthy controls. 
Values are presented as mean and confidence interval. TS: temporal summation, VNRS: verbal 
numeric rating scale, WAD: whiplash-associated disorders, FM: fibromyalgia, **= p < 0.01
Figure 3   Effects of relaxation and cognitive stress on CPM efficacy in patients with 
chronic WAD, FM and healthy controls. 
Values are presented as mean and confidence interval. CPM: conditioned pain modulation, 
VNRS: verbal numeric rating scale, WAD: whiplash-associated disorders, FM: fibromyalgia, 
*= p < 0.05
1= TS baseline mean   2= TS after RELAXATION   3= TS after COGNITIVE TESTS
1= CPM baseline mean   2= CPM after RELAXATION   3= CPM after COGNITIVE TESTS
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Kristian et al (73) investigated the effect of a simple mental stressor (mathematical 
calculations) and a non-stressful intervention (passive listening to a tale for children) on 
CPM of heat pain in healthy participants. They found a reduced CPM effect following the 
stressful as well as the non-stressful intervention, which is in line with our observations. 
Limitations, strengths, and suggestions for further research
The present crossover study has a few study limitations that have to be taken into 
consideration. First, the obtained results only apply for a single session of muscle relaxation 
therapy and cognitive stress, whereby no conclusions can be made for effects on pain 
perception and modulation of chronic cognitive stress and long-term relaxation therapies. 
Second, the number of study participants (n=59) was rather small, whereby bigger 
samples in each group could have provided more generalizable results. Thirdly, the use of 
antidepressiva was significantly different between FM patients and healthy persons. 
Fourthly, the results of the CPM measures are characterized by wide confidence intervals. 
However, the variance for CPM of the 3 study groups was not significantly different 
(p>0.05). At last, autonomic variables, anxiety, and individuals’ perception of stress were 
not measured in this study. Therefore, future protocols could adjust for these variables and 
include the assessment of the individual’s perceived level of mental stress during the 
stressful and non-stressful task. Measurement of cortisol and catecholamine levels could 
give valuable information on the perceived level of stress.
 Despite these limitations, the current study also has important strengths. First, the 
used randomized longitudinal crossover design, in which all participants are exposed to 
both tasks and serve as their own controls, minimizes bias and variability. Second, sources 
of bias like medication use were anticipated and well defined diagnostic criteria were 
utilized for chronic WAD and FM. Finally, this paper adds relevant knowledge to the current 
literature regarding stress-pain and relaxation-pain interactions in patients with chronic 
WAD and FM.  
 Future studies are warranted to help further elucidate the complex relation between 
stress, relaxation, and pain, and the involved underlying mechanisms. It could be 
interesting to examine the effects of other relaxation techniques like mindfulness, yoga, 
mind-body exercises, or visualization on pain modulation in patients with CS pain. 
 Further, inclusion of EMG biofeedback would provide a more accurate assessment of 
actual muscle relaxation.
 The current study obtained new insight in the effect of acute stress and relaxation on 
central pain modulation in the investigated population. The unravelling of influencing 
factors on central pain modulation is in our opinion an important first step in order to 
adapt future interventions for chronic pain patients adequately.
 It remains an important challenge for researchers and therapists to develop effective 
therapy strategies for chronic pain patients characterized by CS.  
 In contrast, unpublished study results show that chronic WAD patients encounter less 
attention and memory problems than FM patients (66). Therefore, it can be hypothesized 
that chronic WAD patients and healthy individuals may have experienced the cognitive 
tests as less challenging and less stressful. Accordingly, this could have led to decreased 
nociceptive ascending transmission, so diminished TS. Indeed, previous researchers have 
reported that the perceived severity of the stressor can influence pain modulation (26).
 Secondly, it is possible that the cognitive tasks diminished pain sensitivity as a result 
of the previously mentioned “distraction effect” (45). This may be the explanation in the 
chronic WAD and control group, since TS of pain was reduced after the cognitive stressor. 
 Regarding the PRT, the format of the relaxation may have served as a physical stressor 
in the FM group, but to a lesser extent or not in the chronic WAD and control groups. 
This relaxation technique requires alternate tightening and relaxing of different muscle 
groups aimed at decreasing overall muscle tension (67). In chronic WAD and FM, PRT has the 
advantage of emphasizing the difference between muscles that are relaxed and those 
that are tensed, since a subgroup of patients continuously tense their muscles which can 
contribute to persistent pain (68). However, it may be that some FM patients tensed their 
(already painful) muscles too tightly and focused their attention even more on the pain 
during the relaxation session, which could have resulted in exacerbating pain and 
enhanced TS. There is one controlled trial in which the effects of biofeedback PRT using 
surface EMG were compared with the effects of a fitness program or a usual-care treatment 
(6 months) (69). PRT was indeed not effective in reducing pain perception or psychological 
distress, including stress and anxiety levels (69). Recently, a systematic review regarding the 
effects of relaxation therapy on pain also showed limited evidence supporting the use of 
muscle relaxation as a sole treatment for reducing pain in FM patients (43). The authors 
suggested that PRT was not effective as a standalone treatment strategy but that it could 
possibly improve pain relief when used in combination with other strategies, such as 
exercise and guided imagery.
 In line with our results of diminished TS after the PRT in healthy individuals, Emery 
et al (70) found an increased nociceptive flexion reflex threshold, which is an objective 
indication for reduced central hyperexcitability, after a single progressive relaxation session 
in healthy pain-free adults. 
 Interesting, this study found decreased CPM efficacy following PRT and a cognitive 
stressor in patients with chronic WAD and FM as well as in healthy persons. Previous work 
has shown that CPM responses depend on the interplay between physical and psychological 
mechanisms (71), influenced by cognitive factors, including attention, distraction, and 
expectations. It is possible that adequate CPM activation after the interventions was affected 
by these factors. Additionally, it could be that before a second CPM activation, a recovery 
period is needed after a previous CPM activation. Previous studies have also demonstrated 
worsened CPM responses following a second CPM measurement (72,73). Therefore, it may 
be that each successive conditioned noxious stimulus decreases CPM efficacy. 
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Clinical implications
Based on the present results, it can be summarized that acute experimental psychophysical 
stress due to the aforementioned interventions can lead to decreased efficacy of pain 
modulation, especially in patients with FM. Noteworthy is that cognitive stress exerted a 
similar influence on pain modulation as a PRT session.
 Therapists should be aware of the possible negative and/or positive influences of 
cognitive demanding tasks and relaxation techniques which depend on body and or 
muscle movements on pain modulation, depending on the patient’s individual ability to 
cope with stress. By assessing and questioning patients, the nature of the effect can 
become clear and the program can be adapted when needed. Measuring pain sensitivity 
and the perceived level of stress following a stressor is valuable for identifying patients 
that have problems with their stress-response system. 
 Taken together, we suggest a multicomponent assessment and rehabilitation in 
which the underlying pathophysiological mechanisms should be taken into account. 
Conclusion
In FM, one session of PRT and cognitive stress exaggerated TS, hence increased nociceptive 
transmission to the brain. Therefore, it can be assumed that a single relaxation session as 
well as cognitive stress may have negative acute effects on pain modulation in patients 
with FM, while cognitive stress and relaxation reduced TS in both chronic WAD patients 
and healthy controls. Lower TS values point towards reduced bottom-up sensitization, 
possibly due to a change in brain focus as a result of distraction. 
 Endogenous pain inhibition, measured with the CPM paradigm, worsened in 
response to both relaxation and cognitive stress in healthy people, chronic WAD patients, 
and FM patients. 
 These results should be taken into consideration when developing therapy strategies 
for patients with chronic WAD and FM.
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Summary and discussion of the results
The core aim of this dissertation was to improve our knowledge of the mechanisms and 
their possible interrelationships underlying the persistent and often unexplained 
symptoms in patients with chronic idiopathic neck pain (INP), chronic whiplash associated 
disorders (WAD), and fibromyalgia (FM). The core aim was furthermore to unravel 
differences in the nature and severity of the underpinning mechanisms between these 
three heterogeneous conditions with chronic musculoskeletal pain. This way, the present 
thesis aimed to further disentangle pieces of the complex pathophysiological puzzle 
underlying chronic INP, chronic WAD, and FM with the ultimate endeavor to increase our 
understanding of these conditions. The present dissertation was composed of three 
major parts, each addressing one overall objective. In the following paragraphs the most 
important results of each part will be summarized and discussed.
Part I:   Is chronic musculoskeletal pain associated with structural and 
functional brain alterations? 
No clear overview of how brain alterations are related to clinical correlates of pain in 
various chronic musculoskeletal pain conditions was present. However, knowledge on 
this relationship is important to unravel the underlying mechanisms of persistent pain. 
Therefore, we performed a systematic review, described in chapter 1, to investigate 
relationships between brain alterations and clinical pain measures in patients with chronic 
musculoskeletal pain.  In line with our hypothesis, most studies revealed significant 
relationships between structural or functional brain alterations, and clinical pain 
correlates encompassing pain intensity, unpleasantness, pain duration, sensory hyper-
sensitivity, and pressure pain sensitivity. Specifically, moderate evidence was found for 
relationships between clinical pain measures and alterations in grey matter (GM) 
morphology (volume and thickness), white matter (WM) microstructure (fractional 
anisotropy and axial diffusivity), and (resting-state) functional connectivity in brain 
regions or networks involved in somatosensory, affective-motivational, and 
cognitive pain processing in patients with chronic musculoskeletal pain. The evidence 
regarding the direction of these relationships (e.g., increased or decreased GM volume 
associated with more severe clinical pain measures) was inconclusive. Noteworthy, the 
direction and nature of the relationships between clinical pain characteristics and brain 
alterations could have been influenced by multiple factors which possibly explains the 
observed incongruent results. These factors could be the variety of patient conditions 
that are classified as chronic musculoskeletal pain, and the different scales or questionnaires 
that have been used to measure clinical features of pain. Furthermore, the various MRI 
acquisition and analyzing techniques as well as the investigated brain regions could have 
influenced the exposed relationships. Also, research has demonstrated the influence of 
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related disability were found (23, 24). Specifically, both increased and decreased regional 
cerebral blood flow were demonstrated in patients with chronic INP and chronic WAD 
compared to healthy controls (23-28). A higher amount of regional cerebral blood flow might 
reflect a compensation mechanism for regional brain atrophy (29), and the variety of brain 
perfusion abnormalities might correspond with the observed diversity in structural brain 
changes in patients with chronic WAD (28). 
 To summarize, some to moderate evidence was found for structural and functional 
brain alterations in patients with chronic WAD, and only for functional brain alterations in 
patients with chronic INP (30). More evidence exists for brain alterations in patients with 
chronic WAD relative to patients with chronic INP, suggesting the presence of different 
underlying mechanisms in both populations. Moreover, the diversity in observed brain 
alterations indicates that various mechanisms are responsible for the brain’s neuroplastici-
ty associated with chronic neck pain. Accordingly, brain alterations and relationships with 
clinical measures should be further investigated in chronic INP and chronic WAD patients 
with more sophisticated and sensitive brain imaging techniques. Therefore, structural 
brain alterations and relationships with clinical measures were examined in women with 
chronic INP and chronic WAD in the original research studies enclosed in chapters 4 and 5. 
Part II:   Differences between idiopathic and traumatic chronic neck pain: 
interrelationships among disability, cognitive deficits, central 
sensitization, and structural brain alterations. 
In part II, three original research studies were described approaching the second overall 
objective of this dissertation to gain insight in possible differences between women with 
chronic neck pain of traumatic and non-traumatic idiopathic origin. We hypothesized that 
the traumatic nature of neck pain in patients with chronic WAD would be associated with 
more severe deficits compared to patients with chronic INP. 
As can be seen in table 1 and figures 1 and 2, the research findings of chapters 3 to 5 
indicated that women with chronic INP and chronic WAD are characterized by some 
similarities but also prominent differences in the assessed clinical variables and structural 
brain measures as well as differences in their interrelationships were found, revealing 
different underlying mechanisms. Consistent with our hypothesis, patients with 
chronic WAD showed more severe deficits than patients with chronic INP. In particular, 
pain-related disability, decreased health-related quality of life, and self-perceived cognitive 
deficits were demonstrated in women with chronic WAD and, to a significantly lesser 
extent in women with chronic INP (31). Furthermore, both patient groups reported higher 
levels of CS symptoms compared to healthy controls, however, only in the chronic WAD 
group these self-perceived symptoms were indicative of CS (central sensitization inventory 
(CSI) score ≥ 40 of 100). In addition, decreased objective cognitive performance and 
age, sex, preexisting vulnerabilities, genetics, previous experiences, use of medications, 
and psychosocial factors on pain and neuroplasticity in patients with chronic pain (1-11). 
 In summary, different chronic musculoskeletal pain syndromes exposed unique 
(specific for each pain syndrome) anatomical and functional brain alterations or “brain 
signatures”. However, it appeared that brain regions implicated in motivational-affective 
and cognitive components of pain processing were involved in the observed neuroplas-
ticity in all these pain conditions. Based on this compelling evidence, we can infer that 
chronic musculoskeletal pain is not only mediated by somatosensory processing of pain 
but there is a shift towards critical involvement of cognitive and motivational- affective 
pain processing in regions often part of the limbic system, such as the anterior cingulate 
cortex (ACC), posterior cingulate cortex (PCC), hippocampus, insula, orbitofrontal cortex, 
and amygdala. Furthermore, it appeared that brain alterations remained unexplored in 
patients with chronic INP and chronic WAD. As such, before performing brain MRI research 
in these patients, the need arose to systematically address the evidence of brain alterations 
in different neck pain patients, examined by a wider range of medical brain imaging 
techniques. Consequently, we conducted a systematic review, enclosed in chapter 2, 
aimed at reviewing the evidence of structural or functional brain alterations in patients 
with acute, subacute, or chronic non-traumatic INP and traumatic neck pain (WAD), 
examined with brain MRI techniques, or Positron Emission Tomography, or Single-Photon 
Emission Computed Tomography.
Based on a paucity of studies, moderate evidence was found for the absence of structural 
brain abnormalities in the acute phase after a whiplash injury. (12, 13). In contrast, in chronic 
WAD patients encountering persistent post-traumatic headache, decreased GM volume 
in the ACC and the dorsolateral prefrontal cortex was revealed (14). The ACC and dorsolateral 
prefrontal cortex are involved in the salience and affective-cognitive dimensions of pain, 
and play an important role in top-down pain inhibition (15-17). On the contrary, increased 
GM volume was demonstrated in the periaqueductal grey, thalamus, and cerebellum in 
these chronic WAD patients (14). Interestingly, the periaqueductal grey is crucially involved 
in endogenous pain inhibition (18). It has been suggested that the observed structural neu-
roplasticity (increased and decreased GM morphology) might result from the aim to 
restore the balance between nociceptive (i.e. pain facilitation) and anti-nociceptive 
(i.e. pain inhibition) modulation (14). 
 With respect to functional brain alterations, some evidence was found for decreased 
brain activation in temporal regions during a visual task in patients with chronic WAD 
compared to controls (19). Furthermore, some evidence was revealed for alterations in brain 
neurotransmission encompassing decreased neurokinin 1 receptor availability in 
patients with chronic WAD compared to controls (20). Interestingly, these receptors are 
involved in pain processing (21) and central sensitization (CS) (22). In addition, several studies 
observed alterations in brain perfusion and associations with self-reported pain and 
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higher levels of pain catastrophizing and hypervigilance were present only in women 
with chronic WAD. In addition, distant hyperalgesia and decreased efficacy of conditioned 
pain modulation (CPM) were shown in chronic WAD but not in chronic INP patients, 
indicating the presence of CS only in the participants with chronic WAD at a group level. 
 This study furthermore revealed relationships among higher disability, more severe 
subjective and objective cognitive deficits, and more extensive local and distant 
hyperalgesia in women with chronic WAD. However, in women with chronic INP, 
relationships were found only between subjective cognitive deficits and local hyperalgesia. 
In contrast to our hypothesis, decreased CPM efficacy or dysfunctional endogenous pain 
inhibition was not associated with decreased cognitive performance. Yet, the study 
enclosed in chapter 6 also did not find significant correlations between decreased 
cognitive performance and CPM efficacy in patients with chronic WAD (32). 
The above outlined findings provided insight in one piece of the puzzle for understanding 
chronic INP and chronic WAD, and their differences. However, we were convinced that 
another part of the puzzle for disentangling the underlying mechanisms could be 
uncovered by performing brain MRI research in these patients. 
Table 1   Summary of the differences revealed between women with chronic INP  
and women with chronic WAD, and compared to healthy pain-free women  
in the studies enclosed in part II.
Features that were demonstrated only in chronic WAD and not in chronic INP patients
Observed only in chronic WAD
Objective cognitive deficits
Experimental signs of CS encompassing distant hyperalgesia and dysfunctional CPM
Higher levels of pain catastrophizing and hypervigilance
Decreased GM volume in the left PCC, the right superior parietal cortex, the right lateral orbitofrontal 
cortex, the left supramarginal cortex
Cortical thinning in the left precuneus
Abnormalities in WM microstructure in the left cingulum hippocampus and the left tapetum
Features that were present in chronic INP and chronic WAD patients  
but to a lesser extent in patients with chronic INP
Chronic WAD > chronic INP
Subjective cognitive deficits
Current neck pain intensity
Pain-related disability 
Limitations on health-related quality of life
Self-reported symptoms of CS
Figure 1   Overview of the observed relationships between the investigated underlying 
mechanisms in women with chronic INP.
Figure 2   Overview of the observed relationships between the investigated underlying 
mechanisms in women with chronic WAD.
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compared to healthy controls (tapetum) or compared to patients with chronic INP 
(cingulum and tapetum). We can very carefully suggest that maybe to some extent these 
findings reflect WM demyelination in these tracts evidenced by the unchanged axial 
diffusivity together with increased radial diffusivity in women with chronic WAD (44-46). 
The revealed pattern of WM microstructural deficits in chronic WAD is consistent with 
the results in other chronic musculoskeletal pain conditions (47). Furthermore, this study 
provided evidence for associations between dysfunctional CPM and the degree of WM 
deficits in the left tapetum in patients with chronic WAD. This demonstrates innovative 
evidence for underlying WM microstructural correlates of disturbed endogenous pain 
inhibition in patients with chronic WAD. Accordingly, the results of part II emphasize a 
pathophysiological role of structural brain alterations in patients with chronic WAD 
compared to chronic INP patients, possibly mediated by the whiplash injury, CS, and more 
severe cognitive deficits. 
 Interestingly, brain microhemorrhages related to trauma or diffuse axonal injury 
were not observed in all study groups. Previous studies could detect microhemorrhagic 
lesions in the brain in patients with mild TBI suggesting differences in underlying patho-
physiological mechanisms between patients with chronic WAD and mild TBI (48). To our 
knowledge this study is the first to assess the presence of brain microhemorrhages in 
patients with chronic WAD. 
Based on the findings of chapter 3, we believed it was clinically relevant to further explore 
the presence of CS in our chronic INP and chronic WAD populations, thus we performed 
additional data analyses including the study sample of chapter 3. The results of these 
analyses are added to the present dissertation as additional research data in appendix. To 
date, efficacy of treatment response is variable in both conditions, which possibly 
originates from the focus on the diagnostic vignette when treating patients with chronic 
INP or chronic WAD, rather than on the underlying mechanisms. Therefore, it could be 
hypothesized that addressing the underlying predominant pain mechanism in the 
individual patient is warranted. This was the rationale for performing additional data 
analyses with the aim to identify subgroups based on the cut-off score of the CSI, in a 
patient group including both women with chronic INP and chronic WAD, distinguishing a 
group with and without distinct self-reported CS symptoms. Subsequently, these 
subgroups were compared with respect to pain, pain-related disability, health-related 
quality of life, cognitive deficits, experimental CS measures, and compared to healthy 
controls. Furthermore, associations among these variables were explored. Two subgroups 
based on the CSI cut-off score (40 of 100) were defined within the group of chronic INP 
and chronic WAD patients. The most important results of these additional data analyses 
are shown in tables 2 and 3 but for detailed tables and figures we refer to the appendix.
The results of the case-control studies described in chapters 4 and 5 provided evidence of 
decreased GM volume in cortical regions associated with pain and cognitive processing 
in women with chronic WAD compared to women with chronic INP and healthy women. 
These results were in line with our hypothesis and could maybe be explained because 
chronic WAD patients have a traumatic origin of neck pain and are characterized by CS in 
contrast to patients with non-traumatic chronic INP. Furthermore, these findings are in line 
with accumulating evidence of decreased regional GM volume in other chronic pain 
populations sharing the common pathophysiology of CS such as FM and chronic low 
back pain compared to healthy persons (33-37). Additionally, in women with chronic WAD, 
decreased GM volume in cognitive and pain processing regions was associated with 
increased cognitive deficits, maladaptive pain cognitions, self-reported CS symptoms, and 
local hyperalgesia. In women with chronic INP, decreased regional GM volume was only 
associated with increased cognitive deficits but compared with healthy controls, no GM 
volume alterations could be revealed. 
 Furthermore, cortical thinning in the left precuneus was found in women with 
chronic WAD compared to women with chronic INP. This result is interesting because the 
precuneus is part of the structural brain core (38) and a core hub (i.e. highly interconnected 
nodes) of the default mode network (39). In addition, the precuneus plays a crucial role in a 
wide range of cognitive and mental processes (40). In contrast to the results of previous 
studies in patients with chronic musculoskeletal pain (34, 41) and mild traumatic brain injury 
(TBI) (42), differences in cortical thickness between patients with chronic WAD and healthy 
controls could not be demonstrated. The latter result is in contrast with the findings 
of decreased regional GM volume in patients with chronic WAD compared to healthy 
controls. Nevertheless, altered GM volume in the precuneus was not observed, highlighting 
that cortical thickness and GM volume reflect different features of the underlying neural 
architecture. Surface area, curvature, and grey/white matter intensity contrast could 
account for some differences between GM volume and cortical thickness (43). Additionally, 
unlike regional GM volume, cortical thinning in the left precuneus was not associated with 
worse cognitive performance or measures of CS in patients with chronic WAD. On the 
contrary, in chronic INP patients, decreased precuneus thickness coincided with worse 
performance on the trail making test (TMT) part B, however compared to controls, 
decreased cortical thickness and worse objective cognitive performance could not be 
revealed. 
 In addition, abnormalities in WM microstructure were revealed in two WM tracts 
carrying information between regions involved in pain and cognitive processing in 
women with chronic WAD compared to women with chronic INP or healthy women. The 
observed WM microstructural alterations in patients with chronic WAD were in line with 
our hypothesis. Specifically, results showed a consistent pattern of decreased fractional 
anisotropy coinciding with increased mean diffusivity and increased radial diffusivity in 
the left cingulum hippocampus and in the left tapetum in patients with chronic WAD 
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Part III:   The relationship between cognitive performance,  
cognitive stress, and central sensitization in patients with 
chronic whiplash associated disorders and fibromyalgia 
The third and last overall objective of this thesis was addressed in part III, which consists 
of a randomized crossover study exploring interactions between cognitive performance, 
cognitive stress, and CS in patients with chronic WAD and FM. Besides the growing 
evidence for cognitive deficits, CS, and reduced quality of life in patients with chronic 
WAD and FM, studies examining relationships among these features in both disorders 
were limited. Accordingly, we performed baseline case-control comparisons in the larger 
crossover study, described in chapter 6. Furthermore, limited research was present 
concerning the influence of cognitive stress and relaxation on central pain modulation in 
patients with chronic WAD and FM. Therefore, the results of the intervention part of the 
randomized crossover study, outlined in chapter 7, attempt to fill this research gap.
Significant features of CS were demonstrated in both patients with chronic WAD and 
FM compared to healthy controls (32). Similar to the results of previous studies (49, 50), 
enhanced temporal summation of pain or increased bottom-up sensitization was 
The subgroup reporting CS symptoms indicative of CS (n= 38) displayed higher pain 
intensity, a higher number of painful days per week, worse pain-related disability, more 
limitations on health-related quality of life, more severe cognitive deficits, and increased 
local hyperalgesia compared to the subgroup reporting symptoms not indicative of CS 
(n= 24). Compared to healthy pain-free controls, only the subgroup showing distinct CS 
symptoms demonstrated cognitive deficits, distant hyperalgesia, and decreased CPM 
efficacy. In addition, moderate correlations were revealed among higher pain intensity, 
local and distant hyperalgesia, and worse self-reported and objective cognitive 
performance only in the subgroup presenting considerable CS symptoms. This study 
yields additional valuable insights and provides evidence for subgroups based on the 
CSI within women with chronic INP and chronic WAD, revealing both heterogeneity 
and overlap in clinical presentation in both conditions, and highlighting the need to 
address the underlying predominant pain mechanism displayed in the individual 
patient. Moreover, only in the subgroup with self-reported indications of CS worse 
cognitive performance was associated with experimental signs of CS. The latter association 
is interesting because it highlights the interwoven relationship between cognitive 
problems and the possible presence of predominant CS pain. 
Table 2   Summary of the results of the additional data analyses regarding pain,  
pain-related disability, quality of life, cognitive deficits, hyperalgesia,  
and efficacy of CPM in the subgroup reporting symptoms indicative of CS  
(n= 38) compared to the subgroup without indication of CS (n= 24),  
and healthy pain-free controls.
Deficits present in  
the subgroup with  
a CSI ≥ 40/100 compared  
to healthy women
Deficits present in  
the subgroup with  
a CSI ≥ 40/100 compared  
to the subgroup with  
a CSI < 40/100
Deficits present in  
the subgroup with  
a CSI < 40/100 compared  
to healthy women
Neck pain Higher neck pain intensity Neck pain
Pain-related disability &
decreased quality of life
Higher pain-related disability &
decreased quality of life
Pain-related disability &
decreased quality of life
Subjective & objective 
cognitive deficits
Subjective & objective 
cognitive deficits
No differences in subjective 
or objective cognitive 
performance
Local & distant hyperalgesia Local & distant hyperalgesia No differences in local or 
distant hyperalgesia
Decreased CPM efficacy No differences in CPM efficacy No differences in CPM efficacy
Note: n= 28 for healthy controls, n= 18 chronic INP and 6 chronic WAD for CSI < 40/100, n= 15 chronic INP and 
23 chronic WAD for CSI ≥ 40/100. The Kruskal-Wallis Test (post-hoc pairwise comparisons using Mann-Whitney 
U test with significance level a <0.017 (0.05/3)) was applied. 
Abbreviations: CSI= central sensitization inventory, CPM= conditioned pain modulation. 
Table 3   Spearman correlations between cognitive deficits and disability characteristics, 
and pain intensity and experimental CS measures in chronic INP and chronic 
WAD patients distinguished based on the CSI cut-off.
chronic INP and chronic WAD Local 
hyperalgesia
Distant 
hyperalgesia
Decreased  
CPM efficacy
Higher pain 
intensity
CSI ≥ 40/100 (n= 38)
Self-reported cognitive deficits ~ ~ ~
Objective cognitive deficits ~
Disability characteristics ~
CSI < 40/100 (n= 24)
Self-reported cognitive deficits
Objective cognitive deficits
Disability characteristics
Note: ~ =measurements are correlated in the same direction. All measurements are presented in the impaired 
form. To correct for multiple comparisons, correlations significant at a statistical threshold level of p< 0.01 
(2-tailed) were deemed significant. Blanco cell = non-significant correlations. n= 67 chronic neck pain patients 
(35 chronic INP, 32 chronic WAD) (5 missings for the CSI). n= 18 chronic INP and 6 chronic WAD for CSI score of < 
40/100, n= 15 chronic INP and 23 chronic WAD for CSI score of ≥ 40/100. 
Abbreviations: CPM= conditioned pain modulation, CSI= central sensitization inventory. 
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objective cognitive performance was revealed in patients with chronic INP (psychomotor 
vigilance task (PVT) lapses), chronic WAD (Stroop, PVT) and FM (Stroop, PVT, OSPAN) 
compared to controls. In contrast with the results of the Stroop task found in chapter 6, we 
did find in this study longer Stroop reaction times in women with chronic WAD compared 
to healthy women. Based on these results, we can infer that patients with chronic WAD 
also encounter problems with selective attention. Also, the study described in chapter 6 
and this study have demonstrated longer Stroop reaction times in patients with FM 
compared to controls. The latter may indicate a general slowing down of information 
processing in patients with FM. Regarding the OSPAN, chronic WAD patients showed 
normal working memory capacity in both studies. In contrast, FM patients presented 
reduced working memory capacity compared to healthy controls in each study. 
 Furthermore, only chronic WAD and FM patients reported average CSI scores higher 
than 40 of 100, indicating significant self-perceived signs of CS, with FM patients reporting 
more extensive CS symptoms compared to patients with chronic WAD. Widespread 
pressure hyperalgesia was demonstrated in patients with chronic WAD and FM, but not in 
chronic INP patients. Remarkably, CPM efficacy was again comparable between all 
groups, which is in line with the results of chapter 6 but in contrast with the results of part 
II. In addition, as summarized in table 4, moderate to strong correlations were revealed 
among more severe subjective and objective cognitive deficits, and more self-perceived 
and experimental signs of CS in all patient groups. 
 In summary, this thesis revealed important differences between women with chronic 
INP, chronic WAD, and FM compared to healthy women, providing evidence for CS 
associated with cognitive deficits only in patients with chronic WAD and FM. Similar 
to the findings of part II, CS could not be demonstrated at a group level in chronic INP 
patients, while cognitive deficits were present, however, to a lesser degree compared with 
chronic WAD and FM patients. Furthermore, more indices of CS, more severe cognitive 
deficits, and more limitations on health-related quality of life were found in patients with 
FM compared to patients with chronic WAD. Accordingly, the chronic INP group may be 
situated somewhere at the beginning of the continuum of chronic musculoskeletal pain, 
followed by the chronic WAD group, and the FM group may be the far end of this 
continuum. As such, the more the experienced pain is centrally driven with increasing 
severity and complexity of associated symptoms, the more a patient is falling at the end 
of the chronic musculoskeletal pain continuum.
As can be seen in table 5, regarding the associations found in chapter 6 between 
cognitive performance and CS in the chronic WAD group, only deep-tissue hyperalgesia 
was significantly correlated with cognitive performance. Possible explanations for the 
scarcely observed relationships between cognitive performance and CS in the participants 
with chronic WAD were obscure and needed further research, which we performed in the 
study enclosed in chapter 3 and in the above outlined additional study. According to our 
observed in patients with chronic WAD and FM compared to healthy controls. Furthermore, 
deep-tissue hyperalgesia was revealed in patients with FM compared to the other study 
groups. Remarkably, efficacy of CPM was comparable between all study groups, which is 
in contrast with our results of decreased CPM efficacy in patients with chronic WAD 
reported in part II. Maybe these incongruent results are due to the different CPM paradigms 
that were applied in both studies, or due to the fact that only women were included in 
part II, whereas the study enclosed in part III also enrolled men. 
 With respect to objective cognitive performance, we demonstrated reduced 
selective and sustained attention in patients with FM compared to healthy controls (32). 
Furthermore, we revealed reduced sustained attention in the chronic WAD group. Based 
on increased Stroop interference effects demonstrated only in FM patients, it seems that 
chronic WAD patients are capable to inhibit irrelevant information, whereas FM patients 
have problems with this attending ability indicating dysfunctional cognitive inhibition. 
Additionally, FM patients experienced problems to inhibit distraction stimuli. In line with 
accumulating evidence, patients with FM also demonstrated reduced working memory 
capacity compared to controls (51). Interestingly, the results of the Operation Span Task 
(OSPAN) showed normal working memory capacity in chronic WAD patients, however, 
the results of the TMT part B applied in part II showed decreased working memory 
capacity in patients with chronic WAD. 
 Furthermore, distinct limitations on health-related quality of life were demonstrated 
in patients with chronic WAD and FM compared to controls (32). These results are in 
accordance with the observed limitations on health-related quality of life in women with 
chronic WAD examined in chapter 3 (31). Worse scores in the FM group on domains of 
physical health were detected in comparison with chronic WAD patients. 
Based on the above summarized findings, we hypothesized that both overlapping and 
different underlying mechanisms exist between patients with chronic INP, chronic WAD 
and FM. Nevertheless, research investigating pathophysiological differences between 
these conditions remained scarce. Therefore, it seemed valuable to perform an additional 
case-control study, including the three chronic musculoskeletal pain conditions 
examined in the present thesis. The results of this additional study are added to this 
dissertation as appendix and will be discussed in this section. In particular, we aimed to 
further explore differences in underlying mechanisms and their relationships focusing on 
cognitive deficits, self-reported symptoms of CS, widespread hyperalgesia, and efficacy of 
CPM in women with chronic INP, chronic WAD and FM compared to healthy women. 
Secondly, we aimed to explore associations between cognitive deficits and measures of 
CS in all study groups.
 Self-reported cognitive deficits were higher in all patient groups compared to healthy 
controls (detailed figures of the results are presented in appendix). Patients with FM 
reported more severe cognitive deficits compared to patients with chronic INP. Worse 
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Based on the results of the intervention part of the randomized crossover study described in 
chapter 7 both acute cognitive stress and a single relaxation session enhanced temporal 
summation of pain in patients with FM, denoting increased nociceptive transmission to 
the brain (52). Therefore, it can be assumed that a single progressive muscle relaxation 
session as well as acute cognitive stress may have negative acute effects on pain 
modulation in patients with FM, while acute cognitive stress and relaxation reduced 
temporal summation of pain in patients with chronic WAD and healthy controls. Lower 
temporal summation values point towards reduced bottom-up sensitization, possibly due 
to a change in brain focus as a result of distraction. In contrast, endogenous pain inhibition 
worsened in response to both relaxation and cognitive stress in healthy people, and in 
patients with chronic WAD and FM. Possibly, performing the cognitive tasks served as a 
high cognitive stressor for patients with FM, encountering attention and memory 
problems (53, 54), which further burdened the central nervous system (CNS) leading to 
further disinhibition and more pain. Noteworthy, the findings of chapter 6 and the 
additional study showed that patients with chronic WAD demonstrated less attention and 
memory problems compared to FM patients (55). Therefore, the chronic WAD patients may 
have experienced the cognitive tests as less challenging and hence less stressful. 
Accordingly, this could have led to diminished temporal summation of pain. On the 
hypothesis, we could reveal numerous associations between decreased cognitive 
performance and signs of CS in women with chronic WAD in chapter 3 and in the additional 
study. In addition, reduced health-related quality of life was associated with worse 
cognitive performance in chronic WAD and partly in FM patients. 
Table 4   Summary of the spearman correlations between self-reported and objective 
cognitive deficits, pressure hyperalgesia, decreased CPM efficacy, and 
self-reported CS symptoms (CSI) in patients with CINP, CWAD and FM, and 
healthy pain-free controls demonstrated in the additional case-control study.
Subjective 
cognitive 
deficits
(mPDQ)
Impaired 
selective 
attention
(Stroop)
Cognitive 
inhibition 
(Stroop 
Interference)
Impaired 
sustained 
attention 
(PVT)
Impaired 
working 
memory
(OSPAN)
Chronic INP (n= 17)
Widespread 
hyperalgesia
Decreased  
CPM efficacy
~
Higher self-
reported CS 
symptoms 
~ ~ ~ ~
Chronic WAD (n= 11)
Widespread 
hyperalgesia
~ ~ ~ ~ ~
Decreased  
CPM efficacy
Higher self-
reported CS 
symptoms 
~ ~ ~
FM (n= 29)
Widespread 
hyperalgesia
~ ~
Decreased  
CPM efficacy
Higher self-
reported CS 
symptoms 
~ ~ ~
Note: ~ =measurements are correlated in the same direction. All measurements are presented in the impaired 
form. Spearman correlations were significant at the 0.05 level or below the 0.01 level or below the 0.001 level 
(2-tailed). Blanco cell = non-significant correlations. 
Abbreviations: mPDQ= modified Perceived Deficits Questionnaire, PVT= psychomotor vigilance task, OSPAN= 
operation span task, CPM= conditioned pain modulation, CS= central sensitization. 
Table 5   Direction of the correlations between cognitive impairment, and impaired 
central pain modulation, and self-reported health-related quality of life 
observed in chapter 6 in patients with chronic WAD and FM.
Impaired selective 
attention
(Stroop)
Impaired sustained 
attention
(PVT)
Impaired working 
memory 
(OSPAN)
chronic 
WAD
FM chronic
WAD
FM chronic
WAD
FM
Deep-tissue  
hyperalgesia
1/~ ~
Increased  
TS of pain
1/~ 1/~
Decreased  
CPM efficacy
~
Reduced  
QoL (SF-36) 
~ 1/~ ~ ~
Note: 1/~: measurements are oppositely correlated, ~: measurements are correlated in the same direction. All 
measurements are presented in the impaired form. Abbreviations: QoL= Quality of Life, SF-36= 36-item 
Short-Form Health Survey Questionnaire, PVT= psychomotor vigilance task, OSPAN= operation span task, TS= 
temporal summation, CPM= conditioned pain modulation.
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Clinical implications
Based on the results of the first systematic review, we can infer that structural and 
functional brain alterations are closely related to clinical features of pain (57). It became clear 
that chronic pain is associated with a complex interplay among various brain regions and 
networks accompanied with alterations in areas that are often engaged in emotional, 
motivational, and cognitive processing of pain. Therefore, it can be recommended that 
the rehabilitation of patients with chronic musculoskeletal pain has to be biopsychoso-
cially-driven and that the CNS including the brain has to be addressed. Hence, therapy 
approaches should tackle the observed affective-, motivational-, cognitive-, and 
psychosocial dysfunctions in the individual patient. 
The findings of this dissertation indicated that women with chronic INP, chronic WAD and 
FM are characterized by similar but also prominently different underlying mechanisms. 
The results can be interpreted in the light of the conceptual framework of the continuum 
of chronic musculoskeletal pain as outlined in the introduction and previously discussed. 
It can be proposed that FM patients are falling at the end of the continuum because the 
medical diagnosis of FM most often implies the presence of predominant CS pain (58, 59), 
while chronic WAD is associated but not uniformly characterized by CS (60), and CS is not a 
characteristic feature in chronic INP.
 But it should be mentioned that these similarities and differences are evaluated on a 
group level and may differ substantially at the individual patient level, regardless of the 
diagnosis. Based on these results, it can be advocated that disability, cognitive deficits, 
signs of CS, and their possible interrelationships should be evaluated and treated with 
the aim of providing more effective and individually focused therapy for patients with 
chronic INP, chronic WAD and FM. Questionnaires such as the Neck Disability Index or the 
Pain Disability Index, the Short Form 36-item Health survey, and the modified Perceived 
Deficits Questionnaire are recommended to evaluate and re-evaluate disability, health- 
related quality of life, and cognitive deficits in patients with chronic INP, chronic WAD and 
FM. Furthermore, the TMT could be used as a quickly administered test to examine 
cognitive performance. Additionally, the importance of assessing the underlying 
predominant pain mechanism in the individual patient is crucial. Therapists should not 
only be aware of the possibility of CS in patients with chronic WAD and FM but also in 
patients with chronic INP because, at the individual patient level, it is still possible that CS 
is present in patients with chronic INP. Therefore, therapists should be able to recognize 
CS. Clinical guidelines for recognizing and treating CS are available in current literature (60, 
61). The evaluation of self-reported CS symptoms for example with the CSI (by interpreting 
the cut-off score of 40 of 100) combined with clinical examination (e.g. assessment of 
pressure pain thresholds or cold sensitivity at sites distant from the symptomatic region), 
and evaluation of the treatment response, all together can contribute to the recognition 
contrary, it is possible that the cognitive tasks diminished temporal summation of pain 
as a result of the “distraction effect” in patients with chronic WAD (56). Regarding the 
progressive muscle relaxation therapy, the format of the relaxation may have served as 
a physical stressor in patients with FM, but not in patients with chronic WAD and controls. 
It may be that some FM patients tensed their (already painful) muscles too tightly and 
focused their attention even more on the pain during the relaxation session, which could 
have resulted in exacerbating pain accompanied with enhanced temporal summation of 
pain. 
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been demonstrated to reverse regional GM volume decreases associated with reduced 
pain catastrophizing and decreased cognitive deficits in other chronic CS pain patients (72, 73). 
Multiple studies have indeed shown in other chronic pain conditions that decrease in GM 
morphology is at least partially reversible when underlying pain is adequately treated (14, 74, 75). 
 In chronic INP patients, only cognitive deficits were related to decreased regional GM 
morphology, and GM morphological alterations or CS could not be revealed. Accordingly, 
fewer indications are currently available for a role of brain alterations and CNS neuroplas-
ticity in the pathophysiology of chronic INP at a group level. 
Finally, based on the results of the study in patients with chronic WAD and FM investigating 
the effects of cognitive stress on endogenous pain modulation (52), therapists should be 
aware of the possible negative influences of stressors such as cognitive demanding tasks 
on endogenous pain modulation, and thus should assess the patient’s individual ability 
to cope with stress. This fits in the clinical biopsychosocial assessment approach which 
we recommend for patients with chronic pain (76). This assessment aims to establish the 
underlying predominant pain mechanism as well as the provoking and sustaining bio-
psychosocial factors in the individual patient. In this type of assessment, the influence of 
different factors associated with chronic pain such as emotional factors (e.g. chronic stress, 
pain-related fear), cognitive factors (e.g. catastrophizing), behavioral factors (e.g. avoidance 
or persistence behavior), social factors (e.g. relationship with partner, work), and motivation 
(e.g. readiness to change) should be determined. This extensive biopsychosocial assessment 
is an important first step in adequate patient-centered pain neuroscience education and 
successful treatment of patients with chronic pain. 
 Taken together, we suggest an individually-tailored multicomponent biopsycho-
social assessment and rehabilitation in which the underlying pathophysiological mechanisms 
and their interrelationships should be taken into account. 
of CS (60). Subsequently, the therapeutic approach should be personalized for each patient 
and clinicians should account for CS when designing the treatment plan in case of CS (62), 
regardless of diagnosis. The need to address the underlying predominant pain mechanism 
is confirmed by the results of the additional data analyses identifying subgroups based on 
the CSI in women with chronic WAD and chronic INP. The fact that this subgroup also 
comprised 15 chronic INP patients affirms our hypothesis that at the individual patient 
level, CS can be present as underlying pain mechanism in patients with chronic INP. 
When the clinical picture of pain patients is characterized or predominated by CS or when 
maladaptive illness perceptions are present (63), pain neuroscience education should 
be applied. The goals of such education are to reconceptualize pain and to change 
inappropriate pain beliefs; reduce maladaptive attitudes and cognitions in relation to pain; 
and subsequent increase participation in active treatment (64, 65). Previous research 
demonstrated significant decreases in pain-related disability and hyperalgesia after pain 
neurophysiology education in chronic WAD patients, and revealed improved health status 
and endogenous pain inhibition in patients with FM (65, 66). In addition, a recent study of our 
research group unpublished results observed in patients with chronic spinal pain including 
chronic INP and chronic WAD patients the effectiveness of a time-contingent biopsycho-
social approach combining pain neuroscience education with cognition-targeted exercise 
therapy for reducing symptoms of CS and disability, and improving pain cognitions, 
and health-related quality of life. On the basis of our results, also cognitive deficits, such 
as attention, concentration, and memory problems, should be taken into account in 
the application of pain education in these patients. In addition, cognitive behavioral 
therapy can be recommended and is able to decrease pain-related disability and 
post-traumatic stress, and improve quality of life in patients with chronic WAD (67, 68) as well 
as reduce pain catastrophizing in patients with FM (69). In acute and subacute chronic pain 
patients, early pain education and cognitive behavioral therapy are important for 
preventing the transition to chronicity (70). When applying hands-on therapies in patients 
with predominant CS pain, clinicians should remember that therapeutic interventions 
triggering more pain will serve as a new peripheral source of nociceptive input and thus 
will sustain the CS process (71).
The brain MRI results furthermore indicated that persistent pain in chronic WAD patients 
should be interpreted, at least in part, as a result of structural plasticity of the CNS 
associated with alterations in GM morphology and WM microstructure of regions involved 
in pain and cognitive processing. As such, clinicians should be aware of the observed 
subtle structural brain alterations in chronic WAD patients, and the associations with 
cognitive deficits, pain catastrophizing and hypervigilance, and CS symptoms. This again 
highlights that therapy approaches for chronic WAD should address the brain and take 
into account neuroplasticity of the CNS, like e.g. cognitive behavioral therapy which has 
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Metrics derived from diffusion-weighted imaging data using the tensor model are indirect 
measures that relate to but do not directly quantify WM microstructural features and are 
influenced by methodological and biological factors (82). These metrics cannot disentangle 
the individual microscopic contributions at the voxel level and therefore should be 
interpreted with caution. It remains unclear whether decreased fractional anisotropy is 
due to changes in membrane permeability, organelles, axon thickness, fiber density, or 
degree of myelination (82). It has been suggested that alterations in radial diffusivity 
combined with unchanged axial diffusivity reflect demyelination (45), but the interpretation 
of these metrics has been a topic of controversy (83). Another limitation of DTI analyses of 
single-shell data pertains to the inability of the tensor model to adequately characterize 
diffusion in voxels containing complex fiber architecture, such as crossing fibers (82). In the 
brain however voxels often contain fiber populations with more than one dominant 
orientation. 
Nevertheless, also several strengths of this dissertation can be outlined. First, the methods 
used for screening and scoring the articles included in our systematic reviews were 
completed by two independent blinded reviewers. Second, the Newcastle Ottawa Scale 
used to assess risk of bias was modified by adding two items specifically developed for 
the topic of both systematic reviews. Consequently, the methodological quality and risk 
of bias of the brain imaging studies could have been evaluated more thoroughly giving 
a more accurate view on the pre-processing of the brain imaging analyses, and on the 
brain imaging acquisition and quality control.
Third, the case-control studies enclosed in chapters 3 to 7 are the first to address the 
outlined clinically relevant research questions regarding differences in underlying 
mechanisms between patients with chronic INP, chronic WAD and FM. This research has 
increased our knowledge of these musculoskeletal pain conditions substantially, which 
could steer further research and development of more effective individualized therapy 
focused on the underlying pathophysiological mechanisms.
 The large sample size of the case-control studies described in part II is a considerable 
strength as many research studies in the domain of chronic pain and in particular of brain 
imaging are limited by small sample sizes, and thus potentially lack sufficient statistical 
power. 
Fourth, an important strength of the case-control studies was the comparability of the 
groups in age, sex, body mass index, and education level. Neck pain duration and 
frequency of neck pain complaints were comparable for the chronic neck pain groups as 
well. Another important strength of all original research studies was that we anticipated 
sources of bias, such as use of medications, caffeine, alcohol, and nicotine; menstrual 
phase; pregnancy; and performance of heavy physical exertion on the assessment day. 
Limitations and Strengths
The study limitations of each study enclosed in this dissertation have been discussed in 
detail in the different manuscripts. In the following section, the most important limitations 
that must be taken into account when interpreting the results, will be discussed. 
To correctly interpret the results of our systematic reviews, it is important to mention that 
different MRI acquisition and analyzing techniques were used in the included studies 
which can affect the study results. Furthermore, the various brain imaging techniques 
used in chapter 2 hampers the possibility of comparison. Next, the included studies 
administered different scales or questionnaires to measure clinical features of pain. This 
might give difficulties comparing results of different studies. In addition, various studies 
included in the second systematic review did suffer from certain risks of bias, which could 
affect their results and implies the possibility to infer only cautious conclusions.
For the original studies, it should be mentioned that the cross-sectional nature implies 
that no conclusions about the causality of the observed correlations can be drawn. 
Furthermore, because the case-control studies included in part II only examined women, 
caution should be taken when generalizing the results to the total chronic INP and chronic 
WAD population. Accordingly, the external validity of the results described in chapters 3 
to 5 is limited to adult female patients with chronic INP and chronic WAD, in particular 
chronic WAD patients diagnosed as WAD II A, B, or C. Nevertheless, we are convinced that 
this limitation is a strength as well because this way we avoided bias in our results due to 
differences between men and women concerning pain sensitivity, pain processing, and 
brain structure (77-79) , and because this way there was less heterogeneity in our study 
sample. Noteworthy, the prevalence of both traumatic (80) and idiopathic (81) chronic neck 
pain is consistently higher in women. Also, with regard to interpretation of the cognitive 
test results, the possible presence of malingering or feigned cognitive deficits in women 
with chronic INP and, in particular, in women with chronic WAD must be considered. This 
limitation was avoided in the additional study in which patients with chronic INP, chronic 
WAD, and FM performed, besides the cognitive tests, the Rey 15-item memory test to 
exclude the presence of malingering. Furthermore, the focus of this dissertation was not 
on psychological correlates of pain such as posttraumatic stress, anxiety, depression, pain 
catastrophizing and hypervigilance, although these important features were also assessed 
and could influence the observed differences and interrelationships. However, these 
psychological aspects will be included in our further data analyses in patients with chronic 
INP, chronic WAD and FM. 
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Directions for further research
This dissertation has increased our knowledge concerning the underlying mechanisms 
and their relationships in patients with chronic INP, chronic WAD and FM as well as their 
differences. Based on our increased understanding, interesting new research questions 
arose and some questions remained unresolved. Accordingly, important recommenda-
tions for further research can be proposed. 
As mentioned before, no conclusions about the causality of the observed relationships 
can be drawn based on the results of the cross-sectional studies. Hence, further 
longitudinal research is warranted to investigate if CS, pain-related disability, and 
reduced health-related quality of life lead to cognitive deficits or vice versa. Furthermore, 
research should investigate which therapy strategies are able to reduce and/or prevent CS 
and associated pain-related disability and psychosocial aspects in patients with chronic 
musculoskeletal pain.
 In addition, longitudinal studies, not only in patients with chronic pain but also in 
patients with acute and subacute pain, are highly warranted to unravel the cause-effect 
relationships between brain alterations, and chronic pain to answer the question if these 
alterations lead to chronic pain or vice versa, or an interaction between both. Longitudinal 
brain imaging research needs to explore the exact temporal characteristics of structural 
and functional brain alterations. As such, this research could increase our insight in which 
brain alterations are mediating the transition from acute to chronic pain. To date, this 
transition is hypothesized to comprise of four phases: predisposition, injury or inciting 
event (e.g. whiplash), a transition period, and a maintenance phase (1, 84). Subsequently, 
research has to investigate which therapies can intervene in which stage of this transition 
for preventing pain chronification. 
 Also, much more effort is needed to explore which therapies are able to reverse the 
observed structural brain alterations in patients with chronic WAD, and if normalizing of 
these brain alterations is associated with diminishment of pain and related disability, less 
signs of CS, decreased pain catastrophizing and hypervigilance, and less severe cognitive 
deficits. To this end, longitudinal research is warranted to unravel which therapeutic 
approaches can re-shape the brain and decrease the associated burden in patients with 
chronic pain. 
Our findings have yielded innovative evidence for structural brain alterations in women 
with chronic WAD compared to women with chronic INP and healthy women. However, 
we are convinced that the present thesis has investigated only one piece of the puzzle 
regarding possible brain alterations in patients with trauma-induced and non-traumatic 
chronic neck pain. Therefore, we want to emphasize the need for further research using 
functional brain imaging techniques such as (resting-state) functional MRI or Electro-
Finally, the brain MRI studies addressing relationships between alterations in GM 
morphology and WM microstructure, and self-reported and experimental features of 
cognition, pain, and CS in women with chronic INP and chronic WAD compared to healthy 
women are highly innovative. 
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We recommend for future research that the assessment of CS in patients with chronic pain 
should include besides the tests applied in this thesis, also more objective experimental 
tests such as the evaluation of the NFR threshold. 
 To date, there is still a lack of absolute diagnostic criteria for identifying the presence 
of CS in pain patients (89). Our research group has proposed a valuable clinical algorithm 
for the recognition of CS in chronic pain patients in clinical practice (60, 61). However, this 
algorithm should be validated in future studies. Also, it should be further discovered how 
researchers and clinicians can examine the presence of dysfunctional facilitating or 
inhibiting pain modulatory mechanisms at the individual level. Possibly, different therapy 
strategies are necessary to restore the balance of endogenous pain modulation in case of 
more prominent dysfunctional facilitating or inhibiting pain modulation. 
To conclude, it remains an important challenge for researchers and therapists to develop 
effective therapy strategies for patients with chronic INP, chronic WAD and FM but our 
results pave the way for the development of novel and more effective treatment 
approaches for these pain conditions.
encephalography in order to disentangle possible functional brain alterations in both 
chronic neck pain populations. Also, whole brain research focusing on structural and 
functional network and connectivity analyses in these patients compared to healthy 
pain-free controls can be recommended. Furthermore, the exact underlying neurobio-
logical mechanisms responsible for decreased regional GM morphology in chronic WAD 
patients remain unclear and have to be elucidated with further studies applying 
sophisticated and sensitive brain imaging techniques. 
 Moreover, the relationships between cognitive performance and CS measures, and 
both structural and functional brain characteristics should be further explored to gain 
more insight in the underpinning mechanisms of chronic pain, and to uncover the specific 
role of brain alterations in the persistent complaints of chronic pain patients. For example, 
it could be interesting to investigate associations between temporal summation of second 
pain or objective quantitative sensory testing measures of CS (e.g. the nociceptive flexion 
reflex (NFR) threshold), and brain alterations in patients with chronic WAD and FM. The 
latter could add valuable insights into the structural and functional brain correlates of CS. 
Furthermore, associations between brain parameters and objective cognitive deficits for 
example examined with performance-based cognitive tests (OSPAN, STROOP, PVT) are 
valuable to investigate. Also, exploration of relationships between experimental measures 
of CS and cognition on the one hand, and pain catastrophizing, hypervigilance but also 
pain-related fear, anxiety, stress, and illness perceptions should be further investigated in 
patients with chronic INP and chronic WAD in order to further unravel the biopsychosocial 
aspects of chronic neck pain. In addition, the influence of psychosocial correlates such as 
pain-related fear and post-traumatic stress on structural and functional brain characteris-
tics in patients with chronic WAD is an interesting avenue for further research.  
 Regarding our findings of abnormalities in WM microstructure in the chronic WAD 
group, and associations with dysfunctional CPM, it seems valuable to further explore 
other alterations in WM in patients with chronic WAD but likewise in acute and subacute 
whiplash patients. WM of the brain also consists of glial cells and research has found that 
glial activation plays an important role in the induction and maintenance of chronic pain 
(85). Moreover, preliminary evidence is present for effects of minor traumatic brain injuries 
on glial cells, such as proliferation and microglial activation (86). Hence, research into 
possible alterations in brain glial activation in WAD is of high interest for example with 
integrated Positron Emission Tomography-MRI (85). This research avenue would also be 
valuable because evidence suggesting that activation of glia cells and neuro-glial 
interactions are mediators of sensitization has been emerged (87, 88). Also, advanced models 
based on the high angular resolution DWI acquisition strategy to provide more robust 
estimates of the fiber orientation in WM are recommended for further research in patients 
with chronic INP, chronic WAD, and FM.
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We recommend that disability, cognitive deficits, and CS, and their relationships should be 
evaluated and treated in patients with chronic INP, chronic WAD and FM with the aim of 
providing more effective and individually focused therapy, which tackles the observed 
deficits. Based on the results of this thesis, it can be recommended that therapy approaches 
for chronic WAD and FM should take into account the role of CNS neuroplasticity. Further 
research is warranted to investigate which therapies can decrease CS, cognitive deficits, 
and disability in patients with chronic INP, chronic WAD and FM. Furthermore, longitudinal 
research should examine which therapeutic approaches can reverse the observed 
structural brain alterations, and should assess if normalization of these brain alterations is 
associated with less severe clinical dysfunctions. 
In conclusion, the results of this dissertation have unraveled important pieces of the 
complex pathophysiological puzzle underlying chronic INP, chronic WAD and FM, and 
have uncovered both differences and overlapping similarities between these chronic 
musculoskeletal pain conditions. The novel findings increase our understanding of these 
conditions substantially, and could steer further research and contribute to more effective 
individually tailored therapy approaches. 
General conclusion
We can conclude that moderate evidence exists for relationships between clinical pain 
measures, and structural and functional brain alterations within regions or networks 
involved in somatosensory, affective-motivational, and cognitive pain processing in 
patients with chronic musculoskeletal pain. Furthermore, this thesis revealed important 
differences between patients with chronic INP, chronic WAD and FM, providing evidence 
for CS associated with subjective and objective cognitive deficits only in patients with 
chronic WAD and FM. Additionally, this research has demonstrated disability associated 
with cognitive deficits in patients with chronic WAD and FM, and to a significantly lesser 
extent in chronic INP patients. Higher disability, more severe cognitive deficits, and more 
indices of CS were revealed in patients with FM compared to chronic WAD and chronic 
INP patients. Accordingly, the chronic INP group may be situated somewhere at the 
beginning of the continuum of chronic musculoskeletal pain, followed by the chronic 
WAD group, and the FM group may be the far end of this continuum. As such, the more 
the experienced pain is centrally driven, the more a patient is falling at the end of this 
continuum. 
 When comparing patients with chronic INP and chronic WAD, distant hyperalgesia 
and decreased CPM efficacy were demonstrated in chronic WAD but not in chronic INP 
patients, indicating the presence of CS, at a group level, only in patients with chronic WAD. 
Nevertheless, when subgrouping based on self-reported symptoms of CS, instead of on 
diagnosis, only the subgroup showing distinct CS symptoms (also comprising women 
with chronic INP) demonstrated cognitive deficits, distant hyperalgesia, and decreased 
CPM efficacy compared to healthy controls. In addition, only in this subgroup with 
considerable self-perceived CS symptoms associations between more severe cognitive 
deficits and distant hyperalgesia were found. These findings highlight the need to address 
the underlying predominant pain mechanism displayed in the individual patient. 
The present thesis has furthermore demonstrated abnormalities in WM microstructure 
and decreased GM morphology in regions associated with pain and cognitive processing 
without detecting brain microhemorrhages related to trauma in women with chronic 
WAD compared to women with chronic INP and healthy women. In patients with chronic 
WAD, decreased regional GM volume was associated with more severe cognitive deficits 
and more signs of CS. In addition, novel evidence is provided for associations between 
dysfunctional CPM and the degree of regional WM deficits in chronic WAD. This yields 
innovative evidence for underlying WM microstructural correlates of disturbed 
endogenous pain inhibition. Accordingly, these results emphasize the role of structural 
brain alterations in patients with traumatic chronic neck pain (WAD) compared to patients 
with non-traumatic chronic INP. Together, these findings indicate a possible negative 
mediating role of the trauma in patients with chronic WAD. 
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English Summary
“There is plenty of tunnel at the end of the light.” 
- Jerry Fodor
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The core aim of this dissertation was to improve our knowledge of the mechanisms and 
their possible interrelationships underlying the persistent, complex, and often unexplained 
symptoms in patients with chronic idiopathic neck pain (INP), chronic whiplash associated 
disorders (WAD) and fibromyalgia (FM). The core aim was furthermore to unravel differences 
in the nature and severity of the underpinning mechanisms between these three 
heterogeneous conditions with chronic musculoskeletal pain. This way, the present thesis 
aimed to further disentangle pieces of the complex pathophysiological puzzle underlying 
chronic INP, chronic WAD, and FM with the ultimate endeavor to increase our understanding 
of these conditions, and to pave the way for the development of more effective treatment 
approaches for these patients. 
To tackle this core aim seven studies were performed, enclosed in three major parts each 
addressing one overall objective:
- Part I addresses the first overall objective: to investigate the current evidence 
regarding relationships between structural and functional brain alterations and clinical 
pain measures in chronic musculoskeletal pain patients, and regarding structural and 
functional brain alterations specifically in INP and WAD. This part comprises two 
chapters including two systematic reviews.
- Part II addresses the second overall objective: to examine differences in disability, 
cognitive deficits, indices of central sensitization (CS), and structural brain alterations, 
and their interrelationships between women with non-traumatic (INP) and traumatic 
(WAD) chronic neck pain and healthy pain-free women. Part II includes one large 
case-control study described in three chapters. We hypothesized that the traumatic 
origin of neck pain in patients with chronic WAD would be associated with more severe 
deficits compared to patients with chronic INP. 
- Part III addresses the third overall objective: to explore interactions between 
cognitive performance, cognitive stress, and CS in patients with chronic WAD and FM, 
thereby studying differences between these chronic pain disorders. This final part 
consists of two chapters enclosing the results of the baseline case-control comparisons 
and the intervention part of a randomized crossover study.
Based on the first systematic review we can conclude that moderate evidence exists for 
relationships between clinical pain measures, and structural and functional brain 
alterations measured with Magnetic Resonance Imaging (MRI) within regions or networks 
involved in somatosensory, affective-motivational, and cognitive pain processing in 
patients with chronic musculoskeletal pain. In addition, we can infer that chronic musculo-
skeletal pain is not only mediated by somatosensory processing of pain but there is a shift 
towards critical involvement of cognitive and motivational-affective pain processing in 
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measures of cognition, pain, and CS in both chronic neck pain groups. Also, possible brain 
microhemorrhages related to trauma were evaluated. 
 The results of chapters 4 and 5 have demonstrated abnormalities in white matter 
microstructure and decreased grey matter morphology in regions associated with pain 
and cognitive processing without detecting brain microhemorrhages related to trauma in 
women with chronic WAD compared to women with chronic INP and healthy women. In 
patients with chronic WAD, decreased regional grey matter volume was associated with 
more severe cognitive deficits and more signs of CS. In addition, novel evidence is 
provided for associations between dysfunctional conditioned pain modulation and the 
degree of regional white matter deficits in chronic WAD. This yields innovative evidence 
for underlying white matter microstructural correlates of disturbed endogenous pain 
inhibition. Accordingly, these results emphasize the role of structural brain alterations in 
patients with traumatic chronic neck pain (WAD) compared to patients with non-traumatic 
chronic INP. Together, these findings indicate a possible negative mediating role of the 
trauma in patients with chronic WAD. 
We recommend that disability, cognitive deficits, and CS, and their relationships should be 
evaluated and treated in patients with chronic INP, chronic WAD and FM with the aim of 
providing more effective and individually focused therapy, which tackles the observed 
deficits. Based on the results of this thesis, it can be recommended that therapy approaches 
for chronic WAD and FM should take into account the role of central nervous system neu-
roplasticity for example with pain neuroscience education, cognitive behavioral therapy, 
and cognition-targeted exercise therapy. Also, our findings highlight the need to address 
the underlying predominant pain mechanism displayed in the individual patient, 
regardless of diagnosis.
 Further research is warranted to investigate which therapies can decrease CS, 
cognitive deficits, and disability in patients with chronic INP, chronic WAD and FM. In 
addition, we want to emphasize the need for future research to unravel functional brain 
alterations in both chronic neck pain populations. Furthermore, longitudinal research 
should examine which therapeutic approaches can reverse the observed structural brain 
alterations, and should assess if normalization of these brain alterations is associated with 
less severe clinical dysfunctions. 
In conclusion, the results of this dissertation have unraveled important pieces of the 
complex pathophysiological puzzle underlying chronic INP, chronic WAD and FM, and 
have uncovered both differences and overlapping similarities between these chronic 
musculoskeletal pain conditions. The novel findings increase our understanding of these 
conditions substantially, and could steer further research and contribute to more effective 
individually tailored therapy approaches. 
regions often part of the limbic system. The second systematic review found some to 
moderate evidence for structural and functional brain alterations in patients with chronic 
WAD, and only for functional brain alterations in patients with chronic INP. More evidence 
exists for brain alterations in patients with chronic WAD compared to patients with chronic 
INP, suggesting the presence of different underlying mechanisms in both populations. 
Furthermore, the results of part II, part III, and additional research data revealed important 
differences between patients with chronic INP, chronic WAD and FM, providing evidence 
for CS associated with subjective and objective cognitive deficits only in patients with 
chronic WAD and FM. Additionally, this research has demonstrated disability including 
pain-related disability and limitations on health-related quality of life associated with 
cognitive deficits in patients with chronic WAD and FM, and to a lesser extent in chronic 
INP patients. Higher disability, more severe cognitive deficits, and more indices of CS were 
revealed in patients with FM compared to chronic WAD and chronic INP patients. 
Accordingly, the chronic INP group may be situated somewhere at the beginning of the 
continuum of chronic musculoskeletal pain, followed by the chronic WAD group, and the 
FM group may be the far end of this continuum. As such, the more the experienced pain 
is centrally driven with increasing severity and complexity of associated symptoms, the 
more a patient is falling at the end of this continuum. 
 When comparing patients with chronic INP and chronic WAD, distant hyperalgesia 
and decreased efficacy of conditioned pain modulation were demonstrated in patients 
with chronic WAD but not in chronic INP patients, indicating the presence of CS, at a 
group level, only in patients with chronic WAD.
 Nevertheless, when subgrouping based on self-reported symptoms of CS, instead of 
on diagnosis, only the subgroup showing distinct CS symptoms (also comprising women 
with chronic INP) demonstrated cognitive deficits, distant hyperalgesia, and decreased 
conditioned pain modulation efficacy compared to healthy controls. In addition, only in 
this subgroup with considerable CS symptoms associations between more severe 
cognitive deficits and distant hyperalgesia were found. These findings highlight the need 
to address the underlying predominant pain mechanism displayed in the individual 
patient. 
Although it could be hypothesized that alterations in regional grey matter volume, cortical 
thickness, and white matter microstructure are present in patients with chronic WAD due 
to the trauma and because of CS, but significantly less in patients with chronic INP, this 
research was lacking. To address the current research gap, the aim of chapters 4 and 5 was 
to examine alterations in grey matter morphology and white matter microstructure in 
brain regions or tracts involved in processing of cognition and pain in women with 
chronic INP and chronic WAD compared to healthy women, measured with MRI. The 
second aim was to investigate associations between structural brain alterations, and 
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Het kerndoel van deze doctoraatsverhandeling was het verbeteren van onze kennis over 
de mechanismen en hun mogelijke onderlinge relaties die onderliggend zijn aan de 
aanhoudende, complexe en vaak onverklaarde symptomen van patiënten met chronische 
idiopathische nekpijn (INP), chronische whiplash geassocieerde aandoeningen (WAD) 
en fibromyalgie (FM). Het kerndoel was het ontrafelen van de verschillen in de aard en de 
ernst van de onderliggende mechanismen tussen deze drie heterogene condities met 
chronische musculoskeletale pijn. Als dusdanig heeft dit doctoraat als doel om delen 
van de complexe pathofysiologische puzzel die onderliggend is aan chronische INP, 
chronische WAD en FM verder te ontrafelen met als ultieme doel het inzicht in deze 
aandoeningen te vergroten, verder onderzoek te sturen en uiteindelijk bij te dragen tot 
het ontwikkelen van meer effectieve behandelstrategieën voor deze patiënten. 
Zeven studies werden uitgevoerd om dit kerndoel te behandelen en werden opgenomen 
in drie grote delen waarbij elk deel één overkoepelend doel behandelt: 
- Deel I behandelt het eerste overkoepelende doel: de huidige evidentie in kaart 
brengen betreffende de relaties tussen structurele en functionele hersenveranderin-
gen en klinische pijnmetingen bij patiënten met chronische musculoskeletale pijn, en 
betreffende structurele en functionele hersenveranderingen specifiek bij INP en WAD 
patiënten. Dit deel bestaat uit twee hoofdstukken die elk een systematische review 
bevatten.
- Deel II behandelt het tweede overkoepelende doel: de verschillen onderzoeken in 
disfuncties, cognitieve problemen, tekenen van centrale sensitisatie (CS), en structurele 
hersenveranderingen, alsook hun onderlinge relaties tussen vrouwen met niet- 
traumatische (INP) en traumatische (WAD) chronische nekpijn en gezonde pijnvrije 
vrouwen. Deel twee bevat 1 grote case-controle studie beschreven in drie verschillende 
hoofdstukken. Onze hypothese was dat de traumatische oorsprong van de nekpijn 
bij patiënten met chronische WAD geassocieerd zou zijn met meer ernstige problemen 
in vergelijking met chronische INP patiënten. 
- Deel III behandelt het derde overkoepelende doel: de interacties tussen cognitieve 
prestatie, cognitieve stress en CS exploreren bij patiënten met chronische WAD en FM. 
Hiermee onderzoeken we verschillen tussen twee chronische pijnaandoeningen die 
gekenmerkt worden door het gemeenschappelijk pathofysiologisch mechanisme van 
CS (dit is een overgevoeligheid van het centrale zenuwstelsel). Dit laatste deel bestaat 
uit twee hoofdstukken die de resultaten bevatten van de baseline case-controle 
vergelijkingen en het interventie deel van een gerandomiseerde cross-over studie. 
Gebaseerd op de resultaten van de eerste systematische review kunnen we concluderen 
dat er matige evidentie is voor relaties tussen klinische pijnmetingen zoals pijnduur en 
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Hoewel verondersteld kan worden dat veranderingen in grijze stof volume, corticale dikte, 
en witte stof microstructuur aanwezig zijn bij patiënten met chronische WAD ten gevolge 
van het trauma en CS maar significant minder te verwachten zijn bij patiënten met 
chronische INP, was onderzoek naar hersenveranderingen bij deze patiëntenpopulaties 
zeer beperkt aanwezig. Bijgevolg was het doel van hoofdstuk 4 en 5 om veranderingen in 
grijze stof morfologie en witte stof microstructuur in hersenregio’s en banen betrokken bij 
de verwerking van pijn en cognitie te onderzoeken bij vrouwen met chronische INP en 
chronische WAD ten opzichte van gezonde vrouwen met behulp van magnetische 
resonantie beeldvorming. Het tweede doel was het onderzoeken van de relaties tussen 
structurele hersenveranderingen enerzijds en aspecten van cognitie, pijn en CS anderzijds 
in beide patiëntengroepen met chronische nekpijn. Ook werd de mogelijke aanwezigheid 
van microbloedingen in de hersenen gerelateerd aan het trauma geëvalueerd. 
 De resultaten van hoofdstukken 4 en 5 hebben abnormaliteiten in de witte stof 
microstructuur en gedaalde grijze stof morfologie aangetoond in hersenregio’s betrokken 
bij de verwerking van pijn en cognitie bij patiënten met chronische WAD ten opzichte van 
chronische INP patiënten en gezonde controle personen. Microbloedingen in de hersenen 
gerelateerd aan het trauma werden niet gevonden. Er werden geen structurele hersen-
veranderingen geobserveerd bij chronische INP patiënten ten opzichte van gezonde 
personen. Bij de chronische WAD patiënten werden er interessante relaties aangetoond 
tussen gedaald grijze stof volume in pijn en cognitieve verwerkingsgebieden en meer 
ernstige cognitieve problemen en tekenen van CS. Eveneens werd er innovatief bewijs 
geleverd voor associaties tussen disfunctionele conditionerende pijnmodulatie en 
regionale witte stof abnormaliteiten bij chronische WAD patiënten. Dit resultaat levert 
innovatief bewijs voor onderliggende microstructurele witte stof correlaten van verstoorde 
endogene pijninhibitie bij patiënten met chronische WAD. Bijgevolg benadrukken deze 
resultaten de rol van structurele hersenveranderingen bij patiënten met chronische WAD 
ten opzichte van chronische INP. Deze resultaten wijzen op een mogelijke negatieve 
mediërende rol van het whiplashtrauma bij patiënten met chronische WAD. 
Gebaseerd op de resultaten van deze thesis kunnen verschillende klinische implicaties 
worden gegeven. We bevelen aan dat disfuncties, cognitieve problemen en CS, en hun 
onderlinge relaties geëvalueerd en behandeld worden bij patiënten met chronische INP, 
chronische WAD en FM. Zodoende kan meer effectieve en individueel gerichte therapie 
die inspeelt op de aangetoonde problemen worden toegepast. Verder kan worden 
aanbevolen dat de therapie van patiënten met chronische WAD en FM de neuroplasticite-
it van het centrale zenuwstelsel in rekening brengt bijvoorbeeld door het geven van pijn 
neurowetenschappelijke educatie, cognitieve gedragstherapie, en cognitie gerichte 
oefentherapie. Ook benadrukken onze resultaten het belang om in de klinische praktijk 
het onderliggend dominant aanwezige pijnmechanisme te herkennen en te behandelen 
bij de individuele patiënt ongeacht de diagnose. 
pijnintensiteit en structurele en functionele hersenveranderingen gemeten met magnetische 
resonantie beeldvorming in hersenregio’s of netwerken die betrokken zijn bij somato-
sensorische, emotioneel-motivationele en cognitieve verwerking van pijn bij patiënten 
met chronische musculoskeletale pijn. Bovendien kunnen we besluiten dat chronische 
musculoskeletale pijn niet enkel gemedieerd wordt door somatosensorische verwerking 
van pijn maar dat er een verschuiving plaatsvindt naar een cruciale betrokkenheid van 
cognitieve en motivationele-emotionele pijnverwerking in hersengebieden die vaak een 
onderdeel zijn van het limbisch systeem. De tweede systematische review heeft beperkte 
tot matige evidentie aangetoond voor structurele en functionele hersenveranderingen 
bij patiënten met chronische WAD en enkel voor functionele hersenveranderingen bij 
patiënten met chronische INP. Bijgevolg is er meer bewijs aanwezig voor hersen-
veranderingen bij patiënten met chronische WAD in vergelijking met chronische INP. 
Deze resultaten suggereren dat er verschillende onderliggende pathofysiologische 
mechanismen aanwezig zijn bij de beide patiëntengroepen. 
Verder hebben de resultaten van deel II en deel III en een bijkomende studie belangrijke 
verschillen onthuld tussen patiënten met chronische INP, chronische WAD en FM waarbij 
CS geassocieerd met subjectieve en objectieve cognitieve problemen werd aangetoond 
enkel bij patiënten met chronische WAD en FM. Bijkomend heeft dit onderzoek disfuncties 
aangetoond waaronder pijn gerelateerde disfuncties en beperkingen in gezondheidsger-
elateerde kwaliteit van leven geassocieerd met cognitieve problemen bij patiënten met 
chronische WAD en FM en in mindere mate bij patiënten met chronische INP. Meer 
disfunctie, meer ernstige cognitieve problemen en meer tekenen van CS werden 
aangetoond bij patiënten met FM in vergelijking met patiënten met chronische WAD en 
chronische INP. Bijgevolg kan de chronische INP groep gesitueerd worden ergens in het 
begin van het continuüm van chronische musculoskeletale pijn gevolgd door de 
chronische WAD groep en de FM groep kan mogelijk gesitueerd worden op het einde van 
dit continuüm.
 Wanneer patiënten met chronische INP en chronische WAD werden vergeleken, 
werden ver algemeende hyperalgesie en verminderde efficiëntie van geconditioneerde 
pijnmodulatie (pijn-inhibeert-pijn mechanisme) aangetoond bij patiënten met chronische 
WAD maar niet bij chronische INP patiënten wat wijst op de aanwezigheid van CS op 
groepsniveau enkel bij chronische WAD patiënten. 
 Echter, wanneer subgroepen gebaseerd op zelfgerapporteerde symptomen van CS 
werden vergeleken in plaats van groepen op basis van diagnose, vertoonde enkel de 
subgroep met uitgesproken CS symptomen (ook bestaande uit vrouwen met chronische 
INP) cognitieve problemen, veralgemeende hyperalgesie en verminderde efficiëntie van 
geconditioneerde pijnmodulatie in vergelijking met gezonde personen. Verder werden 
er enkel in de subgroep met aanzienlijke symptomen van CS associaties aangetoond 
tussen meer ernstige cognitieve problemen en veralgemeende hyperalgesie. 
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Belangrijke aanbevelingen voor toekomstig onderzoek kunnen geformuleerd worden 
op basis van dit doctoraat. Verder onderzoek is noodzakelijk om na te gaan welke 
therapieën CS, cognitieve problemen en disfuncties kunnen verminderen bij patiënten 
met chronische INP, chronische WAD en FM. Verder willen we benadrukken dat het 
interessant is voor toekomstig onderzoek om functionele hersenveranderingen verder 
te ontrafelen bij chronische INP en chronische WAD patiënten. Verder longitudinaal 
onderzoek kan worden aanbevolen met als doel te onderzoeken welke therapeutische 
strategieën de geobserveerde structurele hersenveranderingen kunnen omkeren, en of 
de normalisatie van deze hersenveranderingen gepaard gaat met gedaalde klinische 
disfuncties. 
Tenslotte hebben de resultaten van dit doctoraat bijgedragen tot het verder ontrafelen 
van de complexe pathofysiologische puzzel die onderliggend is aan chronische INP, 
chronische WAD en FM. Bijkomend werden belangrijke verschillen alsook overlappende 
gelijkenissen aangetoond tussen deze drie patiëntengroepen met chronische musculo-
skeletale pijn. Deze nieuwe inzichten leiden tot een belangrijke vergroting van onze 
kennis over deze pijncondities en kunnen verder onderzoek gericht sturen en leiden tot 
meer effectieve en geïndividualiseerde therapie voor deze patiënten. 
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mechanism displayed in the individual patient. Moreover, worse cognitive performance 
was associated with experimental signs of CS only in the subgroup with indication of CS. 
These results may steer further research and contribute to the development of more 
effective therapy approaches. 
Key words: chronic whiplash associated disorders, chronic idiopathic neck pain, central 
sensitization inventory, central sensitization, subgroups, cognitive deficits, disability
Abstract
Background and aims: To date, inconclusive evidence exists regarding the presence of 
central sensitization (CS) in patients with chronic idiopathic neck pain (CINP) (1). On the 
contrary, compelling evidence has demonstrated CS in patients with chronic whiplash 
associated disorders (CWAD) (2). Clinically, both differences and overlapping similarities are 
shown between CINP and CWAD patients (3). Efficacy of treatment response is variable in 
these conditions, which possibly originates from the focus on diagnosis when treating 
CINP and CWAD. Therefore, it could be hypothesized that addressing the underlying 
predominant pain mechanism in the individual patient is warranted. This study aimed to 
identify subgroups based on the central sensitization inventory (CSI), a questionnaire to 
assess self-reported CS symptoms, in a patient group including both women with CINP 
and CWAD, distinguishing a group with and without distinct self-reported CS symptoms. 
Subsequently, these subgroups were compared with respect to pain, disability, cognitive 
deficits, other CS measures, and compared to healthy controls. Furthermore, associations 
between these features were explored. 
Methods: Ninety-five women (28 pain-free controls, 35 CINP, 32 CWAD) completed 
questionnaires to investigate pain-related disability and health-related quality of life. Next, 
patients reported neck pain intensity using the verbal numeric rating scale. The CSI was 
administered to examine self-reported CS symptoms, whereby a score of 40 of 100 
distinguishes between a group of central sensitivity syndrome (CSI ≥ 40/100) and a group 
of non-central sensitivity syndrome patients (4). To investigate CS experimentally, pressure 
pain thresholds, and conditioned pain modulation (CPM) efficacy were examined. In 
addition, self-reported and objective cognitive deficits were assessed. Two subgroups 
based on the CSI cut-off were defined within the group of CINP and CWAD patients. 
Differences between both subgroups, and differences with controls were examined for all 
assessed variables. Finally, spearman correlations were explored within both subgroups 
between pain and CS measures, and disability and cognitive deficits. 
Results: The subgroup reporting CS symptoms indicative of CS (n= 38) displayed higher 
pain intensity, disability, subjective and objective cognitive deficits, and local hyperalgesia 
compared to the subgroup reporting symptoms not indicative of CS (n= 24) (p<0.017) 
(fig. 1, 2, 3, 4). Compared to controls, only the subgroup showing distinct CS symptoms 
demonstrated cognitive deficits, distant hyperalgesia, and decreased CPM efficacy 
(p<0.017) (fig. 3, 4, 5). In addition, moderate correlations were revealed between higher 
pain intensity, local and distant hyperalgesia, and worse self-reported and objective 
cognitive performance only in the subgroup presenting considerable CS symptoms 
(p<0.01) (table 2). 
Conclusions: This study provides novel evidence for subgroups based on the CSI within 
CINP and CWAD patients, revealing both heterogeneity and overlap in clinical presentation 
in both conditions, highlighting the need to address the underlying predominant pain 
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Figure 1   Clinical pain measures in the subgroup reporting symptoms indicative  
of CS (CSI ≥ 40/100) compared to the subgroup without indication of CS  
(CSI < 40/100).
n= 18 CINP and 6 CWAD for CSI < 40/100, n= 15 CINP and 23 CWAD for CSI ≥ 40/100.
CSI= central sensitization inventory, VNRS= Verbal Numeric Rating Scale, IQR=interquartile 
range, *=p<0.05, **=p<0.01. Kruskal-Wallis Test (post-hoc pairwise comparisons using 
Mann-Whitney U test) was applied. 
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Figure 2   Pain-related disability and health-related quality of life in the subgroup 
reporting symptoms indicative of CS (CSI ≥ 40/100) compared to the 
subgroup without indication of CS (CSI < 40/100), and healthy controls.
 
n= 28 for healthy CON, n= 18 CINP and 6 CWAD for CSI < 40/100, n= 15 CINP and 23 CWAD 
for CSI ≥ 40/100.
CON= healthy controls, CSI= central sensitization inventory, NDI= Neck Disability Index, 
SF-36= 36 item short form health survey questionnaire, IQR=interquartile range, ***= p<0.001. 
Kruskal-Wallis Test (post-hoc pairwise comparisons using Mann-Whitney U test) was applied.
Figure 3   Cognitive performance in the subgroup reporting symptoms indicative  
of CS (CSI ≥ 40/100) compared to the subgroup without indication of CS  
(CSI < 40/100), and healthy controls.
 
n= 28 for healthy CON, n= 18 CINP and 6 CWAD for CSI < 40/100, n= 15 CINP and 23 CWAD 
for CSI ≥ 40/100.
CON= healthy controls, CSI= central sensitization inventory, mPDQ= modified Perceived 
Deficits Questionnaire, TMT= trail making test, IQR=interquartile range, *= p<0.017 (0.05/3), 
**=p<0.01, ***= p<0.001. Kruskal-Wallis Test (post-hoc pairwise comparisons using 
Mann-Whitney U test) was applied. The mPDQ investigates self-perceived cognitive 
problems on 4 different cognitive subdomains, i.e. prospective memory, retrospective 
memory, attention and concentration, and organization and planning. The TMT part A 
requires mainly visuo-perceptual and processing speed abilities, whereas TMT part B 
reflects working memory and task-switching ability.
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Figure 4   Local and Distant Hyperalgesia in the subgroup reporting symptoms 
indicative of CS (CSI ≥ 40/100) compared to the subgroup without indication 
of CS (CSI < 40/100), and healthy controls.
n= 28 for healthy CON, n= 18 CINP and 6 CWAD for CSI < 40/100, n= 15 CINP and 23 CWAD 
for CSI ≥ 40/100.
CON= healthy controls, CSI= central sensitization inventory, PPT= pressure pain thresholds, 
IQR=interquartile range, **=p<0.01, ***= p<0.001. Kruskal-Wallis Test (post-hoc pairwise 
comparisons using Mann-Whitney U test) was applied.
Figure 5   Efficacy of Conditioned Pain Modulation in the subgroup reporting symptoms 
indicative of CS (CSI ≥ 40/100) compared to the subgroup without indication 
of CS (CSI < 40/100), and healthy controls.
n= 28 for healthy CON, n= 18 CINP and 6 CWAD for CSI < 40/100, n= 15 CINP and 23 CWAD 
for CSI ≥ 40/100.
CON= healthy controls, CSI= central sensitization inventory, CPM= conditioned pain 
modulation, CPT= cold pressor test, PPT= pressure pain thresholds, IQR=interquartile 
range, *=p<0.017 (0.05/3). Kruskal-Wallis Test (post-hoc pairwise comparisons using 
Mann-Whitney U test) was applied.
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Table 2   Spearman correlations between cognitive deficits and disability 
characteristics, and pain intensity and experimental CS measures in patients 
with CINP and CWAD distinguished based on the CSI cut-off.
CINP 
and 
CWAD
Local 
hyperalgesia
Distant hyperalgesia CPM efficacy Clinical pain 
measure
PPT 
trapezius
PPT 
quadriceps
PPT 
low back
PPT 
hand
CPM 
trapezius
CPM 
quadriceps
Current 
neck pain 
intensity
CSI < 40/100 (n= 24)
Self-reported cognitive deficits
mPDQ 
total
-0,411 -0,024 -0,269 -0,077 0,069 -0,211 0,145
0,046 0,913 0,204 0,721 0,755 0,334 0,498
Objective cognitive deficits
TMT  
part A
-0,132 -0,053 -0,170 -0,325 -0,146 0,096 0,080
0,539 0,807 0,428 0,121 0,505 0,662 0,711
TMT 
part B
-0,164 0,301 0,070 -0,063 -0,192 0,011 -0,068
0,443 0,153 0,747 0,771 0,381 0,961 0,752
Disability characteristics
NDI -0,303 -0,266 -0,212 -0,131 -0,165 -0,290 0,444
0,182 0,243 0,357 0,572 0,487 0,215 0,044
SF-36 
total
0,263 -0,040 -0,050 0,160 0,039 0,339 -0,299
0,215 0,853 0,818 0,455 0,861 0,114 0,156
CSI ≥ 40/100 (n= 38)
Self-reported cognitive deficits
mPDQ 
total
-0,549 -0,365 -0,499 -0,582 -0,330 -0,367 0,578
0,001 0,029 0,002 <0,001 0,080 0,050 <0,001
Objective cognitive deficits
TMT  
part A
-0,397 -0,413 -0,411 -0,540 -0,243 -0,221 0,370
0,015 0,011 0,012 0,001 0,195 0,240 0,024
TMT 
part B
-0,167 -0,242 -0,261 -0,324 -0,018 0,104 0,420
0,323 0,149 0,118 0,051 0,923 0,586 0,010
Disability characteristics
NDI -0,150 -0,266 -0,369 -0,344 -0,069 -0,058 0,314
0,383 0,117 0,027 0,040 0,723 0,764 0,062
SF-36 
total
0,289 0,326 0,319 0,410 0,306 0,012 -0,464
0,078 0,045 0,051 0,010 0,094 0,949 0,003
To correct for multiple comparisons, correlations significant at a statistical threshold level of p< 0.01 level 
(2-tailed) were deemed significant, and are presented in bold and in green. p-values are presented below the 
correlation coefficient. Abbreviations: CINP= chronic idiopathic neck pain, CWAD= chronic whiplash-associated 
disorders, NDI= neck disability index, SF-36= 36 item short form health survey questionnaire, mPDQ= modified 
perceived deficits questionnaire, TMT= trail making test, PPT= pressure pain thresholds, CPM= conditioned pain 
modulation. n= 67 chronic neck pain patients (35 CINP, 32 CWAD) (5 missings for CSI). n= 18 CINP and 6 CWAD 
for CSI < 40/100, n= 15 CINP and 23 CWAD for CSI ≥ 40/100.
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somewhere at the beginning of the continuum of chronic musculoskeletal pain, followed 
by the CWAD group, and the FM group may be the far end of this continuum. As such, the 
more the experienced pain is centrally driven with increasing severity and complexity of 
associated symptoms, the more a patient is falling at the end of the chronic musculoskel-
etal pain continuum.
Key words: chronic idiopathic neck pain, chronic whiplash associated disorders, fibromyalgia, 
cognitive performance, central sensitization, pressure hyperalgesia
Abstract
Background and aims: It can be hypothesized that both overlapping and different 
underlying mechanisms exist between patients with chronic idiopathic neck pain (CINP), 
chronic whiplash-associated disorders (CWAD) and fibromyalgia (FM). Nevertheless, 
research investigating differences in underlying mechanisms between these chronic mus-
culoskeletal pain conditions remains scarce. Therefore, the first aim of this study was to 
examine differences between patients with CINP, CWAD and FM compared to healthy 
controls regarding cognitive deficits, central sensitization (CS) symptoms, pressure 
hyperalgesia, and efficacy of conditioned pain modulation (CPM). The second aim was to 
explore associations between cognitive performance and measures of CS in all study 
groups. 
Methods: Eighty-six women (25 healthy pain-free controls, 18 CINP, 12 CWAD, and 31 FM 
patients) were included. First, the modified perceived deficits questionnaire was 
administered to assess self-reported cognitive deficits related to attention, memory and 
organization. Subsequently, participants performed the Stroop task, psychomotor 
vigilance task (PVT), and operation span task (OSPAN) to examine objective cognitive 
performance encompassing selective and sustained attention, and working memory, 
respectively. Malingering was excluded based on the Rey 15-item memory test. Next, all 
participants completed the CS inventory (CSI) to examine self-reported symptoms of CS 
(≥ 40/100). Finally, pressure hyperalgesia and efficacy of CPM were examined to 
experimentally investigate the presence of CS.
Results: Self-reported cognitive deficits were higher in all patient groups compared to 
controls (p<0.0125) (fig. 1). FM patients reported more severe cognitive deficits compared 
to CINP patients (p=0.005). Worse objective cognitive performance was revealed in 
patients with CINP (PVT lapses), CWAD (Stroop, PVT) and FM (Stroop, PVT, OSPAN) 
compared to controls (p<0.0125) (fig. 1). Furthermore, only CWAD and FM patients 
reported average CSI scores higher than 40 of 100, indicating significant self-reported 
signs of CS, with FM patients reporting more extensive CS symptoms compared to CWAD 
(p=0.001) (fig. 3). Bilateral widespread pressure hyperalgesia at the quadriceps muscle, 
lumbar region and calf was demonstrated in patients with CWAD and FM compared to 
controls (p<0.0125), but not in CINP patients (fig. 2). CPM efficacy was comparable 
between all groups (fig. 3). In addition, moderate to strong Spearman correlations were 
found between more severe self-reported and objective cognitive deficits, and more 
self-reported and experimental signs of CS in all patient groups (p<0.05) (table 2).
Conclusions: The present study revealed important differences between women with 
CINP, CWAD and FM compared to healthy women, providing evidence for CS associated 
with cognitive deficits in patients with CWAD and FM. In CINP patients, CS could not be 
demonstrated at group level, while cognitive deficits were present, however, to a lesser 
extent compared with CWAD and FM patients. The CINP group may be situated 
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Figure 1   Self-reported and objective cognitive performance in patients with CINP  
(n= 18), CWAD (n= 12) and FM (n= 31), compared to healthy controls (n= 25). 
CON= healthy controls, CINP= chronic idiopathic neck pain, CWAD= chronic whiplash- 
associated disorders, FM= fibromyalgia, IQR=interquartile range, mPDQ= modified 
Perceived Deficits, PVT= psychomotor vigilance task, OSPAN= operation span task, 
**=p<0.0125, ***=p<0.001. Median and IQR are presented. Kruskal-Wallis Test (post-hoc 
pairwise comparisons using Mann-Whitney U test) was applied.
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Figure 3   Efficacy of CPM and self-reported symptoms of CS in patients with CINP  
(n= 18), CWAD (n= 12), and FM (n= 31), compared to healthy controls (n= 25).
CON= healthy controls, CINP= chronic idiopathic neck pain, CWAD= chronic whiplash- 
associated disorders, FM= fibromyalgia, CPM= conditioned pain modulation (PPT during 
cold pressor test minus PPT before cold pressor test), kgf = kilogram force (1 kgf = 9,81 N), 
IQR=interquartile range, **=p<0.0125, ***=p<0.001. Median and IQR are presented. 
Kruskal-Wallis Test (post-hoc pairwise comparisons using Mann-Whitney U test) was 
applied. Results of experimental measures of central sensitization are presented, in 
particular measurements of CPM efficacy at the middle trapezius and at the quadriceps 
muscle. In addition, results of the central sensitization inventory (CSI) are displayed to 
investigate self-reported symptoms of central sensitization.
Figure 2   Pressure hyperalgesia in patients with CINP (n= 18), CWAD (n= 12),  
and FM (n= 31), compared to healthy controls (n= 25).
CON= healthy controls, CINP= chronic idiopathic neck pain, CWAD= chronic whiplash- 
associated disorders, FM= fibromyalgia, PPT= pressure pain thresholds, kgf = kilogram 
force (1 kgf = 9,81 N), IQR=interquartile range, **=p<0.0125 (0.05/4), ***=p<0.001. Kruskal- 
Wallis Test (post-hoc pairwise comparisons using Mann-Whitney U test) was applied. 
Results of experimental measures of central sensitization are presented in particular 
pressure pain threshold measurements to examine pressure hyperalgesia.
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Table 2   Spearman correlations between self-reported and objective cognitive performance,  
pressure hyperalgesia, CPM efficacy and self-reported CS symptoms in patients with  
CINP, CWAD and FM, and healthy pain-free controls. 
mPDQ total Stroop RT 
congruent
Stroop RT 
incongruent
Stroop RT  
non-word
Stroop RT  
neutral
Stroop
interference
Stroop RT  
priming neg. inv
PVT RT PVT lapses OSPAN  
total score
CINP (n= 17)
PPT trapezius R -0,330 -0,291 -0,244 -0,202 -0,299 -0,288 -0,249 -0,432 -0,374 -0,302
PPT trapezius L -0,279 -0,108 -0,105 0,010 -0,088 -0,390 -0,199 -0,346 -0,189 -0,037
PPT quadriceps R -0,215 -0,137 -0,054 -0,061 -0,012 -0,118 -0,103 -0,337 -0,219 0,191
PPT quadriceps L -0,131 0,022 0,120 0,135 0,002 -0,208 0,010 -0,327 -0,106 0,140
PPT low back R -0,371 -0,316 -0,260 -0,154 -0,206 -0,272 -0,321 -0,373 -0,324 0,043
PPT low back L -0,423 -0,382 -0,319 -0,191 -0,294 -0,326 -0,397 -0,519* -0,428 -0,021
PPT calf R -0,255 -0,353 -0,238 -0,201 -0,211 -0,228 -0,260 -0,422 -0,506* -0,127
PPT calf L -0,250 -0,350 -0,181 -0,181 -0,284 -0,162 -0,248 -0,465 -0,434 -0,096
CPM trapezius -0,368 -0,259 -0,256 -0,235 -0,276 -0,341 -0,344 -0,471 -0,327 -0,199
CPM quadriceps -0,337 -0,176 -0,235 -0,015 -0,215 -0,571* -0,285 -0,238 -0,120 -0,297
CSI 0,698** 0,610** 0,794*** 0,594* 0,642** 0,566* 0.715*** 0,267 0,382 -0,139
CWAD (n= 11)
PPT trapezius R 0,114 -0,296 -0,232 -0,164 -0,323 -0,150 -0,141 -0,196 -0,087 0,543
PPT trapezius L 0,000 -0,609* -0,500 -0,482 -0,645* -0,509 -0,427 -0,373 -0,514 0,778**
PPT quadriceps R -0,200 -0,482 -0,527 -0,536 -0,491 -0,418 -0,618* 0,100 -0,150 0,310
PPT quadriceps L -0,664* -0,518 -0,600 -0,555 -0,373 -0,355 -0,527 -0,373 -0,238 0,225
PPT low back R 0,169 -0,100 -0,050 -0,082 -0,274 -0,027 -0,142 0,023 -0,099 0,774**
PPT low back L 0,073 -0,378 -0,255 -0,228 -0,506 -0,387 -0,301 -0,200 -0,391 0,421
PPT calf R -0,291 -0,600 -0,655* -0,627* -0,718* -0,627* -0,755** -0,300 -0,365 0,322
PPT calf L -0,355 -0,673* -0,655* -0,727* -0,791** -0,418 -0,691* -0,564 -0,841*** 0,535
CPM trapezius 0,460 -0,025 -0,067 -0,050 -0,285 -0,092 -0,201 0,594 0,306 -0,172
CPM quadriceps 0,212 0,030 -0,091 0,030 -0,164 -0,273 -0,127 0,115 0,496 0,049
CSI 0,834*** 0,564 0,567 0,602* 0,452 0,291 0,564 0,711** 0,819*** -0,164
FM (n= 29)
PPT trapezius R -0,255 0,099 0,194 0,116 0,173 0,220 0,203 -0,201 -0,335 0,162
PPT trapezius L -0,148 0,084 0,169 0,118 0,184 0,094 0,133 -0,177 -0,376* 0,188
PPT quadriceps R -0,350 0,038 0,118 0,089 0,139 0,152 0,090 -0,375* -0,371* -0,018
PPT quadriceps L -0,174 0,08 0,138 0,063 0,152 0,217 0,079 -0,314 -0,336 0,021
PPT low back R -0,109 0,072 0,195 0,104 0,150 0,262 0,162 -0,314 -0,301 -0,055
PPT low back L -0,235 0,031 0,134 0,093 0,150 0,117 0,086 -0,240 -0,323 0,086
PPT calf R -0,293 -0,057 0,026 -0,045 0,033 0,177 -0,005 -0,364 -0,381* 0,060
PPT calf L -0,399* -0,058 0,011 -0,010 0,027 0,125 -0,068 -0,373* -0,420* 0,129
CPM trapezius 0,138 0,042 0,118 -0,028 0,019 0,183 0,029 -0,220 -0,316 -0,061
CPM quadriceps 0,249 0,145 0,223 0,174 0,195 0,087 0,130 -0,035 -0,100 -0,080
CSI 0,552*** 0,559*** 0,491** 0,558*** 0,545* 0,120 0,442* 0,412* 0,399* -0,201
Significant correlations are presented in bold. *Spearman correlations is significant at the 0.05 level (2-tailed). 
** Spearman correlation is significant at or below the 0.01 level (2-tailed). *** Spearman correlation is significant 
at or below the 0.001 level (2-tailed). FM=fibromyalgia, CWAD= chronic whiplash associated disorders, mPDQ= 
modified Perceived Deficits Questionnaire. In the healthy control group, the following significant correlations 
(p<0.05) were observed: mPDQ total score correlated with PPT quadriceps R (-0.427) and PPT calf L (-0.478); 
CPM quadriceps correlated with Stroop RT incongruent (-0.442); PPT calf L correlated with Stroop RT neural (-0.449). 
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List of abbreviations
ACC Anterior cingulate cortex
ACR American College of Rheumatology
AD Axial diffusivity
BOLD Blood oxygen-level dependent 
CINP Chronic idiopathic neck pain
CNS Central nervous system
CPM Conditioned pain modulation
CS Central sensitization
CSI Central sensitization inventory
CWAD Chronic whiplash associated disorders
DLPFC Dorsolateral prefrontal cortex
DMN Default mode network
DTI Diffusion tensor imaging
DWI Diffusion-weighted imaging
FA Fractional anisotropy
FC Functional connectivity
FM Fibromyalgia
fMRI Functional Magnetic Resonance Imaging
GM grey matter
GMV Grey matter volume
HPA Hypothalamus-pituitry-adrenal
IASP International Association for the Study of Pain
INP Idiopathic neck pain
LTP Long-term potentiation
MD Mean diffusivity
mPDQ modified Perceived Deficits Questionnaire
MRI Magnetic Resonance Imaging
MSKP Musculoskeletal pain
NDI
NFR
Neck disability index
Nociceptive flexion reflex
NK1 Neurokinin 1
NMDA N-methyl-D-aspartate
NO Nitric oxide
NOS Newcastle-Ottawa Scale
OSPAN Operation span task
PAG Periaqueductal grey
PCC Posterior cingulate cortex
PCS Pain Catastrophizing Scale 
PET Positron Emission Tomography
PPT Pressure pain threshold
PRT Progressive relaxation therapy
PVAQ Pain Vigilance and Awareness questionnaire
PVT Psychomotor vigilance task
QoL Quality of life
QST Quantitative sensory testing
QTF Quebec Task Force
rCBF Regional cerebral blood flow
RD Radial diffusivity
358 359
Appendices Appendices
RVM Rostral ventromedial medulla
S1 Primary somatosensory cortex
SF-36 Short form 36-item health survey
SPECT Single-Photon Emission Computed Tomography
SS Symptom severity scale
TBI Traumatic brain injury
TMT Trail making test
TS Temporal summation
TSK Tampa scale of kinesiophobia
VAS Visual analogue scale
VBR Ventricle-brain ratio
vmPFC Ventromedial prefrontal cortex
VNRS Verbal numeric rating scale
WAD Whiplash associated disorders
WM white matter
WPI widespread pain index
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